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Abstract 
 
 
Plant cleaning in the pharmaceutical industry is an undervalued but critical stage of 
processing. Cleaning with solvents or other cleaning agents is often the only method capable 
of removing residual particles. 
In a typical multipurpose pharmaceutical plant, cleaning challenges can cost companies 
millions of pounds’ as they must clean plant equipment effectively to satisfy regulatory 
constraints. Failure to do this right first time can result in missed processing schedules often 
with financial consequences. Furthermore, cleaning is often only considered once the process 
chemistry has been optimised. 
The research presented in this thesis describes a new approach to understanding the science 
behind cleaning using multivariate data analysis, principal component analysis (PCA). This 
approach utilises the fact that cleaning agent selection can be determined based on the 
identification of chemical functional groups and physiochemical properties of pharmaceutical 
products. Using PCA, a set of products were identified which could potentially be cleaned 
utilising the same approach. This means that the selection of a cleaning agent can be 
determined for other products with the same chemical functional groups and physiochemical 
properties. 
Adopting this methodology helps decide if the cleaning agent used is appropriate to the 
process chemistry and therefore cleaning can be carried out right first time and as cost 
effectively as possible. 
The findings from this research were developed into a tool and used to support the design of 
manufacturing processes taking cleaning into account from early stages of development 
thereby saving time and money during the processing stages. Ultimately, the tool will be 
incorporated into a suite of original and adapted Britest Ltd tools, entitled Fundamental 
Understanding of Science and Engineering (FUSE) used to identify, understand and provide 
solutions for cleaning challenges. The tool was applied to industrial case studies to assess its 
potential. 
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Chapter 1. Thesis Motivation and Overview 
1.1 Thesis Motivation 
The European Federation of Pharmaceutical Industries and Associations (EFPIA) issuing key 
data for 2014 estimated that pharmaceutical production, research and development 
expenditure and sales have steadily risen since 1990, giving it the status as one of Europe’s 
highest performing advanced technology segments (EFPIA, 2014). In order to achieve this 
status companies in the sector are required to overcome a significant number of challenges 
(Figure 1-1), not least of which are global and economic conditions which saw the market dip 
in 2008 – 2010, regulatory requirements and the threat of new market entrants. In addition 
trends such as a decline in pharmaceutical industry innovation, patent expiration and mergers 
have resulted in low research and development (R&D) productivity (Comanor and Scherer, 
2012). CMR International (2013) stated the outlook for global R&D productivity is rather 
bleak but their figures show a number of encouraging trends in the pharmaceutical sector. 
These include an above average number of New Molecular Entity (NME) first world 
introductions in 2012 (Figure 1-2) and a reduction in overall development time from 15 years 
to a new average of 12 years (product to market). In addition, healthcare reforms in the two 
biggest pharmaceutical market leaders China and America indicate that spending on 
pharmaceuticals is increasing (Daemmrich and Mohanty 2014). 
 
 
Figure 1-1 Competitive pressures and uncertainties. Adapted from Lainez, Schaefer and 
Reklatis, 2012. 
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In order to meet sector market challenges (Figure 1-1) including environmental issues and 
reducing R&D costs, R&D productivity needs to be addressed. It is considered that this 
challenge can only be addressed by proposing specific strategies (Paul, 2010). Research 
indicates that in order to optimise pharmaceutical and chemical processes, satisfy regulatory 
bodies and continue to manufacture effectively, the appropriate in depth process knowledge is 
critical.  
Development of a strategy is common with respect to product development and this involves 
understanding pharmaceutical quality by design (Juran, 1992 and Yu, 2008). This has never 
been more pertinent than in the current economic and political climate. Global market 
conditions and the rise of personalised medicines require pharmaceutical and fine chemical 
companies to continuously improve processes and strive to reduce costs associated with all 
aspects of manufacturing. There are several challenges and business drivers associated with 
this including those identified by Khanna (2012) stating “low productivity, rising R&D costs, 
dissipating proprietary products and dwindling pipelines are driving the pharmaceutical 
industry to unprecedented challenges and scrutiny”. According to research conducted by 
CMR in 2013 globally, pharmaceutical research and development is currently at a 16 year 
high with 39 New Drug Approvals and Biologics License Application approvals in 2012 
(CMR, 2013). (Figure 1-2).  
 
Figure 1-2 Number of Federal Drug Agency Approvals (FDA) per year between 1993 and 
2012 (CMR, 2013) 
The fine chemical industry is experiencing challenges of its own. Sustainable processes are 
sought and green chemistry has become a common phrase alongside safety, reducing cost, 
increasing quality and quantity. It is considered by many chemical bodies and associations 
28
23
29
56
45
37 38
29 29
24
27
36
20
22
18
24
26
21
30
39
0
10
20
30
40
50
60
1
9
9
3
1
9
9
4
1
9
9
5
1
9
9
6
1
9
9
7
1
9
9
8
1
9
9
9
2
0
0
0
2
0
0
1
2
0
0
2
2
0
0
3
2
0
0
4
2
0
0
5
2
0
0
6
2
0
0
7
2
0
0
8
2
0
0
9
2
0
1
0
2
0
1
1
2
0
1
2
N
u
m
b
er
 o
f 
F
D
A
 A
p
p
ro
v
al
s 
3 
 
that the UK government needs to do more to support the fine chemical industry. In 2013 five 
groups formed an alliance to raise awareness and ask for more support. These include the 
Institution of Chemical Engineers (IChemE) and the Royal Society of Chemistry (RSC, 
2013). 
If the pharmaceutical industry and chemical industries are to operate successfully, they 
require process schedules to be efficient, product quality to be superior and optimised product 
batch size. This is important given that there are many stages involved in a drug reaching the 
market (Figure 1-3). It is important to consider that a potential new drug may fail at any stage 
of its development and the success rate for new Food and Drugs Administration (FDA) 
approvals per year is low (Figure 1-2) compared with the amount of potential drugs 
discovered (Figure1-3).  
 
 
Figure 1-3 Drug Development Time (Hodgett, 2013) 
In order to facilitate products through the development pipeline the consideration of Whole 
Process Design (WPD) is increasingly important. This is especially true in high value product 
manufacture. WPD assists the design of new products and helps determine which products are 
suitable to develop and designs processes to optimise criteria such as quality and quantity.  
There are a number of design consultancies which aim to optimise and improve processes in 
various sectors utilising WPD. These companies include R B plant construction LTD (R B 
Plant, 2016), a company which provide engineering consultancy, design and construction 
management services to the process industries, and Allen Associates, who deliver whole 
process design for chemical and process engineering solutions, and have clients including ICI, 
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BARR and Drambuie (Allen Associates, 2016). Each company has a number of tools which 
enable WPD and Whole Process Understanding (WPU). This research is sponsored by Britest 
Limited and therefore the tools examined, used and developed are Britest Limited focussed 
for obvious reasons. 
Britest Limited, a not for profit organisation, has developed a process understanding-based 
approach to WPD that enables organisations to develop ideas and address challenges in the 
pharmaceutical and chemistry industries. Britest members include industry and academia and 
ideas are shared and developed through collaboration. Britest develops tools and 
methodologies to address the identified challenges and provide solutions for industrial 
partners. The Britest tools and methodologies draw upon fundamental Whole Process 
Understanding (WPU) (Figure 1-4) to provide solutions. Implementing WPU allows a flexible 
approach where companies can develop techniques to enrich understanding of processes and 
drive innovation. Whole Process Understanding can be effectively used to influence WPD by 
considering the process as a whole, not as stages or steps. Redesign and optimisation is 
carried out with regard to the effect on the whole process from raw material entry to final 
formulation. The use of Britest’s innovative techniques are estimated to have saved Britest 
industrial members in excess of £600 million between 2001 and 2012 (Britest Ltd, 2014).  
 
 
 
 
 
 
 
 
Figure 1-4 Whole Process Understanding (Adapted from Britest b, 2014) 
The impact of Britest’s approach to WPD is therefore significant, and can help to address 
specific industrial challenges, for example, deciding which raw materials to use in a process 
to prevent unwanted side reactions, or determining the phases of reactants in a vessel. 
Whole Process 
Understanding 
Discovery 
Develop 
Manufacture 
Formulate 
Market 
Chemical 
Entity 
Finished Product 
Time (years) 
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Methodologies and tools used by Britest lead to new innovation, but in order to achieve this 
in-depth process knowledge is required. This involves significant input from people who 
know and understand their products and processes. More importantly, it requires a 
multidisciplinary approach to achieve a fundamental understanding of science and 
engineering involved.  
However, not all stages of a manufacturing process are considered or understood, even if a 
multidisciplinary approach is taken. Due to complexity some challenges take considerable 
effort to begin to understand. One of these challenges is the fundamental understanding of the 
science behind plant cleaning. It is considered that this is one of the most neglected and 
misunderstood areas of pharmaceutical and fine chemical production. Poor or ineffective 
cleaning has an effect on production time and scheduling leading to financial implications. 
There is also an effect on operator safety and environmental consideration. In well thought-
out processes it is essential that information on cleaning is considered as all avenues of cost 
saving must be explored in R&D and process development in the pharmaceutical and fine 
chemical industries. 
The current approaches to developing cleaning protocols are not perfect. It is often the case 
that cleaning protocols are only considered following process development, not as part of it. 
Cleaning protocols are therefore suboptimal and this has an impact on production costs, it 
increases the amount of plant and equipment downtime and leads to lost opportunity costs. 
As stated Whole Process Design is essential in pharmaceutical and fine chemical 
manufacture, but how can Whole Process Understanding be considered complete without a 
fundamental knowledge of plant cleaning? Therefore, how can costs reduce without 
fundamental understanding of process plant cleaning? Further work must be carried out in 
order to address this gap in knowledge.  
 
1.2 Aims and Objectives 
The primary aim of this thesis is to develop an understanding of the fundamental science 
behind process plant cleaning. Key objectives include - 
1. Understanding the current industrial requirements and limitations of cleaning 
2. Production of a tool or set of tools to aid decision making for solvent/cleaning  
agent choice 
3. Ensure the tool can be used early in the process design stage of manufacturing 
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4. Incorporate a whole process design methodology to plant cleaning by the inclusion 
of engineering and process considerations that affect cleaning 
The creation of a suitable tool or the adaption of existing tools to aid cleaning agent/solvent 
choice will be used by Britest Limited to respond to the challenges associated with cleaning, 
for both the pharmaceutical industry and fine chemical sectors. 
 
1.3 Research Questions 
The main issue which drives the research in this thesis is:  
RQ1: What would be the best way to increase the fundamental understanding of the science 
behind cleaning linked to solvent and cleaning agent use? 
There are several research questions which underpin this question. These are: 
RQ2: What is meant by the term “fundamental science” in relation to process plant cleaning? 
RQ3: What are the main challenges associated with process plant cleaning for Britest 
members? 
RQ4: What common methods do Britest members utilise to clean their process equipment? 
RQ5: Which cleaning challenges are associated with plant engineering or choice of cleaning 
agent?  
RQ6: What information is currently available in literature to help understand cleaning 
challenges? 
RQ7: Which Britest tools and methodologies would be the best to examine cleaning and what 
adaptations would they require?  
RQ8: How can process plant cleaning be demonstrated after the application of the knowledge 
gained in this thesis? 
It is considered that the answers to these questions can be addressed by a Britest member 
survey, Britest member site visits and interviews, the literature review, an examination of 
Britest tools, methodologies and also industrial data collection. 
During the course of this research further questions will be taken into account based on an 
appreciation of the knowledge and data accumulated. 
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1.4 Industrial Relationship 
Motivation for this thesis was based on Britest members requisite to gain fundamental 
understanding of the science behind cleaning. The main driver for this work is the potential 
benefits to Britest members. Therefore, Britest industrial members were actively involved in 
the provision of data and information present in this thesis. Industrial members contributing 
information included AMRI UK, Fujifilm Imaging Colorants Ltd, Hovione, Johnson Matthey, 
Pfizer, Robinson Brothers Ltd and Shasun.  
 
1.5 Thesis Structure 
Chapter 2, Considerations and Literature review, examines the industry requirements for 
process plant cleaning including aspects such as safety, environmental legislation, and 
regulatory requirements from bodies such as the FDA, which affect cleaning. This chapter 
also examines the contributing factors which underpin cleaning challenges and its complexity, 
including the effect of adhesion and cohesion of particles, solubility theories and mechanical 
aspects of soil or residue removal. Current cleaning understanding will be examined in the 
current literature available on cleaning and solubility theory. Industrial aspects of cleaning 
and the associated challenges will be considered with reference to a Britest member’s survey, 
to begin to understand how to address the challenges and potentially identify solutions. Gap 
analysis of Britest tools and methodologies will be considered with a view to understanding, 
adaptation and developing for use in effective cleaning analysis and cleaning agent choice. In 
addition, cleaning metrics will be established to identify the benefits of further understanding 
of cleaning, based on the current industrial methods and solutions. 
Chapter 3 identifies current science and theories which have helped to shape this research. 
This chapter discusses the industrial significance of this research by examining Britest 
members survey results relating to cleaning practises and challenges. In addition a number of 
site visits to Britest members are discussed which highlight their specific situations and 
dilemmas.  
Chapter 4 begins to examine the knowledge and identify methodologies to solve the 
challenges associated with Britest member criteria. This requires analysis of theoretical and 
statistical methods to generate information and suggest solutions to the thesis questions. This 
chapter introduces and discusses attaining data and creation of databases for analysis.  
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Chapter 5 discusses analysis of the data by multivariate analysis, what using this method 
potentially indicates, and how it can be utilised in the design of a tool to aid choice of 
cleaning agent in industrial cleaning. Ultimately this chapter will begin to discuss design of a 
tool or suite of tools to be used with Britest members to facilitate a more scientific approach 
to process plant cleaning. 
Chapter 6 demonstrates the use of adapted Britest tools for process cleaning and examines 
case studies where use has provided improved cleaning understanding. This chapter 
introduces the concept of FUSE, a suite of tools to assist and inform cleaning choices using a 
Fundamental Understanding of Science and Engineering. Finally the chapter discusses and 
infers the implications and benefits for using FUSE. 
Chapter 7 concludes the thesis by discussing the initial research question and summarises the 
conclusions. This chapter also presents further work. 
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Chapter 2. Literature Review 
 
2.1 Introduction 
This literature review aims to encapsulate the current understanding of industrial plant 
cleaning in a number of fields. Through this review, the application of fundamental science 
and engineering concepts behind cleaning are identified. This will help to determine accepted 
understanding and also identify gaps in current knowledge that can be investigated. Several 
areas were identified for the literature review, including Cleaning within the Dairy Industry 
(section 2.2.1), Cleaning and Removal of Food Particulates (section 2.2.2), Industrial 
chemical plant cleaning – ink and oil soil removal (section 2.2.3) and General cleaning 
information from industry and the biopharmaceutical industries (section 2.2.4). One of the 
fundamental questions this review aims to answer is - are there any commonly used cleaning 
methods or tools which can be applied to the pharmaceutical sector? It is considered that one 
of the most challenging questions for anyone considering cleaning in any sector is 
determining when clean is clean enough. It is therefore necessary to establish how this is 
determined and considered in this literature review.  
Testing to ascertain whether equipment is clean is often carried out using analytical methods. 
This is the case in the pharmaceutical industry. The presence of residues and contaminants 
post cleaning are important considerations for this project, as they indicate inadequate or 
unsuccessful cleaning. Analytical methods are used for both equipment testing and also active 
pharmaceutical ingredient (API) testing for impurities, and can therefore determine whether 
cleaning has been successful. The current advances in analytical methods used to determine 
both validated cleaning and residual analysis will be considered in section 2.2.5. In addition to 
this, it is important to look at the regulatory stance with regard to cleaning in the 
pharmaceutical sector, and the implications this has on ensuring cleaning is carried out 
correctly. This review (sections 2.2.6 and 2.2.7) discusses several International Conference of 
Harmonisation (ICH) documents which are important in relation to pharmaceutical 
manufacture. The ICH is considered important as it ensures that standard medicines 
developed internationally are manufactured are safe, high quality and effective. The ICH also 
considers the associated levels of cleaning which are connected with the production of 
different types of active pharmaceutical product, or active pharmaceutical ingredients, as 
required by the regulatory bodies.  
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One of the major factors determining the effectiveness of cleaning, as determined by any 
analytical testing in any sector, is solubility. In section 2.2.8 the current understanding of 
solubility and its influence on cleaning, solutions and contaminants is discussed. Key 
solubility theories and models that help understanding of both process chemistry and cleaning 
challenges are indicated and their impact on this research is discussed. Similarly, the impact 
and relevance of identifying and defining chemical grouping, including by group contribution 
theory as a means to identify cleaning agents, is discussed in section 2.2.9. This has been 
considered by two means - classical chemical groups which are determined by chemical 
functional group, and secondly chemicals grouped by chemical reactivity. This will be 
discussed further in section 2.2.9. 
 
2.2 Literature Review 
2.2.1 Dairy Industry plant cleaning 
The similarities between the bio-manufacturing and the dairy industry are apparent through 
the equipment required, the nature of the products made, and the need to control cleaning 
according to stringent regulatory requirements. The literature review will seek to determine 
the current cleaning problems and solutions in the dairy industry. By carrying out this review, 
challenges and solutions to current cleaning issues in the bio-pharmaceutical, chemical or 
pharmaceutical industries may be identified. 
In the dairy industry, research has been carried out to determine the best methods to remove 
aggregated protein from industrial vessels and equipment, such as Bird, (1994), Bird, (1991), 
Bott, (1995), Burton, (1968) and Chen, (1998). The majority of the research carried out has 
concentrated on understanding why residues adhere to surfaces and how to remove them. It is 
acknowledged that cleaning is a major issue in the dairy industry. This is due to the frequency 
of cleaning that needs to take place. In the dairy industry emphasis is placed on making sure 
cleaning is effective to reduce the cost of repeated cleaning, and also to reduce the cost of the 
cleaning chemicals involved. Plant down time is a significant factor and it is important to 
reduce this and make sure the plant remains operational.  
Research in the dairy industry on plant cleaning has focussed on a number of factors to help 
drive understanding and longer term improvements. One area includes the chemical 
composition of the residues, and the methods that influence their formation. Liu et al (2006a) 
described a technique to measure the adhesive strength of whey protein deposits. The work 
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concludes that the adhesive quality of the deposit is stronger than the cohesive strength. The 
contributing adhesive factors between surface and the deposit include van der Waals forces, 
electrostatic forces, hydrogen bonding and hydrophobic binding, together with contact area 
effects. It was stated that the greater the area, the greater the total attractive force. Liu et al 
(2006a) also describes the work of Visser, (1995) who stated that the adhesive forces can be 
reduced by the effect of surface hydration. Cohesive properties are thought to be due to 
covalent bonding. This paper indicates a good degree of understanding about the forces that 
affect soiling and soil removal. 
Physical properties considered during soil removal have included both properties of the 
product and also how the plant is operated (Changani, 1997). The paper discusses the 
composition of the residue and the properties of the bulk fluid, in this case milk which has 
shown seasonal variation. Modelling for cleaning was carried out, with respect to chemical 
and physical properties. This was useful for comparing different cleaning chemicals. 
Grasshoff, (1999) determined that the rate at which cleaning was carried out was a first order 
rate constant but that this varied with time. It means that if a model is created for cleaning of 
deposits on surfaces it will be complex (Changani, 1997). This has implications for the 
development of a model for cleaning during this research, as it is likely that the creation of a 
model to determine the effectiveness of industrial cleaning will be complex and involve 
understanding of many factors. Other mathematical models have been developed to create 
understanding and predictability of cleaning. This includes work by Dürr (1999). 
A mathematical model created by Dürr (1999) considered the removal of solid deposits on 
milk heat exchangers. This model indicated that factors such as flow mechanics, working 
time, composition, concentration and temperature of the cleaning agents, composition of the 
cleaning agents, composition of the deposits and the surface characteristics all influence the 
effectiveness of cleaning. Due to the factors involved which vary considerably, a 
mathematical model proved difficult to produce. However, a model was generated based on 
particle size of dust removal using a vacuum cleaner. This model was effective but it is not 
certain whether all of the above factors would have been included in this model.  
Gillham, (1999), investigated the effects of cleaning in place (CIP), using alkali based 
solutions at a range of temperatures and flow rates. The results reported that cleaning 
comprised of three stages, these were a stage where the deposit swelled, a phase where the 
deposit began to uniformly erode and a stage where the deposit began to decay. It was shown 
that the rate of change in each stage was influenced by flow rate and temperature. The 
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research successfully showed the influence of the factors but it was not enough to enable 
modelling to take place. 
Stainless steel cleanability in relation to the dairy industry has been studied by Leclercq-Perlat 
et al (1993). They investigated the effect of cleaning in relation to chemical modifications due 
to industrial cleaning procedures. The study reported that the cleanability of stainless steel 
types depended on a number of factors which included factors relating to the nature of the 
surface. This included the topography and the roughness of the steel. These factors influenced 
soiling due to the availability of attachment sites for soil or chemical bonding. The attachment 
of soil also depended on the properties of the soil. They indicated overall that soiling was less 
likely to occur on stainless steel that had a smooth finish on a microscopic scale. This is due 
to the fact that it has more hygienic properties, which it is likely to retain throughout its 
working life. They also thought that the use of a detergent that does not alter the surface will 
be the best for cleaning purposes. 
Overall there has been a lot of research into fouling and soil removal in the dairy industry. 
This is useful in shaping ideas behind the mechanisms involved in chemical and 
pharmaceutical soil removal.  
 
2.2.2 Cleaning and Removal of Food Particulates  
With reference to industrial plant cleaning, it is thought that the largest body of relevant 
research lies within the removal of food soil other than dairy product, which has been 
discussed previously. The mechanisms of food particle deposit and removal are well 
discussed in literature. Many factors have been investigated which indicate why deposits 
occur and indicate methods and techniques for removal. 
Durkee, (2006) described tasks involved in soil management as cleaning, rinsing, relocation 
of soil within the cleaning machine, drying and disposal of the waste soil. He states that in 
each of these tasks, ‘soil is managed to produce a set of acceptable ends; part quality, 
productivity, disposal impact and operating costs’. Durkee, (2006) explains that cleaning 
choices are based on the soils present or the equipment present. The depth of fundamental 
knowledge and understanding is not indicated in this work. The mechanism for removal is 
stated but there is no indication of why this is the best method, based on scientific or 
engineering principles. 
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Significant research has also been carried out to try and categorise, classify and define 
cleaning issues and types of fouling, as well as the mechanisms of deposit formation. The 
surface structure of the vessels used and the composition of the vessels have been evaluated 
with respect to the adhesive and cohesive properties of deposits, (Fryer, et al (2009)). These 
included both physical and kinetic properties (Simmons, 2007). Fryer et al (2009) identified a 
five stage mechanism which resulted in fouling. This mechanism briefly comprised of 
initiation, transport, attachment, removal and ageing. This was thought to occur for all soil 
types. The removal methods of soil are thought to vary according to soil complexity. A 
cleaning map indicting soil removal mechanisms shows the effect of cleaning fluid and the 
effect of mechanical removal. The effectiveness of both factors in conjunction is largely not 
considered. It is logical that both mechanisms can occur simultaneously and therefore should 
be considered. Methods researched in the field of food deposit removal make use of flow 
dynamics, temperature variations and the use of different cleaning fluids (Pritchard, (1988) 
and Van Asselt, (2002).  
Liu (2006b) describes mechanisms of food particle removal. It is stated in the paper that food 
deposit removal is the result of failures in adhesive and cohesive properties. This means 
effective cleaning is influenced by these factors along with surface characteristics of the 
vessel and other unidentified factors. It was found that some food particles have stronger 
cohesive properties and others are more adhesive. This potentially means that different types 
of deposits could be removed effectively by targeted cleaning according to their adhesive or 
cohesive properties.  
Liu (2006c) describes the identification and modelling of model food deposits by different 
modes. It is clear from this work that models can be produced for food deposit studies, 
showing how a food substance can fracture and break. The modelling carried out was simple 
and requires more development to understand what is happening at a fundamental scientific 
level, and also to determine what forces are causing the deposits removal.  
It is clear from the preliminary literature review on removal of food deposits that there is a lot 
of unknown information relating to cleaning. The basic fundamental mechanisms of cohesion 
and adhesion are known but it is unknown why some deposits are more cohesive while others 
are more adhesive. The factors associated with soiling are many and this makes understanding 
what is happening difficult. Although modelling has been carried out on food deposit 
removal, it is not effective as yet. 
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2.2.3  Industrial chemical plant cleaning - Ink and oil soil removal 
The ink and paint industries are good examples of industries that need to find fast effective 
solutions for the removal of soil. In the print industry removal of dried ink has a high cost 
impact due to the nature of removing soil from the microscopic cells on ink rollers. The 
cleaning method used needs to be effective, quick and leave the roller surface undamaged. 
Cleaning has generally been carried out by immersion in ultrasonic caustic baths, high 
pressure washing or manual cleaning which is ineffective and messy. However, successful 
methods to improve cleaning have determined supercritical mixtures of carbon dioxide and 
organic solvent (Della Porta, 2006). This operation indicates that properties of supercritical 
fluids are good at removing ink due to the density of the fluid and the viscosity, which falls 
in-between that of a gas and a liquid. The addition of an organic solvent to the supercritical 
fluid increases its cleaning ability. The only limitation of this is the fact that many solvents 
chosen for removal of soil have ignition temperatures close to those required for production of 
supercritical fluids under operation at the required high pressures. Della Porta (2006) indicates 
that supercritical fluids have a role in industrial ink removal as they remove ink quickly and 
effectively. Due to the properties of supercritical fluids indicated, high diffusivity and near 
zero surface tension may prove valuable in other fields as agents to remove difficult soil.  
Supercritical fluids are of use in removing soil in the dry cleaning industry, as indicated by 
van Roosmalen (2004). During this application, mixing supercritical fluids with surfactants 
improved cleaning. When solvents were used in combination with supercritical fluids and 
surfactants, soil removal from textiles improved. This would indicate that the presence of the 
correct factors is the key to soil removal in any industry. Durkee, (2006), indicates that the 
cost of using high pressure equipment to achieve the conditions needed for cleaning in an 
industrial plant would be significant. 
The removal of oil from vessels in industry is known to be challenging but due to the nature 
of the industry it is known that this is carried out infrequently. In the oil industry mechanical 
removal is the most common method of soil removal. This is often carried out by pigging in 
pipe work and by jetting and manual scrubbing in vessels, Harrington (2001). Manual 
cleaning is time consuming. It is important as with other industrial cleaning and maintenance 
programs that cleaning is scheduled into the manufacturing programme. Ishiyama (2010) 
describes the problems associated with fouling in oil refineries. A mechanism to prevent 
fouling was described and shown to be effective in a series of case studies. This involved the 
production of a simulation-based tool that was effective in controlling the desalter inlet 
temperature inside the boundary of a management strategy for foul control. The tool enabled 
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control of temperature alongside other factors to control fouling and it also emphasises the 
need for fouling control in the oil industries. It is thought that simulation and modelling 
similar to this could not be carried out in chemical and pharmaceutical industrial plants, due 
to the complex nature of industrial plant cleaning. 
It is not known if chemical agents are used to remove oil from plant equipment on a large 
scale. Oil removal by chemical means has been shown by Al-Obeidani et al (2007). This was 
carried out on microfiltration membranes coated in oily seawater. It was found that a 
combination of alkaline and acid cleaning agents worked effectively, if the ratio of operating 
time and chemical cleaning time was increased and the amount of soaking time was reduced.  
After a review of available literature it is apparent that the preliminary information found on 
ink and oil soil removal is of little relevance to this body of work. 
2.2.4 General Cleaning Information from Industry and the Biopharmaceutical Industries 
Cleaning is thought to be strongly influenced by factors such as flow rate and temperature. 
Work carried out by Cole (2010) indicates that removing type 1 soil (toothpaste) without 
using chemicals can be effective and that data collected during this exercise can be used to 
produce a model. Cole (2010) indicates that turbidity was used to monitor the removal of the 
toothpaste from a coupon in two locations while undergoing cleaning. The toothpaste was 
shown to leave the coupon in two stages. The two stages of removal were the core toothpaste 
removal and secondly a gradual removal of the remaining toothpaste. Modelling is currently 
underway to produce a cleaning model from this data. 
It is thought by some that a good method for improving cleaning in the food industry is to use 
pulsed flow in pipe work. Augustin, (2010) states, ‘A low flow oscillation imposed on a 
stationary flow of liquid has been shown to enhance sheer stresses imposed on a surface to 
mitigate fouling or enhance cleaning’. Modelling indicates that this method may be of benefit 
in the food industry for removal of food deposits. It is not known whether this could work in 
the chemical or pharmaceutical sector. Prosek, (2005), also researched pipe cleaning using 
rinse based cleaning. In this study, pipe work of various geometries was designed, made and 
filled with a model solution. The work indicated that pipe work of different configurations 
was cleaned less efficiently in some cases. Pipe work that had valves or bends proved more 
difficult to clean. This study has implications on this plant cleaning project when considering 
the design of plant equipment in relation to the type of cleaning method used, the type of soil 
and many other factors. This is also a factor which concerns industrialists and will be 
discussed further in Chapter 3. 
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2.2.5  Analytical methods for determining residues and contaminants in vessels and in 
active pharmaceutical products 
As the regulatory bodies require higher standards of drug purity and request more information 
on manufacturing processes, there is a greater need for improving analytical techniques in the 
pharmaceutical sector (Berridge, 1995). This is beneficial as it highlights purity, quality and 
gives an improved safety margin. It can also highlight residues, impurities in active 
pharmaceutical ingredients (API) and cleaning solutions left in vessels. It is necessary to 
identify, characterise and control any entity having Critical Quality Attributes (CQA) which 
has an impact on the quality of the drug substance (International Conference on 
Harmonisation ((ICH), Q11, 3.1.3). It is therefore important to consider the current and 
developing analytical methods which may be used to determine API purity, and also 
cleanliness of process equipment. 
Currently the food and drug administration (FDA) are important in assuring public health as 
they ensure a level of drug, medical device and biological product safety, efficacy and 
security. The FDA also requires a level of cleanliness appropriate to the vessel used and drug 
type and potency. Drug impurity profiling is not a new technique but it is a critical task for 
pharmaceutical companies. Impurities above a detection limit of 0.1% are reportable in most 
circumstances (FDA, 1999). This means quantitation must be accurate. However, in some 
situations impurity levels of 0.01-0.1% are reportable (FDA, 1999). This level of reporting is 
applicable when there is the possibility of contamination with toxic or highly potent 
impurities. Currently several methods are used for impurity detection at these levels. These 
include chromatographic techniques such as high performance liquid chromatography 
(HPLC) carried out by many companies for isolation and characterisation of process related 
impurities. Several papers refer to this technique - Krishna Reddy (2002), Bharathi (2007) and 
Goverdhan (2009), who used the technique to detect impurities at levels below 0.10% in the 
drug Zafirlukast, used to treat pulmonary disorders. HPLC techniques have also been used to 
determine the effect of metal (copper and iron) degradation on the purity measurements of 
drugs by Dotterer (2011). It was found that the presence of less than 0.1 part per million 
(ppm) could lead to falsely low purity results. Spectroscopic methods such as mass 
spectrophotometry (MS) and nuclear magnetic resonance (NMR) spectrometry are used 
widely in industry as papers by Alsante (2001) and Roy (2002) indicate. Other techniques 
used are HPLC/ diode-array UV, Gas Chromatography/Mass Spectrometry (MS) and 
HPLC/MS (Görög, 1997).  
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Analytical techniques in use for characterising the quality of bulk pharmaceuticals have been 
questioned by some such as Görög (2005) who debates that the results of the final bulk drug 
assays give questionable results, leading him to believe that the drug quality measured is not 
what is achieved. 
In carrying out this project confidential information on analytical techniques has been 
provided during the Britest member survey (Carr, 2011). It has been determined from this 
information that the analytical techniques carried out by Britest members are effective and 
they are also the only ones that are available to use in their circumstances. This will be 
discussed further in Chapter 3. 
The area of analytical methods carried out for validation and verification of vessels and 
equipment used in processing post cleaning has been driven by industry standards. These 
include visual inspection, swabbing (which is then analysed by techniques used for drug 
impurity profiling, such as HPLC) and rinse water analysis. This was recognised during the 
examination of industrial survey results which will be discussed in chapter 3 (Carr, 2011). It 
is important to note that there are more novel methods of analysis under examination, some of 
these take into account surface properties of the materials of construction. This is an important 
consideration, as it has been determined by industrialists that material type, age and condition 
could affect the level of soil or cleaning residue accumulation in a vessel. In addition to this, 
the average velocity of cleaning detergents and the geometry of a vessel has been examined 
(Jensen, 2006). This describes the importance of the flow velocity of detergent as a factor in 
carrying heat and chemicals to clean vessels, and how changing this affects cleaning difficult 
plant geometry. Difficult plant geometry is described as crevices and dead-ends.  
In the pharmaceutical industry standard practises drive the analytical assay types. This is 
important. As some companies strive to improve detection techniques, others must keep pace 
with new developments that, once established, become the techniques of choice by the 
regulatory bodies.  
It is recognised in the pharmaceutical and biopharmaceutical industries that cleaning 
verification and validation take time to carry out. One reason for this is the length of time 
taken to analyse samples. In order to reduce this time, research is being carried out to provide 
solutions to reduce the time lag. Ion mobility spectrometry (IMS) has been used to determine 
residual API’s and their intermediates on equipment surfaces as a cleaning verification 
method utilising the normal swabs and rinse samples. This analytical technique is very 
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sensitive and able to determine quickly (in one minute) if a surface has residual contamination 
(Qin, 2010). 
Another method currently in development by an American company, Block Engineering 
(2012), is designed to provide non contact real time verification of process vessel cleanliness. 
This is a technique that utilises infra red spectroscopy to determine the level of contamination 
from residual materials on the surface of stainless steel vessels. It is not known how the 
instrument deals with complex geometry found in vessels, but it has the potential to be a good 
tool for the assessment of cleaning. This would decrease the need for downtime while the 
vessel waits for analytical cleaning verification. 
In addition to advances in analytical methods to help reduce cleaning time and increase 
effectiveness of detection, there have been advances in physical cleaning methods. This has 
included improving the method and operation of spray balls by Envirowise. This company 
states that it has advanced cleaning so effectively in the chemical, processing and 
manufacturing industries it has saved individual sites in excess of £80,000 year. (Envirowise, 
2008) 
Adhesion to different material surfaces including plastics such as polyvinyl chloride (PVC) 
floors and surfaces has been examined by several researchers such as Cramer (1972), Shebs 
(1987) and Pesonen-Leinonen (2006). Work has also been carried out on building materials, 
with modifications to enable the cleanability of easy to clean or self-cleaning characteristics to 
be determined (Määttä, 2011). This has shown the nature of these surfaces and revealed their 
nature using radiochemical methods, which are not generally applicable to vessels in the 
manufacturing industry, as the chemicals used are too hazardous.  
Work carried out by Zayas (2006) and Resto (2007) has shown that it is possible to detect low 
level traces of detergents such as LpHse and CIP-100 in cleaned equipment. This was carried 
out by HPLC. In order to create industrial standards all assays developed and the results 
produced are subjected to regulatory inspection. This is critical in the pharmaceutical industry 
and of great relevance to this project, as can be determined from section 2.2.6. 
2.2.6 Regulatory documentation and guidelines 
In order to understand how the pharmaceutical industry is guided and monitored by the 
regulatory bodies, it is necessary to consider their documentation. Familiarisation with the 
regulations surrounding cleaning is an important aspect of understanding cleaning challenges. 
This is due to the fact that the development of a tool for use in the pharmaceutical industry 
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needs to incorporate an awareness of ICH and FDA regulatory guidelines. As there is not a lot 
of literature available on industrial cleaning, a valuable source of information on standard 
industry practises is found in regulatory guidelines. Regulatory guidelines for cleaning 
consider both physical and chemical aspects of cleaning. The acronym TACT; time, action, 
concentration and temperature is used to determine effective cleaning practises. It is thought 
that these factors play an important part in cleaning together and as a consequence they will 
be incorporated into cleaning tools developed in this research. The regulatory bodies consider 
that cleaning parameter selection is required when discussing cleaning and its effectiveness. 
Characterisation of biological entities in relation to cleaning challenges and different 
properties of soil is recognised. These factors must be understood in order to remove soil. The 
distinction between physical removal and chemical mechanism of removal is made by the 
regulatory bodies (Table 2-1). 
Table 2-1 
Physical Removal Chemical Mechanisms 
Static Soaking Solubility 
Convection Emulsification 
Dependant on soil size and 
degree of adhesion to surface 
Wetting 
 Chelation 
Dispersion 
Hydrolysis 
Oxidation 
Table 2-1 Physical and Chemical Cleaning Factors (Adapted from Roessling, 2011) 
Table 2-1 gives individual factors involved in cleaning but the factors can interact to clean.  
If Fryer’s (2009) work on cleaning contaminant characterisation and mapping is taken into 
account, then the cleaning challenges which are present in the biopharmaceutical industry lie 
within his map. Differences between the equipment and the chemicals used in the food, 
cosmetic and pharmaceutical industries mean that without further investigation it is not 
20 
 
possible to say in which zone entities belong. In order to help establish cleaning methods and 
improve the understanding of cleaning factors which interact, experimenters use coupons. 
Cleaning experimental design can be discussed with reference to the use of coupons of known 
materials and surface types. The coupons can then be impregnated with a know amount of soil 
and cleaned to determine the effectiveness of the cleaning and the percentage soil recovery. 
This is used in industry to determine cleaning effectiveness. However it is difficult to get a 
truly representative coupon with regard to age and surface roughness. Coupon use must 
always take this into account. Application of design space for cleaning experiments and the 
importance of identifying risks within this space is key. Cleaning limits with regard to vessels 
and also limits of contaminants and carryover into bulk drugs should be considered. Methods 
used to determine the maximum allowable carryover limit are discussed with reference to ICH 
guidelines. Firstly, it is important to discuss the need for identification of potential risk factors 
and their control (deemed critical process parameters (CPP)) and the impact to cleaning 
processes. Critical quality attributes (CQA) are factors used to determine the effectiveness of 
the cleaning activity. It is thought that a list of both CPP and CQA can be created for 
incorporation into a cleaning tool which is generic to the pharmaceutical industry, but specific 
enough to fulfil company requirements. Another consideration which must be addressed when 
designing cleaning tools is the influence of the regulatory bodies. 
2.2.7 International Conference on Harmonisation (ICH) regulations 
In industry, pharmaceutical processes are generally well understood by companies who use 
them. Process characterisation has the benefit of ensuring products are produced to the correct 
specification, the right quality and the best yield. However, full characterisation of processes 
is not generally carried out. This is due to several factors which include time and resources. It 
is not thought to be beneficial to fully characterise a process in industry and impurities are 
only considered if they are present in large amounts and limit the process yield. They may 
also be characterised if they are thought to interfere with the safety or the efficacy of the 
active pharmaceutical ingredient (API).  
If impurities are not fully characterised in enough detail there is a risk that products can carry 
unknown impurities (unwanted chemicals that stay with an API or develop with it during 
processing). This is a critical issue and, in order to address and control this risk, the 
International Conference on Harmonisation (ICH) has produced several guidelines in order to 
control impurities. Many of the ICH guidelines have influence over this body of work and 
these are listed in table 2-2 which describes the relevance of each document to this project.  
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Table 2-2 
ICH Document Reference Relevance to Industrial Cleaning Project 
Validation of analytical 
procedures: Text and 
Methodology  
Q2(R1) 
Guideline relates to the validation of methods 
for use in identifying and quantifying 
contaminants, impurities and residues. 
Advises on assay validation characteristics 
such as accuracy, precision, repeatability, 
intermediate precision, specificity, detection 
limit, quantitation limit, linearity and range 
Impurities in new drug 
substances Q3A(R2) 
Impurity classification (solvents, organics and 
inorganics) and reporting.  
Evaluation and recommendation 
of Pharmacopoeial texts for use 
in the ICH regions on Test for 
particulate contamination: Sub-
visible particles general chapter 
Q4B ANNEX 3(R1) 
Guidelines on testing for particulate 
contamination: Sub-visible particles 
Specifications: Test procedures 
and acceptance criteria for new 
drug substances and new drug 
products: Chemical substances 
Q6A 
Guidance on setting and justification of 
acceptance criteria and selection of test 
procedures for new drug substances of 
synthetic chemical origins and new drug 
products produced from them. 
Good manufacturing practise for 
active pharmaceutical 
ingredients Q7 
Guidelines on operating within Good 
Manufacturing Practises (GMP). Covering 
personal, quality management, buildings, 
process equipment, documentation, facilities 
management, storage and distribution and 
production and in-process controls.  
Pharmaceutical Development 
Q8(R2) 
Guidance on pharmaceutical development, 
designing a quality product and 
manufacturing process.  
Pharmaceutical Quality Systems 
Q10 
Guidelines for establishing a quality system 
Development and manufacture of 
drug substances (Chemical 
entities and Biotechnological/ 
Biological entities) Q11 
Guidelines for developing and understanding 
manufacturing process of a drug substance. 
 
Table 2-2 ICH Documentation Relevant to the Industrial Cleaning Project (Adapted from 
ICH documentation). (ICH Q2 to ICH Q11 guidelines) 
 
There are two documents listed above (ICH Q3 and ICH Q11) which bear more relevance on 
this research than the others. It is necessary to briefly explain their relevance. 
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ICH Q3 as listed in table 2-2 discusses impurities in drug substances. Analysis of API 
products can show contamination. It is important to understand where this comes from to 
minimise it and potentially prevent it from happening in future batches.  
One of the most important areas which can lead to contamination of drug products is a lack of 
process understanding. This can take many forms, such as a lack of understanding of the 
process chemistry giving rise to contaminants, for example from side processes. Impurities 
may also enter products from solvents used in the processes, including cleaning solvents, if 
the correct cleaning techniques are not adopted. It is possible that impurities may be left in 
vessels from one manufacturing process which can then contaminate the following process. 
Issues like these highlight the need for greater scientific understanding, including during 
cleaning processes. ICH Q3 details guidelines for validating analytical procedures to help 
determine impurities, and also gives limits for the detected impurities. Impurity limits are 
determined by the type of impurity, the toxicity and the amount present. The document gives 
guidelines on this. 
ICH Q11 is a guideline which details how understanding the manufacturing process can lead 
to consideration of impurity development and how this can be minimised. The guideline 
describes two methods for developing a drug product. The first is the traditional method and 
the second is described as an enhanced method. The traditional method determines the 
development of a product within a series of set points and operating ranges for process 
parameters. The strategy is to control the process and show it is reproducible and can meet 
determined acceptance criteria. This is commonly used in industry.  
The enhanced method is more detailed and examines risk management and scientific 
knowledge to provide an in-depth understanding of process parameters and operations that 
can influence critical quality attributes (CQAs). This provides information for the 
development of control strategies which can be used over the entire process. This can include 
creating a design space. A design space is identified as the ‘multidimensional combination 
and interaction of input variables (e.g., material attributes) and process parameters that have 
been demonstrated to provide assurance of quality’ (ICH Q11, section 3.1.6). If operations are 
carried out within the design space the process is not considered as changed and does not 
require regulatory post approval change process.  
Guidance is given on linking material attributes and process parameters to drug substance 
CQAs. This is relevant to the research carried out in this project as it advises the development 
of a design space based on using prior knowledge (experience of the chemistry and the 
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process) and also chemistry first principles. This indicates that process understanding should 
be based on scientific understanding. Understanding the chemistry behind cleaning is 
therefore critical. In order to carry this out the influence of solubility theories are examined in 
section 2.2.8. 
2.2.8 Solubility Theories and Models 
As determined in section 2.2.5 there are a number of factors which can influence and affect 
cleaning. In order to understand cleaning it is therefore important to consider the impact that 
solubility has on cleaning solutions and contaminants. This has also incorporated current 
Britest members understanding of solubility in relation to their cleaning operations, which 
will be discussed in chapter 3. Solubility of chemicals during processing, analysis of product 
samples and chemical residues (soil) and in aqueous agents and solvents has not been 
extensively studied by researchers. It has however, been determined that solubility is not only 
a critical aspect of understanding how to improve processes and product manufacture, it also 
vastly improves the ability to clean equipment post processing. In order to understand 
solubility it is necessary to establish the importance of choosing parameters. These parameters 
have been discussed by Durkee (2004a), where he states that there are ways to determine how 
to match the best solvent to a soil. Durkee maintains that by understanding systems such as 
the Kauri Butanol (Kb) test, the Hildebrand Solubility Parameter and the Hansen Solubility 
Parameters, this can be achieved.  
Kauri Butanol was the primary test used to typify the dissolving power of a solvent. It is a 
measure of solvent strength. This indirect test involves using thick Kauri gum (a hardening 
agent in varnishes and enamels) as soil and determining if a solvent can solubilise it. This 
produces a solvent Kb value. The test is only useful if the soil has similar properties to Kauri 
gum. This test can only be used for hydrocarbon solvents such as Benzene or Toluene. It is 
not used for polar solvents such as esters or alcohols and the values produced for these 
solvents have no meaning (Baldeschwieler et al, 1935).  
The Hildebrand Solubility test is a method of characterising solubility in solvents (Hildebrand 
et al, 1949). It was proposed by Hildebrand that energy is required in order to overwhelm 
intermolecular forces. Simplified this means that ‘like dissolves like’ (Durkee, 2004b). The 
best way of calculating how much energy is required to solubilise soil is to determine how 
much energy is required to vaporise the solvent (Durkee, 2004b). One dimensional solubility 
is based on all intermolecular forces within a solvent, such as Van der Waals forces, polar 
interactions, dispersion forces and hydrogen bonding forces. 
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Hansen expanded on the ideas of Hildebrand, among others, and divided the Hildebrand 
solubility parameter into a three dimensional system. Each part was associated with an 
intermolecular force (Durkee, 2004b). This created advantages in understanding and 
predicting solubility as some molecules within solvents are driven by some forces with more 
strength than others. Hansen’s solubility factors are one of the most established and accepted 
solubility theories, but an important consideration when using Hansen’s parameters is that 
they must be known for a soil as well as the solvent (Hansen, 2007). Work is still ongoing to 
determine and enhance knowledge in this area, using techniques such as quantitative structure 
activity relationship modelling (QSPR), combined with Conductor like screening model 
(COSMO). This has provided information that can be used to help characterise solvents at a 
molecular level and further understanding of solubilisation (Járvás, 2011). 
There are many other systems for understanding parameters around solubility and the choice 
of a solvent in relation to materials, such as the work by Aharoni (1992) on swelling 
measurements, Adamski (2008) using inverse gas chromatography, Roberts (1993) using 
mechanical measurements, Bustamante (2000) utilising solubility/miscibility measurements in 
liquid with known cohesive energy and Gharagheizi (2006) by viscosity measurements.  
Solubility is not the only aspect of chemistry influencing this research. Important and relevant 
fundamental chemical interactions also need to be addressed. It is important to consider the 
relevance of identifying and defining chemical grouping. In order to achieve this, chemical 
functional groups and reactive groups are examined in section 2.2.9. This has been considered 
by two means - classical chemical groups determined by functional group, and also by 
chemical reactivity. 
2.2.9 Chemical functional groups and reactive groups 
Significant work has been undertaken in order to determine a system to group chemicals in 
organic chemistry, in order to predict behaviour and help understand their properties. 
Chemicals can display huge variations in their properties and the way they act and react 
together. Two major systems of classification have been developed. The first is to group 
chemicals according to reactivity (devised in the 1930’s), and the second is to group 
chemicals based on their chemical functional groups. Chemical reactive grouping is based on 
the fact that typically chemicals react in similar ways due to the fact that they have similar 
chemical structures. These groups are identified in table 2-3.  
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Table 2-3 
Reaction Type Example 
Nucleophilic Substitution Alkyl Halides 
Electrophilic Substitution Alkyl Metals 
Radical Substitution Alkanes 
Nucleophilic Addition Aldehydes, Ketones and Nitriles 
Radical Addition Alkenes, Alkynes 
Nucleophilic Addition - 
Elimination 
Carboxylic Acid Derivatives 
Electrophilic Addition - 
Elimination 
Arenes 
Elimination Alkyl Halides 
Pericyclic 1, 3 Dienes 
 
Table 2-3 Reaction Types and examples. (Adapted from information supplied in Massey, 
1990). 
 
As the information in table 2-3 suggests, there are a number of reactive groups, and several 
chemical types are found in more than one group, as they have more than one reaction type. 
The grouping is easy to understand and there are only fifty groups, which is an advantage over 
the second method, grouping by chemical group. 
The second method, or chemical grouping, is by functional groups and was the first method 
devised in order to group chemicals. Functional groups are based on organic chemistry 
(Inorganic chemistry has the same functional groups but, it is the elements which dominate 
the chemistry and the functional groups perform a moderating function). There are known to 
be over one hundred groups identified by this method. Some of these groups are listed in table 
2-4. 
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Table 2-4 
Functional Group Definition 
Alkenes 
Alkynes 
Aromatics 
Contain C + H only 
Nitriles 
Amines 
Amides 
All contain Nitrogen 
Alcohols Involve a single bond which 
contains Oxygen 
Phenols Involves double bonds which 
contain Oxygen 
Ethers Involve a single bond which 
contains Oxygen 
Aldehydes 
Ketones 
Carboxylic Acids 
Acid Chlorides 
Acid Anhydrides 
Esters 
Involve double bonds which 
contain Oxygen 
Thiols 
Thiol ethers 
Contain Sulphur 
 
Table 2-4 Chemical Functional Groups Information. (Adapted from Housecroft, 2005). 
 
It is this method of grouping chemicals which will be utilised for this research. Chemical 
grouping, identifying key characteristics, was chosen in order to group common chemistries 
for this project. This is because the method is easy to understand and the grouping structures 
are easy to explain to industrialists. There is also a lot of literature available on this 
methodology. The common chemistries including those described in table 2-4 will be used for 
this research project moving forward. This information and how it will be used in this 
research is further discussed in Chapter 4. It is also important to consider group contribution 
methods which may bear relevance to this work. This will be discussed in section 2.3. 
 
2.3 Group contribution methods 
Methods for predicting the behaviour of groups of chemicals are known as group contribution 
methods. There are many forms of these methods which all have slightly different reasons for 
groupings. It is well known that several of these methods are known to be inaccurate and 
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unreliable (Constantinou, 1994) and therefore they may not be very useful for this project 
work. Methods of group contribution include grouping by primary properties (for example 
molecular structure, critical pressure, normal boiling point and Gibbs energy) and by 
secondary properties. Another class of group contribution methods are based on the type of 
functional groups such as Benson Group Increment Theory (BGIT) (Benson, 1958). This is 
known to be a complicated method of group contribution method (Constantinou, 1994). 
Another group contribution method is universal functional activity coefficient model 
(UNIFAC). This is a method which uses functional groups present on the molecules that 
make up liquid mixtures to calculate activity coefficients. It was devised to predict 
interactions between molecules ,by describing occurring molecular interactions based on the 
functional groups present on the molecule, (Fredenslund,1975). In the pharmaceutical 
industries this is a recognised and commonly used method for predicting interactions and 
activities of molecules.  
Methods by analytical solutions of groups (ASOG) are also used, for example in order to 
determine water activity in solutions of sugars and urea (Correa, 2004). Some researchers 
indicate that UNIFAC and ASOG methods can have weaknesses (Gmehling, 1993). Group 
contribution methods have been used for predicting the solubility of solutions by several 
researchers for seed polyphenols of vitis vinifera (Savova, 2007) and non-electrolyte organic 
compounds (Gharagheizi, 2011). Water solubility of organic chemicals was estimated by 
group contribution methods (Kühne et al, 1995) and the solubility of selected pharmaceuticals 
in both aqueous and non aqueous solutions was predicted with a group contribution method 
(Pelczarska et al, 2013) with a degree of success. Therefore it is possible that the use of a 
similar method for determining groups for industrial cleaning chemicals, residues and 
contaminants may be used. This is because solubility of pharmaceuticals in solvents used for 
cleaning is a similar challenge to solubilising pharmaceuticals for drug manufacturing and 
delivery purposes. 
2.4 Chapter 2 Summary 
In Chapter 2 it has been possible to examine some of the current literature and theories which 
will help to shape and guide this research. The literature review has shown that the most 
commonly published information in the area of cleaning is the dairy and food industries, 
where there are some key similarities. These similarities include difficult to remove entities, 
complex plant or equipment and often fouling by similar residues. The literature review also 
determines that cleaning is often specific to a process or a type of equipment. There are 
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differences in how cleaning is approached in sectors using combinations of key removal 
factors such as physical removal, chemical removal or a combination of both.  
In addition, the literature review indicates that the use of group contribution methods as a 
method to help group cleaning agents may be effective, but it should be approached carefully 
due to flaws in many methods. The most apt method for grouping pharmaceuticals and API in 
this research may be the UNIFAC method. The advantage of this is that it is a widely used 
method in industry and any cleaning models created during this research will be easier for 
industrialists to understand and implement. 
The literature review on the subject of industrial cleaning itself helps to determine one factor 
moving forward in this research. That is, there is not a lot of literature in the public domain on 
pharmaceutical plant cleaning. It can be concluded that the best, and significantly the most 
important way of examining current cleaning practises, is by direct contact with industrialists. 
This is discussed in Chapter 3, where approaches to cleaning are discussed with the help of a 
survey aimed at industrialists on a variety of plant. Chapter 3 will also further examine the 
economic reasoning behind this research using defined metrics gained from industrial 
understanding of pharmaceutical plant cleaning. As the aim of this project is to determine or 
design a methodology or tool for pharmaceutical plant cleaning which fits into the Britest 
remit, it is also important to consider the remit of Britest tools in Chapter 3.  
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Chapter 3. Industrial Considerations  
3.1 Introduction 
This chapter identifies current science in industry and theories which have helped shape and 
position this research in addition to the academic literature review in Chapter 2. It is important 
to consider the industrial significance of this project and establish why it is important to 
conduct this research. This was carried out with the aid of a cleaning survey and site visits to 
Britest members. The survey helped gain an overview of the current challenges and 
approaches taken to solve them (section 3.2). Site visits gave valuable insights into the 
engineering and cleaning challenges that Britest members are facing (section 3.3). This 
chapter will help position the research by answering RQ3, RQ4 and RQ5 (section 3.4). It is 
known that the nature of cleaning is complex and factors which determine effectiveness can 
vary due to the nature of the equipment and the products made in the equipment. At this stage 
in the research it is critical to introduce and review the Britest tool set (section 3.5). This will 
help to determine if any existing tools and methodologies can be used in their current format, 
to help Britest members understand cleaning challenges and how to improve plant cleaning 
methodologies.  
Furthermore, the cost of cleaning will be assessed in this chapter, in sections 3.6 and 3.7, to 
establish how implementation of potential findings of this research could save industry time, 
financial cost and resources. Finally, section 3.8 will summarise this chapter and indicate the 
direction of the research in Chapter 4. 
  
3.2 Industry Requirements contributing to the Research 
This section aims to answer the following research questions by engaging with Britest 
members by survey and site visits to view plant equipment:  
RQ3: What are the main challenges associated with process plant cleaning for Britest 
members? 
RQ4: What common methods do Britest members utilise to clean their process equipment? 
RQ5: What cleaning challenges are associated with plant engineering or choice of cleaning 
agent?  
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As stated in Chapter 1, section 1.4, the need for this research is underpinned by Britest 
member’s requirement for a fundamental understanding of the science behind cleaning. In 
order to understand exactly what is meant by this term it was necessary to ask Britest 
members some questions. This was carried out by engaging Britest members in a survey on 
process plant cleaning.  
Prior to considering the results of the survey, it is important to determine what is meant by the 
term ‘plant’, as used in the context of this research. The term plant indicates a general term to 
describe the processing or manufacturing equipment used by Britest members in the 
pharmaceutical, fine chemical or chemical industry. It is necessary to state that this equipment 
is generally complex. The complexity of equipment derives from the ages and types of 
equipment used (which are described below). The number of processes which are involved to 
manufacture a product make it quite complex and often the system of pipework used to 
connect the equipment is not designed specifically for purpose, leading to deadlegs in pipes 
which are difficult to clean. In addition the layout or design of the equipment may be 
determined by current use, or by historical use. Plant tends to be different dependent on the 
product manufactured. In many companies the majority of plant is composed of similar 
classic unit operations and equipment. For the purposes of this research typical plant 
equipment and unit operations are identified as reactors and holding vessels, separation 
equipment such as centrifuges and chromatography columns, filtration equipment, drum 
dryers, vacuum dryers or spray dryers. In addition, raw material handling equipment, such as 
glove boxes and powder handling systems are considered typical plant. Britest member plant 
also includes pumps, associated pipe work, and commonly, condensers and heat exchangers. 
As plant can be configured differently at different companies, it is important to understand 
individual Britest members cleaning challenges. In order to achieve understanding, Britest 
members were surveyed.   
An initial survey carried out (Talford, 2009) indicated there was a need for increased cleaning 
understanding and indeed cleaning awareness. Britest industrial members felt that plant 
cleaning protocols were developed in an ad hoc fashion, with little consideration or 
understanding of the science behind what they were trying to achieve. It was indicated that 
cleaning methods were developed on the basis of trial and error. This mode of operation gave 
an intolerable level of cleaning failures and consequently it resulted in a number of negative 
impacts. These include cost of cleaning agent use and disposal, missed scheduling times for 
batches and ultimately a financial cost in plant down time or lost opportunity. The primary 
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target for plant cleaning is to achieve right first time (RFT) cleaning. Britest members 
indicated that there was a demand for increased fundamental scientific knowledge around 
cleaning and specifically wanted Britest tools to help understand and solve cleaning 
challenges.  
This information is considered important, but in order to gain more insight a second survey 
was commissioned for this research project (Appendix 1 - Survey questions). There were 11 
responses to this survey from different pharmaceutical and chemical companies (There were 
18 member companies at this time).  
The second Britest member’s survey on cleaning was specifically aimed to answer RQ3, RQ4 
and RQ5. The aim was to understand process cleaning with respect to the following - 
How is a plant cleaning protocol developed? 
Are there any specific plant cleaning issues? 
What are the current plant cleaning methods? 
Which cleaning agents are used on site for cleaning? 
What effect do analysis time/cost and validation requirements have on cleaning? 
What are the financial and time implications of ineffective cleaning? 
The survey key findings indicated Britest members developed plant cleaning protocols largely 
based on contaminants present (Figure 3-1). Given that there is a need to ensure that cleaning 
is carried out efficiently but rapidly, this is understandable. The question does not however, 
indicate the depth of contaminant understanding. 
 
Figure 3-1 Are Cleaning Protocols based on understanding contaminants? 
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Further to this Britest members understood the types of contaminant or residues present in the 
vessels and equipment. Chemical contaminants or residues are indicated as the main 
objectives of removal (Figure 3-2).  
 
 
Figure 3-2 What is the main contaminant type in your process? 
 
With the main contaminants known, cleaning should become easier as cleaning agent 
selection can be targeted. In spite of this, there are several other factors to consider when 
devising a cleaning protocol. These factors include solubility of the contaminant and 
mechanical action (Chapter 2). Figure 3-3 indicates that there is generally more than one 
factor influencing cleaning protocol decisions for Britest members.  
 
Figure 3-3 Factors influencing cleaning protocol design.  
Figure 3-3 indicates the level of complexity around cleaning and shows a need to identify all 
factors involved in the design of a cleaning protocol if it is to achieve RFT cleaning. In 
addition to Figures 3-1 to 3-3, a number of qualitative answers to questions were received, 
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indicating how Britest members create cleaning protocols. This suggested that a majority of 
companies surveyed used a very simple method to select cleaning agents. This will be 
discussed later in this section. Qualitative answers were informative as they set the scene for 
plant visits, gave questions for targeted interviews and indicated potential cleaning case 
studies (section 3.3). They also highlighted common cleaning challenges associated with 
equipment, such as those surrounding condensers. Cleaning methods varied between Britest 
member companies. This highlighted the fact that a lot of cleaning methods are unique to 
companies and often specific sites within those companies if there are multiple plants. The 
reason for this is not known. It could be considered that a well run optimised plant cleaning 
process gives a competitive advantage over others if it works RFT, therefore cleaning 
information is not commonly available in literature, or willingly shared. It is thought that by 
improving plant cleaning the cost of drug products could be reduced, due to decreased 
overheads associated with cleaning. As the survey was aimed at all Britest members it is 
important to state that the member companies can be categorised according to different 
factors, such as size, pharmaceutical production and fine chemical production, and therefore 
the type of cleaning required (Table 3-1).  
Company   Multiple 
site 
Type of 
manufacture 
Type of cleaning required*1 
Validation Verification Other*2 
Johnson 
Matthey 
Y Chemical/ 
Pharmaceutical 
Y Y  
Pfizer Y Pharmaceutical Y Y  
Fujifilm 
Imaging 
Colourant 
Y Chemical  Y Y 
Hovione Y Pharmaceutical Y Y  
Albany 
Molecular 
Research 
Y Chemical/ 
Pharmaceutical 
Y Y  
Robinson 
Brothers 
Y Chemical  Y  
Isochem Y Chemical Y Y  
Chemie 
Uetikon 
 
Y  Chemical/ 
Pharmaceutical 
Y Y  
Astra 
Zeneca  
Y Pharmaceutical Y   
 
Table 3.1 Britest member participation in the cleaning survey. 
*1 Indicates type of cleaning required which depends on type of product manufactured. 
*2 Indicates it may be possible to determine clean equipment by stating visually clean.  
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AstraZeneca submitted more than one set of survey results based on the findings of two 
different departments.  
In addition to this, cleaning can also depend on the type of product manufactured and the type 
of product, which is made after the vessel is cleaned. For example, if a batch of product is 
made in multipurpose equipment which has been used for a toxic or potent product, then it 
may be expected that the cleaning carried out on the equipment is quite extensive. 
The cleaning survey implied that process plants are often made up of the same equipment, but 
the equipment can differ significantly in age, operational use and design. This makes plants 
dissimilar. The cleaning equipment used at each plant varies significantly and it is often 
common to target specific areas for special cleaning. These areas can vary, between batches 
of different product and batches of the same product in the same vessel. Key survey findings 
revealed that contamination does not occur in one specific part of process plant. Methods to 
target specific areas for cleaning can thus vary (Figure 3-4).  
 
Figure 3-4 How is an area targeted for specific cleaning? 
 
Figure 3-4 gives a number of responses to the question and shows that companies will adopt 
more than one approach to attempt to get equipment clean. This indicates a trial and error 
approach. Companies consider it appropriate to bring in specialised equipment or cleaning 
companies for process cleaning challenges. Therefore, placing the cleaning responsibility in 
someone else’s hands is easier than cleaning themselves. This could render equipment out of 
use or cause a schedule hold up if cleaning specifications are not met quickly. Figure 3-5 
indicates that the cleaning methodology used is based on solubility of the contaminants, as 
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specific cleaning agents are used to solubilise a contaminant rather than choosing an agent 
based on known molecular structural properties. The selection of a cleaning agent is currently 
carried out by trial and error in the majority of companies surveyed. This can be achieved by 
using a simple solvent screen carried out for the reaction chemistry. It does not however, take 
into account the solubility of potential contaminents.  
 
Figure 3-5 Have you identified any biological or chemical structure which can be targeted by 
the inclusion of a specific cleaning agent? 
 
Where yes was indicated (Figure 3-5) it is necessary to state that the structure or contaminant 
is targeted by an acid or alkali cleaning agent. The methodology used here points towards trial 
and error with companies selecting cleaning agents until they achieve the most effective 
cleaning, which is not optimised. The effectiveness of cleaning protocols was assessed during 
the survey. The results showed that a majority of the time cleaning protocols were considered 
sometimes effective (Figure 3-6). 
 
 
Figure 3-6 How effective is your cleaning protocol? 
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The responses showed no protocols were completely effective or ineffective. It is not known 
how Britest members define effective. If ineffective cleaning is found, cleaning is repeated 
until it is satisfactory. This may mean cleaning using the whole protocol again in full, 
repeating parts of the cleaning, or isolating process equipment as necessary for special 
cleaning. This may mean that cleaning documents are not as defined as other process 
documents. It is certainly true for verified cleaning protocols. Britest members implied that a 
range of cleaning agents are used (Figure 3-7). This indicates that the agent varies with the 
process or product manufactured. The use of cleaning with detergents other than aqueous 
detergents was not indicated in the survey. 
 
Figure 3-7 Cleaning agents used by Britest members. 
 
Most respondents indicated they used water to clean equipment in addition to other agents 
such as organic solvents, acids and alkali. Respondents were asked to indicate how they 
selected their cleaning agents (Figure 3-8).  
 
Figure 3-8 Criteria used by Britest members to select cleaning agents. 
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Figure 3-8 indicates that the selection of cleaning agent is not an early consideration during 
the development process. Often the decision on which cleaning agent to use is made during 
the late product development. This can be problematic. If cleaning were to be considered as 
part of whole process design, it is possible that this may influence the selection of the process 
chemistry. A less elegant process chemistry may give sustainability benefits once cleaning 
was factored into the life cycle assessment. Solvents for cleaning purposes are chosen based 
on solubility studies and not fundamental science. The method of choice in industry is best 
shown figuratively (Figure 3-9). 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 3-9 Industrial method for selecting a cleaning agent as provided by Britest members. 
Where tube D is the best choice of solvent with no visible residue remaining.  
 
Figure 3-9 shows the method of solvent selection in industry. This is not considered the most 
rigorous or scientific based methodology, but it gives an indication of the best solvent to use. 
It must be remembered that industrial methods such as the one described above only considers 
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the key reagents, not all the potential products as contaminants. The impact of solubility on 
determining the direction of this research is considered in Chapter 2 (section 2.2.8).  
Britest members indicated that this method is not an adequate method of choosing a solvent 
for cleaning purposes. This is also apparent in the response to questions regarding 
effectiveness of cleaning (Figure 3-10). Respondents had varying degrees of success with 
their cleaning protocols. 
 
 
Figure 3-10 Effectiveness of current cleaning protocol?  
 
Figure 3-10 indicates that although the effectiveness of cleaning is tolerated by the 
industrialists who were surveyed, right first time cleaning was rarely achieved. This survey 
question highlights evidence which indicates that the cleaning protocols in place are not 
optimised. Good Manufacturing Practice (GMP) guidance is given on cleaning post 
manufacture and pre-manufacture, which determines the recommended parts per million 
(ppm) contaminants in drug products, drug product intermediates and in vessels used for 
manufacturing dependant on quality control and quality assurance departments with 
organisations (as referred to in Chapter 2 sections 2.2.6 and 2.2.7). In order to achieve this, 
without significant lost time and waste cleaning agent due to repeated activities, cleaning 
must be optimised. It is considered that the main impact of this situation is on process 
scheduling and the financial implications of this. If the effectiveness of cleaning is tolerated, 
the next questions which must be asked is - what are the range of cleaning agents in use by 
Britest members and how are these selected? Figure 3-11 and 3-12 indicate the answers to 
these questions. 
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Figure 3-11 What cleaning agents do you use? 
 
Figure 3-11 implies that the types of cleaning agents used by Britest members are both 
aqueous and solvent. Three companies indicated that they did not use aqueous detergent.  
If companies are using more than one type of cleaning agent, how are they selecting those 
cleaning agents? Figure 3-12 indicates the answer to this question. 
 
Figure 3-12 How are your cleaning agents selected? 
 
Figure 3-12 shows that the selection of solvents is mainly determined by two factors which 
are firstly a laboratory selection during process development, as indicated by figure 3-9. This 
method of choosing a solvent is not adequate, as the survey data related to cleaning 
effectiveness indicates (Figure 3-10). Right first time cleaning is not often achieved. In 
addition, the methodology used to determine solubility does not take into account the different 
surface types, ages and equipment which needs to be cleaned in processing plant. The 
complexity of this equipment is difficult to simulate in a laboratory environment. Solubility of 
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the worst case product is used in the selection of a cleaning solvent. This does not consider 
the importance of intermediate and side products which may form in processing and prove 
more difficult to remove than the product used for the solubility test. The second most 
favourable choice for solvent selection is during plant commissioning. At this stage in the 
life-cycle of process design it is very late to change a manufacturing process. This may mean 
that a process is introduced into a plant with ineffective cleaning processes designed too late 
in the process life-cycle to change. The survey results overall indicate that cleaning 
considerations occur later than should be expected if whole process understanding is to be 
applied and this lacks fundamental scientific understanding of the cleaning processes 
employed by the Britest members. Figure 3-13 shows in more detail the effectiveness of 
Britest members cleaning protocols with regards to cleaning carried out right first time. 
 
Figure 3-13 Can you state the Effectiveness of your current Cleaning Protocol? 
 
Figure 3-13 suggests that the cleaning protocols work 50% of the time and effective cleaning 
takes more than two attempts every time. If it takes more than two attempts to effectively 
clean plant it is not financially effective and warrants considerable downtime, costs in lost 
processing opportunities, and the associated re-scheduling of production.  
In summary, the survey results indicated a number of significant opportunities to improve 
cleaning. It was felt that the results from this survey indicated that the companies consulted 
did not have a true understanding of cleaning at the scientific level and were not able to 
identify contaminants. It was felt that more in depth information is required from industry to 
understand specific challenges. Industrial site visits were therefore recommended to increase 
understanding. This would also give firsthand knowledge of plant equipment, its geometry, 
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and organisation. Site visits to several manufacturing plants and the information obtained 
from the visits is discussed in section 3.3.  
3.3 Information obtained from Industrial Visits with Britest member Companies 
Section 3.2 showed that the information gained from the survey is valuable, but in order to 
gather more information it is considered vital at this point of the research to visit 
pharmaceutical and manufacturing plants to observe cleaning and increase the amount of 
knowledge known about plant cleaning. Site visits are considered invaluable as they are able 
to give a deeper understanding of specific challenges. It was possible to visit two companies 
with an interest in increasing their understanding of plant cleaning and discuss cleaning 
challenges. The information gained during the site visits is given in sections 3.3.1 and 3.3.2.  
3.3.1 Site visit to Britest Member company 1   
Company 1 is a globally integrated drug discovery company. It specializes in development, 
manufacturing and outsourcing solutions. Company 1 became involved with the plant 
cleaning project after realizing some of the benefits which occur with increased understanding 
of cleaning. Company 1 is a small multinational company who wish to examine a range of 
cleaning challenges surrounding several processes.  
This company is unique among the Britest member companies as it has challenges in both 
food and pharmaceutical manufacturing. A lot of the problems in this company relate to 
equipment. A lot of large complex pieces of equipment including stirred tank reactors are 
used during processing and as it is a multi-product plant a lot of the equipment is used for 
more than one product. Process equipment used in one process (figure 3-14) shows the 
complexity of the equipment which adds to cleaning challenges. Company 1 has pieces of 
equipment that operators have been unable to clean effectively after processing particular 
products. The challenges associated with this have meant the dedication of plant equipment to 
products and in one case an entire section of processing equipment is not longer in use. The 
plant is also old in parts and this adds to the challenges, as the older the equipment becomes, 
the more damaged and worn it is. This requires operators to resort to manual cleaning more 
frequently and also carry out more dismantling of equipment.  
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Figure 3-14 Equipment complexity as described by Company 1 (Company 1, 2011a) 
 
In addition to other factors, this company were keen to stress during a site visit that the 
complexity of cleaning involves consideration of the materials of construction. This can 
include vessels, pipe work and gaskets, all of which can be in the same processing equipment 
and require cleaning together. Company 1 advised this is a critical consideration and should 
be considered when thinking of developing a cleaning model. Materials of construction can 
include glass-lined mild steel, borosilicate glass, stainless steel, Hastelloy and fluoropolymers 
such as Polytetrafluoroethylene (PTFE) or Edlon™. 
Company 1 also discussed the recent adoption of improved cleaning equipment, including 
spray balls which follow a hydrodynamic spray pattern. This is beneficial as it provides better 
vessel coverage. It has been determined that stubborn contamination can be removed using 
the defined cleaning sequences. 
Further cleaning challenges which Company 1 face are listed as - 
Stubborn contamination which requires multiple applications of a defined cleaning sequence.
Highly coloured compounds (aryl azo compounds) visible at <1ppm and are therefore very 
difficult to remove from vessels and equipment. 
Company 1 have a number of ‘sticky’ products which are food polymers and are very difficult 
to remove from equipment. 
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A major challenge for this company is sublimation of products and intermediate products into 
vent condensers/headers. Sublimated product is difficult to remove, due to the considerable 
complexity of this cleaning equipment and also because the contaminant is often unknown, 
and therefore the best method or solvent to clean the equipment is difficult to determine. 
Another major challenge for this companies operators is cleaning ‘Tide-line’ residues on 
vessels (from degradation or evaporation). These are very common on vessels in most 
manufacturing sites. The manufacture of products is carried out to specific recipes or 
methods. This requires using the same volume of liquid in a vessel and therefore the vessel 
has a splash zone at the tide-line. This is depicted in figure 3-15. 
 
 
Figure 3-15 Splash zones in a reactor (Company 1, 2011b) 
 
Mixed residues (organic/inorganic) can cause a considerable cleaning challenge, as it 
becomes difficult to determine which cleaning agent to use, and also to decide the order of use 
of any cleaning agents. This can lead to significant time lost due to trial and error. 
Worn (‘pitted’) surfaces on vessels and other equipment are more difficult to clean.  
Due to the complexity of plant equipment (figure 3-14), accessing some areas of plant to 
clean is difficult. As plant cleaning needs to be verified, inspected or occasionally swabbed to 
establish cleanliness, any inaccessible equipment becomes challenging to manage. 
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During the site visit to Company 1 it became apparent that determination of visually clean is 
difficult. Whether equipment is visually clean is often governed by who does the inspection. It 
is known that people have different standards and interpretations of vessel cleanliness. 
The fact that many pieces of plant equipment have imperfections such as surface blemishes 
and scratches can compound the assessment of visually clean. It also means that any product 
or intermediate residue is likely to stick or gather in these areas.  
Glass surfaces in reactors can suffer from markings or fogging caused by damage by water or 
chemicals. This is known as ‘Bloom’ marking. Bloom makes cleaning difficult as it cannot be 
removed as it is a change in the chemical structure of the glass . 
Similarly ‘Rouge’ marking on stainless steel surfaces is a cleaning challenge.  
The issues at this company’s plant have meant that management have determined that the 
general standard of cleaning needs improving. This is currently happening and standards are 
higher due to improvements in vessel cleaning and by increased understanding. This is being 
carried out using a contract cleaning company to determine the best use of detergents and 
solvents for cleaning. The American company Steris offer customised services which give 
solubility information in relation to their detergents and customers chemistries (Steris, 2011). 
This is good, but Steris do not divulge the nature or composition of their detergents. This is 
important as any product which is used in a pharmaceutical manufacturing process must be 
proven to be removed from the equipment, or present in low enough concentrations so as not 
to harm any recipients of any final drug product. If the composition of the detergents is not 
known how can their presence be detected, and how can they be proven eradicated from any 
equipment? 
Company 1 raised a lot of cleaning issues which are useful to consider when developing 
cleaning tools. This company provided a lot of information and gave a good idea of their 
challenges which indicated that other similar companies may face the same difficulties. 
 
3.3.2 Site visit to Britest Member company 2 
Member company 2 is a large multinational pharmaceutical contract manufacturing company. 
The company is very interested in working towards improving cleaning standards and looking 
to reduce cleaning costs.  
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A visit to this company showed that the company is interested in reducing plant cleaning 
costs. This includes finding methods to ensure that the processes are carried out in the most 
sustainable manner, and continuously improving their processes to improve yields and reduce 
costs. The company operates to methods designed within the organisation that may not be the 
best industrial practices, but give an internal consistency to operations worldwide. The 
company also operates with ICH guidelines as the backbone for designing processes and 
methods and systems of operation, as is expected of a pharmaceutical company. The purpose 
of this site visit was to begin to understand cleaning challenges that the company face. It is a 
multipurpose site where the process equipment is in continual use for different products. This 
means that cleaning is critical and understanding it and improving it will help reduce plant 
down time and increase plant availability for processing.  
At this site the manufacture of active pharmaceutical ingredients (API) is the main business 
concern. This means that the cleaning needs to be effective to reduce residual entities that 
could contaminate the next product into the equipment. This is especially important when 
manufacturing potent or toxic API’s. 
It is important to consider the level of cleaning required in these cases, which can change 
depending on what has been in the vessel, or what is made in the vessel next. For example, if 
the cleaning carried out in the vessel requires verification the maximum allowed carry over 
limit (MACO) may be higher than if the cleaning requires validation. The equipment cleaning 
required may be to validate between different products manufactured in the same vessel, or it 
may only need verification between batches of the same product in the same vessel. The 
protocols or procedures for cleaning may therefore change depending on the standard of clean 
required. If cleaning verification is required a short cleaning protocol or part of a protocol 
may be used. If cleaning validation is needed the full cleaning protocol may be used. This site 
visit was useful at this stage in the research to determine the importance of plant cleaning. It 
has also been useful to help determine answers for three of the research questions asked at the 
beginning of Chapter 3. This is discussed in the next section 3.4. 
 
3.4 Research Question answers 
At the beginning of Chapter 3 three research questions were asked. 
RQ3: What are the main challenges associated with process plant cleaning for Britest 
members? 
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RQ4: What common methods do Britest members utilise to clean their process equipment? 
RQ5: Which cleaning challenges are associated with plant engineering or choice of cleaning 
agent? 
Through the answers received from the survey it is possible to answer these questions.  
RQ3 Answer: The main challenges associated with process plant cleaning for Britest 
members are achieving right first time cleaning and understanding the fundamental science 
behind the cleaning. The fundamental science behind cleaning is not known by Britest 
members although the contaminants may be known in some cases. The cleaning seems to be 
based wholly on solubility with little regard to deeper understanding (Figure 3-9). This 
approach to cleaning is challenging, especially because cleaning is not considered early 
enough in the manufacturing process to fully understand the science behind cleaning. 
RQ4 Answer: The common methods used by Britest members to clean their plant equipment 
are targeting a specific area for cleaning with a specific cleaning agent, flushing an area with 
cleaning agent and isolation of pieces of plant equipment for cleaning. This may involve 
disassembly of equipment to ensure that it is cleaned efficiently. In addition the survey results 
indicate that the cleaning agents commonly used are organic solvents, mineral acid or alkali. 
As well as solvent cleaning a majority of respondents used water and aqueous detergents.  
RQ5 Answer: The answers to RQ5 are strongly linked to the answer to RQ3 and RQ4. The 
challenges associated with plant engineering and cleaning agents are achieving right first time 
cleaning. This is the most favourable cleaning situation. In addition, time spent isolating, 
dissembling equipment and waiting for it to be confirmed clean are challenges associated with 
a majority of Britest members. This is very time consuming and increases the amount of time 
a piece of plant equipment cannot be used for manufacturing.  
The survey results show that there are common challenges for Britest members. It is important 
at this stage of the research to examine the suite of tools and methodologies which are within 
the Britest portfolio. This will help to shape the research and begin to start to address the 
cleaning challenges by finding a tool or methodology which can be used to aid Britest 
members in cleaning their plant equipment. Firstly, in section 3.5.1 Britest tools are 
introduced. In section 3.5.2 Britest tools will be examined further, by determining which tools 
can be used by Britest members to help solve cleaning challenges.  
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3.5   Britest, Britest Tools and Methodology  
3.5.1 Britest  
The Industrial sponsor for this project on industrial cleaning is Britest. Britest is a not for 
profit company which is owns intellectual property in the tools and methodologies, which 
Britest members have access to. In addition a related benefit is that they provide an area for 
members to share best practise at a pre-competitive level. Britest is a way for members to 
collaborate to develop solutions to key common challenges in order to drive knowledge 
forward. It is stated that, ‘member companies benefit from access to a range of propriety tools 
and methodologies focused on whole process understanding’ (Britest, 2011). It is estimated 
that Britest have delivered over £500 million of tangible value to their members to date 
(Britest, 2011). Benefits from using the tools include higher product yield, enhanced product 
quality and, critically, a robust and understood process. It is hoped that through this project, 
tools can be developed to improve the understanding of industrial cleaning and improve 
sustainability of day to day plant operations. The development of appropriate tools for these 
areas would complement the existing tools, bringing whole process understanding to another 
level. 
3.5.2 Tools and Methodologies 
Britest have a portfolio of tools and methodologies which are successfully used in 
manufacturing sites throughout the world to identify and solve process related challenges. 
Britest tools encompass a range of qualitative and semi-quantitative models. The models 
allow users a method with which to capture knowledge and critical information in relation to 
their processes, in a way that can be easily understood and further analysed. Importantly, the 
models also highlight lack of knowledge and understanding in some areas. The methods allow 
the users to consider information from other experts within their organisation as 
multidisciplinary teams work together to resolve issues. In addition, Britest team members 
work alongside the member teams, teaching them how to apply the tools through training, and 
bringing their previous experience and skills to facilitate their use. The Britest tools provide 
an effective way to focus teams and improve communication to reach solutions and solve 
problems. Importantly, this can only work if the team members involved are the right people, 
with the correct process understanding, and are allocated time and space to work through the 
process using the models. 
Britest methodologies are described as the ‘expertise and knowledge required to obtain the 
best answers by using the correct tools’. This is important as only the correct tools will 
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provide the best solutions to problematic situations. The methodologies allow consideration of 
the best tool for the situation to be chosen. They allow logical and focussed thinking around 
an issue. 
The methodologies also allow Britest members to get the best value out of the tools, ensuring 
they are used in the correct manner to obtain better process understanding. This may be by 
Britest Lite, or by a full Britest study. A full Britest study is carried out by a number of 
experts in the area of consideration. For a process related investigation this may include 
process operators, analytical staff, chemical engineers and chemists. Everyone who is 
important to aiding the production of a solution should be part of the study. The full study 
takes a day or longer and will be in-depth, focussing on individual aspects of chemistry and 
engineering that may be altered to provide a possible solution. The application of most Britest 
tools will be considered in order to reach the best potential outcome. 
It may be that a very specific plant cleaning problem can quickly be investigated and potential 
solutions identified using Britest Lite. Britest Lite is a shorter condensed version of a full 
Britest study. It is useful if less time and people are available to participate in the study. 
Britest Lite is used for problem solving in specific areas and fewer tools will be used in this 
study. In a potential plant cleaning study of this nature it may be possible to bring a small 
group of knowledgeable people together to solve a specific problem with Britest Lite.  
These kinds of problem solving can be carried out in house, after initial Britest enablers have 
been put in place. Britest enablers are methods of introducing and empowering the Britest 
members to problem solve using the Britest tools and methodologies. These include training 
packages in specific Britest tools, website resources and background knowledge that allow the 
best application of the tools. Tool selection is considered an important aspect of the Britest 
methodology. There is no reason why a number of tools cannot be tried in order to achieve the 
best fit tool. A vital key to the use of Britest tools is realising what the challenge is, and which 
question requires an answer.  
Core methodologies of potential interest in this research include the following; Initial 
Screening Analysis (ISA) and Duty Definition and Equipment specification (DuDEs). ISA is 
useful methodology that can be used to start any Britest study or Britest Lite study. ISA is a 
method that gives an overview of the whole problem through a number of stages.  
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Initially the methodology tool known as ISA is used to define the problem, so that the team 
knows what the outcome of the study needs to be. This means that the purpose of the study is 
known, such as reducing the cost of a cleaning step by using less resources. 
Once the purpose of the study is known, the scope of the study can be considered. An 
example of this is a plant cleaning problem in a specific process, but the study is constrained 
to finding a solution for one part of the process. This is useful as it brings a focus to the study 
and it is considered that this tool will be important in future plant cleaning investigations.  
The intent of the study is then to define the product, which may be a pharmaceutical or 
chemical product. This is critical as understanding the product and the product characteristics 
indicates how the product interacts and the process reactions occur. The product required can 
be specified in terms of its physical and chemical properties. Once the product is defined then 
the key by products and reagents can be understood and identified. Therefore the process used 
to make the product can be defined. The identification of further tools and methodologies 
required to best indicate potential solutions to the problems can now be addressed. 
Duty Definition and Equipment specification (DuDEs) is a methodology that may be applied 
in future plant cleaning case studies. It is used primarily for process decision making, such as 
whether to buy new equipment or for justifying capital investment. Both of these scenarios 
could be possibilities for case study companies during the plant cleaning project. It may be 
that a solution to the cleaning problem is to buy a specific CIP unit. This would require a tool 
such as DuDEs to help select the correct equipment or identify modifications to existing plant. 
This methodology has the following stages.  
1 Initially, process understanding would be clarified. This is important to the plant 
cleaning project, as the fundamental chemistry and physics behind the process need to 
be identified and appreciated.  
2 A process plan would then be created that allowed all processing options to be 
considered carefully.  
3 Equipment specification would then be established to determine what the new or 
modified equipment needs to be able to do. 
4 Research and analysis of the equipment would then be carried out to select the best 
option. This would be carefully reviewed prior to proceeding to the next stage. 
5 After these stages, the equipment may be selected and designed.  
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Further Britest methodologies consist of the following tools and models. An indication of the 
application of the tools to plant cleaning is now considered. 
Process summary information map (PrISM) is a tool which is incorporated into the ISA 
methodology. It is specifically used to represent a process in a map format. It shows the main 
stages in a process and therefore focuses attention on known facts that happen during 
processing, such as what are the process inputs and outputs. It can also be used to capture 
known relevant information, including processing costs at each stage. During plant cleaning 
research this tool may be used to break down process stages into smaller steps to begin to 
understand chemical interactions and the formation of by-products and intermediates. It is 
thought that many of the by-products could be a cause of difficult to remove contaminants in 
Britest member’s processes. This is therefore a good tool to capture and analyse known 
information and it may be critical in discovering gaps in process knowledge. 
Process Definition Diagrams (PDD) is a tool that uses knowledge from chemists and chemical 
engineering and brings them together in one place to consider the effect that they have on 
each other and on the overall process. The tool uses a form of state – task approach. This 
means the process is described as a series of tasks which transform starting materials into 
products. This is a fundamental concept of the plant cleaning project. The information is 
collected in a way that describes the process, in its simplest form. This means that factors 
such as scale and the equipment used are not considered. The plant cleaning project will focus 
on chemical, physics and equipment interactions. It is therefore considered that PDD could be 
used with another tool or adapted to encompass this. The mechanisms for undertaking this are 
yet to be determined but it is considered that the flow of a cleaning agent could be tracked 
through plant equipment in a similar way to a product to determine what happens to it. A 
simple method for including this information may be to annotate the PDD according to the 
equipment used, by the addition of a series of developed symbols.  
Rich Pictures (RP) is a simple but powerful tool. It enables a clear description of a process 
stage or piece of equipment, and can help determine what is physically happening in a great 
amount of detail. It can be applied to chemical reactions and fluid circulation which is 
important in plant cleaning. This has been used in previous cleaning studies to determine 
areas that a spray ball could not reach inside a vessel. It is therefore thought that this 
technique will be of importance during the plant cleaning project. The visualisation of a vessel 
or a piece of equipment can indicate many factors that have not been considered previously 
and therefore can suggest solutions to problems. It is thought that a number of RPs could be 
  
51 
 
used for varying flow rates of cleaning fluid, or positions of jet washers of spray balls to 
determine the scope of their influence. This would need to be carried out in conjunction with 
analytical methods that indicate clean and unclean areas. These could then be mapped onto 
the RP and analysed to determine potential reasons for differences. Figures 3-16 and 3-17 
give examples of how RP may be used to model complex process tasks by showing coffee 
making in a cafetiere. 
 
Figure 3-16 Inside the cafetiere where water is poured onto a bed of ground coffee beans. The 
Rich Picture is able to capture and visualise changes taking place in the cafetiere (Britest 
2016). 
 
Figure 3-17 Detailed RP giving finer detail about how the coffee is made and the 
considerations and ideas which could arise from a discussion around making coffee in a 
cafetiere. (Britest, 2016) 
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Rich Cartoons (RC) are similar to RP and could also be used effectively during the plant 
cleaning project. They allow visualisation pictorially of movement through stages of 
processes with time. A cartoon drawn of a process stage can show how chemicals interact and 
raise questions about what potentially remains at the end of a stage. It can be drawn to reveal 
limitations and solutions within processes. Ultimately it shows how events unfold in what 
sequence they occur and what is happening at the same time. It may be apparent from this that 
factors not thought to interact do interact. This may be very valuable when considering the 
nature of contamination and how it occurs. RC could potentially show that contaminants are 
produced as a result of parallel reactions not previously considered. 
Transformation Maps (TM) are used to show how the sequence of rate processes, both 
chemical and physical rate processes happen. TMs show reactions can produce wanted and 
unwanted products. It can be used to distinguish intermediates and also show how reactions 
happen. An example of a TM for aspirin indicates where all of the reactions take place and 
where phase changes can occur (Figure 3-18). 
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Figure 3-18 Transformation Map (TM) of Aspirin (Britest, 2016) 
Notes for Figure 3-18:  
Where MT is Mass Transfer and R is Reaction 
Where arrows are coloured, green indicates a desired reaction or direction of equilibrium, and red indicates an undesired reaction or direction 
of equilibrium. 
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Figure 3-18 gives a good indication of the level of detail which can be achieved using a 
simple product TM. The above TM shows states which form during the process and can 
indicate a good cleaning solvent for used equipment. It is known that the solubility of both 
acetyl salicylic acid (3 g/L at 20 oc) and salicylic acid (2 g/L at 20 oc) is relatively low. This 
can often cause the product to contain un-reacted salicylic acid. This needs to be removed by 
re-crystallisation. This implies that water would not be a good choice of cleaning agent for 
cleaning manufacturing or plant equipment used during this process.  
TM is often used as a tool to clarify information prior to using Driving Force Analysis (DFA). 
TM will be of use during this project to potentially identify contaminants and hopefully it can 
be used in conjunction with DFA to prevent or limit their formation.  
DFA is a tool that identifies in the form of a matrix which factors influence the rate of product 
and side product formation and the rate of formation. It can be very powerful in determining if 
the factors that influence reactions truly reflect observations during plant operation. This 
could be used to reduce or eliminate contaminants in processes by altering factors that can 
limit or drive their reactions. Different chemistries or conditions can then be utalised as part 
of whole process design.  
Transformation, Entities, Properties, Physics, Parameters, Order of magnitude (TE3PO) is 
also thought to be useful for the plant cleaning project. This tool enables teams to focus on 
physical processing and transformations. It identifies in a structured manner the key entities 
and properties in a transformation as well as the fundamental parameters that govern the 
transformation. Chemical processes can be complex and this gives a logical approach to 
thinking through those processes, with regard to the entities that are present in the process 
stage, what the physical properties might be and what physics is needed to go through the 
required transformation. All these factors are important when considering how to remove 
contaminants from processes. TE3PO could therefore indicate practical methods of 
contamination removal during this project. 
The application of the tools is dependent on the member companies’ requirements and can be 
applied to the whole process or to a specific area of the process. Two case studies will be 
discussed in this report which successfully used Britest tools to examine process challenges. It 
is thought that initial plant cleaning study tools may include ISA and PDD; it is considered 
that a combination of RC and RP will be useful during PDD assessment when considering 
staining or residue analysis. Depending upon the process study, it may be useful to carry out 
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TM and DFA to indicate how to prevent the formation of contaminants.TE3PO may provide 
useful information on how to remove contaminants. 
It is known that the established Britest tools may not provide solutions for all cleaning 
problems encountered. It is thought that the influence of the type of equipment and scale of 
the process is not truly explored in the current tools. This was developed during the course of 
this research as it was anticipated that the equipment type contaminated and CIP used were 
factors influencing removal of contaminants. This appeared to lie beyond the scope of the 
current tools, with the exceptions of RP and RC. 
Examination of the current Britest tools and methodologies has indicated that there is scope to 
use them to develop a suite of tools specifically for cleaning. The current Britest toolkit does 
lack a tool to help choose a cleaning agent or methodology early in process development, and 
it is this tool or methodology which this research must focus on. Focussing on this issue will 
mean right first time cleaning occurs more frequently than currently stated in the survey in 
figure 3-13. One fundamental question which remains unanswered in this research is, how 
much does failing to clean right first time cost? In order to answer this question it is critical to 
examine the costs or metrics associated with plant cleaning, and determine if current plant 
cleaning is cost effective. This will be considered in section 3.6. 
3.6 Plant Cleaning Metrics 
Research information from AstraZeneca suggests that large pharmaceutical companies can 
spend up to 50% of plant time carrying out cleaning. The average time associated with this is 
500 man hours and 8 tonnes of solvent with an associated cost (including downtime, labour, 
waste treatment and lost opportunity) of £1 million per process clean (AstraZeneca, 2008). 
Smaller companies involved in fine chemical manufacture indicate that the downtime 
associated with cleaning can be up to 20% of plant time. The cost of the 20% of unused plant 
capacity is £20 million. This equated to approximately 10% of turnover (Britest, 2009). 
Cost Benefit Analysis (CBA) is important in industry, including the pharmaceutical sector. 
This is because in order to justify changes in any process or operations it is necessary to 
determine financial impact. The industrial plant cleaning project looks to reduce plant 
cleaning costs and therefore it is useful to consider applying this analysis to cleaning in the 
pharmaceutical industry.  
In order to fulfil this remit for the research project there must be an improvement in the 
cleaning methods or techniques applied. This must be measurable either by financial or other 
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means. It could be considered that the metrics for processing pharmaceuticals are well 
documented. This is not the case. It is very difficult to gain access to financial information 
from companies who consider that sharing this information may be disadvantageous for a 
number of reasons, for example, giving other companies a competitive advantage if solvent 
purchase prices are shared publicly. It is also apparent from information gained in the survey 
discussed in section 3.2, that companies who took the survey do not break down operation 
costs for every process in terms of overheads. Although costs of API’s are known and solvent 
prices are known the cost of the operation of specific equipment is not often considered. This 
makes it difficult to analyse the costs for overall pharmaceutical processes and more difficult 
to determine the costs of cleaning equipment.  
For the purposes of this research the cost of specific pharmaceutical products can be found in 
the Drug Tariff. For example, one of the most expensive drug products on the market in the 
UK is Pramipexole (3.15mg modified release tablets) at £12.03 per tablet. One of the cheapest 
drugs on the market in the UK is Aspirin at approximately 4 pence per tablet (NHS, 2013). 
The cost of an off-patent drug is based on the cost of the process, the cost of the raw materials 
and the size of the batch. For drugs that are still under patent a significant cost is the markup 
for the pharmaceutical company which aims to recover the cost of research and development 
costs which can be considerable. One of the biggest costs during any manufacturing process is 
often the raw materials. The cost of solvents fluctuates but some can be significantly more 
expensive to buy, to use, and to dispose of (as discussed in section 3.6.1). It is therefore 
critical that solvent use is kept as low as possible in order to reduce costs. Costs associated 
with solvents include purchase, storage of solvents pre and post use, and disposal of solvents. 
It is clear from the industrial information provided in section 3.2 that this is not always 
possible. This is due to repeat cleaning costs, the inability to achieve cleaning RFT. These 
factors and plant downtime are potentially not factored into the cost of drug production. In 
order to achieve this a lot more information must be understood about cleaning metrics.  
Cleaning metrics for aqueous cleaned systems in the food and cosmetic industry have been 
determined by Benson (2009) with the use of a benchmarking tool.  
In order to determine the cost of aqueous cleaning Benson, along with Ecolab Ltd, developed 
a tool which could easily and quickly calculate the cost of cleaning using non solvent cleaning 
agents. This work was sponsored by the Technology Strategy Board in 2009. The resulting 
tool was called Zero Emissions through Advanced cLeaning (ZEAL). It was considered 
important to examine modifying this tool to gain information on cleaning metrics for the use 
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of solvent based cleaning. One of the Britest members involved in the survey (section 3.2), 
Company 3, was chosen to participate in this exercise. The industrial plant cleaning project 
looks to reduce plant cleaning costs and therefore it is useful to consider applying the Zeal 
database to the pharmaceutical industry. The Zeal database has been used to great effect by 
many companies who wanted to assess and analyse cleaning methods. The tool provides a 
valuable method for collation of data and allows identification of areas for improvement, 
determining where money, time and resources could be reduced if changes are made.  
An on-site visit was carried out with Company 3, who had an interest in reducing plant 
cleaning costs in order to begin to understand how the ZEAL tool could be adapted to provide 
metrics for this research. Company 3’s interests include finding methods to ensure that 
cleaning processes are carried out in the most sustainable manner, and continuously 
improving cleaning processes to improve yields and reduce costs. The company operates to 
methods designed within the organisation that may not be the best industrial practices, but 
give an internal consistency to operations worldwide. Company 3 operates with ICH 
guidelines (Chapter 2 Section 2.2.7) as the backbone for designing processes and methods and 
systems of operation, as is expected of a pharmaceutical company. The purpose of this site 
visit was to begin to understand cleaning challenges that the company face on site. It is a 
multipurpose site, where the process equipment is in continual use for different customer 
products. This means that understanding and improving plant cleaning is critical, and will 
help to reduce plant down time and increase plant availability for processing.  
At the site the manufacture of active pharmaceutical ingredients (API) in a multipurpose plant 
is the main business concern. This means that the cleaning needs to be effective to reduce 
residual entities that could contaminate the next product into the equipment. This is especially 
important when manufacturing potent or toxic API’s. 
It is important to consider the level of cleaning required in these cases, which can change 
depending on what has been in the vessel, or what is made in the vessel next. For example, if 
the cleaning carried out in the vessel requires verification, only the maximum allowed carry 
over limit (MACO) may be higher than if the cleaning requires validation. The equipment 
cleaning required may need to be validated between different products in the same vessels, or 
it may only need verification between batches of the same product in the same vessel. The 
protocols or procedures for cleaning may therefore change, depending on the standard of 
clean required. If cleaning verification is required a short protocol or part of a protocol may be 
used. If cleaning verification is needed the full cleaning protocol may be used.  
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This information is not currently captured on the ZEAL database, as cleaning in the food and 
(dairy industry) and the cosmetic industry does not require similar levels of cleaning in terms 
of verification and validation. In order to make the database suitable for the pharmaceutical 
industry, this information needs to be considered and captured to reflect its importance. 
In addition to this, further site visits highlighted other information and differences between 
the ZEAL database, and the data it suggests contribute to cleaning costs and the requirements 
of the pharmaceutical industry. These are listed and discussed in the sections indicated: 
 Waste product differences leading to waste treatment diversification of cleaning waste 
treatment and cost of waste disposal (Section 3.6.1). 
 Cleaning standards verification and validation (Section 3.6.2). 
 Analytical methods and time taken to analyse samples (Section 3.6.3). 
 Multi process operation by staff (Section 3.6.4). 
 Multi produce use compared with the dairy industry or the brewing industry (3.6.5). 
 Additional differences and information (3.6.6). 
3.6.1 Waste Disposal 
One of the main differences between the food industry and the pharmaceutical industry is 
cleaning waste disposal. In the food and cosmetic industries cleaning waste disposal is 
generally considered easier. Cleaning waste generated in the pharmaceutical industries is 
more complex and can include a lot of solvents used in cleaning (and during processing) and 
also water contaminated with solvent and other residual elements, some of which may be 
toxic and require specialist disposal.  
This means that companies who manufacture pharmaceuticals may have several complex 
disposal routes for each manufactured product. An example of this is product X manufactured 
by company 3. The waste disposal route required for the cleaning products is shown in figure 
3-19. 
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Figure 3-19 Waste Disposal from Process X at Company 3 (Generated from information 
provided by company 3). 
 
As figure 3-19 indicates waste disposal can be complex. Waste is either disposed via the bio 
plant or it is disposed of offsite, which is more expensive as it has additional transport costs 
associated. For this particular process X there are three waste disposal routes. The first 
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concentrates on disposal of halogenated waste, which requires expensive treatment by 
incineration. The second route is deemed cost neutral and disposes organic solvent. The third 
route involves the sale of some solvents which generates money for this company. 
It is possible to say that the above figure is complex, but in addition to this the costs incurred 
in packaging the waste also need to be considered in the ZEAL database. The waste disposal 
on site is more cost effective to dispose of, as it can be directly pumped to the bio-plant. Costs 
increase when the waste disposal is carried out off site.  
The initial cost of waste disposal is determined by how the waste is packaged. There are 
several options available for this. The waste may be packed into 500 or 1000L intermediate 
bulk containers (IBC’s). This is more cost effective than other methods but it cannot be used 
for all types of waste. This is due to IBC materials of construction; some solvents are not 
suitable for use with these vessels. 
A more expensive method for disposal of waste is to put it into 200L barrels. The challenge 
associated with this method is that the barrels are expensive to loan or buy. Once barrels are 
used they are returned to the company where they came from. The barrels may not be clean 
when they arrive on site and therefore any waste solvent deemed saleable must be put into 
clean or new barrels so the contents do not become contaminated by the barrels. Only solvent 
content above a certain limit can be bought by companies, for example for use in car 
windscreen wash. This requires careful operation of cleaning waste and knowledge of the 
barrel contents post use. Another issue with barrel use becomes apparent when halogenated 
waste requires disposal. This is expensive to carry out. In these cases the barrels are 
incinerated and cannot be reused or returned to the company, which increases the cost of 
disposal by this method. Another factor which requires consideration is whether the waste is 
stored on site and the associated cost this incurs until the waste can be disposed of. Overall, 
packaging, disposal and potential storage of waste can greatly contribute to cleaning costs, 
which is not considered in the original ZEAL database.  
The addition of this information to the ZEAL database for pharmaceutical companies would 
show how much was spent on waste disposal, and this would lead to suggestions and options 
to reduce these costs. Waste contents are important, as this determines how it is disposed and 
how much it costs to do this. Cleaning standards are also important and can impact upon the 
financial cost of cleaning.  
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3.6.2 Cleaning standards verification and validation 
Unlike the food and cosmetic industries, pharmaceutical companies operate to cGMP 
standards and within regulatory guidelines. This has already been discussed in Chapter 2 
sections 2.26 and 2.2.7. The food and cosmetic industries have their own regulations and 
operating regulations. In the food industry for example, identifying hazards and critical 
control points (HACCP) is applied. In the food and cosmetic industries processing equipment 
is kept clean, but there may be only one type of cleaning. When cleaning is carried out in any 
industry, the equipment is either clean, or not clean. Generally clean is determined by visible 
inspection or by assay (Refer to Chapter 2 section 2.2.5). In the pharmaceutical industry 
cleaning can either be verified or validated. Importantly, survey results in section 3.2 (Carr, 
2011) indicated that a number of Britest member pharmaceutical plants operate as 
multiproduct facilities. This may not be the case in the dairy industry, which the database was 
designed for. 
This information is not currently recorded on the ZEAL database, and it is an important factor 
in pharmaceutical cleaning. A verified clean may only require cleaning equipment with part 
of a cleaning protocol, or omit dismantling equipment. This not only saves time but means 
that cleaning could take less manpower, therefore needs to be captured on the ZEAL database. 
Equipment dismantling cleaning and reassemble is time consuming for Britest members. 
Validated cleaning is stringently controlled cleaning and the method for validation can vary 
between companies. This needs to be captured on the database to ensure that time and 
resources can be properly calculated for these operations. 
One of the most important omissions required for recording pharmaceutical cleaning is the 
number of cleans taken to achieve the required standards (either verified or validated cleans). 
Although the 2011 cleaning survey (section 3.2) showed Britest members were confident 
enough to state their cleaning protocols achieved good consistent results, speaking to 
members showed this was not true. In reality cleaning in many companies does not achieve 
the required results every time and cleaning may need repeating. The database must be 
adapted in order to reflect this, as if a vessel is not cleaned right first time it costs more 
money, time and resources. This can have a negative effect on processing and delay it 
significantly. An example of a vessel not cleaned right first time is shown in figure 3-20. 
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Figure 3-20 Example of Stained Blue Glass lined vessel post cleaning (Company 3, 2012). 
 
Figure 3-20 shows vessels are not always cleaned right first time. A key achievement linked 
to this project is to help achieve right first time cleaning. There is a lot of staining and residue 
left on the vessel post cleaning. Some of this residue is clearly apparent as a tide mark line, 
which corresponds to cleaning challenges indicated at other surveyed companies, including 
company 1. It is obvious if a visual inspection is carried out on a vessel and it appears as 
above that cleaning will have to be repeated. At this stage analytical methods would not be 
carried out. Analytical methods will be discussed in section 3.6.3. 
3.6.3 Analytical methods and sample analysis time 
The analytical methods and time taken to analyse samples is not recorded on the ZEAL 
database. This is due to the amount of time it can take for assay results to become available. 
Often in industry cleaning assays can take time to carry out, therefore results can take time to 
reach production managers. In order to continue manufacturing in the same vessel, clearance 
by quality control and quality assurance is needed. When this occurs is dependent on many 
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factors. This can include the time quality control staff are available to give the equipment 
clearance. Sometimes communication is poor between departments and critical assay results 
need to be chased. Assay priorities may not fall with cleaning assays. Final product assays 
take priority in a majority of cases, delaying cleaning results. It is recommended that the 
ZEAL database is modified to incorporate this information. 
The failure of cleaning assays or assay repeats are commonplace in industry for many 
companies. If this does occur equipment downtime can increase while awaiting results.  
If equipment is not required for processing post use, assay results can be delayed further while 
other assays take priority. 
Another key factor not represented on the ZEAL database regarding cleaning analysis is 
drying time. In order to properly assess vessels visually and also take swab samples, vessels 
need to be dry. Drying time can be very variable between vessels and the same vessel at 
different times of the year. This information needs to be collected in order to accurately assess 
how long equipment remains out of use. This is particularly relevant when considering the 
role of operators on plant as discussed in section 3.6.4. 
3.6.4 Multi process operation by staff 
Due to current manufacturing processes it is possible for more than one process to be operated 
by one person. This makes it difficult to apply costing for a labour resource to cleaning, 
particularly when waiting for cleaning cycles to finish and equipment to dry. In order to 
achieve this, careful consideration must be given not to overestimate labour resources applied 
to cleaning. This must be captured onto the ZEAL database. 
3.6.5 Multi produce use and Product Types 
Product types require alteration for the pharmaceutical industry. This is due to two reasons, 
which are firstly, that Pharmaceutical plants tend to be multipurpose, based on the evidence 
gained from the survey results in section 3.2. Secondly, definitions need to be altered from 
dairy milk and cream (fat, protein and carbohydrate) to appropriate products and residual 
types for the pharmaceutical industry. 
3.6.6 Further Database Adaptations 
In addition to the above adaptations there are several software changes which could be carried 
out in order to make the database more applicable for the pharmaceutical industry. The key 
assessment information required for cost benefit analysis is listed below indicating 
adaptations to each sector. 
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I - Utilities, labour, effluent and product and chemical costs 
Cleaning waste such as packaging is not recorded in the ZEAL database. It is recommended 
that this is included in the database, as it represents significant cost to pharmaceutical 
companies disposing of solvent waste. 
The number of hours of labour or man hours is not recorded for people who carryout multiple 
tasks at once. It is recommended that the database should be altered to allow this to be 
captured. 
It was discovered that changes to recording cleaning waste are required in the database, 
including packaging waste. In addition, labour use (in person hours) should be recorded with 
regard to multi-process operations by employees. That is, if people are carrying out multiple 
tasks, then the proportion of time on each process task should be recorded.  
II - Cleaning Scenario 
Product types need adaptation to the pharmaceutical industry. 
III - Cleaning Times and Consumptions 
The ZEAL database should be adapted to account for disassembly of equipment and 
equipment drying time. Any time taken to assay and feedback the assay results, and clear the 
cleaned vessels for use is not captured on the database and should therefore be included. The 
type of cleaning required either verified or validated should be incorporated in this section. 
IV - Site information 
No adaptations. 
V - Cleaning Data 
Addition of analytical information is required. 
VI - Process and Cleaning Diagrams 
Ensure incorporation of disassembly information and transfer times taken to do this onto 
cleaning times. 
VII - CIP and effluent monitoring 
Capture internal and off plant waste disposal and packaging waste. 
VIII - Management View 
No adaptations. 
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IX - Overall Cost Summary 
Ensure that the cost summary reflects changes and adaptations to give the best representation 
of cleaning costs. 
The above adaptations would help capture cleaning information and therefore allow cost 
based analysis. This would result in improvements based on changes. This was taken into 
account when using the ZEAL database with Company 3, as described in section 3.7. 
3.7 Cleaning Cost Benefit Analysis for Company 3 using ZEAL database 
In order to determine the cost of cleaning for Company 3, one post process cleaning process 
was examined. Examining the process highlighted a lot of differences between 
pharmaceutical and the industries the database has been previously used with, as discussed in 
section 3.6.  
Although Company 3 provided a lot of information to enable cost benefit analysis of one 
cleaning process, more information needs to be provided in order to fill in the database. It was 
determined the best method to carry this out was to analyse the cleaning process by using the 
Britest tool Process Definition Diagrams (PDD). Using this technique it is possible to reveal 
what each vessel contained at each stage of the cleaning process, and what the conditions 
were inside the vessel in terms of temperature and holding time.  
This highlighted other issues with the cleaning process in relation to the information shown 
on the PDD. In order to clean vessels and pipes, it is important to consider what residues and 
potential contaminants are present, which the PDD can do, but, it is also important to consider 
the age of the vessels and the materials of construct and geometry, which can affect cleaning. 
This is not generally shown on a PDD. Therefore the PDD tool itself needs adapting to this 
purpose. The PDD model will be adapted to a Process Definition Cleaning Diagram 
(PDCD).This is due to the fact that cleaning is a process that relies upon the correct treatment 
of multiple variables which affect it. The vessel geometry, age and material of construct have 
important roles to play in determining the effectiveness of a clean. This may be the reason 
why cleaning produces variable results and does not always result in right first time cleaning 
scenarios. A standard PDD is shown in figure 3-21. 
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Figure 3-21 PDD Model Pre adaptation (Britest, 2015). 
 
Figure 3-21 shows information captured on the model in a given situation. This can include 
the state of the process, such as whether wet solids are present, aqueous or solid phases, 
organics present and also energy used. It informs the user what conditions occur in the vessel 
during a process, such as a cleaning process. 
In order for this tool to be more useful for visualising cleaning in vessels, adaptations can be 
made, converting the PDD into a Process Definition Cleaning Diagram (PDCD) Figure 3-22. 
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KEY 
A Feed stream chemicals/ type of water used  B Feed stream detergent used 
C Waste Stream (denote waste type) and type of packaging required or used. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-22 An adapted Britest PDD model known as PDCD. 
 
In addition to the changes indicated in figure 3-22 it may also be possible to include details of 
sampling for cleaning purposes and temperatures in the vessels. 
It can be determined that the use of a Rich Picture (RP) could be used at this point to help 
show specific staining on a vessel in association with the PDCD. This would give a whole 
vessel overview on those vessels that provide specific cleaning challenges.  
In addition to adaptations to the PDD it may be necessary to consider using transformation 
maps (TM), which are used by Britest members to determine chemical transformations and 
adaptations taking place in their processes. This is an important tool for use in helping to 
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optimise processes, but used in the context of cleaning it can help determine potential residues 
and contaminants left in vessels (shown in the PDCD or RP) which require removal.  
Key contaminants not considered during the development of a process can be identified by 
using a transformation map. Many contaminants are present post reaction therefore 
identification of these residues or contaminants may help understand how they can be 
removed by use of solvents or detergents. This part of the analysis is complex and requires 
understanding chemistry, not just in the cleaning but in the processes themselves. 
Transformation maps are able to show process transformations in green, and negative non 
value added transformations of side reactions in red.  
Once this information has been processed, the database can be populated with any relevant 
information and the true cost of cleaning can be determined, which leads to the identification 
of cleaning process improvements. ZEAL database adaptation has been achieved by 
determining cleaning information using modified Britest tools as described. However, it is 
considered that there is a gap in understanding the fundamental science behind cleaning, 
which is necessary to fulfil the requirements of Britest industrial members and the remit of 
this research.  
 
3.8 Chapter 3 Summary 
Chapter 3 has provided further evidence of the need for a greater understanding of plant 
cleaning. It is now considered that most cleaning related information is contained in industry 
and due to reasons relating to confidentiality it is not often shared outside of companies. It is 
important to this research project that information relating to cleaning and the understanding 
of cleaning was gained from both the survey and the survey members.  
This was recognised by interpreting the survey results which indicated - 
 The understanding of contaminants in process plant was not fully understood but a 
majority of companies considered the contamiant to be chemical. 
 Cleaning protocols were designed with the consideration of a number of factors such 
as contact time, removal of contaminants and volume of cleaning agent used.  
 Process plants generally consist of the same components but the size and complexity 
can vary. Each process plant can be said to be unique. 
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 Process plants are cleaned according to the type of plant, the product which has been 
in the equipment and the product proceeding it, the organisation carrying out the 
cleaning, and special requirements. Special requirements may include disassembly or 
targeted cleaning in specific areas. 
 Most companies surveyed suggested that their cleaning was sometimes effective, this 
means cleaning would have to be repeated until cleaning was carried out to the desired 
level. 
 In order to clean equipment companies use a number of cleaning agents which include 
organic solvents, aqueous detergents, mineral acid or alkali and water. 
 The choice of solvent was governed by selection in the laboratory using a non 
scientific based solvency test after the process was developed and the API was made. 
The choice of cleaning agent was also made during plant commissioning, which is 
generally after the process has been transferred into manufacturing. This is not ideal, 
as if the chosen cleaning agent is not able to clean the equipment, a lot of time and 
resources could be used to try and clean the equipement at this stage. It is important to 
prevent this.  
In addition, site visits have determined some company specific cleaning challenges which 
have been useful in considering the direction of the next phase of this research. If plant 
cleaning is to be more effective it must be considered at an earlier stage of the process than 
the survey data suggests and using WPU to carry this out. It is also important to consider 
understanding the fundamental science behind cleaning rather than the solubility profile 
alone, which does not always make a cleaning agent effective.  
Chapter 3, section 3.4 answered research questions RQ 3, RQ 4 and RQ 5 based on the results 
of the cleaning survey and member site visits. 
Britest tools have shown that in a theoretical sense they can potentially be powerful in 
describing processes, confirming what is known about processes and what is not known. A 
gap in the Britest tool and methodologies has been identified which is a tool to help 
understand the fundamental science behind cleaning. This will be considered in the following 
chapter (Chapter 4). 
Identifying cleaning metrics are important and in this chapter cleaning metrics have been 
considered with regard to the ZEAL project and in terms of the cost of pharmaceutical drugs 
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produced and solvent costs. It is considered that this is possible, but that the information 
required in order to operate a tool such as the ZEAL database is difficult to obtain.  
It is therefore considered that any tool developed for improving cleaning must consider the 
following points. It must incorporate the fundamental scientific understanding of either 
solvent or product (including APIs, API intermediates and side products). The tool must be 
developed for use with the existing Britest tools which as previously discussed, can provide 
valuable information of chemicals in the process and reactions taking place, and identify 
potential cleaning challenges. In addition it is considered that the tool must be easy to 
understand and used earlier in the manufacturing process, before a product is manufactured at 
small scale in a laboratory, or large scale in a manufacturing plant. This would give anyone 
using it a significant advantage. This is because potential cleaning challenges may be 
identified earlier in the process design. At this point they can be either eliminated or reduced 
by changing chemicals in a process for different ones and avoiding the production of side 
reaction compounds or intermediates which may be hard to clean from equipment. 
3.9 Conclusions 
Chapter 3 indicates that there is a lot of knowledge around process plant cleaning, but the 
depth of knowledge is not enough. There is a lack of fundamental scientific understanding 
around process plant cleaning. If the gap in fundamental scientific understanding was 
addressed it would lead to improvements in choices of cleaning methods which would save 
time and resources. This chapter has shown that companies may not always be aware of the 
challenges associated with cleaning until the processing plant is commissioned. This is late to 
consider the choice of cleaning agents. Even if the cleaning agent is chosen before this stage 
there is no real scientific understanding behind the choice of cleaning agent. This is because 
an agent is chosen based on a solubility test in a test tube, which does not reflect real process 
equipment, or anticipate the challenges associated with cleaning complex equipment. Site 
visits to Britest members has indicated process plant equipment is complex and can be very 
challenging to clean. This would indicate that it is considered necessary to consider plant 
cleaning at a very early stage in the manufacturing process. This is in keeping with the 
philosophy of understanding WPD and in particular WPU. It is considered that a fundamental 
scientific understanding of the science behind cleaning needs to be carried out. The 
development of a tool for these purposes will be considered in Chapter 4, which discusses the 
choice of methodologies for the development of any tool or methodology to begin to address 
the challenge of understanding the fundamental science behind plant cleaning. 
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Chapter 4. Materials and Methods 
 
4.1 Introduction 
The previous chapters have discussed the answers to several of the research questions raised 
at the beginning of this thesis, RQ3 to RQ7 (Section 1.3). It is recognised that there is a need 
for more fundamental understanding of the science behind cleaning with solvents and other 
cleaning agents. This chapter describes the methodology used in order to develop a Britest 
tool, which can be used by industrialists to begin to understand the fundamental science 
behind cleaning.  
While research has been carried out to begin to understand cleaning mechanisms, for 
example, adhesion and cohesion (Fryer et al 2009), and the mechanics of cleaning such as the 
most effective cleaning flow rate (Fryer et al 2009), no-one has yet considered trying to 
understand cleaning using knowledge of the basic chemistry of molecules, and which solvents 
would be considered the most effective to remove residues from a surface. It seems logical to 
try and understand cleaning by looking at this aspect, as different chemicals have different 
molecular structures and different physicochemical properties. Therefore, by understanding 
the make-up of chemicals such as API’s, the physicochemical properties of the structure can 
be understood. Although this is commonplace in industry when considering how to 
manufacture products such as API’s, this has not been applied to cleaning. In order to begin to 
understand this, this chapter aims to answer the research question RQ2 - what is meant by the 
term ‘fundamental science behind cleaning’, in relation to process plant cleaning? 
In order to answer this question this chapter investigates the chemical structures (the relative 
arrangement of the atoms) of a series of API’s, their composition (the various atoms making 
up the molecule), and physicochemical properties. This information was used to create 
databases. The fundamental science in relation to process plant cleaning must lie within the 
fundamental molecular information and the physicochemical characteristics. This will be 
investigated in order to answer RQ2. Therefore this chapter will initially discuss the formation 
of databases used in this research, and the methodology used to answer the main research 
question RQ1 - what would be the best way to increase the fundamental understanding of the 
science behind cleaning linked to solvent and cleaning agent use? This chapter discusses data 
recognition and the acquisition of data, (section 4.2), the construction of databases containing 
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the data, and the data pre-treatment (section 4.3). Section 4.4 discusses the choice of 
methodology and gives a literature review for multivariate analysis, hierarchical clustering 
and PCA. The initial methodology used for this research is discussed in section 4.5. Section 
4.6 discusses the use of Principal Component Analysis (PCA) to gain further understanding 
and answers to the research questions which are the main aim of this thesis (Section 1.2 and 
1.3). This chapter will be summarised in section 4.7 and conclusions are made in section 4.8. 
 
4.2 Data Recognition and Acquisition 
4.2.1 Recognition of data 
As the aim of the research is to develop a tool to help understand the fundamental science 
behind cleaning, fundamental scientific data was required in order to do this. Fundamental 
data of API’s concerns the molecular structure and recognisable structural features. This can 
also mean the physicochemical characteristics of the molecule. In order to clean equipment 
according to the proposed method as discussed in Chapter 3, it is necessary to know what 
chemicals, including products and API’s, the equipment was in contact with. The most direct 
way of finding out about the molecular and physicochemical information relating to Britest 
members API’s was to ask Britest members. Obtaining this information from Britest members 
proved challenging due to concerns around process and product confidentiality. In order to 
overcome this barrier the research databases were created using API data, which is publically 
available on Britest member’s websites. These API are largely generic molecules of which 
there is a lot of information available in the open literature. This not only overcame the 
challenge but it meant that a lack of any data on intermediate chemicals and side reactions 
from processes reduced the complexity and the size of the data sets for the initial analysis and 
methodology selection.  
A list of 75 API’s was identified from Britest member’s websites in the public domain. The 
list was expanded to include several API’s from non Britest members which were included in 
order to increase the amount of data. Once the list of API’s had been determined it was 
necessary to find molecular, structural and physicochemical information for each one. In total 
81 API’s were selected. 
4.3 Database construction and Data pre-treatment  
Before database construction and data pre-treatment is discussed it is necessary to discuss the 
importance of pre-processing of data. Pre-processing of data is a very important first step in 
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analysis. Any data may be used, as it is as Wold says, ‘in statistics it is customary to put all 
data into a matrix and analyse the lot....all data reflect legitimate phenomena’. Wold (1987) 
also makes it clear that outliers can severely influence PCA and efforts should be made to 
remove them from the data set. This is somewhat contradictory and consideration of both 
points will be carried out for any analysis of the datasets used in this analysis. Other types of 
data pre-screening which can be utilised are transformation or data expressed as percentages. 
Transformation of data makes the data more symmetrically distributed, this kind of pre-
treatment is common with chromatography data (Wold, 1987). The data may also be auto 
scaled, means centred, or normalised. The best method to use for specific data can only be 
determined by trying a few pre-processing methods and selecting the best (Zitko, 1994). 
Unfortunately, there is still a lot to understand about pre-processing methodologies and how 
they can be used most effectively (Praveena et al 2012). 
Molecular, structural and physicochemical information for each API identified for this 
research was required in order to create databases of information. It was recognised that this 
would generate a lot of data, as there are a large number of variables associated with API’s. 
Therefore, early in the research it was established that three databases were needed. It was 
determined that the best method to use for pre-processing the data was normalisation. This 
was because databases 1 and 2 needed to be combined. The variables all had different units 
and without using this technique analysis would be difficult. Normalisation gave each of the 
variables an equal weight. This is further discussed in section 4.3.5. Descriptive statistics are 
provided in Appendix IV for database 1 and database 2 in order to help characterise the 
databases.  
4.3.1 Database 1: Chemical functional groups  
The first database was constructed using information on chemical functional groups for the 
API’s identified. This was carried out by visual inspection. An example of how the chemical 
group information was obtained is given for the drug Aspirin (figure 4.1). Initially the 
structure of the API was identified by entering the generic name of the API or the company 
specific name for the API into software. The software used for this purpose was ChemSpider 
(Chemspider, 2015) or ChemDraw (2015). This gave the structure of the API providing 
information used for the research. This data matrix was composed of variables associated with 
the chemical functional groups of the API. This includes information such as the type and 
number of amine groups present, the type and number of carbonyl groups present, or any 
structural features such as an organic framework. A list of variables used in database 1 is 
given in Appendix IV. The database is also shown in Appendix IV. 
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Figure 4.1 Chemical functional groups in Acetylsalicylic acid (Aspirin) Molecular Formula 
C9 H8 O4 (Pubchem, 2015). 
  
 
 
 
 
  
Figure 4.1 Chemical functional groups found in Aspirin. 
Each of the chemical functional groups identified as indicated in figure 4.1 would be recorded 
in an appropriate column in an Excel spreadsheet. This methodology resulted in the 
generation of data on chemical functional groups. The variables were tabulated and stored in 
an Excel spreadsheet (Excel, 2007). Figure 4.1 shows that Aspirin would be recorded as 
containing one carboxylic acid group, one Ester functional group and one aromatic functional 
group (benzene ring). Tabulation of the data for each API recorded multiple instances of 
chemical functional groups in some cases. The creation of this database allowed analysis of 
the compositions of each API.  
4.3.2 Database 2: Physicochemical properties 
Construction of the second database also required the use of the software ChemDraw and 
Chemspider, as it required information on physicochemical properties (variables) of the same 
75 API’s. Physicochemical information for the purposes of this thesis included information 
specific to properties such as melting point of the API, information on Henry’s Law, Gibbs 
Law, and many other characteristics that were identified from the indicated software.  
The information was collated and entered into a database in Excel to enable analysis.  
A list of variables used in database 2 is given in Appendix III. The database is also given  
in Appendix IV. 
4.3.3 Database Three  
Database three was constructed from database one and database two. The data contained in 
both databases was combined into one excel spreadsheet in order to make it easier for 
analysis. This database was therefore a complete set of all of the data collected.  
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4.3.4 Database Information 
It is important to state that not all of the required information concerning chemical functional 
groups, structure or physicochemical characteristics was available for the entire set of 
identified API’s. (This led to challenges concerning missing data during analysis which will 
be discussed later in Section 4.4.1). 
 It is also important to state that it was not known at this point if all of the information 
collected in both databases was of relevance to this research.  
4.3.5 Data Pre-Treatment 
Due to the nature of the data, databases one and two required pre-screening prior to analysis. 
It was important to treat both databases in the same manner in order to allow easy merging of 
the databases for analysis of all data variables in database three.  
Pre-screening involved assessment of the data and required the removal of some 
pharmaceutical product information, which contained limited data from the product list to 
ensure that data fields were as complete as possible. As previously stated it was not possible 
to obtain data for all identified API for this research. For the initial analysis the databases 
were used with data gaps as indicated in section 4.4.1. It was therefore necessary to omit some 
API’s from the analysis due to a lack of data availability after this initial research. This 
reduced the number of API’s used in this analysis. This list of API’s is given in Appendix II. 
The data sets were also normalised to obtain values between 0.0 and 1, using the following 
calculation (equation 4.1). 
 (V - mean of V)/s 
Equation 4.1 Normalisation calculation 
Equation 4.1 can be explained as follows. V is the variable dataset. V is divided by the mean 
value of every variable data set. The result is then divided by s which signifies the standard 
deviation of every variable.  
It was important to introduce normalisation because of multiple measurement parameters or 
scales involved in the physicochemical database. It was also important as the first and second 
databases were to be combined to create the third database. Other pre-treatment of data was 
not carried out in this research although the researcher is aware of other techniques (discussed 
in section 4.3).  
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Once pre-treatment was carried out for each variable database, analysis could then begin. The 
next step was to determine which methodologies to use to analyse the data. This is discussed 
in section 4.4.  
4.4 Choice of Methodology  
This section discusses the reasoning for using multivariate analysis. The data collected for this 
research project was complex due to the multiple variables, and any methodology chosen to 
analyse the data would need to be multivariate, to allow visualisation of the interactions of the 
variables in the data set. However, there are several types of multivariate analysis. Hanley, 
(1983) gave an overview of multivariate analysis and described it as “a collection of statistical 
techniques for dealing with several data items in a single analysis”. This concerned data 
defined as 3 variables and above analysed at the same time. Hanley, (1983) also described the 
method of analysis chosen to be dependent on “whether one is interested in interrelationships 
or in comparisons, and on whether variables are qualitative or quantitative.” The data 
collected for this research thesis was quantitative and it was important to consider the 
interrelationships. In order to select the best methodology it was necessary to carry out 
research into the uses of each method by carrying out a literature review (section 4.4.1) 
followed by trying different methods with the data. 
The software package available for use for the analysis was Minitab, as licenses were 
provided for this it seemed logical to use this software over other packages such as R or 
SPSS. Minitab software has several options available for analysing data. Analysis of data 
structure by covariance can be carried out using Principal Component Analysis (PCA) or 
Factor Analysis. Prior to using a technique to examine the data structure it was considered 
important to look at the data using a grouping method or cluster analysis to see if any 
immediate patterns or clustering was present. This was deemed a “quick and dirty analysis”. 
The types of methods available for this were the grouping observations. There were also 
several options available including cluster observations, cluster variables and cluster K-
means. This was carried out to see if anyone had carried out similar research in this field and 
also to determine what other researchers were using to using these methodologies for. This is 
discussed in the next section 4.4.1. 
4.4.1 Literature Review of Methodologies 
This section will initially discuss some of the theory associated with Multivariate analysis. 
Multivariate analysis has been described as a “codification of techniques of analysis, regarded 
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as attractive paths rather than straightjackets, which offer the scientist valuable directions to 
try” (Bishop et al, 1976). Carrying out an initial literature review on multivariate 
methodology it quickly became clear that these techniques are carried out in a number of 
scientific and social science research areas for multiple purposes. This observation fits in with 
Bishops definition that analytical paths have been chosen by many people for many purposes. 
Considering the data available for the research it was important to ask what the outcome of 
the research was. For this thesis it was important to discover if any patterns or links could be 
found in the data which would indicate how chemicals could be cleaned from process 
equipment. Any links and patterns may indicate ease of cleaning or difficulty in cleaning 
chemicals. It may help discover new cleaning methodologies for chemicals that are difficult to 
remove from vessels. Therefore the interaction between the data was important and therefore 
all variables in the analysis were treated equally. This meant that any technique used needed 
to take this into account. Techniques which can do this are PCA, Factor Analysis and Cluster 
Analysis. This narrowed down the techniques used in this thesis to these three techniques. 
Where cluster analysis groups objects based on a measure of proximity and classification, 
PCA and Factor analysis do not classify data but do reduce its dimensionality. Factor analysis 
and PCA are similar techniques but the aim of the thesis was to provide a useful technique to 
identify cleaning agents for the Pharmaceutical industry. It was important to use PCA as the 
method of choice because it reduces the number of variables to those which give the most 
variation in the data set. For this reason the literature review will concentrate on the use of 
Cluster Analysis (section 4.4.2) and PCA (section 4.4.3). 
4.4.2 Literature Review of Hierarchical Cluster Analysis  
This section discusses the theory behind cluster analysis and will also discuss some uses of 
the technique. Cluster analysis, initially mentioned in section 4.4, is further described here. 
Clustering methods are used in exploratory data mining and are also a common technique in 
statistical data analysis. There are many types of clustering methods including the hierarchical 
methods, portioning relocation methods, grid based methods and density based partitioning 
methods (Kogan, 2006). This thesis will use hierarchical clustering methods (also called 
connectivity based clustering), so this literature review will focus on these techniques. There 
are two types of Hierarchical clustering methods. The first is agglomorative and the second is 
divisive. Agglomorative clustering describes “bottom up” clustering where at the start of the 
analysis each variable belongs in its own cluster. During analysis clusters merge until one 
cluster remains for example using the Sequential Agglomerative Hierarchical Non-
overlapping (SAHN) technique by Sneath and Sokal (1973).  The second method is described 
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as “top down” where one cluster is present at the beginning of the analysis and then it is 
divided successively until each item is in its own cluster. Clustering for each method 
continues forming appropriate sub-clusters until a stopping criterion is achieved. Stopping 
criterion will be discussed later in this thesis.  
There are advantages and disadvantages to using hierarchical clustering. Advantages include 
that the technique can be used for any attribute type, the techniques shows a degree of 
flexibility regarding the level of granularity and its similarity or distance in any form can be 
handled with ease. There are several disadvantages to using this method which must be taken 
into consideration. These include the difficulties in choosing the correct stopping criteria and 
the fact that most hierarchical algorithms do not revisit (intermediate clusters) once they are 
constructed (Kogan, 2006). In addition, divisive clustering is thought to be more sophisticated 
and provides more robust clustering (Izenman, 2013).  
The results for both types of hierarchical clustering of data are best shown in a dendogram. 
The choice of clusters is made by algorithms which produces a hierarchy. Hierarchical 
clustering deals with N x N matrix of distances which can be similarity or dissimilarity 
between data points. One of the most difficult aspects of using clustering techniques is cutting 
or partitioning the data in the dendrogram at a certain height to give a partition of the data. 
This is also known as stopping criteria. This is carried out by calculating the distance between 
data points. The most commonly used method to measure distance is the Euclidean distance 
metric, which measures the geometric distance in the multidimensional space. This was used 
for this research thesis, as the data variables in the database chosen were all in the same 
physical units. Stopping methods for optimising clustering is a fundamental problem and it is 
challenging. Decision rules do exist and have been provided by Milligan and Cooper (for 
agglomerative clustering) to determine the appropriate level of the dendrogram. Principal 
Direction Divisive Partitioning (PDDP), a dynamic threshold based method, aims to stop the 
partitioning when the centroid scatter value exceeds the maximum cluster scatter value at any 
particular point (Jung et al, 2002). 
Choice of linkage is the other decision a researcher needs to make when using hierarchical 
clustering. This shows patterns and gives structure to the data. The choice of a linkage method 
determines how the variables are shown. On a dendrogram the height of clusters indicates the 
similarity or dissimilarity.  Similar variables are shown at low heights, while dissimilar 
variables are shown by a difference in height. Clustering can be difficult as there is no right 
answer. Clustering will be discussed further later in this section. 
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There are multiple possibilities for linkage the most common methods include complete 
linkage (furthest neighbour) or single linkage (nearest neighbour), the average link method, 
and Ward’s method (1963). The method chosen for this research was single linkage. This 
looked at linking data when any two variables in two clusters were closer together. The 
problem with this linkage method is that it can chain data together, called “chaining”, where a 
sequence of close observations in different groups can cause the groups to merge early.   
There are several methods for cutting or splitting data in an agglometric dendrogram. The 
oldest method is by Williams and Lambert (1959). In this method objects are split based on 
the values of only one variable. In the Macnaughton –Smith et al. (1964) method, a split is 
decided by taking the most distant object from the cluster for a new cluster. Other objects are 
then aggregated to the new cluster if they are closer to the new subset than the cluster they are 
in. This idea is similar to Huberts (1973) method, which takes a pair of objects which are 
most dissimilar to the cluster for the new cluster. The new clusters are then built according to 
distances between the original cluster and the new pair. In 1991 Roux exploited this idea and 
considered clustering generated by all pairs of objects, creating a priori like criterion. 
It is important to treat cluster analysis with caution, as different decisions concerning 
similarities in groups can give different dendrograms. Sometimes a hierarchical structure is 
imposed on the data even if it is not appropriate. Sorlie et al (2003) used the method to 
examine patterns of gene expression for clinical classification of tumours. The clustering lead 
to new theories which found that some breast tumour subtypes represent distinct biological 
entities, but in the profiling the data observed in clinical samples disproved these theories. 
Clustering is a popular method for analysing data in many fields for example in medicine 
(Boly, 2012, Leite, 2015) and in astrophysics which is discussed below. 
Cluster analysis can be carried out by cluster observations, cluster K-means, or clustering 
variables. Clustering observations are a useful technique when there is some information 
available about potential clusters. This methodology is popular in several fields of research 
including in space physics and geophysics, where researchers have used the technique to 
analyse Electromagnetic ion cyclotron (EMIC) waves in plasmaspheric plumes. This 
determined that cold plasma density was not a good predictor of EMIC occurrence inside 
plumes (Usanova, M.E 2013). Researchers have also used this technique to determine density 
irregularity in the plasmasphere boundary layer (Decreau et al, 2005). The methodology has 
been used to determine star clusters in galaxies by several researchers including Hattori et al, 
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(1997) and Joyce, M et al (2015). Cluster observation has also been used in many other fields 
including research into water quality (Singh et al, 2004), and Vialle, C et al, (2011). 
Cluster K (Number of K clusters means) methodology has been used in several different 
fields by researchers. It appears to be a common methodology in public health, where 
researches have used it, for example, to determine the dietary patterns of middle aged Irish 
men and women (Villegas, 2004) . Cluster K means has also been used by sports scientists to 
determine the motivational orientations and imagery use in goal profiling (Cummings, 2002).  
Clustering variables is a method which is used when there is no obvious relationship or 
grouping in the data. This method is frequently used by researchers in many fields, including 
earth sciences, to determine the physical and chemical variables in soil for example, by 
Arslan, (2013) and Irigoin (2016).   
There was limited available literature on using these techniques for pharmaceutical cleaning 
purposes, or for trying to group or cluster chemicals based on chemical functional groups or 
physicochemical properties. Two research groups used multivariable techniques for similar 
purposes, to determine clusters in data relating to pharmaceutical solvents (Xu, 2007), and 
analysis of collections of chemical compounds to identify potential lead drug candidates 
(Stanton, 1999). 
4.4.3 Literature Review Principal Component Analysis 
This section will focus on the theory behind principal component analysis before discussing 
some of the uses of PCA. PCA was initially developed by Pearson who described it “as 
finding lines and planes of closest fit to systems of points in space” (1901). This technique 
was further developed by other researchers, notably Wold (1987) and Hotelling (1933).  
PCA is a multivariate analysis mathematical methodology for reducing a large database of 
interrelated information or variables to a reduced number of principal components. The aim of 
the analysis is to show or explain the maximum amount of variance within the data set with 
the least number of principal components. A principal component is a new latent variable and 
all principal components are linearly uncorrelated to others. Principal components are ordered 
during the analysis so that the first few principal components retain the most variation which 
is present in the original variables (Jolliffe, 2002). The variance in the original data can be 
expressed as linear combinations of the principal components, i.e. - 
X=P*T 
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Where X is the data matrix and P and T are two smaller data matrix which capture the 
variability or the essential data in X. “Plotting the columns of T gives a picture of the 
dominant ‘object patterns’ of X and, analogously, plotting the rows of P shows the 
complementary ‘variable patterns’” (Wold, 1987). 
There is more than one type of PCA, including Common PCA, Functional PCA, Multiway 
PCA and Rotated PCA, and details of how these techniques have been used by researchers is 
provided below with their reasoning for use of the technique where appropriate.  
Principal Component Analysis (PCA) has been used in a number of diverse fields to analyse 
multiple variables, find patterns in data and use the information to find the best solution for 
storage (such as food or drink) or interpret variables. One of the most challenging aspects of 
PCA is understanding which components to retain. Webster (2001) says judgement must be 
made when choosing which components to retain and many tests proposed for this purpose 
are at best guides. Literature has shown that different fields favour different types of PCA and 
different methods to choose components to retain. Examples of research using PCA to analyse 
data, show different techniques and the breadth of its use across disciplines are described 
below.  
PCA has been widely used in social sciences to understand and analyse water chemistry 
(Dong, 2007), to determine mineral composition in Cigua (Oliveira et al, 2014), and to 
determine stream and water chemistry conditions in waste water (Wallace and Champagne 
2013). 
PCA has been used extensively in science, for example, Maere et al (2012) used the technique 
along with fuzzy clustering to determine bioreactor fouling behaviour. They used PCA 
(common PCA and types of functional PCA (expert PCA and B-splines PCA) to analyse 
transmembrane pressure data. It was possible to use functional PCA as the data set was 
known well. This technique required data conversion into a set of function parameters 
(separately estimated for each data series prior to PCA). This resulted in scores which 
captured the most variance in the data. Using this technique the results of the PCA analysis 
shift from the raw data to parameters of the functions. This technique has several advantages 
over common PCA which are that the estimated functions are able to express expert 
knowledge. This makes the data easier to interpret. The choice for one particular function 
means that analysis can focus on variations of interest, and also the number of PCA 
parameters using this model is generally lower than the number of variables in each series 
(than in common PCA). (Maere et al, 2012). This research allowed them to choose the best 
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method to use for this type of data. The preference was for expert PCA, as it handled outliers 
and noise better than the common PCA and it is less complex than the B splines method.  
PCA has also been used in food science, for example to evaluate the aroma quality of Chinese 
traditional soy paste during storage (Peng et al, 2014). Using PCA analysis the researchers 
were able to determine 15 volatile components in the samples and place them into three 
groups (overall odour types in storage periods which were floral roasting and pungent) based 
on the distribution on the factor loading plot. PCA has been used to differentiate gelatine 
sources based on polypeptide molecular weights (determined by sodium dodecyl sulphate 
(SDS) -PAGE). Analysis by PCA showed that using the molecular weights of gelatine it was 
possible to determine 5% porcine gelatine in bovine gelatine. This technique is useful for 
determining the purity of gelatine in a product. 
PCA is used in the chemical and manufacturing fields for many applications, one of which is 
described below. Nomikos and MacGregor (1994) used a non-linear PCA technique 
(multiway principal component analysis) to track batches of product in manufacturing. This is 
important as it ensures safe operation and to ensure that high quality products are produced. 
Nomikos and MacGregor (1994) did this using historical data of successful batches and 
compressing the data onto a low-dimensional space that summarizes both the variables and 
their time histories. A new batch of chemical could then be monitored by comparing its 
progress against the normal previous successful batches (Dong and McAvoy (1996)). Dong 
and McAvoy subsequently used a different method, Non-linear PCA, to successfully track 
batches of product in a manufacturing environment. Non-linear and linear PCA are the same 
apart from the fact that the non-linear approach summarizes the data with a smooth curve that 
is determined by nonlinear relationships among all the variables. Most batch data is non-linear 
and using a non-linear methodology was shown to have advantages over the multiway PCA. 
This is because it is thought to compresses data more efficiently. The multiway PCA is 
considered cumbersome if more than three components are needed to describe the data, as 
there are too many plots to analyse (Dong and McAvoy, 1996). In addition, using the 
multiway method may mean that the results are inadequate as minor components may be 
discarded. These minor components may contain important information. PCA has been used 
in other fields but research linked to this thesis topic has been difficult to find. Some analysis 
of data has been carried out in chemistry, for example Malinowski used PCA to analyse 
proton shift of methanes in a variety of solvents with (Trimethylsilyl groups) TMS (1970).  
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4.4.4 Cluster Analysis 
Selecting clusters in a dendrogram, PCA or other analysis techniques has been approached by 
researchers in many different ways. There is no defined optimal method and many consider 
the results of clustering as misleading (Gordon 1996). Many researchers have created new 
ways to cluster data as they try and look for more efficient methodologies, and importantly, 
validating the results of their analysis. These include stopping rules which define when to stop 
clustering data (Howe, 1979, Legendre et al 1985), or augmentation of a single class, the 
simultaneous test procedure developed by Gabriel and Sokal (1969). This provides a bound 
for the probability of incorrectly subdividing any class which is specified as homogeneous by 
a statistical model (Gordon, 1996).  
How researchers select the number of groups in clusters can be carried out by a number of 
algorithms or methods.  Many of the methods are developed in specific fields of research 
where difficulties present themselves when identifying clusters. For example, Guidi et al, 
(2009) proposed the use of random simulation test (RST) proposed by Ibanez (1973) to 
identify meaningful principal components. The RST takes into account if the data set contains 
statistical outliers and if they are present it isolates them instead of clustering them. This 
method was later used by Nicolls et al (2010) for the determination of the optimal number of 
clusters to be extracted from a classification used in ecological studies.  
Cluster analysis is a popular technique in operations management to determine manufacturing 
strategy taxonomy by Miller and Roth (1994), and Wathan (1995). Since the early 1990s the 
method has been used many times. Less traditional methods are being used in this field as 
more emergent techniques become available. These include p-median clustering, model-based 
clustering, neural network clustering, overlapping and fuzzy clustering and network 
clustering. It is considered by some that these emergent methods are not a replacement for the 
traditional clustering methods, but are suitable alternatives for some applications (Brusco, 
2012).  
In this section the uses of Hierarchical clustering, PCA and choice of clusters have been 
examined. The following two sections will discuss the initial method development using 
hierarchical clustering (section 4.5) and PCA (section 4.6). 
 
84 
 
4.5 Initial Method Development - Hierarchical Clustering 
4.5.1 Initial Method development - Multivariate analysis 
The initial methodology development was carried out using the information of the 
physicochemical properties (data in database 2). The most important criteria for choosing a 
methodology to analyse the information was the multivariate nature of the data. This meant 
that the initial methodology considered for analysing the data for groupings and clustering 
effects was multivariate analysis. The first analysis technique chosen was a hierarchical 
clustering system with the aim of clustering the variables into groups. This was chosen over 
other methods because potential groupings were unknown and no information on how the 
data may be grouped existed.  The aim of clustering is to find an optimal grouping where the 
variables in each group are similar, but the clusters are also different from each other. The 
resulting groupings in the data are ones which the researcher can see are sensible and can 
make sense of (Rencher, 2002). Hierarchical clustering in this case is carried out where a 
number of variables start out at the beginning of the analysis as discrete clusters. As the 
analysis progresses, the number of discrete clusters decreases as similarities are found 
between the data. This resulted in a hierarchy of clustering in the data, where cuts in the data 
can be made according to the relationships found.  
Using this methodology in Minitab (version 16), it is important to choose the correct linkage 
option. The linkage type option chosen for this technique was single linkage (nearest 
neighbour). This was because it identified groups which were spatially close in the data. The 
resultant clustering is visualised in a dendrogram generated in Minitab with database two, 
which shows the similarity and patterns within the data (Chapter 5, section 5.2). The main 
challenge associated with using this methodology was the amount of missing data. This was 
due to the nature of the data itself, and the fact that for some of the pharmaceuticals initially 
listed, it was not possible to obtain or generate data needed for the analysis. Some of the 
variables, which were included in the research data, were not calculable for every API.  
Database 1 initially gave 64 variables, which are listed in appendix III. This list was reduced 
to 57 variables by the exclusion of the structural and molecular features listed - sulfonated 
molecules, aldehydes, anhydrides, expoxides, nitriles and thiol.  
Database 1 initially contained 81 API’s. This was reduced to 73 during the analysis, due to the 
limitations of available data. 
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The data in database 1 was analysed with PCA (as was the data in database two). The use of 
PCA as a methodology will be described in section 4.6. 
4.6 Principal Component Analysis  
4.6.1 Principal Component Analysis Examination as a methodology 
This section builds on the knowledge gained from the previous section 4.4. Due to the number 
of variables in the datasets, it was important to consider another multivariate analysis 
technique to analyse the data. The next technique considered for examination of the data was 
Principal Component Analysis (PCA). PCA was used in this research because it was 
important to determine the interrelatedness between and within the variables. Due to the 
complexity of the databases, this type of methodology would reduce the number of variables 
considered as significant. It would compress the data and filter out some of the noise within it. 
The main aim of principal component analysis is to give reasons for the amount of variance in 
a data set with the fewest number of principal components. The principal components can be 
defined as “linear combinations of the original variables calculated with the maximum 
variance criterion. Principal components are centred, uncorrelated, and ordered from the 
largest to the smallest variance” (Minitab, 2016). The first principal component is the  
linear combination of all of the x-variables that comprise the maximum variance amongst  
all of the data. 
4.6.2 Principal Component Analysis of the data 
The data sets described in section 4.3 were entered into Minitab software (Version 16) and 
PCA was carried out. For this analysis, correlation or covariance could be used to measure the 
strength between two random variables, looking for patterns and linkages in the data set. 
Covariance was chosen for this analysis because it is a measure of the strength of the 
correlation, and not the strength of the linearity between the variables. The analysis was 
initially carried out with database 1 (on normalised data), which contained information on the 
variables associated with the chemical functional groups, and which were identified in the 
chosen list of API’s. A list of the chemical functional groups and properties chosen for this 
analysis is given in Appendix IV. Analysis was performed by PCA to help establish links and 
clustering effects between pharmaceutical products and the chemical functional groups. The 
results of this analysis are shown and discussed in Chapter 5 of this thesis. 
Further analysis was carried out on each of the remaining databases (two and three). The 
results of both of these analyses are shown and discussed in Chapter 5. 
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4.7 Chapter Summary 
This chapter discussed the origin of the data, which was required for the research. It was 
important to consider what information would address the challenge of beginning to 
understand the fundamental science behind cleaning. It was considered that the fundamental 
data must involve characterisation of the API’s that Britest members produce. This included 
obtaining information on the chemical functional groups and structural features which the 
API’s all consist of. Each structural and chemical make-up is unique to each API. This means 
that it might be possible to use a multivariable analysis technique allowing features to be 
clustered and grouped. This could be considered as a methodology to group API’s together 
for analysis with respect to cleaning purposes. In addition this analysis must include the 
fundamental physicochemical information, as it may also be able to indicate where API’s may 
be clustered together for analysis with respect to cleaning purposes.  
Carrying out a literature review on multivariate analysis techniques, and in particular 
Hierarchical clustering and PCA, has shown that trial and error often leads to the selection of 
the correct multivariate technique to use to analyse data. It is considered that one of the most 
important aspects of carrying out analysis using multivariate techniques is to understand how 
to examine clusters of data on plots produced during analysis. This will be considered when 
analysing data in this thesis. 
4.8 Conclusions 
This chapter identified the methodology to use to carry out the research as PCA. This is due to 
the nature of the data as discussed in section 4.4.  
The answer to research question RQ2 (Chapter 1, section 1.3), i.e. What is meant by the term 
‘fundamental science’ in relation to process plant cleaning, has therefore been partially 
identified for the purposes of this research. Chapter 5 seeks to further identify an answer to 
this question by focussing on the results obtained from the analysis of the three databases. 
This will lead to the identification of key variables that can indicate the best methodologies, 
which can be used to clean process plant equipment post manufacturing specific APIs.  
The results of the analysis on each of the databases will be discussed in Chapter 5 and 
consideration will be given to the construction of a model which can be used to meet the 
primary aim of this research, to develop an understanding of the fundamental science behind 
process plant cleaning. The production of a model to increase the knowledge of process 
cleaning will be a tool to help Britest members understand cleaning. This will be discussed in 
Chapter 5. Chapter 5 will also indicate where the tool will fit into the Britest tool set that was 
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identified in Chapter 3 as of considerable use to Britest members seeking to understand the 
fundamental science behind cleaning.  
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Database 1 and Database 2: Raw Data 
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Chapter 5. Results of Database Analysis by Minitab using  
Multivariate analysis 
5.1 Introduction 
This chapter gives the results of the analysis performed by Minitab (version 16). Analysis 
shown in this chapter is dendrogram analysis and PCA for the three databases whose 
construction was described in chapter 4. Chapter 5 aims to answer the Research Question 
RQ2: What is meant by the term ‘fundamental science’ in relation to process plant cleaning? 
Chapter 4 gave an insight into what the term means, but the aim of this chapter is to fully 
answer the question. This will be carried out by examining the multivariate analysis from the 
dendrograms and PCA for the appropriate database of variables.  
Section 5.2 of this chapter discusses initial results obtained from carrying out multivariate 
analysis using Minitab software and analysing data using dendrograms.  
Section 5.3 examines and discusses the results from analysing the variables using PCA on the 
functional and structural properties of known API’s. This is the information contained in 
database 1 (This information is listed in appendix II). In section 5.4 the results of the analysis 
by PCA on the second database containing information on the physicochemical properties of 
the same API’s will be presented and discussed. In section 5.5 the PCA results from the third 
database containing the combined variables of databases one and two will be shown and 
discussed. 
The results of both types of multivariate analysis used in this research will be further 
discussed in section 5.6. The choice of methodology to analyse the databases will be 
discussed and this will lead to the best choice of methodology and database to use for this 
research. This discussion will lead to a choice of database, which will be used to analyse 
industrial data provided by Britest members. Section 5.7 discusses the model development 
and begins to consider how cleaning agent and solvents data can be mapped onto the API data 
to create a more informative model, which will fulfil the remit of the aims of this thesis given 
in Chapter 1. In section 5.8 the purpose of the new model will be considered and how it can 
work with the existing remit of Britest tools discussed in Chapter 3. It is considered that the 
development of this model and its positioning in an adapted set of tools already discussed 
(chapter 3), will make a fundamental difference to the understanding of process plant 
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cleaning. Section 5.9 provides a summary of this chapter. A conclusion of this chapter is also 
provided in section 5.10. 
5.2 Multivariate analysis – Initial results - Dendrograms 
This method (as described in chapter 4) was used to analyse database 2 containing data on the 
physicochemical properties of the chosen API (listed in Appendix III). The horizontal axis of 
the dendrogram on figures 5-1 and 5-2 represent the distance between the clusters, or how 
much they are dissimilar. These figures show the amalgamation of information and suggest 
that clustering can be used to identify distinct groupings with similarity. One of the main 
discerning features of using this technique is that it can show discrete clusters. Figure 5-1 
indicates before the final cut the clusters are more discrete but have a lower similarity. Figure 
5-2 showing the final cut indicated that the clusters formed had a small number of variables.  
This method was used as an initial analysis of the data to determine whether any patterns or 
similarities could be observed in the information. A dendrogram analysing by single linkage 
was used because it looks for the closest distance between points. Absolute correlation 
coefficient distance was chosen because it shows the relationship between variables in the 
data. Figure 5-1 shows the greater the similarity the stronger the relationship between the 
data. 
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Figure 5-1 Dendrogram of data in database two relating to chemical properties of Britest 
member’s pharmaceutical products and ingredients. The information is showing clustering of 
variables according to similarity prior to the final cut. 
Figure 5-1 indicates that there was similarity in the data and a number of key clusters are 
shown. It is possible to determine that there is a similarity between data ACD/BCF (pH5.5), 
ACD/BCF (pH7.4), ACD/KOC (pH5.5) and ACD/KOC (pH7.4). This information can be 
described as follows - Advanced Chemistry Development Inc (ACD) is a company, which 
developed software for NMR prediction, nomenclature, chemical structure drawing, and 
physicochemical property prediction. The clustered information in figure 5-1 refers to tests at 
various stated pH values for the bioconcentration factor (BCF) and soil absorption coefficient 
(KOC). BCF - which is the term given to the concentration of a contaminant in or on a water 
organism such as fish. Bioaccumulation tests can use bioconcentration factors (BCF) to 
predict the concentrations of hydrophobic contaminants in organisms. BCF is the ratio of the 
average concentration of test chemical accumulated in the tissue of the test organism (under 
steady state conditions) to the average measured concentration in the water (Schäfer, 2015). A 
high BCF figure indicates low solubility of that particular chemical. KOC is the term 
indicating the tendency of a chemical to bind to, or adsorb to soil, per amount of water. 
Chemicals with large KOC figures tend to bind to soil (reach-serv, 2016). The clustering of 
this information is interesting, as it relates to the solubility of the chemical in water, which is 
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one of the factors that was discussed in chapter 3 as being important in terms of cleanability. 
Two other clusters of data, visible on figure 5-1, are molar refractivity and polarizability. 
These two variables are connected, so it is appropriate that they should form a cluster on the 
dendrogram. In order to explain this it is necessary to give a definition for molar refractivity. 
Molar refractivity is a measure of the total polarizability of a mole of a substance. 
Polarizability is ‘a measure of the ease with which the electron distribution in a molecule can 
shift in response to a change in electric field; the ability of an atom to accommodate a change 
in electron density’ (Fox, 2016). The value for the variable molar refractivity takes into 
account the value of total polarizability. Therefore once this was known it was likely to 
assume that these variables should cluster together. Both of these variables were similar to 
CMR on figure 5-1, indicating they are similar. Another cluster identified on figure 5-1 was 
boiling point and enthalpy of vaporisation. Boiling point indicates the temperature at which a 
chemical boils. Enthalpy of vaporisation is the energy which needs to be expended to turn a 
liquid into a gas. There is a relationship between the energy which is needed to convert a 
liquid to a gas and the boiling point of a chemical, and therefore a close relationship would be 
expected between these two variables. In order to analyse the data further it was necessary to 
cut the data to give clusters shown in figure 5-2. 
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Figure 5-2 Dendrogram of data in database two relating to chemical properties of Britest 
member’s pharmaceutical products and ingredients. The information showed clustering of 
variables according to similarity after the final cut. 
The final cut taken for this specific set of data was indicated in figure 5-2. This figure shows a 
higher similarity between the variables. Clusters of interest were considered to be those with a 
similarity greater than 80%, as shown on figure 5-2. These clusters were ACD/KOC (pH7.4), 
ACD/KOC (pH5.5), ACD/BCF (pH5.5) and ACD/BCF (pH7.4), which was identified in the 
previous figure, and CMR, Molar Refractivity and Polarizability. In addition, in the same 
cluster, relative molecular mass (MR) was identified as being similar. It is not known why 
this variable clustered in this position. Other clusters of variables identified were ACD/LogD 
(pH5.5) and ACD/LogD (pH7.4). In order to understand why these variables have clustered 
with a high similarity, it is important to consider what the term LogD means. A definition is 
given by the ACD website ‘(Log) D is the distribution coefficient and is a pH dependant 
measure of the propensity of a molecule to differentially dissolve in two immiscible phases, 
taking into account all ionized and unionized forms (micro species). It serves as a quantitative 
descriptor of lipophilicity’ (ACD Inc, 2016). LogD is a useful variable to know and 
understand in the pharmaceutical sector, because it can be used to assess drug likeness, and 
also in pharmacokinetics to help determine the ability of a drug to be absorbed, metabolised 
and also excreted. These variables relate to the solubility of a chemical, which is an important 
  
128 
 
consideration in plant cleaning as described in chapter 2. Closely related in similarity to the 
variable LogD is the variable LogP. LogP is described where P is the partition constant and is 
a measure of the propensity of a neutral molecule to differentially dissolve in two immiscible 
phases. It also serves as a quantitative descriptor of lipophilicity. This variable indicates the 
ability of a drug or chemical to be absorbed and it can also be used to assess drug likeness. 
This variable is also associated with solubility of chemicals. 
Another interesting cluster of variables were Hydrogen (H) bond acceptors and polar surface 
area. These two variables are defined as follows - H bond acceptors are molecules with the 
ability to accept Hydrogen bonds, and polar surface area is the total surface area over all the 
polar atoms. Polar atoms include oxygen and nitrogen and their associated H atoms (Clayden 
et al, 2001). Associated with this cluster is the variable tPSA. Topological polar surface area 
(tPSA) is defined as a measure of polar surface area (Prasanna, 2009). It is therefore logical 
that the variable tPSA would be associated with the variable polar surface area. 
Boiling point and enthalpy of vaporisation were variables associated in a cluster in figure 5-1. 
In addition to this figure 5-2 shows other variables associated with this cluster. These were 
index of refraction and surface tension. Index of refraction is the number that refers to the 
ability of light to travel through a medium. Surface Tension is the tension of the surface film 
of a liquid, which is caused by the attraction of the particles in the surface layer by the 
majority of the liquid. This tends to minimise the surface area (Clint, 1992). There seems to 
be no physical, chemical or other explanation for the similarity of these variables in the 
analysis. 
In addition to the variables described other clusters are visible the hierarchy of clustering is 
visible on figure 5-2. These will not be described further.  
The dendrogram cluster analysis has indicated that it may be a useful tool to cluster 
information when beginning to analyse cleaning methodologies. In order to determine if this 
is the best method to use for this analysis, it is important to consider other forms of analysis 
for the same data. In order to decide the best methodology for the examination of the data, a 
further methodology based on multivariate analysis was explored. Principal component 
analysis was investigated in section 5.3. 
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5.3 Principal Component Analysis Results and Discussion 
5.3.1 Introduction 
The method of principal component analysis (PCA) is discussed in chapter 4. In the next 
sections of chapter 5 the results of the analysis of each database 1 to 3 are presented and 
discussed. It is important to note for the purpose of clarity that some of the information and 
results are stated in this chapter as being of significance. The term significance within the 
body of this research means of greater impact and of greater weight than other results. This 
term was used with the understanding that within PCA analysis any results produced are 
evaluated by subjective decisions. 
5.3.2 Introduction Database One Results and Analysis 
Database 1 Results are shown in a series of figures (5-3–5-11). Where figure 5-3 shows a 
scree plot of the analysis, figure 5-4 shows the score plot of the analysis and figure 5-10 
shows the loading plot of the analysis. It is considered important that each plot is examined in 
order to determine if the analysis of this data would make a good model or tool to aid 
industrialists in cleaning process equipment. The initial analysis which was examined was the 
scree plot in section 5.3.3. 
5.3.3 Scree Plot examination for the PCA analysis carried out on Database 1 containing 
structural and functional group information on Active Pharmaceutical Ingredients. 
The scree plot (figure 5-3) gives a visual plot of eigenvalues against principle component 
values. The scree plot was challenging to interpret but it was considered that the initial 
principle components of interest were in the initial 27 points. At 27 points the ‘elbow point’ 
of the plot is shown. The actual data which corresponds to the scree plot is shown in appendix 
V. Using this data it was possible to state that the first ten component numbers have an 
eigenvalue of greater than 2. It is often considered according to the Kaiser criterion that 
principal components with a value above 1 should be retained (Kaiser, 1960). In this research 
the principal components with a value greater than 1 were retained, but other criteria (it is 
common practice when using PCA to use several techniques to interpret the data (Joliffe, 
2002)) were taken into account to decide which principal components to retain. This meant 
that some of the principal components not retained had values of greater than 1. This was due 
to the fact that the explained variance was a criterion used to determine the principal 
components. 
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Figure 5-3 Scree plot from PCA of variables in database 1 on the functional groups and 
structural features of API’s manufactured by Britest members. 
The initial principle component produces the greatest total variation in the data set 
(eigenvalue 4.7752 and a total percent variation of 8.4%). The eigenvalues decrease in value 
after this point as would be expected, given that they account for less variation in the data. 
(The data used in the scree plot (figure 5-3) is shown in figure I in appendix V). The figure 
numbered I gave the eigenvalues for each principal component as shown in figure 5-3. It was 
necessary to consider that some of the principal components added less variation to the data. 
The components which explained 70% of the variance in the data were retained in this 
analysis. This accounted for the initial 14 principal components out of a total of 57 
components examined. These principle components were taken to be of interest when 
examining the rest of the data and score and loading plot respectively for database 1. This was 
because the scree plot had determined the principal components and this strongly relates to 
the information in both the score and loading plot. 
In addition to the criteria chosen to determine the principal components, eigenvalues for each 
principal component were considered to be insignificant if they had an eigenvalue of below 
0.150. Eigenvalues above 0.150 were determined as significant and negative eigenvalues 
greater than -0.150 were also considered significant values. These values were chosen 
because they gave a range of data determining the extremes of the data showing the greatest 
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variance. Outside of these boundaries eigenvalues were not considered as important to the 
research. This method was used to determine the eigenvalues considered the most significance 
for the first 14 principal components. This was carried out by examining the eigenvalues for 
each principal component and determining if the value was within the remit required (above 
0.150 or below -0.150) to be considered significant. This gave an indication of which 
eigenvalues were significant to which principal component and this information could then be 
related back to the variables. The principal component values all related back to variable data 
and this was determined in each case. This gave the information in table I in appendix V. 
The scree plots (figure 5.1) were used to identify the functional group and structural features 
of interest, shown in Table I (appendix V). This was carried out by relating the functional 
group and structural information back to the eigenvalues for the principal components.These 
features provide the most variation in the data set according to the scree plot analysis of the 
first 14 principal components.  
The information produced from analysis of the scree plot was correlated back to the API’s in 
the analysis by determining which API’s contained the variable of interest to see if any 
clusters or groupings of API could be determined. This produced a list of API which 
contained the structural features, or functional group, associated with variation in the data. 
This information is shown in Table II in appendix V. 
The information in table II (appendix V) showed information of interest in the scree plot and 
related it to the API’s used in the analysis. The pharmaceuticals identified as having chemical 
functional groups or structural features contributing to the variability in the data set are given 
in table 5-1. 
Pharmaceutical product identified Significant functional groups or structural 
features identified 
Betamethasone disodium phosphate Na+ Association, Hydrozone, Phosphate 
group, Phosphonate group, Tertiary alcohol 
association 
Bambec Secondary amine group, Phenyl ring 
Blopress Carboxylic acid group, Phenyl ring 
Brofen Carboxylic acid group, Phenyl ring  
Citanest Secondary amide group, phenyl ring 
Clarithromycin Macrolide, Tertiary alcohol structure 
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Pharmaceutical product identified Significant functional groups or structural 
features identified 
Deflox Phenyl ring, Aromatic enamine group 
Doxcycline monohydrate Tertiary alcohol group, Vinyl alcohol group 
Epival Na+ Association, Carboxylic acid group 
Folic acid Primary amine group, Secondary amide 
group, Aromatic enamine group, Carboxylic 
acid group 
Furosemide Carboxylic acid group , Phenyl ring, 
Secondary amine group 
Gadopentetate dimeglumine (Gadolinium) Gd3+ Association, Carboxylic 
acid group , Secondary amine group 
Gadopentetate monomeglumine (Gadolinium) Gd3+ Association, Carboxylic 
acid group , Secondary amine group 
Gopten Carboxylic acid group, Secondary amine 
group, Phenyl ring 
HPMPC Phosphonate group, Aromatic enamine group 
Hytrin Aromatic enamine group, Phenyl ring 
Invermectin Tertiary alcohol group, Macrolide 
Klacid Tertiary alcohol group, Macrolide 
Levothyroxine Primary amine group , Carboxylic acid 
group, Phenyl ring 
Lupron Aromatic enamine group, Secondary amide 
group , Phenyl ring 
Marcaine Secondary amine group, phenyl ring, 
Secondary amide group 
Metrolazole Secondary amine group, Phenyl ring 
Oxis Secondary amine group , Secondary amide 
group, Phenyl ring 
Plendil Phenyl ring, Aromatic enamine group 
Quinapril Carboxylic acid group, Secondary amide 
group 
Roxithromycin Tertiary alcohol group, Macrolide, Oxime 
group 
Salmeterol xinafoate Secondary amine group, Carboxylic acid 
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Pharmaceutical product identified Significant functional groups or structural 
features identified 
group 
Sevelamer Primary amine group, Secondary amine 
group, Tertiary alcohol group 
Teveten Carboxylic acid group , Hydrozone group 
Warfarin Vinyl alcohol group , Phenyl ring 
 
Table 5-1 Pharmaceutical products, their associated chemical functional groups and  
structural features, which were identified as showing the most variation within the data set  
in database 1. 
Table 5-1 shows the pharmaceutical products which were identified as having characteristics 
that generated the most variation within the data set. The most prominent functional groups in 
table 5-1 will be considered in this section. The characteristics identified in table 5-1 could 
include features of API’s which could influence the cleanability of equipment. It is known 
that chemicals can be grouped according to chemical functional groups (Chapter 2 section 
2.2.9) and this method shall be used to determine if there were any patterns or reasons why 
these characteristics could have been identified in this research. It was considered that certain 
functional groups contribute to water solubility and some of these functional groups are 
represented in table 5-1. These include hydroxyl or alcohol OH group and carbonyl groups 
(aldehyde groups and ketone groups). Table 5-1 shows that there were API’s which contain 
different functional groups which include hydroxyl groups. These include tertiary alcohol 
association and vinyl alcohol groups in several API’s listed (Betamethasone disodium 
phosphate, Doxcycline monohydrate, Invermectin, Klacid and Sevelamer). Other types of 
alcohol groups were not found in these API’s. The carbonyl functional groups were 
represented by secondary amide groups in table 5-1. These were present in the API’s Citanest, 
Folic acid, Marcaine and Quinapril. There were no other carbonyl groups represented in the 
data in table 5-1. This may have been expected as they increase polarity and reactivity of 
molecules and therefore increase solubility. Amines are known to be very soluble in water and 
therefore API’s containing amines should be easy to clean from surfaces during plant 
cleaning. This can depend on the size of the molecule as the hydrocarbon chain gets longer 
the solubility of the molecule decreases (Clark, 2004). Table 5-1 shows that there were 
several types of amine identified. These included primary amine groups (in which only one of 
the H groups is replaced, which have a higher boiling point than secondary and tertiary 
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amines because they can form hydrogen bonds with each other as well as van der waals and 
dipole – dipole interactions (Clark, 2004)). Primary amines were present in Folic acid, 
Levothyroxine and Sevelamer. In secondary amine groups, two of the hydrogen in an 
ammonia groups are replaced by hydrocarbon groups, and this means that their boiling point 
is lower than primary amines (Clark 2004). In table 5-1 these were present in Bambec, 
Furosemide, Gadopentetate dimeglumine, Gadopentetate monomeglumine, Gopten, Marcaine, 
Metrolazole, Oxis, Salmeterol xinafoate and Sevelamer. There were tertiary amine functional 
groups represented in table 5-1 (Betamethasone disodium phosphate, Invermectin, 
Roxithromycin, Sevelamer, Clarithromycin, Doxycycline monohydrate and Klacid). In these 
groups all of the hydrogen in an ammonia molecule have been replaced by hydrocarbon 
groups (Clarke 2004). The other amine group represented in table 5-1 was the 
aromatic/enamine group. This functional group is an unsaturated compound. It is relatively 
reactive and it is nucleophilic. This means that they can be converted into aldehydes and 
ketones by acid catalysed hydrolysis (Clayden, 2001). This group was represented in API’s 
HPMPC, Plendil, Deflox and Folic acid in table 5-1.  
Other functional groups represented in table 5-1 included the acid groups, which were 
represented by acidic functional groups. The carboxylic acid group was the only group 
represented in table 5-1. Carboxylic acids are organic acids that contain a carbon atom that 
participate in both a hydroxyl and a carbonyl functional group. These functional groups can 
hydrogen bond with themselves in non-polar solvents, which raises the boiling points of 
API’s they are connected to (Clayden, 2001). Therefore, it could be considered that these 
functional groups are influential in the structures of API’s. This is because raising the boiling 
point of an API will change the ability to remove it from process equipment. Carboxylic acid 
functional groups were present in several API’s including Gadopentetate monomeglumine, 
Gopten, Levothyroxine, Quinapril, Salmeterol xinafoate, Teveten, Blopress, Brofen, Epival, 
Folic acid, Furosemide and Gadopentetate dimeglumine.  
In addition to the functional groups identified in table 5-1 there were several structural 
features. These were macrolides and phenyl rings and associations with Gd3+. Macrolides are 
a class of antibiotics which are bacteriostatic. They inhibit the growth of bacteria by inhibiting 
bacterial protein synthesis (Schlecht, 2016). Marcolides are large complex mixtures of closely 
related antibiotics and are basic in nature. They are poorly water soluble but they do dissolve 
in more polar organic solvents. Macrolides have a number of functional groups and this 
makes it possible for them to take part in multiple chemical reactions (MSD, 2015). The fact 
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that they are poorly soluble means that it is not surprising that they have been identified in the 
analysis, as this will have an effect on the ability to clean these API from vessels post 
manufacture. The API’s which contain macrolides in this research are indicated in table 5-1, 
and include the antibiotics Clarithromycin, Invermectin, Klacid and Roxithromycin. There are 
several classes of antibiotics represented by API’s used in this research, see Appendix II. 
Each antibiotic has different structures, properties and modes of action and it is possible that 
each class of antibiotic requires very different cleaning agents to remove it from vessels post 
manufacture. 
Another structural feature which was identified in table 5-1 was the phenyl ring functional 
group. Phenyl rings are very common in the API’s used in this research, which is not 
surprising as the formation of a phenyl ring gives a very stable structure which is required as a 
drug property. Phenyl rings are formed when a benzene ring is attached to a molecule by only 
one of its carbon atoms (Clayden, 2001). Phenyl rings are considered to be hydrophobic and 
they are therefore unlikely to be cleaned easily from production vessels using water alone. It 
is considered that the presence of a phenyl ring may have an influence on how an API may be 
removed from a production vessel by cleaning and choice of cleaning agent. The structural 
feature is found in many API’s in this research, see Table 5-1, these include Warfarin, Plendil, 
Oxis, Metrolazole, Marcaine, Lupron, Levothroxine, Hytrin, Gopten, Furosemide, Deflox, 
Citanest, Brofen, Blopress and Bambec.  
The final structural feature which will be discussed in relation to table 5-1 is Gadolinium 
(Gd3+) association. This was identified in the pharmaceutical products Gadopentetate 
monomeglumine and Gadopentetate dimeglumine. Both of these API’s are used in Magnetic 
Resonance Imaging (MRI) as contrast agents. Therefore they need to be soluble in the human 
body. These API’s are described as freely soluble in water (O’Neil, 2013) and therefore the 
ability of cleaning API’s associated with Gd3+ could be affected by this.  
In Table 5-1 also pharmaceutical products (API’s) can be found which have more than two 
features of interest. These products include Betamethasone disodium phosphate (Tertiary 
alcohol association, Hydrozone, Phosphonate group, Phosphate group and Na+ association), 
Folic acid (Primary amine group, secondary amide group, aromatic/ enamine group and 
carboxylic acid group), Gadopentetate dimeglumine (Gd3+ association, carboxylic acid group 
and secondary amine group), Gadopentetate monomeglumine (Gd3+ association, carboxylic 
acid group and secondary amine group), Gopten (carboxylic acid group, secondary amine 
group and phenyl ring), Levothyroxine (Primary amine group, carboxylic acid group and 
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phenyl ring), Lupron (Aromatic enamine group, Secondary amide group and Phenyl ring), 
Marcaine (Secondary amine group, phenyl ring and Secondary amide group), Oxis 
(Secondary amine group , Secondary amide group and Phenyl ring) and Sevelamer (Primary 
amine group, Secondary amine group, Tertiary alcohol group). It is not known which 
functional groups dominate the properties of the API over others and therefore could 
significantly influence the choice of cleaning method or agent.  
A number of API’s (23) have not been identified in the analysis and are not shown in table  
5-1. These are comprised in table III in appendix V. The features of these APIs do not greatly 
contribute to variation within the dataset, although some of the products showed similar 
chemical functional groups. Commonly occurring functional groups in products included the 
functional groups esters, which were present in eleven products; ketone functional groups, 
which were present in eleven products; steroid features, which were found in ten products; 
secondary alcohol functional groups, which were present in ten products, and ether functional 
groupswhich were present in nine products among others listed in appendix V in table III. 
The significance of the properties associated with the structural features and functional groups 
will be examined and discussed later in chapter 5. First, it is important to further analyse the 
information in database 1 created by PCA, by examining the score plot in  
section 5.3.4. 
5.3.4 Score plot examination for the PCA analysis carried out on Database 1 containing 
structural and functional group information on Active Pharmaceutical Ingredients. 
The score plot (figure 5-4), related to data associated with chemical functional groups in a 
series of API’s or pharmaceutical products. The score plot describes the relationship between 
the data, in this case based on the relationships between the first and second principal 
components.  
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Figure 5-4 Score plot showing data associated with chemical functional groups in a series of 
pharmaceutical products manufactured by Britest members. The numbers shown on the plot 
are row numbers used in the analysis which relate to different API’s. (Appendix V). 
Figure 5-4 clearly shows that the data was clustered, linked and separated based on the 
relationships found within the data set based on the first two principal components. It is 
apparent that a large amount of API’s were clustered around the zero point on both axes. In 
order to identify the API’s in each cluster, the original row numbers given to the API’s were 
used to identify them on the score plot. Figure 5-4 indicates that variation is found in the data, 
however the first and second principal components account for only 15.4% of the variation in 
the data set. It is clear that within the first two principal components there are groups of points 
that indicate clear separate distributions in the data. In order to discuss this data clearly it is 
important to reproduce the plot and indicate possible groupings (Figure 5-5) 
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Figure 5-5 Score plot (figure 5-4) reproduced with annotation. 
Figure 5-5 shows there were several identifiable groupings and prominent features which 
were circled. The circling or clustering was carried out by visual inspection which determined 
identifiable groups. A number given post the product refers to the pharmaceutical product 
reference number (in black font) the number given in blue font identified the group or 
cluster). These were identified in Table 5-2. 
Identified Group or 
prominent feature 
Identified Pharmaceutical products  
1 Betamethasone disodium phosphate (9) 
2 Clarithromycin (15), Invermectin (42), Doxcycline hyclate 
(22), Klacid (44) 
3 Lupron (46) 
4 Doxcycline hyclate (21)Roxithromycin(63) 
5 Nizatidine (55) 
6 Levothyroxine (45) 
7 Gadopentetate dimeglumine (29), Gadopentetate 
monomeglumine (30) Imdur (36) 
8 HPMPC (34),Teveten (69) 
9 Epival (23), Isradipine (41) 
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Identified Group or 
prominent feature 
Identified Pharmaceutical products  
10 Advicor (1), Androgel (3), Ciclesonide (13), Conholip 
(17), Progesterone (60) 
11 Beclomethasone dipropionate (6), Beclomethasone 
dipropionate monohydrate (7), Betamethasone acetate (8), 
Clobetasol propionate (16), Dexamethasone dipropionate 
(20), Fluticasone furoate (24), Fluticasone propionate (25), 
Halobetasol (33), Mometasone furoate anhydrous (52), 
Mometasone furoate monohydrate (53) 
12 Aluvia (2), Nimbex (54), Venlafaxine (70) 
Main data set Atenolol (4), Bambec (5), Blopress (10), Brofen (11), 
Calcijex (12), Citanest (14), Cycloserine (18), Deflox (19), 
Folic acid (26), Furosemide (27), Gabapentin (28), 
Ciclosporin (31), Hytrin (35), Iodixanol (37), Iopanidol 
(39), Isoflurane (40), Marcaine (47), Meperidine (48), 
Meprobamate (49), Methohexital (50), Olanzapine (56), 
Oxis (57), Paricalcitol (58), Plendil (59), Quinapril (61), 
Ranitidine (62), Salmeterol xinafoate (64), Severane (66), 
Tamsulosin (68), Warfarin (71) 
Products not 
identified in analysis 
Sumatriptan Base (67), Selelamer (65), Gopten (32), 
Iohexol (38), Metronazole (51) 
  
Table 5-2 Identified clusters and prominent features within score plot. 
There are a few points that stand alone as statistically relevant points of interest and these are 
Betamethasone disodium phosphate (nine) and Lupron (46). It is considered that there is 
something considerably different about these API’s which may mean they are cleaned from 
vessels differently from other API’s identified in the score plot. This may be due to the 
contribution of functional groups and structural features in each API (given in table IV in 
appendix V). There are also two products which are outside of the main group, these are 
groups five (Nizatidine (55)) and six (Levothyroxine (45)). A series of small clusters has been 
identified. These are shown in table IV (in appendix V) as groups seven, eight, nine, ten, and 
twelve. Two larger clusters of data are shown in the score plot (figure 5-5) and these are 
labelled as group eleven and the main data set. The main data set clusters close to and around 
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zero. These comprise the majority of products. Several pharmaceutical products do not appear 
in the data set. These are also indicated in table 5-2. 
Groups of products were identified in the score plot and this information was back related to 
the pharmaceutical products and the chemical functional groups and structures they contain, 
see Table IV in appendix V. Some of the characteristics in this table are primary 
characteristics, which were identified from the scree plot (table 5-1). In addition to these 
characteristics, a further set of characteristics was identified from the score plot analysis. 
Table IV, appendix V shows features that were determined in these groups from the score 
plot. These shall be called the secondary characteristics. In addition to the primary 
characteristics determined by the scree plot, the secondary characteristics will be discussed in 
the identified groups. This will help to determine whether these secondary characteristics are 
of importance in the score plot. The functional and structural information of the 
pharmaceutical products in identified groups on the score plot shall be analysed as follows. 
Group 1 
Group 1 contained one point of interest relating to the pharmaceutical product Betamethasone 
disodium phosphate (Figure 5-5). This is significantly different to the other data on the score 
plot. The first component is -14.5365 and the second component is -7.54679 and it lies in the 
upper left quadrant of the score plot. No other pharmaceutical product scores as low as this 
value. This product contains a significant number of groups identified as of interest in the 
scree plot (table IV, appendix V). It can be stated that the variance showed by this point is 
greater than the other points due to this factor. The groups of interest in this pharmaceutical 
product exceed any other group. These groups or features of interest are Na+ association, (it is 
associated with two Na+, unlike the product Epival in group nine which is associated with 
one), and it also has a hydrozone feature and tertiary alcohol association. In addition the 
product is associated with both phosphate and phosphonate groups. These features make it a 
unique point within the data set. Secondary characteristics identified in this group include 
secondary alcohol, ketone, Aryl halide functional groups and steroid structures. 
Group 2 
Group 2 consists of four different pharmaceutical products which lie in the bottom left 
quadrant of the score plot (figure 5-5). These data points refer to pharmaceutical products 
Clarithromycin, Invermectin and Doxcycline monohydrate and Klacid. These four products 
all have Tertiary alcohol functional groups within their structures that give them a common 
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link. The other feature associated with Clarithromycin, Invermectin and Klacid is a structural 
feature macrolide. The two pharmaceutical products Klacid and Clarithromycin have the same 
structural and functional group properties as they are the same product. This data was 
included in the dataset as an internal control. The pharmaceutical product Doxycycline 
monohydrate does not have this feature, although Doxycycline monohydrate has the presence 
of vinyl alcohol. In terms of secondary features in Group Two there are a mix of different 
functional groups and structural features. The group of products as a whole all contain 
secondary alcohol functional groups and three of the set contain both Esters and Ether groups. 
This set of data does contain products which have large numbers of Ether functional groups in 
comparison to the other pharmaceutical products. Clarithromycin and Klacid have six Ether 
functional groups each and Invermectin has nine. 
Group 3 
Group 3 consists of one pharmaceutical product which is Lupron. This product lies distinct in 
the right hand quadrant of the score plot (Figure 5-5). Its co-ordinates are given as first 
component 4.4029 and its second component is 5.41164. This product adds significantly to 
the variation within the dataset. This is composed of several features which were identified on 
the scree plot as being of significance. These features include aromatic enamine, secondary 
amide and a phenyl ring. It is an interesting product because it has multiple features in 
combination that makes it different to other API’s in the data set. In terms of secondary 
features this product contains primary alcohol groups, phenol groups, secondary amide, 
guanidine, alkyl groups greater than 5 carbons and N-heterocyclic features. 
Group 4 
Group 4 consists of two pharmaceutical products, which are Doxcycline hyclate and 
Roxithromycin. This group lies in the bottom left quadrille of the score plot. It is quite close 
to the position of Group 2. The pharmaceutical products in this group, similar to Group 2 also 
have tertiary alcohol structures in their construct. Both products have additional groups 
identified by the scree plot as being of interest. Doxcycline hydrate has an associated vinyl 
alcohol feature, which makes it similar to Doxcycline monohydrate. These products are close 
in position on the score plot. Roxithromycin is a product, which contains an oxime group. It is 
the only product within the dataset to contain this feature, which means that the oxime group 
could have an effect on variation within the dataset. This is because it is the oxime group 
which makes it different from the other API’s in the data set. The oxime group is known to be 
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very poorly soluble in water (Clayden, 2001) which may account for the difference in terms 
of solubility. This may then affect the ability to clean this product from equipment post 
manufacturing. Group 4 has two pharmaceutical products with very different functional 
groups in the secondary characteristics. Both products (Doxcycline hyclate and 
Roxithromycin) have tertiary amine functional groups. 
Group 5 
Group 5 consists of one pharmaceutical product, and although it lies close to the main central 
dataset, it is visually distinct from the main group. This product is Nizatidine. The only group 
of interest identified by the scree plot in this product is an aromatic/enamine. In terms of 
secondary characteristics functional groups include tertiary amines, thioesters, nitro groups. 
Secondary structural characteristics include N-heterocyclic and S-heterocyclic structures. 
Group 6 
Group 6 consists of a single pharmaceutical product closely associated on the score plot to 
Nizatidine, which is in Group Five. This product does not contain features identified by the 
scree plot as being of interest. The features associated with this product Levothyroxine are a 
primary amine, carboxyl acid and a phenyl ring. This product is different from other API’s in 
the data set as it is a hormone with multiple functional groups. The other hormone in the data 
set (Progesterone) has different functional groups to Levothyroxine and was found in Group 
10. Secondary structural features include Phenol, Ether, Aryl halide groups and the structural 
feature of a hormone. 
Group 7 
Group 7 consists of three pharmaceutical products. These are Gadopentetate dimegumine, 
Gadopentate monomeglumine and Imdur. The first two products are very similar in 
construction. Both products contain secondary amine, carboxylic acid, GD3+ association and 
secondary amides. In addition to this Gadopentate monomeglumine contains water. The third 
product in this group, Imdur, is interesting as it contains no features identified by the scree 
plot analysis as adding significantly to this variability within the data. It has a variety of 
features, which include secondary alcohol, ether, nitrate and O- heterocyclic. This data point 
does lie significantly close to the main data set in comparison to the other two products. 
However, given the absence of common features it could be stated that this point belongs in 
its own category. The only common feature in the secondary characteristics of interest is 
Secondary alcohol functional groups. 
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Group 8 
Group 8 contained two pharmaceutical products, which are Hydroxyl 2 Phosphonomethoxy 
Propyl Cytosine (HPMPC) and Teveten. Both these products contain different features 
identified by the scree plot as contributing a high degree of variation to the dataset. HPMPC 
contains phosphonate and aromatic groups. Teveten contains carboxylic acid and hydrozone 
features. The two products lie very close to each other on the score plot. The reason for this 
will be investigated at a later stage in this report. The primary and secondary characteristics of 
these two products are not similar as indicated in table IV, appendix V. 
Group 9 
Group 9 contains the pharmaceutical products Epival and Isradipine. Epival has features 
which have been identified by the scree plot analysis as adding to the variation, these include 
carboxylic acid and Na+ associations. Isradipine does not contain any features identified 
during the scree plot analysis. It has features which include ester, pyridine, alkyl >5 carbons 
and N-heterocyclic structures. Therefore it is not known why this product clustered within this 
group. The primary and secondary characteristics of these two products are not similar as 
indicated in table IV, appendix V. 
Group 10 
The pharmaceutical products identified within Group 10 are Advicor, Androgel, Ciclesonide, 
Conholip and Progesterone. Table 5-2 shows none of these products are associated with the 
characteristics that have been identified as adding to the variability as described by the scree 
plot. There are no common primary or secondary characteristics. In addition, it can be stated 
that both Advicor and Ciclesonide contain Ethers, Ciclesonide and Progesterone both contain 
Esters, Ciclesonide and Androgel both contain secondary alcohols and Progesterone, 
Conholip and Ciclesonide all contain Ketone groups. Therefore the reason why it should 
cluster in this group was not determined at this point. 
Group 11 
Group 11 is a large group of pharmaceutical products which appear close to the main product 
group. With the exception of Betamethasone acetate, which contains a tertiary alcohol group, 
none of the identified products have any feature identified as significantly adding to the 
variation within the dataset. The other identified pharmaceutical products are Beclomethasone 
dipropionate, Beclomethasone dipropionate monohydrate, Clobetasol propionate, 
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Dexamethasone dipropionate, Fluticasone furoate, Fluticasone propionate, Halobetasol and 
Mometasone furoate monohydrate. The significance of the inclusion of Betamethasone 
acetate in this group will be discussed later in this report. Common secondary characteristics 
are found in all products, which are secondary alcohol groups, ketone, ester groups and 
steroid structural features. It may be that the accumulation of these secondary features is the 
reason for the clustering effect.  
Group 12 
Group 12 contains three pharmaceutical products. These are Aluvia, Nimbex and 
Venlafaxine. In this group there is only one product which has been identified by scree plot 
analysis as adding significantly to the variation in the dataset. This product is Aluvia, which 
contains primary amine features. Nimbex structure includes ester, ether, sulfone and N- 
heterocyclic features. One common secondary characteristic in all of these products is not 
found. However, both Nimbex and Aluvia contain Ester groups and both Venlafaxine and 
Nimbex contain Ether functional groups.  
Main Dataset 
The main dataset is located around the central point of the plot at the zero position. Table 5-2 
shows it includes a lot of data points equating to a significant number of pharmaceutical 
products. These products are listed below with any common identified chemical functional 
groups or structural features given in brackets - 
Atenolol, Bambec, Citanest, Mepridine (Phenyl ring) 
Blopress and Brofen (Carboxylic acid, Phenyl ring) 
Deflox, Plendil and Hytrin (Phenyl ring, Aromatic enamine) 
Cycloserine (Primary amine) 
Calcijex and Paricalcitol (Tertiary alcohol) 
Marcaine and Oxis (Secondary amine, Secondary amide, Phenyl ring) 
Folic acid, Salmeterol xinafoate and Furosemide (Secondary amine, Carboxylic acid) 
Iodixanol, Iopanidol and Ciclosporin (Secondary amide) 
Gabapentin (Primary amine, Secondary amide) 
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Quinapril (Carboxylic acid, Secondary amide) 
Tamsulosin (Secondary amine) 
Rantidine (Aromatic enamine) 
Warfarin (Vinyl alcohol, Phenyl ring) 
Methohexital, Meprobamate, Olanzapine, Isoflurane and Severane  
(No significant functional group or structural features identified by  
scree plot analysis). 
In the main data set there is a wide range of secondary characteristics. No particular pattern of 
information is identifiable. Further analysis of the main group of products identified in section 
5.3.4 was carried out and was discussed in section 5.3.5. 
5.3.5 PCA of the main group of identified products 
PCA was carried out using only the products in the main data set identified in section 5.3.4. 
This indicated the following results. The scree plot showed an elbow point after the first three 
principal components, all of which had eigenvalues greater than 2 (figure II, appendix V). 
Figure II indicated that this accounted for 33% of the variation in the data set. The first three 
variables in the dataset which account for this variability were the products Atenolol (15% of 
the variability in the data set), Bambec (10% of the variation in the data set) and Citanest 
(7.8% of the variation in the data set). All of these variables had phenyl rings identified in 
their structures. Other variables accounting for the variability in the data set with eigenvalues 
over 1 (taking into account Kaisers criterion), include Meperidine (also with a phenyl ring in 
its structure) (eigenvalue of 2.1344), Blopress (eigenvalue of 1.9974), Brofen (eigenvalue of 
1.8286), Deflox (eigenvalue of 1.6475), Plendil (eigenvalue of 1.4493), Hytrin (eigenvalue of 
1.3736), Cycloserine (eigenvalue of 1.2332), Calcijex (eigenvalue of 1.1429) and Paricalcitol 
(eigenvalue of 1.0156). Together these variables account for 79.4% of variation in the data 
set. The score plot of the same data (figure III, appendix V) shows the presence of individual 
and clustered data. It is possible to determine from figure III that a lot of the data is located 
around the zero point, which would indicate that a lot of the data shows no variation. There 
are points of data such as variable 2 (Bambec), variable 50 (Ciclosporin, the only macrocyclic 
product in the data set with a high number of secondary (4) and tertiary amides (7) and 
variable 16 (Salmeterol xinofoate (2 phenol alcohol groups, 1 long alkyl functional group and 
1 ether group, 1 carboxylic acid group, 1 secondary alcohol group and 1 secondary amine 
group)), which are separate from the main data set. This indicates that there is variability in 
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the data associated for these variables. Analysis of the data suggests that the presence of one 
or more phenyl rings seems to account for a lot of the variation shown in the data set. The 
products Bambec and Atenolol both have one phenyl ring in their structures. In addition other 
similarities include the presence of secondary amine functional groups and secondary alcohol 
groups. The products are very different in some ways as Bambec has two carbamate 
functional groups and Atenolol has both primary amide and ether functional groups. Citanest 
also has 2 phenyl ring structure, and similarly to Bambec and Atenolol it has a secondary 
amine group. There is also a secondary amide functional group present. Meperidine has a 
phenyl ring and N-heterocyclic, tertiary amine and ester functional groups. Blopress is an 
interesting product within the data set as it contains 3 phenyl rings (and also 2 N-heterocyclic 
structures and an ether and a carboxylic group). It is possible to determine from this that the 
presence of a phenyl group may be of more significance than other variables in this data set. 
Analysis of the score plot (figure III, appendix V) shows that variables Atenolol (1) and 
Tamsulosin (53) have clustered closely together. The only similarity in the data is both have a 
secondary amine functional group. The variables Brofen (6) and Ipomidol (49) have clustered 
together, although there are no common functional groups between them. The Loading plot 
(figure IV, appendix V) showed the position of the products in relation to each other. The 
figure IV shows that the majority of the products which accounted for the highest variation in 
the data set are on the right hand side of the figure. The similarity of these products was 
discussed above and most contain a phenyl ring structure. The Loading plot shows Warfarin 
as one of the products on the right of the figure. This is possibly due to the fact that its 
structure contains 2 phenyl rings, but this product was not identified in the scree plot as being 
of high variation within the data set. It has other structural features such as an O-heterocyclic 
structure which contribute to the fact that it is not soluble in water (Melnikov, 1971), which 
may be the reason for this. It may be gathered from this data that although the main data set 
examined from figure 5-5 and table 5-2 was not considered of high relevance to the research 
in the first PCA, separate analysis shows that some variables (including phenyl ring structures 
and the presence of secondary amine functional groups are of relevance. It is important to 
determine whether analysis of the principal components by examination of the score plots 
PC3 and PC4 and PC5 and PC6 gives any more information on the variance within the data 
set. This will be discussed in section 5.3.6. 
5.3.6 Analysis of further principal component score plots (PC3 v PC4 and PC5 v PC6). 
In addition to the analysis carried out in section 5.3.5 it was important to consider the variance 
indicated in the other principal components to contribute significantly to the variation in the 
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data set. In order to achieve this, principal components 3 versus 4 (figure 5-6) and principal 
components 5 versus 6 (figure 5-8) were plotted. Principal components 1, 2, 3 and 4 
combined together account for 27% of variation in the data. If principal components 1 to 6 are 
accumulated together this accounts for 40% of the variation occurring in the data set. The first 
plot under consideration is the score plot or scatter graph of the 3rd and 4th principal 
components (figure 5-6). 
 
Figure 5-6 Score plot of Third and Fourth Principal Components showing data associated 
with chemical functional groups in a series of pharmaceutical products manufactured by 
Britest members. The numbers shown on the plot are row numbers used in the analysis which 
relate to different chemical functional groups and features. (Appendix V). 
Figure 5.6 indicates some positioning of data around the zero point of both axes. It is possible 
to determine a number of clusters and groups within the dataset relating to the variables. 
Clustering is indicated by the addition of annotation (figure 5-7) and this is considered in 
table V, appendix V. 
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Figure 5-7 Score plot of the third and fourth components visualising groups and clusters 
identified by the analysis. Some of the groups of variables are identified in table V,  
appendix V. 
Figure 5-7 and table V (appendix V) indicate that although it was possible to identify clusters 
in the data set, it was difficult to analyse the information. The distribution of the variables in 
figure 5-7 is broad. The variables which do appear to be clustered (table V, appendix V) 
correlated to information on variables found in API’s in this research. It is possible to 
determine from table V (appendix V) that several API’s have chemical functional groups or 
structural features present in more than one group. It is therefore not possible to give a similar 
interpretation of the results as for the score plot (figure 5-6). It was possible to determine from 
tableV (appendix V) that there are several distinct variables in the dataset. (For ease of clarity 
during analysis these shall be referred to as groups). These are considered to add significantly 
to the variability of the data in the principal components 3 and 4. These variables are listed in 
table V (appendix V) as group 5 (Secondary amide groups), group 11 (Steroid structure), 
group 12 (Tertiary amine groups), group 13 (Thioester groups) group 14 (Ester groups), group 
15 (Fluorine groups), group 16 (Enone groups), group 17 (Primary amide groups), group 18 
(Phenyl ring structure) and group 19 (Hydrozone structures). In addition the groups 1, 2, 9 
and 10 and the variables they contain are of interest (table V, appendix V). In these groups it 
is possible to determine that there are several variables which correspond to the same API. In 
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group 1 Roxithromycin has all of the variables contained in the cluster (tertiary alcohol group, 
an oxime group, an ether group and macrolide structure). In addition this API has several 
other variables which have been identified in other groups within figure 5-7 and table V 
(appendix V). In group 2 (table V, appendix V). Lupron is identified more than once as 
having features and variables which are present in this cluster as it contains a guanidine group 
and a phenol group. Group 3 contains several features associated with Betamethasone 
disodium phosphate. These are a phosphate group, a phosphonate group and a Na+ group. It is 
possible to state that a majority of API’s are associated with more than one group or cluster 
identified in figure 5-7 and table V (appendix V). After analysing figure 5-7 it is important to 
consider what a plot of principal components 5 vs principal components 6 can add to the 
analysis of the variables within the dataset. Principal components 5 and 6 were plotted (figure 
5-8). This gave the following results. 
 
Figure 5-8 Score plot of Fifth and Sixth Principal Components showing data associated with 
chemical functional groups in a series of pharmaceutical products manufactured by Britest 
members. The numbers shown on the plot are row numbers used in the analysis which relate 
to different chemical functional groups and features. (Appendix V). 
In order to analyse figure 5-8 it was necessary to annotate it to show potential clusters and 
groupings indicated within the data set by plotting principal components 5 versus principal 
components 6. Figure 5-8 indicates a number of clusters in the data which have been 
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identified by annotation. These clusters are listed in table VI, appendix V. Table VI shows  
the APIs associated with the variables associated with each of the identified clusters in  
figure 5-8. 
There are a number of groups which could be associated with the variability in the dataset 
(table VI, appendix V). The table refers to the variability of the data in principal components 
5 versus 6. Table VI (appendix V) indicates which variables add to the variability of the data 
and which of the API’s in the dataset contain the variables. Groups of interest are the ones 
which are considered to be furthest away from the zero on both axes. These are considered to 
be group 1 (vinyl alcohol groups), group 2 (Secondary amine groups), group 3 (Gd3+, 
Carboxylic acid groups, Primary amide groups), group 8 (N-heterocyclic structures), group 9 
(Aromatic/enamine, groups, Thioether groups, S-heterocyclic structural features, nitro 
groups), group 10 (Guanidine groups), group 11 (Erythromycin derivative structural features), 
group 12 (Water associated API’s) and group13 ( HCL and Tetracycline associated structural 
features). Several groups contain more than one variable associated with one API. These are 
group 3, which is associated with Gadopentetate monomeglumine and some of its variables 
Gd3+ structures, carboxylic acid groups and the variable primary amides. Group 9, which can 
be associated with Nizatidine for all variables which are contained in the group 
(Aromatic/enamine groups, Thioether groups, S-heterocyclic structural features and 
Guanidine groups). There are other variables associated with the API Nizatidine which are not 
associated with this group. These are nitro groups and N- heterocyclic structural features. 
There are some variables which have been identified in other groups, which feature in the 
same API (Table VI, appendix V). An example of this is group 6 where the API 
Roxithromycin appears to contain all three variables associated with the group (Secondary 
amide, Ether group, Oxime group). Therefore, it is possible to state that the API’s associated 
with these variables are present in more than one group as associated with the data in figure 5-
7 and table V (appendix V). This information concerns the data plotted for principal 
component 3 versus principal component 4, or the information obtained from the initial figure 
5-2, the score plot of principal component 1 versus principal component 2. 
The individual data for each figure 5-2, 5-7 and 5-8 is interesting and using this, it was 
possible to suggest variables which may be considered to contribute to the most variation 
within the data set. This is considered in section 5.3.7. 
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5.3.7 Analysis of the first six principal components for database 1  
This section aims to identify the variables within the first 6 principal components which add 
most to the variation within the data set. In order to analyse this information it important to 
identify the variables which were identified as adding considerably to the variability in each 
of the figures analysed in sections 5.3.4 and section 5.3.6. These were figure 5-2, PC1 versus 
PC2, figure 5-7, PC3 versus PC4 and figure 5-8 PC5 versus PC6. This is given in table 5-3 to 
5-5. 
Table 5-3 showing characteristics determined as important in adding to the variability of the 
data set according to PC1 versus PC2. 
Variables 
Amine Alcohol OH Acid Carbonyl 
Groups 
N 
Groups 
Other 
characteristics 
Primary 
amine 
Secondary 
amine 
Aromatic/ 
enamine 
 
Tertiary 
alcohol 
structure 
Vinyl alcohol 
 
Carboxylic 
acid 
Secondary 
amide 
 
Oxime 
 
Phosphonate 
Phosphate 
 
 
 
Table 5-3 Identified functional group and structural variables within the PC1 and PC2 score 
plot analysis (figure 5-2). 
Variables 
Amine Alcohol 
OH 
Acid Carbonyl groups N groups Other  
characteristics 
Tertiary 
amine 
group 
Vinyl 
alcohol 
group 
Carboxylic 
acid group 
Ester group 
Thioester group 
Secondary amide 
group 
Enone group 
Primary amide group 
Ketone group 
None 
identified 
Steroid 
Fluorine group 
Phenyl ring 
Hydrozone structural feature 
Gd3+ group 
Thioether group 
Erythromycin derivative 
 
Table 5-4 showing variables adding to the variability of the data in the principal components 
PC3 and PC4 score plot analysis (figure 5-7). 
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Variables 
Amine Alcohol 
OH 
Acid Carbonyl 
Groups 
N 
Groups 
Other characteristics 
Secondary 
amine group 
Aromatic/ 
Enamine groups 
 
Non 
identified 
Carboxylic 
acid group 
Primary 
amide 
Guanidine Gd3+ group 
N-heterocyclic structures 
Thioether group 
S-heterocyclic structural features 
Water association 
Nitro group 
Erythromycin derivative 
Tetracycline structural features 
HCL association 
 
Table 5-5 showing variables adding to the variability of the data in the principal components 
PC5 and PC6 (figure 5-9) 
The information in tables 5-3 to 5-5 can be combined to give a list of variables of interest  
as determined by the first 6 principal components. The variables of interest are given in  
table 5-6. 
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Variables 
Amine Alcohol 
OH 
Acid Carbonyl 
groups 
N groups Other characteristics 
Primary 
amine 
Secondary 
amine 
Aromatic/ 
Enamine 
Tertiary 
amine 
group 
Secondary 
amine 
group 
Vinyl 
alcohol 
group 
Tertiary 
alcohol 
structure 
 
Carboxylic 
acid group 
Primary 
amide 
Ester group 
Thioester 
group 
Secondary 
amide 
group 
Enone 
group 
Ketone 
group 
Guanidine 
Oxime 
 
Gd3+ group 
N-heterocyclic structures 
Thioether group 
S-heterocyclic structural features 
Water association 
Nitro group 
Erythromycin derivative 
Tetracycline structural features 
HCL association 
Steroid 
Fluorine group 
Phenyl ring 
Hydrozone structural feature 
Thioether group 
Erythromycin derivative 
Phosphonate 
Phosphate 
 
Table 5-6 The combination of tables 5-3 to 5-5 indicates that there are a lot of variables 
which contribute to 38% of the variation in the dataset. There are a number of variables which 
appear in tables 5-3 to 5-5 more than once. These variables are carboxylic acid groups, 
primary and secondary amides and aromatic/enamine groups.  
It is clear from table 5-6 that the features which give the most variation to the data set are 
those listed other variables. These variables are not common in every product. It seems 
possible to use the information in table 5-6 to help determine how an API may be cleaned 
from a process plant post manufacturing. This is because there are some differences in the 
variability of the data set. In order to further investigate the information in data set 1, the 
Loading plot was analysed .The Loading plot is analysed and discussed in section 5.3.8. 
5.3.8 The Loading Plot for Database 1 
The Loading Plot of variables for PC1 and PC2 in database 1 (figure 5-9) indicates functional 
groups and structural features, and their position in relation to each other. 
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Figure 5-9 showing the Loading plot of all variables for the principal components PC1 versus 
PC2. 
Figure 5-9 was the only Loading plot considered during this analysis and it shows the 
loadings or variables used in the analysis (the functional groups and structural properties) in 
relation to the eigenvalues from the first and second principal components. In order to show 
how this information corresponds with the scree plot (figure 5-3) and the score plots (figures 
5-4 to 5-9) it is necessary to show the loading plot with groupings identified with circles 
(figure 5-10). The groupings were identified by visual inspection of the Loading plot. 
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Figure 5-10 Loading plot showing relationship between first and second component. The 
circles drawn on the figure indicate groupings or points of interest. 
Figure 5-10 shows groups of interest which have been circled and numbered one to six. 
Overall, the loading plot shows some properties which are separate to the main cluster of 
points which is central to zero on the plot. The circled and numbered variables are the ones of 
interest for clarity these are given in table VII (appendix V). 
The significant characteristics and individual points found in the analysis of figure 5-10 are 
described as follows - 
Group 1 
Group 1 contains characteristics of importance as determined by the scree and score plot 
analysis. This cluster contains phosphate and phosphonate functional groups, Na+ associated 
groups and Hydrozone characteristics. In addition this group contains a characteristic which 
refers to forms of acid other than Sulfonated and Carboxylic. In this group it is possible to 
determine that there are both functional groups which are considered soluble in water (Na+ 
associated groups) and less soluble in water (phosphate, phosphonate functional groups) and 
the structural characteristic hydrozone. 
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Group 2 
Group 2 contains primary characteristics Aromatic/enamine, Phenyl ring, Secondary amide. It 
also contains secondary characteristics, functional groups and structural features N-
heterocyclic structures, Phenol (moderately soluble in water) and Guanidine. All of these 
functional and structural features are water soluble. 
Group 3 
Group 3 contains primary characteristics Secondary amine, Gd3+ and Tertiary alcohol. It also 
contains Tertiary amine. Carboxylic acid also associated in this cluster but not as distinctly. 
Group three lies close to the main cluster of information, which is not considered of 
importance. All of these functional and structural features are water soluble. 
Group 4 
Group 4 contains the primary characteristic Macrolide. In addition to this Ether, Erythromycin 
derivatives, plus other secondary characteristics are identifiable. All of these characteristics 
are moderate to lowly soluble in water. 
Group 5 
Group 5 contains the primary characteristic Tertiary alcohol functional groups. It is presented 
in a group on its own in this interpretation but it is associated with Ester functional groups on 
the loading plot. Tertiary alcohol groups are soluble in water. If the hydrocarbon chain length 
of the alcohol increases the functional group becomes less soluble. Esters are soluble in water 
but if the chain length increases the solubility of the ester decreases. 
Group 6 
Group 6 contains two characteristics which are considered of secondary importance (therefore 
coloured blue in table IV in appendix V). These are Steroid organic frameworks and Ketone 
(Carbonyl) functional groups. These groups appear to be significantly distinct from the rest of 
the information, due to their position on the loading plot. Both steroid organic frameworks 
and ketones are soluble in water. These two characteristics lie close to Fluorine on the loading 
plot.  
In addition to the above identified groups several other characteristics appear distinct from the 
rest of the information. They include Pyridine, Fluorine, Thioester, Ester Aryl halide and 
Alkyl halide.  
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Within the dataset on the loading plot it is difficult to determine the position of some 
characteristics, which are considered of importance in the analysis of the score plots (figures 
5-4 to 5-10. These variables are Primary amine groups and Vinyl alcohol functional groups. 
Conclusions from the analysis of all of the information from database 1 will be discussed in 
the next section 5.3.9. 
5.3.9 Dataset one analysis conclusions 
The information provided in sections 5.3.3 to 5.3.8 considers the analysis of the data set in 
database one which contains information on functional groups and structural features of API’s 
identified as being manufactured by Britest members. The three different plots, the scree plot 
(figure 5-3), the score plot (figures 5-4 to 5-9) and the loading plot (figure 5-10) all give 
information about the variables of importance in the first six principal components. 
Considering all of the information and interpreting it is the best way to ensure that a good 
proposal or model is generated in order to give Britest members an idea of how information 
on functional and structural properties of chemical products can be used to devise cleaning 
strategies.  
The information generated from these data has drawn the following conclusions. 
There appears to be some characteristics within the dataset which can be considered of higher 
importance when clustering information together. This information could be separated into 
primary and secondary characteristics. These were determined on the basis of the number of 
factors - the loadings plot information (section 5.3.8), the score plot information (section 
5.3.7) and the scree plot (section 5.3.4) which determined how many principal components 
should be considered of importance for this analysis. The primary characteristics are 
composed of the following structural and functional group characteristics grouped by 
classification (table 5-7 and table 5-8). 
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Table 5-7 Identified primary characteristics functional groups. 
 
Primary Characteristics 
Organic Framework Framework Features 
Hydrozone 
Phenyl ring 
Macrolide 
Na+ Association 
Gd3+ Association 
 
Table 5-8 Identified framework and structural primary characteristics. 
Primary characteristics have been identified which could be used to link or group chemicals 
together, in order to suggest similar cleaning methods, which was the aim of this research 
(table 5-7 and table 5-8). In addition to this, a series of secondary characteristics (table 5-9) 
were identified that in combination with primary characteristics help could define 
pharmaceutical products into categories for realising different cleaning methodologies.  
 
Secondary Characteristics 
Alcohol Carbonyl Other Organic Framework 
Secondary 
alcohol 
Ketone 
Ester 
Ether Steroid 
 
Table 5-9 Secondary characteristics of importance. 
Primary Characteristic 
Amine Alcohol OH Acid Carbonyl 
Groups 
N 
Groups 
Other 
characteristics 
Primary amine 
Secondary amine 
Aromatic/ 
enamine 
Tertiary 
alcohol 
structure 
Vinyl 
alcohol 
Carboxylic 
acid 
Secondary 
amide 
 
Oxime 
 
Phosphonate 
Phosphate 
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In addition to the information presented in tables 5-7, 5-8 and 5-9, combinations of the 
primary and secondary characteristics of interest in grouping products are shown in  
Table 5-10. 
Group Number Characteristics 
Group 1 Na + Association, Hydrozone, Phosphate, Tertiary alcohol structure  
Secondary alcohol structure, Ketone, Aryl Halide, Steroid 
Group 2 Tertiary alcohol structure, Macrolide, +/-Ketone, Ester, Ether 
Vinyl alcohol 
Group 3 Aromatic /enamine, Secondary amide, Phenyl ring, Phenol 
Alkyl >5 carbons, Guanidine, Primary alcohol 
Group 4 Oxime group, +/- other properties 
Group 5 Aromatic/ enamine 
Group 6 Tertiary amine 
Group 7 Secondary amine, Carboxylic acid 
Group 8 Phenyl ring, +/- Secondary amine 
  
Table 5-10 Combinations functional groups and structural features of interest as a basis for 
cleaning methodology development, based on the score plot information.  
It is considered that the features identified in tables 5-7, 5-8, 5-9 and 5-10 will help identify 
potential groupings or links that allow cleaning methodologies to be tailored for particular 
uses and cleaning challenges. This was one of the aims of this research. The research in this 
report has served to give an indication of certain pharmaceutical products which could 
potentially be grouped together for cleaning purposes. 
The research carried out in this report means that there is now an identifiable list of chemical 
functional groups and structural features that can be provided to Britest members. What is not 
known is whether certain functional groups or structural characteristics are genuinely more 
important than other characteristics. If many of the identified features are present in a 
pharmaceutical product it is not possible to determine which ones are dominant. 
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In order to decide if analysis on data set one is the correct set of data to use as a model to 
begin to understand how to cleaning manufacturing equipment more effectively by 
understanding the fundamental aspects behind cleaning, it is important to consider the data in 
the second data set database two. Database two contains information relating to the same 
API’s considered in database one but uses a different approach. This is to determine the 
effectiveness of beginning to analyse the data by considering the physicochemical properties 
as a basis to cluster the API’s, and determine if cleaning can be carried out on the basis of 
this. Section 5.4 begins to look at the analysis of this second data set comprising of 
information on physicochemical properties. 
5.4 Database Two Analysis 
5.4.1 Introduction 
This section discusses analysis of database two which contained information on the 
physicochemical properties of the API’s chosen for this study (listed in appendix III). As 
previously mentioned it was difficult to obtain this data due to the nature of the information 
required. Data of a physicochemical nature is often not published by companies due to 
confidentiality. In addition, it was often not possible to obtain specific data as it was just not 
available. Full characterisation of API’s to the extent which was required for this research is 
not carried out. Therefore, in order to analyse this database it was necessary to reduce the 
number of API’s used (to 55) removing those where information was not available.  
5.4.2 Database two analysis Scree plot examination 
Database two was examined by PCA as discussed in chapter 4. Initially, the scree plot was 
examined (figure 5-11). 
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Figure 5-11 Scree plot of physicochemical property information found in database 2. 
The scree plot (figure 5-11) gives a visual plot of eigenvalues against principal component 
numbers. The number of components which contributed to the most variability was 
determined from this plot. These were deemed the significant principal components. Figure 5-
11 shows a typical scree plot shape as described by Minitab (version 16). There were a 
number of components essential to the variability of the data. It was determined from figure 
5-11 that the ‘elbow’ point of the data was up to five components. Within this dataset there 
were four components with an eigenvalue of greater than two. These data points significantly 
contributed to the variation, accounting for 80.4% across the data. It was therefore determined 
that the first four principal components were the ones to focus on in order to analyse both the 
score and loading plots. Principal component 1 had the greatest total variation in the data set 
with an eigenvalue of 20.443 and it accounted for 47.5% variation in the data. The second 
principal component had an eigenvalue 7.390 and accounted for 17.2% of variation in the 
data. The third principal component had an eigenvalue 4.095 and accounted for 9.5% of the 
data variation. The fourth principal component had an eigenvalue of 2.661 and accounted for 
8.04% of the data variation.  
The remaining components contributed 20% of the variation and were not considered for 
analysis. This decision was supported by the fact that components five and six only accounted 
for 6.7% of the variation within the dataset.  
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In order to establish what this meant in terms of the data involved, it was necessary to 
examine the variable values for each principal component one to four. This was carried out by 
examining the data for each given variable and determining its significance. The data was 
studied and eigenvalues below -0.150 and above 0.150 were determined as cut off values of 
significance. The reasoning and method used for database 1 (section 5.3.3) was used for 
database 2. This was carried out in order to give continuity throughout the analysis of all data 
in this research. It is possible to determine which components contributed to the variation in 
database 2. The scree plot showed which of the variables contributed to the variation within 
the data set considering the first four principal components (table VIII, appendix V). 
The list of variables, which showed the greatest variability in the data set within the first four 
principle components is given in Table VIII, appendix V. The variables analysed which 
appeared to give the most variation across the four principle components were tPSA and Polar 
surface area. These variables were also linked in the dendrogram analysis described in section 
5.2 of this chapter. For reasons discussed in section 5.2 it is not surprising that these variables 
should add considerably to the variation in this data set. Other variables showed significant 
contributions to variability across the initial four principle components (table VIII, appendix 
V). Variables including H bond acceptors, ACD/KOC (pH5.5) and ACD/BCF (pH5.5), 
contributed to a large amount of the variability within the data set. These variables were 
considered to cluster in the dendrogram analysis (section 5.2). Other variables adding to the 
variability included exact mass and molecular weight, Fluorine and Nitrogen content (both 
gases at room temperature and therefore considered easy to remove from equipment during 
cleaning). Also contributing to the variability in the data set in the first 4 principal 
components was Log P, which was identified in section 5.2 in the dendrogram analysis as 
relevant to cleaning research, as it is an indicator of chemical solubility. Surface tension and 
vapour pressure showed a high amount of variability within the first four components. These 
variables were not identified in the dendrogram analysis as adding greatly to the variation in 
the data set. Surface tension could have been identified because it is known to be important in 
cleaning processes. Surface tension is the tangential force that keeps a fluid together at an air 
liquid interface and it is considered an important factor in the choice of cleaning agents 
(Durkee, 2014).  
The only variables which were not accounted for in the first four principle components were 
Oxygen and Sulphur. It was considered that this was because both of these variables were 
present in most of the products used in the analysis. 
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In order to relate this analysis back to the pharmaceutical products it was necessary to 
establish which products had the properties identified in table VIII (appendix V). The best 
method considered to determine the API’s of interest was to examine the information in the 
scree plot in association with the score plot. This was carried out in section 5.4.3. 
5.4.3 Database two information: Score plot analysis 
In addition to the analysis carried out on the scree plot (section 5.4.2), the score plot was 
analysed for the first two principal components. Analysis of the score plot (figure 5-12) 
showed the relationship between the scores (chemical pharmaceutical products). This gave an 
indication of the relationships between the components determined by the first two principle 
components.  
 
Figure 5-12 Score plot of Physicochemical information in database 2. 
In Figure 5-12 pharmaceutical products were shown located around the zero point on both 
axes. Clusters of components were prominent on the score plot. These were represented by 
numbers which refer to different pharmaceutical products. In order to visualise the groupings 
and individual points which require analysis, the score plot was reproduced in Figure 5-13 
with indications of groupings shown by circles. These groupings and individual points were 
identified by visual analysis of the score plot. 
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Figure 5-13 Score plot of First and Second Component taken from analysis of database two, 
physicochemical information. The circled and numbered red dot numbers in each group refer 
to the pharmaceutical product reference number in the analysis. 
As figure 5-13 shows there were several identifiable groupings and prominent features 
circled. These were identified in table IX in appendix V and are discussed below.  
Figure 5-13 gives products that stand alone as points of interest. For ease of interpretation 
these are defined in this analysis as groups. The content of each group is identified as follows 
and this includes the number assigned to the product during the analysis (This helps 
identification on figure 5-13). These were groups 4 (Progesterone (45)), 5 (Plendil (44)), 7 
(Ciclesonide (9)), 8 (Fluticasone propionate (17)) and 10 (Hytrin (25)). There were several 
groups of two chemicals which were group 2 consisting of Meperidine (34) and Brofen (7), 
group 3 consisting of chemicals Isoflurane (28) and Severane (49) and group 6 consisting of 
Calcijex (8) and Paricalcitol (43). Two groups contained 3 chemicals these were group 1 
containing Atenolol (3), Meprobamate (35) and Gabapentin (20) and group 11 containing 
Warfarin (54), Marcaine (33) and Androgel (2). There was one group of six chemicals which 
was group 9. This contained chemicals Gopten (22), Quinapril (46), Halobetasol (23), 
Mometasone furoate monohydrate (38), Clobetasol propionate (12) and Dexamethasone 
dipropionate (15). The remaining chemicals within the data set were not found on the score 
plot. Table IX in appendix V gives chemicals which were identified by the score plot of first 
two principal components. Observing the data in table IX (appendix V) and in figure 5-13, 
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one relationship between the grouped products becomes clear. The chemicals have grouped 
primarily according to their molecular weight among other factors. This observation is clear 
when shown on a plot (figure of the molecular and exact mass of each product shown in table 
IX (appendix V). The relationship between the products is subject to other factors which has 
been determined because several of the products with similar molecular weights have not 
grouped together. In order to analyse the information given in figure 5-13 further, the 
common or unique features were determined for each group (table 5-11). This analysis was 
carried out by comparing non normalised data for each variable.  
Group 
Number 
Identifying features 
1 In group 1 the chemicals Atenonol, Meprobamate and Gabapentin were 
identified. The similar physicochemical properties in the group were the fact 
that the chemicals all have the same elements present which are Carbon, 
Oxygen, Hydrogen and Nitrogen. All three chemicals had a low C Log P 
value ranging between -0.66 and 0.915, which was the lowest of all 
identified groups. This group also had low ACD/LogD (pH5.5), ACD/LogP 
(pH5.5), ACD/BCF (pH5.5), ACD/Log D (pH7.4) values. Additionally, 
surface tension values were similar and H bond donor ability had a tendency 
to be higher in this group than the other identified groups. 
2 Group 2 chemicals were identified as Meperidine and Brofen. Both of these 
API contain no Fluorine, Sulphur or Chlorine. Meperidine had Nitrogen 
present but Brofen does not. The chemicals both had a similar Henry’s Law 
value, a similar C Log P value and a similar CMR value. They had the same 
number of freely rotating bonds (4). They had a similar value for Index of 
Refraction and Surface Tension and a similar Boiling point. 
3 This group of API consisted of 2 chemicals which were Isoflurane and 
Severane. These chemicals both contained no Sulphur or Nitrogen but 
Isoflurane contained Chlorine. The API in this group contained the lowest 
Gibbs Energy and Henry’s Law values identified among the data set. Similar 
characteristics in this group between the two chemicals were a low Heat of 
Form value and the same value for tPSA. They also had similar C Log P 
values, CMR values, Vapour pressure values, Enthalpy of vaporisation, 
Density, Polarisation value, no H bond acceptors, and similar ACD/Log D 
(pH7.4) values. Both API had similar Boiling point, and Surface Tension 
and Molar Volume values. The Index of Refraction was also similar and the 
number of Freely rotating bonds was the same (2). The number of H bond 
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Group 
Number 
Identifying features 
acceptors was the same and the ACD/ Log D value (pH5.5) and ACD/Log P 
values were similar. 
4 Groups 4, 5, 7, 8 and 10 only contain one chemical each. It is therefore not 
possible to compare the common physicochemical features in these groups. 5 
7 
8 
10 
6 Group 6 contained two API’s these were Calcijex and Paricalcitrol. These 
chemicals had very similar physicochemical characteristics. These included 
the same exact mass, the same molecular weight and the same number of 
Carbon, Oxygen and Hydrogen molecules. Both chemicals had no Fluorine, 
Sulphur, Nitrogen or Chlorine molecules. The chemicals had similar boiling 
points, melting points, critical temperature values, and critical pressure 
values. The API have similar Log P numbers, MR values, Henry’s Law 
values, similar Heat of Form values and the same tPSA values. Calcijex and 
Paricalcitrol had similar CMR values, ACD/Log P (pH5.5) and ACD/Log D 
values. The ACD/BCF (pH5.5) values were very similar and also higher 
than those of the other groups, with the exception of group 7. The 
ACD/KOC (pH5.5) values were higher in this group than in all other groups. 
Both chemicals had 3 H bond acceptors and a higher number of freely 
rotating bonds than most other groups identified. The API’s had similar 
molar volumes and boiling points and the same flash point values. High 
ACD/BCF (pH7.4) and ACD/KOC (pH7.4) values were indicative of this 
group. The group of chemicals also had the same number of H bond donors, 
the same polar surface volume, similar molar refractivity values, similar 
polarizability values and Enthalpy of vaporisation values 
9 Group 9 was the largest group of chemicals identified. It contained 
chemicals Gopten, Quinapril, Halobetasol, Mometasone furoate 
monohydrate, Clobetasol propionate and Dexamethasone dipropionate. The 
chemicals in this group were identified by the fact that they have a very 
similar number of Carbon, Oxygen and Hydrogen atoms. None of the 
chemicals in this group had Sulphur present and the amount of Fluorine, 
Nitrogen and Chlorine varied between the chemicals. The API’s had a 
similar boiling point which was higher in this group than in the other groups 
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Group 
Number 
Identifying features 
(with the exception of group 10). The chemicals in this group also had 
similar critical pressure values, critical pressure values, and critical volume 
values, Gibbs Energy values and Log P values. Heat of form values in this 
group were similar and all of these values were negative. The chemicals had 
similar tPSA values and CMR values 
11 In group 11 there were three chemicals. These were Warfarin, Marcaine and 
Androgel. Similar physicochemical characteristics between the three 
chemicals were the amount Carbon present. All of these chemicals had no 
Fluorine, Sulphur or Chlorine atoms. One chemical, Marcaine had Nitrogen 
present. The chemicals had similar melting points, MR values, CMR values, 
ACD/Log P values and molar volumes. The API’s are all able to donate one 
H bond and they had a similar molar refractivity value. 
 
Table 5-11 Features of groups identified in the score plot during PCA analysis of Database 2. 
 
In order to further analyse the data generated in the score plot (figure 5-13) it was compared 
against the average physicochemical property values for the dataset. A discussion of this 
analysis is given in appendix V. Appendix V also includes a breakdown of the main 
physicochemical characteristics of each of the API’s identified in table 5-11, and a flow chart 
indicating the simplest way to determine which group each API would be associated with. 
In order to further analyse the information provided during the PCA it was important to 
examine the score plot of the third and fourth principal components (figure 5-14). This shall 
be carried out next. 
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Figure 5-14 Score plot of the third and fourth principal components. Where c3 and c4 
indicate principal components 3 and 4.  
Figure 5-14 indicated visibly identifiable clustering of variables. The groupings were shown 
as numbered clusters (1-15) on figure 5-14. An explanation of what each cluster represents 
was discussed as follows. The numbers given in brackets following a variable indicate the 
analysis reference number. 
Group 1 
This cluster showed the relationship between identified variables H (6) and Gibbs energy (15) 
which were both identified in the third principal component as contributing to the variability.  
Group 2 
This cluster shows variables ACD/KOC (pH5.5), (26), ACD/KOC (7.4), (36), ACD/BCF 
(pH5.5), (25), ACD/BCF (pH7.4), (35) and H bond donors (37). These variables are identified 
in the scree plot analysis as adding to the variation in the first four principal components.  
Group 3 
This cluster contains variables including tPSA (20), H bond acceptors (27), Polar surface area  
(38), Vapour pressure (43), F (5). The variables in this group have not been previously 
identified as contributing to the variation in the score plot of principle components 1 and 2. 
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They were identified with the analysis of the loading plot, which will be discussed later in this 
research thesis (section 5.4.4). 
Group 4 
Group 4 was a small cluster of three variables which were exact mass (1), molecular weight 
(2) and Cl (9). These variables had been identified as adding significantly to the variation in 
the scree plot and the loading plot. 
Group 5 
Group 5 was the largest cluster of variables identified on figure 5-14. It contained variables 
ACD/Log P (23) not identified as being of significant on any other plot analysed. Carbon (3) 
identified in both the scree plot and the score plot of principal components 1 and 2. Critical 
temperature [K] (12) identified in the scree plot as being significant in principal component 1. 
ACD/Log D (pH7.4), (34) was identified in the scree plot as being significant in terms of 
adding to the variability within the data set and also in the loading plot, as well as the score 
plot of the first two principle components. ACD/Log D (pH5.5), (24) had been identified in 
the scree plot and the loading plot as being of significance. The variable boiling point °C (33) 
was identified in this plot as being of significance; it was also identified in the scree plot. 
Variable enthalpy of vaporisation was identified in the scree plot as adding significantly to the 
variation (42), variable Boiling point [K], (10), was identified as adding significantly to the 
variation of the data set in the loading plot and the scree plot. Molar volume (30) was found to 
add to the variability of the data set in both the scree plot and the loading plot. The variable 
melting point [K], (11) was found to add to the variation of the data set significantly in the 
scree plot. The variable flash point was found to add to the variation of the data set in the 
scree plot (32). The variable CMR was found to be significant in the scree plot (22). Variable 
Molar refractivity (39) was found to be significant in the scree plot. The variable MR (17) was 
found to be significant in the scree plot. 
Group 6 
Group 6 contains a cluster of three variables. These were LogP (16), and Index of Refraction 
(29), both identified in the scree and loading plot as adding to the variability of the data set. 
Density (41) was identified in the scree plot as contributing to the variability of the data set. 
Group 7 to group 15 
Group 7 contained one variable which was the variable Carbon (3). 
Group 8 contained one variable of interest which was the variable Sulphur (7).  
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Group 9 contained two variables which were the variable Oxygen (4) and the variable  
ClogP (21). 
Group 10 contained one variable of interest which was heat of form (19) 
Group 11 contained one variable of interest which was critical pressure (13). 
Group 12 contained one variable of interest which was Nitrogen (8). 
Group 13 contained one variable of interest which was freely rotating bonds (28). 
Group 14 contained one variable of interest which was Henry’s Law (18). 
Group 15 contained one variable of interest which was Fluorine (5). 
A summary of how this information contributed to the variation in the data set was discussed 
after consideration was given to the information provided in the loading plot which was 
interpreted in section 5.4.4. 
5.4.4 Database Two: Loading plot analysis  
The loading plot showed the relationship between functional groups and structural properties 
of the data set in relation to the eigenvalues for the first and second principal components. In 
order to determine how this information corresponded with the scree and score plot, it was 
necessary to show the loading plot with groupings identified. For clarity, variables of interest 
were indicated by circles labelled A to L (figure 5-15). These were considered as follows - 
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Figure 5-15 Loading plot showing the relationship between the first and second component. 
The circled data indicates groups of interest. These were labelled A to L. 
Variables of interest are shown circled and labelled A – L on figure 5-15. These were 
discussed as follows - 
Group A  
This group contained one physicochemical feature which was the element Nitrogen. This 
element was found to be of significance in the scree plot and the score plot. 
Group B 
Contained one feature of importance which was the physicochemical characteristic of vapour 
pressure identified in the scree plot. 
Group C 
Fluorine was the physicochemical feature identified of significance on the loading plot in 
group C. This was also found to be significant in the scree and the score plot. 
Group D 
The element Chlorine was found to be of significance in this group on the loading plot. 
Chlorine was also found to be significant in the scree and the score plot. 
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Group E 
This grouping of physicochemical characteristics on the loading plot contained all data 
relating to ACD/ BCF, ACD/KOC and ACD/ Log D at both pH values (pH 5.5 and pH7.4). 
There is a relationship between these values (as previously discussed in section 5.2) and 
therefore they would be expected to be close on the loading plot. Group E contained features 
which were shown to be of significance on both the scree and the score plot. The other 
physicochemical characteristic present in this grouping was the Log P value which was found 
to be significant in the scree plot analysis. 
Group F  
This grouping contained features which were identified as being of significance in data 
analysis of the scree and the score plot. In this group both molecular weight and exact weight 
were present. Molar volume identified in the scree plot analysis was also present in this 
group.  
Group G 
This group contained the boiling point [k] but not boiling point °C. There is a very definite 
relationship between these two values and it is not known why the analysis showed them to be 
different. Boiling point [k] was found to be significant in the score plot.  
Group H 
This was a large group of variables which contained features that are considered significant 
by scree plot analysis, such as polar surface area and H bond acceptors. There were other 
physicochemical characteristics in this group which were not identified as having significance 
in the scree or the score plot. This included the variables of flash point and index of refraction. 
Group I 
This group contained H bond donors which have been identified as of significance during 
analysis of the score plot. 
Group J  
Group J contained variables which were identified in other plots. These variables included 
critical temperature, melting point, freely rotating bonds, boiling point (°C), enthalpy of 
vaporisation. This group also included Carbon. 
Group K  
Group K contained the variables flash point, index of refraction, surface tension dyne, H bond 
acceptors, Polar surface area and tPSA.  
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Group L 
This group contained only one variable which was Critical Pressure (Bar). This was not 
identified as being significant by any other plot. 
Other Observations 
The characteristics density and heat of form are shown as distinctly separate (location wise) 
from other features on the loading plot. 
PCA of database two indicated that there were a number of interesting clusters and linkages in 
the data. This information was collated in table 5-12. 
Variables of Significance in Database Two determined by Principal Component Analysis 
Molecular weight Critical Temperature C ACD/LogD (pH7.4) 
Exact Mass Critical Pressure F ACD/BCF (pH7.4) 
Gibbs Energy Critical Volume H ACD/KOC (pH7.4) 
MR H bond acceptors N ACD/LogP 
Henry’s Law Freely rotating bonds Cl ACD/LogD (pH5.5) 
Heat of Form H bond donors  ACD/BCF (pH5.5) 
Flash Point Index of Refraction  ACD/KOC (pH5.5) 
Boiling Point (°c) Molar volume  Log P 
Boiling Point [K] Surface Tension   tPSA 
Melting Point Polar surface area  CLogP 
 Molar refractivity  CMR 
 Polarizability   
 Density   
 Enthalpy of vaporisation   
 Vapour pressure   
 
Table 5-12 Variables contributing to the greatest variability in database two. 
The variables identified in the analysis of database two are shown in table 5-12. A majority of 
the information show in table 5-12 relates to factors which are important when considering 
cleaning vessels post manufacturing API’s. This includes a number of the elements found in 
the data set (C, F, H, N, Cl). This could be due to the nature of the elements which can 
determine the state of the API at room temperature gas, liquid or solid at given temperatures. 
Fluorine, Hydrogen, Nitrogen and Chlorine are gases at room temperature. The number of 
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Carbon (C) atoms in an API related to the size of the product and potentially the solubility. 
Henry’s Law relates to the solubility of a gas in a liquid and therefore if the state of a product 
is considered an important characteristic. It is not surprising that this variable has also been 
identified. Molecular weight, relative mass (MR) and exact mass have been identified in this 
analysis as being of significant within the data. These relate to the size of a molecule which is 
a factor in cleaning. Variables which relate to the states at different temperatures were also 
identified in this analysis as being of greater significance than other variables. These include 
flash point, melting point and boiling point. These physicochemical characteristics are 
considered important when designing cleaning protocols. Gibbs free energy was found to be 
of significance in this research. This may be because it concerns the amount of free energy 
associated with chemical reactions that can do work. Heat of Form is of significance as it is 
the amount of heat generated during the formation of one mole of a compound from its 
component elements. The importance of H bonds in relation to cleaning has been discussed in 
section 5.2. Surface tension, tPSA and Polar surface area and their importance in cleaning 
were also discussed in section 5.4.2. Variables including ACD/LogD (pH7.4), ACD/BCF 
(pH7.4), ACD/KOC (pH7.4), ACD/LogP, ACD/LogD (pH5.5), ACD/BCF (pH5.5), 
ACD/KOC (pH5.5), Log P, CLogP and their significance to cleaning has already been 
considered in this chapter.  
Both databases of information were examined and the analysis has been discussed. It is 
important to now consider what PCA analysis of the full data set indicates. This requires 
analysis of databases 1 and 2 together (both the functional and structural detail of the API’s 
and the physicochemical information collected on the same group of API’s). This will be 
discussed in section 5.5. 
5.5 Database 3 Analysis 
Both databases analysed by PCA have indicated patterns and connections in the data which 
could be used to indicate appropriate cleaning methodologies in the pharmaceutical industry. 
It is thought that analysis of the two databases together as one database may indicate more 
groupings and patterns than the individual databases alone. Analysis of database three by 
PCA will be discussed in this section. Initially, the analysis will focus on the information 
contained in the Scree Plot (section 5.5.1). 
5.5.1 The Scree Plot 
The scree plot (figure 5-16) visualises the eigenvalues for each principal component during 
analysis of Database 3. 
  
175 
 
1009080706050403020101
12
10
8
6
4
2
0
Component Number
E
ig
e
n
v
a
lu
e
Scree Plot of Variables in Database Three
 
Figure 5-16 Scree Plot indicating the eigenvalues given for each component during analysis 
of Database 3. 
Figure 5-16 showed the relationship between the eigenvalues and the components. The scree 
plot shows the typical shape, as already described earlier (section 5.3). It was important to 
determine the number of principal components which added the most to the variability in the 
data set. The first 14 components within the data set gave the most variability in the data. This 
number of components corresponded with the “elbow” point on the plot. The scree plot also 
shows that there is a considerable amount of data which contributes to less than 1% of the 
variability in the data set. This includes data from the last 49 principal components. Principal 
components 1 to 14 account for 65.3% variability in the data and therefore the first 14 
principal components were examined. The eigenvalues from the first 14 principal components 
were found for each variable (table XII, appendix V). Some variables were not represented in 
the first 14 principal components. These variables, including functional and structural features 
and physicochemical properties, were listed (table XIII, appendix V) and not considered 
further in the analysis of the information presented by the scree plot for database three.  
The number of variables represented in the first 14 principal components was large (Tables 
XII and XIII). It was not considered appropriate to consider them all to be of significance at 
this stage of the analysis. It was important to reduce the number of variables at this stage of 
the analysis to include only those contributing the most to the variability in the data set. This 
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was carried out by reducing the number of principal components considered to be of 
significance to the first six components. A further observation from the analysis of this data 
set was that the majority of the variables of interest in the analysis were physicochemical 
characteristics of the APIs. The information provided in table XIII also indicates that most of 
the variables not of interest in the first 14 principal components were functional and structural 
features. 
Table 5-13 was constructed in order to reduce the number of variables considered to 
significantly add to the variability of the data set. This indicates the variables which add the 
most variability within the first six principal components. 
Variable name 
Functional and 
structural 
features 
Principal 
component 
associated with 
the variable 
Variable name 
Physicochemical 
features 
Principal component associated 
with the variable 
Aromatic/enamine c2  Nasal and 
inhalation 
classification 
c4 c5 
Primary 1 c6  Injectable 
classification 
c4 c5 
Tertiary 1 c5 c6 Antibiotic 
classification 
c4 c5 
Ketone c3  API classification c4 c5 
2 amide c2 c6  Exact mass c2 c6 
Tertiary amide c2  Molecular weight c6 
Ether c6  Contains N c2 c3 
Thioether c6  Contains P c4  
Fluorine c5  Contains Na c4 
Pyridine c4 Contains I c6  
Aryl halide c4 Boiling Point [K] c1 
Alkenes c5  Melting Point [K] c1 c3 
Phosphonate c4  Critical 
Temperature [K] 
c1 c3 
Hydrozone c4  Critical Pressure 
[Bar] 
c3 
Other features c4 Critical Volume c1 
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Variable name 
Functional and 
structural 
features 
Principal 
component 
associated with 
the variable 
Variable name 
Physicochemical 
features 
Principal component associated 
with the variable 
(cm3/mol) 
Phosphate c4 Gibbs Energy 
(KJ/mol) 
c5 
Nitro c6 MR (cm3/mol) c1 
Steroid c3 c5  Henrys Law c1 c3 
S-heterocyclic c6  tPSA c3 
  C Log P c1 
  CMR c1 c3 
  ACD/Log P c1 
  ACD/Log D 
(ph5.5) 
c1 c3  
  ACD/BCF (pH5.5) c1 c5  
  ACD/KOC 
(pH5.5) 
c1 c5  
  H bond acceptors c2 c3 
  Freely rotating 
bonds 
c2 
  Index of Refraction c1 c6 
  Molar Volume 
(cm) 
c2  
  Surface Tension 
dyne/cm 
c6 
  Flash Point c2 
  Boiling Point (°c) c2 
  ACD/BCF (pH7.4) c1 c5  
  ACD/KOC 
(pH7.4) 
c1 c5  
  H bond donors c2 
  Polar surface area 
A 
c2 
  Molar Refractivity c2  
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Variable name 
Functional and 
structural 
features 
Principal 
component 
associated with 
the variable 
Variable name 
Physicochemical 
features 
Principal component associated 
with the variable 
(cm) 
  Enthalpy of 
vaporisation kJ/mo 
c2 
 
Table 5-13 Variables associated with the first 6 principal components during analysis of the 
scree plot for database three. 
Table 5-13 showed the number of variables considered important to adding to the variability 
of the data set within the first 6 principal components. This represented 40.5% of the 
variability in the data set. The variables of importance are functional group and structural 
features as well as physicochemical properties. It became clear from table 5-13 that there were 
more physicochemical variables represented in the first six principal components than in the 
functional groups and structural features category. It was also apparent that most of the 
variables which were represented in the first three principal components (accounting for 
25.3% of the variation), were physicochemical variables.  
In order to understand the analysis of database three it is important to consider the score plot 
and the loadings plot. Therefore, before considering what the clustering or groupings of data 
mean for industrialists considering pharmaceutical plant cleaning it was important to analyse 
the score plot in section 5.4.2. 
5.5.2 The Score Plot 
The score plot (figure 5-17) was produced during analysis of database three containing all 
data (of functional and structural features and physicochemical properties of products). 
During this section it was necessary to consider what the analysis indicated. A number of 
clusters and points of interest were visually identified on figure 5-17. In order to investigate 
the points of interest it was necessary to annotate the score plot to identify groupings  
(figure 5-17). 
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Figure 5-17 Score Plot indicating the relationships between variables in database three. The 
red dots on the plot indicate a specific API. The identity of the API can be determined by the 
number it is associated with. 
 
Figure 5-18 Annotated score plot indicating clusters of interest during analysis of  
Database 3. 
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In Figure 5-18 points and clusters of interest are indicated. To help analyse these points 
further the clusters are presented in table 5-14. 
Cluster number 
(figure 5-15) 
Row numbers 
associated with 
the cluster 
Products associated with the cluster or 
point of interest 
1 9 Betamethasone disodium phosphate 
2 21 22 63 Doxycycline hyclate, Doxycycline 
monohydrate, Roxithromycin 
3 29 30 Gadopentetate dimeglumine, 
Gadopentetate monomeglumine 
4 46 Lupron (Leuproreline) 
5 37 Iodixanol 
6 54 Nimbex (Cisatracurium besilate) 
7 34 55 62 69 44 
15  
HPMPC (Cidofovir), Nizatidine, 
Ranitidine, Eprosartan (Teveten), Klacid 
(Clarithromycin), Clarithromycin 
8 31 Ciclosporin 
9 35 26 10 Hytrin, Folic Acid, Blopress 
(Candesartan cilextil) 
10 61 32 Quinapril, Gopten (Trandonapril) 
11 59 Plendil (Felodipine) 
12 12 20 16 33 53 Calcijex (Calcitriol), Dexamethosone 
dipropionate, Clobetasol propionate, 
Halobetasol, Mometasone furoate 
monohydrate 
13 58 24 25 Paricalcitol (Zemplar), Fluticasone 
furaroate, Fluticasone propionate 
14 2 Aluvia (Lopinavir or Ritonavir) 
15 13 Ciclesonide 
16 66 40 Severane, Isoflurane 
17 52 Mometasone furoate anhydrous 
18 64 70 1 50 14 36 Salmeterol xinafoate, Venlafaxine, 
Advicor (Niacin or Lovastatin), 
Methohehexital, Citanest (Prilocaine), 
Imdur (Isosorbide mononitrate) 
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Cluster number 
(figure 5-15) 
Row numbers 
associated with 
the cluster 
Products associated with the cluster or 
point of interest 
19 23 65 42 Epival (Sodium valproate), Sevelamer, 
Ivermectin 
Main group 60 18 41 5 56 19 
68 4 51 27 6 28 7 
47 57 71 49 48 
11 43 39 3 17 
Progesterone, Cycloserine, Isradipine, 
Bambec (Bambuterol), Olanzapine, 
Deflox (Terezosin hydrochloride), 
Tamsulosin, Atenolol, Metolazone, 
Furosemide, Beclomethasone 
dipropionate, Gabapentin, 
Beclomethasone dipropionate 
monohydrate, Marcaine (Bupivacaine), 
Oxis (Formoterol), Warfarin, 
Meprobamate, Meperidine, Brofen 
(Ibuprofen), Ketoprofen, Iopamidol, 
Androgel (Testosterone), Conholip.  
 
Table 5-14 Groupings and points of importance as shown in figure 5-18. API names were 
shown in the table (alternative names for the same API are shown in brackets proceeding the 
initial name of the API). 
Table 5-14 shows that there were several similarities between the groups identified during 
examination of the score plot for Database 1. These included individual products of interest. 
Betamethasone disodium phosphate (9) and Lupron (46) were found to be physical located 
apart from other API’s on the score plot. Doxcycline hyclate and Roxithromycin were also 
physically located close to each other on the plot. Other groups identified in table 5-14 were 
very different from those identified in the score plot of Database 1 examining principal 
components 1 and 2. This is probably due to the increase in variables. There are not many 
similarities between groupings on the score plot of Database 2 and Database 3. Ciclesonide is 
located physically apart from the rest of the data on both score plots.  
At this point in the analysis it is important to consider the information which can be gained by 
examining the score plot of principal components 3 and 4 (figure 5-19). 
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Figure 5-19 Scatter plot of principal components 3 and 4 taken from principal component 
analysis of database three. 
Several points of interest among the variables can be found in Figure 5-19. These were 
examined further using an annotated diagram to determine groups and points of interest 
(Figure 5-20). 
 
Figure 5-20 Annotated figure 5-19 showing points and clusters of interests. The red dots 
indicate a variable of interest which was identified by the number associated with it in black 
writing. Clusters were indicated by the circled data and given a group number in orange 
writing. 
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Table 5-15 shows clustering of variables according to the relationship between principal 
components 3 and 4. Figure 5-20 indicates there were a number of points of interest which 
correspond to variables. These variables are listed in table 5-15 according to the groups on 
figure 5-20. 
Groupings 
identified in 
Figure 5-20 
Variables 
associated by row 
number in analysis 
Variables associated in 
the identified group by 
name 
1 33 72 35 36 56 Phosphonate, Na 
association, Other features 
and groups, Phosphate 
groups, Na atoms 
2 71 34 Phosphate atoms 
Hydrozone 
3 85 83 70 78 tSPA, Henrys Law, 
Nitrogen atoms, Critical 
Pressure (bar) 
4 30 Aryl halide 
5 28 Pyridine 
6 7 Tertiary amide-1 
7 11 40 89 103 95 91 
101 64 27 32 104 90 
Ketone groups, Alkyl 
groups greater than 5 
carbons, Steroid features, 
Molecular weight, 
Fluorine groups, ACD/Log 
D (pH5.5), ACD/BCF 
(pH5.5), ACD/KOC 
(pH5.5), Molar Volume 
cm, ACD/KOC (pH7.4), 
Polar Surface Area A, 
Molar Refractivity cm.  
8 49 63 99 13 92 88 Macrocyclic, Exact Mass, 
ACD/Log D (pH7.4), H 
bond acceptors, 
ACD/LogP, Ester groups 
9 29 98 97 107 93 Alkyl halide groups, 
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Groupings 
identified in 
Figure 5-20 
Variables 
associated by row 
number in analysis 
Variables associated in 
the identified group by 
name 
Boiling Point, Flash point, 
Enthalpy of vaporisation 
kJ/mo, Freely rotating 
bonds. 
10 59 60 52 61 62 Nasal and inhalation, 
Injectables, Antibiotics 
and API classifications, 
Barbiturates 
11 10 3 67 57 9 Carboxylic groups, 
Tertiary, Phenol groups, 
Gd3+ groups, Fluorine 
atoms 
12 2 Secondary amide 
13 46 Phenyl ring structures 
14 77 76 87 Melting Point [K], Critical 
Temperature [K], CMR 
15 66 Oxygen atoms 
 
Table 5-15 Variables associated with principal components 3 and 4 generated during analysis 
of database 3. 
Table 5-15 indicates that there are a number of variables which were considered important in 
the analysis of the principal components 3 and 4. Prior to further discussion of these findings 
it is important to determine what principal components 5 and 6 can show in terms of analysis. 
Figure 5-21 was created using the principal components 5 and 6. 
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Figure 5-21 Annotation of figure 5-20 indicating the groups and points of interest. The red 
dots indicate a variable of interest which was identified by the number associated with it in 
black writing. Clusters were indicated by the circled data and given a group number in orange 
writing. 
Figure 5-21 shows that a majority of the variables are located around the zero axes. It was 
possible to identify points of interest which were marked with numbered circles on the plot. 
The variables associated with the groupings were shown in table 5-16. The most interesting 
point on figure 5-21 was the variable 94 which was data related to index of refraction. This 
was because it was located at some distance from the other variables.  
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Groupings 
identified in 
Figure 5-20 
Variables associated by 
row number in analysis 
Variables associated in 
the identified group by 
name 
1 54 64 63 Ethanol, Molecular 
weight, Exact mass 
2 7 Tertiary amide 
3 94 Index of Refraction  
4 38 26 96 Nitro groups, thioether 
groups, Surface Tension 
dyne/cm 
5 69 Sulphur molecules 
 
Table 5-16 variables of interest in groups identified from the scatterplot of principal 
components 5 and 6 while analysing Database 3. 
Analysis of figure 5-21 indicated that there were several variables which were located 
distinctly away from the main data set. Table 5-16 lists these variables. Several variables are 
located close enough to visually group together. These are group 1 and group 4. Group 1 
contains variables ethanol, molecular weight and exact mass. As exact mass and molecular 
weight are strongly linked these two variables would be considered likely to group together. It 
is not known why ethanol should also cluster in this group. In group 4, the variables nitro 
groups and thioether groups were clustered together with surface tension. Nitro groups are 
groups known to draw electrons away from a reaction centre. Thioethers are volatile 
functional groups. The connection between the two functional groups and ethanol is not clear. 
For ease of explanation individual points of interest on figure 5-21 are described as groups in 
this research, therefore individual points of interest are labelled as groups 2, 3 and 5. Group 2 
contains the characteristic tertiary amide, which is known to show low solubility in water. It is 
not known why the physicochemical characteristic index of refraction is physically distinct 
from other variables. Sulphur atoms are the only variable in group 5 which are physically 
located close to group 4 on figure 5-21. This could be because there is a link between Sulphur 
atoms and Nitro groups (sulphur groups are found in nitro groups). It is possible to state that 
there was not a lot of information gained in examining 5-21. The next stage of the analysis 
will focus on examining the loading plot for Database 3 in section 5.5.3 
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5.5.3 Loading Plot Analysis 
To complete the analysis of Database 3 it is important to consider the information which can 
be gained by examining the Loading Plot (figure 5-22). Figure 5-22 shows the relationships 
between the variables when the first and second principal components are plot.  
 
 
Figure 5-22 Loading Plot indicating the relationship between the variables in database three. 
Figure 5-22 shows the variables and indicated by the distance from the zero axes the 
importance of some variables to the variation of the data. For clarity the clusters of 
significance are shown on an annotated figure of 5-23. The variables were clustered according 
to visual inspection and the clusters thought to be of significance are shown in table 5-17. 
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Figure 5-23 Annotated figure 5-22 showing points and clusters of interests. Clusters were 
indicated by the circled data and given a group number in orange writing. 
Visual examination determined 8 clusters. These are listed in table 5-17. 
Groupings 
identified in 
Figure 5-23 
Variables associated in the identified group by name 
1 Gibbs Energy [kJ/mol] 
2 Aromatic/enamine groups, Exact mass, Molecular weight, N-
heterocyclic groups, Tertiary amide, Nitrogen molecules  
3 Secondary amide groups, Freely rotating bonds, H bond 
donors, Polar surface area A, H bond acceptors. 
4 Flash point, Boiling Point (°c) 
5 Surface Tension dyne/cm, Alkyl greater than 5 carbon, Molar 
volume, Enthalpy of vaporisation kJ/mo, Molar Refractivity 
cm. 
6 Henry’s Law, tPSA, Index of Refraction, Boiling point [K] 
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Table 5-17 showing variables identified on the loading plot (figure 5-22). 
Table 5-17 shows that a lot of the variables determined as contributing to the variability in the 
individual database analysis also contribute to the variability of the whole data set. Analysis 
of database three by PCA has indicated a number of variables adding to the variability of the 
data in each plot (the Scree plot, the score plot and the loading plot). The collated variables of 
significance in database three are shown in table 5-18 for clarity. 
Variables of interest structural features 
and functional groups 
Variables of interest physicochemical 
properties 
Aromatic/enamine  Nasal and 
inhalation 
classification 
CMR 
Primary 1  Injectable 
classification 
ACD/Log P 
Tertiary 1  Antibiotic 
classification 
ACD/Log D 
(ph5.5) 
Ketone  API classification ACD/BCF (pH5.5) 
2 amide  Exact mass ACD/KOC 
(pH5.5) 
Tertiary amide  Molecular weight H bond acceptors 
Ether  Contains N Freely rotating 
bonds 
Thioether  Contains P Index of 
Refraction 
Fluorine  Contains Na Molar Volume 
(cm) 
Pyridine  Contains I Surface Tension 
dyne/cm 
  Boiling Point [K] Flash Point 
Aryl halide  Melting Point [K] Boiling Point (°c) 
7 CMR, Melting Point [K], Mr [cm3/mol], Clog P, Critical 
Volume, Critical Temperature, ACD/BCF (pH5.5), ACD/KOC 
(pH5.5), ACD/KOC (pH7.4), ACD/Log D (pH7.4),  
8 ACD/Log D (pH5.5), ACD/LogP 
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Alkenes   Critical 
Temperature [K] 
ACD/BCF (pH7.4) 
Phosphonate  Critical Pressure 
[Bar] 
ACD/KOC 
(pH7.4) 
Hydrozone  Critical Volume 
(cm3/mol) 
H bond donors 
Other features  Gibbs Energy 
(KJ/mol) 
Polar surface area 
A 
Phosphate  MR (cm3/mol) Molar Refractivity 
(cm) 
Nitro  Henrys Law Enthalpy of 
vaporisation kJ/mo 
Steroid  tPSA  
S-heterocyclic  C Log P  
 
Table 5-18 variables identified as significant in database three. 
Examination of table 5-18 and the scree plot of Database 1 showed the following similarities. 
Variables that were considered to contribute to the greatest variation in both Databases 1 and 
3 are listed as follows - Aromatic/enamine, primary amine and tertiary amine, secondary 
amide, phosphate and phosphonate groups. Structural features included Hydrozone structures. 
The reason why these variables could be considered to add to the variability in the data set has 
been discussed in section 5.3. In addition to these variables, other variables which added to 
the variability in the data set in Database 3 were ketones, ether groups, Thioether groups, 
Pyridine, Aryl halide groups, Alkenes, a group with other features and Nitro groups. 
Structural features adding considerably to the variability included Steroid and S-heterocyclic 
structures. 
Every variable identified in Database 3 was common to Database 2 in terms of adding 
significantly to the variability of the data set with the exception of the product categories. 
There were some additional variables in Database 2 which were not identified in analysis of 
Database 3. These were Polarizability, Density, and Heat of Form. The analysis of the three 
databases has determined a number of variables which add to the variability of the data set in 
each case. There was a lot of information generated during this analysis. It was therefore 
  
191 
 
necessary to determine the most useful data to use in order to improve pharmaceutical plant 
cleaning. This will be considered in the next section 5.6. 
5.6 Model creation 
In order to examine and make sense of the theoretical results, it was vital to determine how 
this research relates to industry. Analysis of the databases of information indicated that some 
of the variables clustered together and some individual variables were distinctly different and 
added significantly to the variation in the data set according to the scree, score and loading 
plots. The provision of cleaning agent information by company D enabled the first links to 
cleaning in industry and information on the variables in the score plots (of principal 
components 1 and 2) for each PCA in particular. Data on specific pharmaceutical products 
and their solubility are shown in table IX in appendix V. 
The information on cleaning agents was plot onto the score plots (of principal components 1 
and 2) from each database analysed. The results are given in figures 5-24 - Database 1 
information on chemical functional groups and structural features, figure 5-25 - Database 2 
information on physicochemical characteristics, and Database 3 - both sets of data combined. 
This produced some interesting observations. 
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Figure 5-24 Score plot generated during PCA analysis of database 1. The plot has been 
annotated to show the location of products and the relevant cleaning agent provided by 
company D. The numbers on the plot by the red dots refer to specific pharmaceutical 
products. 
Figure 5-24 indicates that there is an association between some of the known products and 
known cleaning agents provided by company D for information provided in Database 1. Table 
5-19 shows the variables identified in the pharmaceutical product cleaned from process 
equipment and the cleaning agent used to clean process equipment post processing. 
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Identified cleaning 
agents/ method 
Chemical functional groups in identified cluster  
Water Na+ Association, Hydrozone, Phosphate, Phosphonate, Tertiary alcohol 
association, Secondary alcohol, Ketone, Aryl halide, Steroid 
Methanol Tertiary alcohol structure, Vinyl alcohol, Oxime group, Macrolide, Tertiary 
amine, Tertiary alcohol, Ketone, Primary amide, Tetracycline, 
 Secondary alcohol, Ester, Oxime, Ether, Erythromycin derivative 
Methanol 1% HCL  Macrolide, Tertiary alcohol structure, Vinyl alcohol ,Tertiary amine, Secondary 
alcohol, Ketone, Ester, Ether, Primary amide, Tetracycline 
DMF Contain a mix of functional groups and identifying features Phenyl Ring, 
Primary amine, Secondary amine, Tertiary alcohol, Carboxylic acid, Aromatic 
enamine , Secondary alcohol, Secondary amide, Secondary amide, Primary 
amide, Ether, Carbamate, N-heterocyclic, Alkene, Alkyl >5 carbons, , Ketone, 
Oxazolidonone, Tertiary amide, Guanidine, Water, O-heterocyclic, Aryl halide, 
Sulfonamide, Macrocyclic, Primary alcohol, Tertiary amine,  
Carbamate, Urea, Barbitute, Thioester, Phenol, Long alkyl, Thioether, Nitro, 
O-heterocyclic, Sulfonamide, Vinyl alcohol, Phenyl ring, Ketone. 
Acetone or DMF No significant functional group identified by scree plot analysis in any of 
company D’s pharmaceutical products.  
Do contain some common features Secondary alcohol, Ketone, Ester, Steroid, 
Alkyl halide, Water, Tertiary alcohol, Ketone, Fluorine, Thioester, Ether 
 
 
Table 5-19 Variables associated with products produced by company D and the cleaning 
agents used to remove them from process equipment post manufacture. The black writing 
indicates features found in the products. Blue writing indicates common features identified in 
the analysis. 
Table 5-19 provides some interesting observations and can therefore be used to state the 
following in the absence of other practical cleaning information. There was only one product 
(Betamethasone disodium phosphate) which was freely soluble in water. The product was 
located distantly from other products on the score plot. There was one product (Doxycycline 
monohydrate) which was identified as unique (the only product cleaned from equipment using 
methanol and 1% HCL) in the data provided by company D. Two products manufactured by 
company D which clustered together are soluble in methanol (Roxithromycin) or freely 
soluble in methanol (Doxycycline hyclate). The remaining pharmaceutical products were 
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predominantly in group 11 (Betamethasone acetate, Halobetasol, Dexamethasone 
dipropionate, Clobetasol propionate, Beclomethasone dipropionate, Beclomethasone 
dipropionate monohydrate, Fluticasone propionate, Mometasone furoate anhydrous, 
Mometasone furoate monohydrate) all of these products were soluble in DMF and/or soluble 
in acetone, which is used in cleaning the products from process plant. There were three 
company D pharmaceutical products used in the PCA analysis which have not been 
mentioned so far. Tamsulosin was identified in the main data set. This product is cleaned 
from plant with DMF according to company D. Products not identified in the analysis on the 
score plot were Sumatriptan Base which was cleaned from process plants using DMF and 
Iohexol cleaned from process plants using water. These products were not identified in the 
analysis on the score plot for database 1. It is not known why Tamulosin was identified and 
yet a product with the same cleaning agent was not represented. 
The above observations may indicate that clustering of products on the score plot. These 
products have similar functional groups as shown in table 5-19 which may indicate why the 
same cleaning agents are used to remove them from process equipment. It is important to 
consider whether this relationship was found on the score plot for PCA analysis of Database 2 
(the physicochemical information). This was considered in figure 5-25. 
 
Figure 5-25 Score plot generated during PCA analysis of database 2. The plot has been 
annotated to show the location of products and the relevant cleaning agent provided by 
company D. The numbers on the plot by the red dots refer to specific pharmaceutical 
products. 
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Figure 5-25 identified only four products made by company D. These products were found in 
two groups. The first group identified was group 8. This contained one product which was 
Fluticasone propionate. This product is cleaned from process equipment using acetate. 
The second group identified on figure 5-25 contained three products manufactured by 
company D. These were Mometasone furoate monohydrate, Dexamethasone dipropionate and 
Clobetasol propionate. Company D uses Acetone or DMF to clean these products from 
manufacturing vessels. These API’s had a similar boiling point, similar critical pressure 
values, critical volume values, Gibbs Energy values and Log P values. Heat of form values in 
this group were similar and all of these values were negative. The chemicals had similar tPSA 
values and CMR values. 
 
Figure 5-26 Score plot generated during PCA analysis of database 3. The plot has been 
annotated to show the location of groups of containing company D products and the relevant 
cleaning agent provided by company D. The numbers on the plot by the red dots refer to 
specific pharmaceutical products. 
Figure 5-26 shows the location of groups which company D products are found and the 
cleaning agents used to clean the products from equipment post manufacture. 
This plot shows Betamethasone disodium phosphate in a distinct position away from other 
products on the plot. Water was used to clean this product from equipment. Group 2 (found 
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on figure 5-26) identifies group two as containing company D products Doxycycline hyclate, 
Doxycycline monohydrate and Roxithromycin. All of these products were cleaned from 
vessels using methanol, although cleaning of vessels used for manufacturing Doxycycline 
monohydrate uses a mix including methanol and 1% hydrochloric acid. Group 12 identified 
on figure 5-26 contained company D products Clobetasol propionate, Halobetasol, 
Mometasone furoate monohydrate and Dexamethasone dipropionate. All of these products 
were cleaned from vessels by company D using Acetone or DMF. Group 13 contained 
company D product Fluticasone propionate, among other products manufactured by other 
companies. Fluticasone propionate was cleaned from vessels using Acetate. Group 17 
contained one company D product which was Mometasone furoate anhydrous. Company D 
cleaned this product from vessels post manufacturing using Acetone. The final group 
containing products manufactured by company D was the main data group. This contained 
three products manufactured by company D. These were Tamsulosin (cleaned from vessels 
using DMF), Beclomethasone dipropionate and Beclomethasone dipropionate monohydrate 
(both cleaned from vessels post manufacture by Acetone or DMF).  
It was considered important to determine the common features in each of the groups above 
(chemical functional and structural features and physicochemical features). This was carried 
out to see if the effectiveness of a cleaning agent could be linked to the variables of each 
product. This information has already been determined for functional and structural features 
(Table 5-19). Determining this information for the physicochemical variables was 
challenging. This was because a lot of the information on variables required to make sense of 
the analysis was not available. It was decided that using the physicochemical information to 
interpret why certain chemicals were cleaned from vessels post manufacturing was not viable. 
The construction of a model to determine the relationship between cleaning agents and 
functional and structural features is the most reliable and significant use of the analysis. 
Therefore the model which was used in the rest of the analysis, and used to construct a tool 
which Britest members can utialise to determine the most effective method of cleaning 
products from vessel post manufacturing, is the model constructed using database 1 (figure 5-
24). The construction of the model has been carried out in this section, but it was important to 
consider how this model would be used in association with other Britest tools.This will be 
considered in Chapter 6 which will discuss industrial case studies. The next section (5.7) will 
provide a summary of this chapter.  
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5.7 Chapter Summary 
This chapter has presented and discussed the results from analysis of the databases of 
information. This has included the intial dendrogram results on database 2 physicochemical 
information for each product, which indicated potential groupings of variables and showed 
that it was possible to determine patterns and clusters in the data. It was considered that using 
dendrograms to determine patterns in the data was not sufficient to give results necessary to 
create a tool to help determine the best cleaning method for Britest members. Therefore, 
another method was used to determine relationships in the data, namely PCA. PCA was 
carried out on each database of information relating to pharmaceutical products. This 
suggested that it was possible to find the variables in each data set which added the most 
variation in each data set. It was possible to determine a number of patterns and clustering 
effects for each data base during PCA analysis. This revealed a number of variables in each 
database which were considered of significance. These are listed in Table 5-10 (functional 
and structural features), Table 5-12 (physicochemical variables) and Table 5-19 (combined 
functional and structural features and physicochemical variables). The analysis provided 
information on variables which added to the variability in the each data set and this was 
related to the pharmaceutical products used in the analysis. During the analysis some of the 
pharmaceutical products clustered together on plots due to common variables. The link 
between the information given in the plots and cleaning in industry was key to understanding 
the data. Information relating to cleaning agents, which was provided by company D, showed 
a link between certain pharmaceutical products, and their composition, to specific cleaning 
agents. Using cleaning data from company D, it was possible to determine the best model 
(data from database 1, 2 or 3) to use to indicate potential cleaning agents. It was found that the 
best model to use was the score plot (principal component 1 and principal component 2). This 
was because there was insufficient physicochemical information to give a robust enough 
model. Therefore the model which was used in case studies was model 1, using the chemical 
functional and structural data. This model will be applied to industrial data in case studies in 
chapter 6. 
In previous chapters information and results from analysis have been presented with the aim 
of answering the research questions poised at the beginning of this research in chapter one. In 
particular research question RQ2: What is meant by the term ‘fundamental science’ in 
relation to process plant cleaning? This chapter has shown it is possible to take information 
relating to specific products or API’s and analyse it. This identified patterns in the data and 
indicated the significance of some variables over others in determining the variability in the 
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data set. Fundamentally, it was possible to say that this information was useful in providing 
the methodology to answer research question 1, RQ1: What would be the best way to 
increase the fundamental understanding of the science behind cleaning linked to solvent and 
cleaning agent use. 
PCA analysis of databases of information relating to the fundamental composition and 
structure of pharmaceutical products has shown links to the cleaning agent used for some 
known products. Without understanding the chemistry behind the variables it is considered 
that this would not have been possible. In order to establish if this model is a tool which can 
be useful in industry it is important to consider three points. The first point - is can the model 
be used in industry to determine potential cleaning methods and help to select a cleaning 
agent? The number of known pharmaceutical products and successful cleaning agents have 
been provided by one company. In order to improve the model, it needs populating with more 
data.  
The second point to consider is - do companies use different cleaning agents to successfully 
clean the same pharmaceutical product from vessels post manufacturing? Knowing this would 
help Britest members choose the best methodology to clean pharmaceutical plant equipment 
according to limitations on plant equipment, such as age of equipment, or material of 
composition. 
The third point relates to understanding whole process design. This research has only used 
information on pharmaceutical products. During manufacturing there will be hundreds of 
reactions which produce intermediate products and side products. Some of these products will 
be difficult to remove from process vessels and it is therefore necessary to identify them by 
using Britest tools such as TM (discussed in Chapter 3). Identification and characterisation of 
these products can be carried out and PCA could be used to identify them as a cleaning 
challenge and determine potential cleaning agents to remove them from vessels. 
In order to address some of these points the model based on the fundamental science was used 
with industrial cleaning data provided by Britest members. This was carried in chapter 6. 
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Chapter 6. Case Studies 
6.1 Introduction 
The previous chapters have discussed the need for a fundamental understanding of the science 
behind plant cleaning and how this research could achieve the main research aim RQ1: What 
would be the best way to increase the fundamental understanding of the science behind 
cleaning linked to solvent and cleaning agent use? 
Chapter 5 presented results of analysis, which aimed to answer this research question and 
improve understanding of industrial plant cleaning. It was considered that this could be 
achieved by understanding the chemical functional groups and structural features, which 
compose the pharmaceutical products. The identification and classification of the functional 
groups in the products used in this analysis resulted in the creation of a model (Chapter 5). It 
is believed that this model could be used to help predict the best cleaning agent to remove 
unwanted residues of products from process vessels post manufacturing. In order to 
demonstrate the importance of the model it must undergo a trial with further industrial data. 
This chapter examines two case studies to determine if the model developed in this research is 
able to help determine the best cleaning agent to use to remove a specific product from 
equipment post manufacturing. In addition to examining cases studies consideration will be 
given to other Britest tools, which may be useful in understanding other aspects of cleaning as 
discussed in Chapter 3. The next section discusses the use of Britest tools to solve cleaning 
challenges, by considering a suite of tools called FUSE (Fundamental Understanding of 
Science and Engineering).   
6.2 FUSE 
FUSE aims to consider all aspects of industrial plant cleaning, bringing WPU to cleaning. 
Chapter 3 introduced the Britest tools and methodologies, which could be used to understand, 
identify and solve cleaning challenges. In this section it is important to reconsider them with 
reference to the model, which was created in section 5.6. One of the most important aspects of 
the research project was to consider cleaning as a part of the manufacturing process. 
Information provided by Britest members in a survey in chapter 3 indicated that this was not 
currently the case. The importance of plant cleaning during a manufacturing process is often 
overlooked and under considered. This research project aimed to give Britest members a way 
to change how they think about cleaning by realising that it needs to be considered at the 
beginning of a manufacturing process. In this respect the model developed should be used 
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before the product is manufactured as a part of Whole Process Design (chapter 1). Therefore, 
it is thought that the best use of the model (and the data surrounding the model determining 
functional groups common to products in groups cleaned by certain cleaning agents) is at the 
beginning of product and process design. Currently the scope or operational space of the 
Britest tools used to give WPU lies within the blue boxes (figure 6-1). 
 
 
 
 
Figure 6-1 Britest tools and methodologies operation space in industrial processes (adapted 
from Britest material, 2011). 
The tool developed during this research should initially be used during the development stage, 
once the chemical entity is invented. This represents an important step change in how 
researchers think about cleaning. Using this model may mean that the production of the 
chemical entity is not required to determine the cleaning agent required to remove it 
successfully from production vessels post manufacture. In addition the model may be used in 
the make stage of the process if there is a cleaning dilemma. If the tool developed in this 
research is to be used as part of FUSE then it is important to establish how this would fit in 
with corresponding Britest tools. Chapter 3 (section 3.5.2) discussed Britest tools and those 
which would be useful in providing information on selection of cleaning agents. It is 
considered that the tool developed in this research project should be used alongside Britest 
core methodologies, although it could be used as a standalone tool. Although there is often no 
specific order in which to use the Britest tools discussed, it is thought that methodologies 
could be considered to help address cleaning challenges in the following order (figure 6-2). 
 
 
Figure 6-2 An example of a FUSE Roadmap. 
ISA/PrISM TM TE3PO
Cleaning 
model
PDCD
Action 
Plan
SELL MAKE DEVELOP INVENT FORMULATE 
Chemical 
Entity 
Finished 
Product 
 
Whole Process Understanding 
   RP or RC can be used where indicated 
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Initially, it is important to define what the cleaning challenge concerns and identify what is 
not known. In order to achieve this ISA (used to define a problem and bring focus to it), or 
PrISM can be used. PrISM helps to summarise the process and determine what is happening 
at a stage in a manufacturing or indeed the cleaning process. This could be used to determine 
where residue is forming during processing. The use of Rich Pictures (RP) or Rich Cartoons 
(RC) may help identify the cause of this. Transformation Maps are an important Britest tool, 
which should be used in conjunction with the cleaning model. This is because it will help to 
identify desired and undesired processes when manufacturing a product. Identification of 
these processes may identify side reactions and intermediate products, which can be used in 
the cleaning model to determine their cleanability from process equipment (Chapter 3, section 
3.5.2). 
TE3PO provides information on physical processing and transformations. It allows formation 
of records and analysis of the data found. Chemical processes can be complex and this gives a 
logical approach to thinking through those processes, with regard to the entities that are 
present in the process stage, and what the physical properties might be. This tool may be able 
to help identify contaminants which cause residues in vessels (figure 3-16, Chapter 3), and 
may also be able to determine practical methods of contamination removal during this project. 
The cleaning model could be used at this stage of FUSE. The cleaning model can be used 
with information provided from the previous Britest tools. The tool requires known structural 
and functional groups, which will have been identified by PrISM and TM. The information 
relating to the functional groups and structural features can be used in two ways. Firstly, the 
information can be fed into the original database and PCA can be carried out to determine the 
position on a score plot of the product, side reactant or intermediate. The product location on 
a score plot would help determine the best cleaning agent to use to remove it from vessels 
post manufacture. Secondly, it is also considered that the chemical and functional groups 
composing the product may be checked against a list of identified functional and structural 
features identified during this research as being found in products successfully cleaned from 
vessels (figure 5-21 reproduced as table 6-1). 
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Identified cleaning 
agents/ method 
Chemical functional groups and structural features in identified in 
products cleaned from vessels post product manufacture  
Water Na+ Association, Hydrozone, Phosphate, Phosphonate, Tertiary alcohol 
association, Secondary alcohol, Ketone, Aryl halide, Steroid 
Methanol Tertiary alcohol structure, Vinyl alcohol, Oxime group, Macrolide, Tertiary 
amine, Tertiary alcohol, Ketone, Primary amide, Tetracycline, Secondary 
alcohol, Ester, Oxime, Ether, Erythromycin derivative 
Methanol 1% HCL  Macrolide, Tertiary alcohol structure, Vinyl alcohol ,Tertiary amine, Secondary 
alcohol, Ketone, Ester, Ether, Primary amide, Tetracycline 
DMF Contain a mix of functional groups and identifying features Phenyl Ring, 
Primary amine, Secondary amine, Tertiary alcohol, Carboxylic acid, Aromatic 
enamine , Secondary alcohol, Secondary amide, Secondary amide, Primary 
amide, Ether, Carbamate, N-heterocyclic, Alkene, Alkyl >5 carbons, , Ketone, 
Oxazolidonone, Tertiary amide, Guanidine, Water, O-heterocyclic, Aryl halide, 
Sulfonamide, Macrocyclic, Primary alcohol, Tertiary amine,  
Carbamate, Urea, Barbitute, Thioester, Phenol, Long alkyl, Thioether, Nitro, 
O-heterocyclic, Sulfonamide, Vinyl alcohol, Phenyl ring, Ketone. 
Acetone or DMF No significant functional group identified. 
Do contain some common features Secondary alcohol, Ketone, Ester, Steroid, 
Alkyl halide, Water, Tertiary alcohol, Fluorine, Thioester, Ether 
 
 
Table 6-1 Variables associated with products and the cleaning agents used to remove them 
from process equipment post manufacture. The black writing indicates features found in the 
products. Blue writing indicates common features identified in the analysis but not found in 
the products. 
Figure 6-1 may be used as a quick check to determine potential cleaning agents by 
composition of chemical groups. Once these are known a cleaning agent may be selected. As 
this suite of tools considers Whole Process Understanding (WPU), it is important to have a 
tool in the suite which is able to help identify specific engineering challenges or materials, 
which may make cleaning from particular vessels difficult. The tool, which has been designed 
for this purpose is PDCD, an adaption of PDD. The PDCD described in Chapter 3 (figure 3-
17) can indicate the age, material and staining of the vessel, in conjunction with a Rich 
Picture (RP). It can be used to show complex vessel geometry, which is often difficult to 
clean. It is considered that the choice of a cleaning agent cannot be made without using this 
diagram as cleaning needs to be carried out using a holistic approach. This requires taking 
into account the fundamental engineering challenges as well as the scientific understanding. 
In addition to the FUSE roadmap (figure 6-2) additional tools RP and RC may be used to help 
target specific problems and focus on issues surrounding the vessel which requires cleaning, 
or the manufacturing process that is taking place specifically in one piece of equipment. 
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Once FUSE has been applied to a challenge an important part of the roadmap is to take action 
to make changes, which will increase the effectiveness of cleaning and aim to ensure that the 
next clean carried out post manufacturing is carried out RFT. 
An additional tool, which can be used to help industrialists, is Duty Definition and Equipment 
Specification (DuDEs). DuDEs is used for process equipment decision making and may also 
be used to consider the selection criteria of new cleaning equipment. This may be carried out 
if specific cleaning equipment is required to clean a vessel identified in PDCD analysis.  
Britest's tools and methodologies are very adaptable and this makes them suitable for the 
identification of many industrial challenges and their solutions. The aim of this research was 
to create a tool to help understand the fundamental science behind cleaning. In order to 
determine whether the cleaning model developed is useful to industrialists, it is important to 
use it to carry out case studies and test the theory behind the cleaning model. The case studies 
will be discussed in the next section 6.3. 
6.3 Case Study Introduction 
The suite of tools designed to help industrialists understand the science behind cleaning was 
discussed in section 6.2. In this section it was important to consider if the model developed 
during this research, based on understanding the fundamental science behind cleaning, is 
effective. In order to achieve this, two case studies were carried out. The first case study used 
information provided by company C. The second case study was carried out using 
information provided by company B. PCA analysis of data from both companies was carried 
out at the same time. Therefore there is only one set of PCA results. The case studies, the 
results obtained from the analysis and the conclusions drawn from the results are given in the 
following sections 6.4, 6.5 and section 6.6. 
6.4 Case Study 1 Company C 
The first case study involved information provided by company C. Company C is a large 
multinational company, which produces pharmaceutical products. Information provided by 
company C composed of functional groups and structural information for one product and 4 
intermediate products for the same process. Company C were unable to provide information 
relating to physicochemical properties for any of the products they gave for the case study. 
This indicates that the information was difficult to obtain. It is thought that this was especially 
true of intermediate and side products. It was considered that using intermediate products was 
a good way to determine how the tool could be used to help decide which cleaning agent to 
use to clean vessels post manufacture. Industrialists often choose a cleaning agent based on 
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the final products solubility or a problem intermediate which is the most difficult to remove 
from a vessel. The information provided by company C did not indicate which of the 
chemicals was the most difficult to clean out of vessels. The company also gave no indication 
of the type of vessels which are involved in processing. The information provided by 
company C is indicated below (table 6-2). Table 6-2 shows the chemical and structural 
information, which was provided for each chemical labelled P1 to P5.  
Table 6-2  
Product 
name 
P1 P2 P3 P4 P5 
Identified 
position in 
process* 
Intermediate 
product 
Intermediate 
product 
Intermediate 
product 
Intermediate 
product 
Final Product 
Functional 
groups 
identified 
Tertiary amine, 
primary amine, 
Fluorine atom, 
Alkene group, 
Alkyl group 
greater than 5 
carbons 
Tertiary 
amine, 
aromatic/ 
enamine 
group, 
carboxylic 
acid, Fluorine 
atom, Alkyl 
group greater 
than 5 carbons 
Tertiary 
amine, 
Primary 
alcohol (OH) 
group, 
Fluorine atom, 
Alkyl group 
greater than 5 
carbons  
Tertiary 
amine, Ether 
group, 
Fluorine atom, 
Alkyl group 
greater than 5 
carbons, Other 
feature (not 
identified) 
Secondary amine, 
Fluorine atom, Alkyl 
greater than 5 carbons 
Structural 
feature 
identified 
Phenyl ring   Phenyl ring 2 Phenyl rings  
cleaning 
agent used 
Methanol 
Unsuccessfully 
used 
Methanol 
Unsuccessfully 
used 
Toluene  
Successfully 
used 
Methanol 
Unsuccessfully 
used 
Methanol (highly 
soluble in 50% 
solutions but still a 
cleaning challenge) 
Cleaning 
agent 
suggested 
using 
information 
DMF DMF DMF DMF DMF 
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Product 
name 
P1 P2 P3 P4 P5 
in table 6-1 
Cleaning 
agent 
suggested 
using PCA 
analysis and 
position on 
score plot 
Acetone or DMF DMF DMF DMF Acetone or DMF 
 
Table 6-2 contains the information that was provided by company C. *The intermediates and 
product in this table have been identified in one process. 
Table 6-2 also shows the cleaning agents which company C currently uses to try and remove 
the listed chemicals. The cleaning agent used for most intermediate product removal is 
methanol. Methanol is a volatile and flammable liquid with a flash point of 52°c (11°c). It is 
classed as hazardous waste and it is harmful to aquatic life in low concentrations. The 
recommended method of disposal is burning.  
Intermediate product P3 is removed from vessels by rinsing with toluene. Toluene may be a 
teratogen in humans. It is extremely flammable with a flash point of 40°F (4°c). Hazard 
classifications given to this solvent indicate that it is detrimental to health (GHSO7, GHS08). 
This would make it difficult to clean with this solvent especially in open process vessels. 
Toluene is described as hazardous waste and it must be removed via a chemical waste 
disposal service. This can become expensive as discussed in chapter 3.  
Analysis was carried out by comparing the chemical functional groups and structural features 
associated with known cleaning agents found in the analysis (table 6-1). After examination of 
the information available for each case study chemical against the information in table 6-1, it 
is possible to say that DMF might be used to clean vessels containing residues of the 
chemicals listed by company C. This solvent has a higher flash point (136°F or 57.77°c) than 
the other two solvents currently used. This means it may be easier to use. In addition it is not 
considered as harmful to human health as toluene or methanol. Disposal of DMF requires a 
chemical waste disposal service, but if cleaning is carried out right first time the levels of 
solvent for disposal post cleaning may significantly reduce. 
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In addition to looking at the information in table 6-2 the new information provided by 
company C was normalised and analysed by PCA. This gave the results in section 6.4.1 
(figures 6-2, 6-3 and 6-4). As the PCA analysis was carried out in conjunction with the data 
for company B, it was first important to discuss the information given for case study by 
company B for analysis before the results of the PCA are discussed. The case study for 
Company B will be discussed in section 6.4. 
 
6.5 Case Study Two Company B 
Company B is a large pharmaceutical and agrochemical manufacturing and contract 
manufacturing organisation. The information provided by Company B is shown in table 6-3. 
The information provided for the case study included TM, which was helpful in 
understanding the chemicals presented for the case study. However, because of confidentiality 
these cannot be reproduced in this research.  
Product 
name 
P6 P7 P8 P9 P10 P11 
Identified 
position in 
process 
Undefined Undefined Undefined Undefined Undefined Undefined 
Functional 
groups 
identified 
2 Ketone 
groups, 1 
Ether group, 
1 Alkyl 
greater than 
5 carbon,  
1 other 
organometallic 
group  
Unknown 
numbers of 
primary alcohol, 
ester, Alkyl 
greater than 5 
carbon groups, 
Unknown 
numbers of 
primary 
alcohol, 
carboxylic 
acid, ester, 
Alkyl 
greater than 
5 carbon 
groups, 
1 Alkyl 
greater than 
5 carbon 
group 
1 Primary 
amine, 1 
secondary 
amine (both 
unknown 
polymers), 1 
ester, 1 
primary 
amide and 1 
secondary 
amide.  
Structural 
feature 
identified 
1 O-
heterocyclic 
group, 1 
Long alkyl 
group 
Other Unknown 
numbers of 
Long alkyl 
group 
Unknown 
numbers of 
Long alkyl 
group 
1 Phenyl 
ring, 1 Long 
Alkyl group 
An unknown 
number of N-
heterocyclic 
features and 
an unknown 
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Product 
name 
P6 P7 P8 P9 P10 P11 
number of 
Phenyl rings 
cleaning 
agent used 
Unknown 
but currently 
using water 
Water Polyisobutylene, 
caustic and 
water 
Caustic 
soluble but 
cleaning as 
yet 
undefined 
85% 
Phosphoric 
acid in water 
Soluble in 
water 
Cleaning 
agent 
suggested 
using 
information 
in table 6-1 
DMF Insufficient 
information 
DMF DMF DMF DMF 
Cleaning 
agent 
suggested 
using PCA 
analysis 
and 
position on 
score plot 
DMF DMF Acetone or 
DMF 
DMF DMF DMF 
 
Table 6-3 Information provided for case study by Company B. 
Company B provided a lot of information about the chemicals it supplied for the case study. 
Table 6-3 shows some of this information. Each chemical was labelled sequentially following 
on from the chemicals listed in table 6-2 for clarity. The chemicals supplied were classified as 
undefined. This means they were not considered products or intermediates. There is not a lot 
of information supplied about any of the chemicals compositions, which means that the data 
that is usable in the PCA analysis is limited. This is not a surprise. The survey data in chapter 
3 indicated that industrialists do not fully understand their processes and often do not know 
the composition of most intermediate chemicals, which remain undefined. The complexity of 
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manufacturing chemicals is appreciated and in these cases a TM or TE3PO analysis may have 
helped define the chemicals and increase understanding of their composition.  
P6 was defined as insoluble, but water was being used to remove it from vessels post 
manufacture, as the chemical hydrolyses in water. Company B do not know how to remove 
this chemical from process vessels. Physicochemical data provided by Company B for this 
chemical was the density (0.96g/cm3). P7 was not a challenging product to clean from vessels 
and water was used to remove it from vessels post manufacture. There was only limited 
information provided about this chemical, other than it contains an organometallic group, 
which is defined as other group in the PCA. Some physicochemical properties were provided 
for this chemical. These were values for the flash point (17°c), Density (1.013g/cm3), Vapour 
pressure (173 bar @ 20°c), and the Boiling point which was 338-342K. As the amount of 
physicochemical data is limited it is not possible to use this information in the analysis. P8 
was a chemical, which Company B found difficult to remove from vessels post manufacture. 
Polyisobutylene (PIB) was used to remove this chemical from vessels (PIB is used as an 
additive in engine fuel to prevent soot, sludge and other deposits from leaving residues on 
surfaces). P9 was an undefined chemical, which was a challenge to clean from vessels. 
Company B did not know how to remove this from equipment but did know that it was 
soluble in caustic. Physicochemical properties for this chemical were limited but the melting 
point was provided (<253K), the flash point (>24°c) and the density (0.98 @ 20°c). Company 
B provided information on the undefined chemical P10, which was challenging to remove 
from their equipment. They removed this chemical with 85% Phosphoric acid in water. They 
were able to provide very limited physicochemical data for this chemical, which was the flash 
point (191°c) and the melting point (393K). This chemical was insoluble in water and soluble 
in alcohol. The final chemical provided for the case study was P11, which was not a challenge 
to clean from vessels as it was soluble in water. It was cleaned from vessels using 85% 
phosphoric acid in water. The flash point (>100°c), the boiling point (100°c) and the density 
(1.15@ 20°c) of the chemical were known. Comparisons between the information provided in 
table 6-1 and 6-3 indicated in some cases there was not a lot of information provided to 
determine which cleaning agent could be used for chemical P7. The other chemicals P6 and 
P8 to P11 were all determined to be cleaned from vessels with DMF. This is probably due to a 
lack of information. The cluster of products which have been determined to be cleaned by 
DMF is large and therefore there are many functional groups associated with this cleaning 
agent. The 6 chemicals provided by company B for this case study were all undefined and a 
lot of the information provided was uncertain. This made the analysis difficult. A number of 
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functional groups (given in table 6-3) were listed as present, but the number of the functional 
groups was unknown. For the purposes of PCA this made analysis difficult as the number of 
functional groups of one type affects the analysis. Unavailable data meant that one functional 
group was recorded against the type in the PCA analysis where there could have been more. 
PCA of the information provided by Company B was carried out with the data provided by 
Company C in section 6.5. 
6.6 PCA Analysis of the case study data for company B and company C 
The case study information for both company B and C was analysed by PCA. The result and a 
discussion of this analysis are provided in this section. Figure 6-2 shows the scree plot 
produced from PCA analysis of the original data set and with the addition of the new case 
study data. All data was normalised. 
6.6.1 Scree Plot analysis of the original data and the case study data 
Analysis of the data began by examining the scree plot (figure 6-2) 
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Figure 6-3 Scree plot from PCA analysis including data obtained from industrial case studies 
for both company C and company B. 
Figure 6-3 indicates that there are potentially two elbow points in the data. The first point 
occurs at the third principal component. Data up to this point on the scree plot accounts for 
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22.8% variation in the data set. The second elbow point in the data occurs at the 14th principal 
component. The data on the scree plot, up to and including this principal component, accounts 
for 68.2% of the variation in the data. Therefore it is the first 14 principal components which 
add the most variation in the data set. Analysis of the first 14 principal components indicated 
the variables of interest (table 6-4).  
Variable of Interest Principal Component 
number 
Variable of Interest Principal Component 
number 
Primary amine C9, C13, C14 Phosphonate C2 
Secondary amine C2, C3, C6, C12, C13 Hydrozone C2 
Tertiary amine 
C3, C5, C10 Other C2 
Aromatic / enamine C4, C5, C9 
Phosphate C2, C3, C5 
Primary alcohol C3, C10, C12 
Carbamate C12 
Secondary alcohol  C1, C3, C4, C10 
Nitro C4, C5, C6, C9, C10 
Tertiary alcohol C1 
Nitrate C7, C9, C12 
Vinyl alcohol C4, C5 
Steroid C2, C6, C9, C11 
Phenol C6, C8, C12, C13, C14 Hormone C8, C11, C12, 
C13,C14 
Carboxylic C3 
O-heterocyclic C4, C14 
Ketone C2, C4, C6 
N-heterocyclic C4, C7, C8, C9, C10 
Thioester C6, C10, C12 S-heterocyclic C4, C5, C6, C10 
Oxime C1, C4, C13 Long alkyl C10,C12, C13, C14 
Oxazolidinone C14 Phenyl ring C6, C8, C9, C11 
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Variable of Interest Principal Component 
number 
Variable of Interest Principal Component 
number 
Urea C8, C11 
Erythromycin 
derivative 
C1, C4, C13 
Guanidine C9, C12, C13 
Tetracycline C1, C4, C13 
Ether C1, C9, C12, C13, C14 
Macrocyclic C4, C5 
Sulfonamide C12, C14 
Macrolide C1, C13 
Sulfone C11, C12, C13, C14 Benzodiazepine C10, C12 
N-oxide C7, C9, C12 Barbiturate C8, C11 
Thioether C4, C5, C6 Water C5, C9 
Fluorine C2, C6, C10 
Ethanol C4, C5, C6 
Pyridine C2 
HCL C4, C5 
Alkyl halide C6, C9, C10, C11 
Na+ C2, C3 
Aryl halide C6, C8, C11, C13 
Gd3+ C3, C4 
Alkene C9, C11, C12, C13, 
C14 
  
Alkyl greater than 5 
Carbons 
C9, C11, C12, C13, 
C14 
  
 
Table 6-4 Principal components identified in the scree plot as contributing to the variability in 
the data set. Variables which added the most variability in the first 3 principal components are 
highlighted in red.  
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Analysis of the scree plot indicated that every variable added to the variability of the data set 
in the first 14 principal components. The data showed the variables which added to variability 
in the first 3 principal components. This was where the most variation in the data set was 
found. These were highlighted in red in table 6-4. These variable groups and structural 
features were listed as Phosphonate, Hydrozone, Other, Phosphate, Steroid, Erythromycin 
derivative, Tetracycline, Macrolide, Na+, Secondary amine, Tertiary amine, Primary alcohol, 
Tertiary amine, Primary alcohol, Secondary alcohol, Tertiary alcohol, Carboxylic acid groups, 
Ketone, Ether, Fluorine and Pyridine. This list was compared to the list of functional groups 
and structural features, which were found to be of interest in the analysis of database 1 
(Chapter 5, table 5-3). The following similarities were found. Both analyses identified the 
variables primary and secondary amine groups, phosphonate groups, phosphate groups and 
carboxylic acid groups. Analysis of the score plot form the PCA analysis was carried out next 
(section 6.5.2) in order to determine more information on the case study chemicals. 
6.6.2 Score plot analysis of the original data and the case study data 
The score plot was a useful tool in previous analysis of this research in chapter 5. It was able 
to show a link between data on cleaning agents and the products, which in turn gave 
information on shared functional and structural features. The score plot generated for analysis 
of the case studies is shown below (figure 6-3). 
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Figure 6-4 Score plot from PCA analysis including data obtained from industrial case studies 
for both company C and company B. 
PCA analysis produced the score plot (figure 6-4). The figure shows a lot of data points 
located around the zero axes. There are some data points which are located distinctly away 
from others on the plot. Annotation of the score plot indicates some of the data points, which 
are associated with different cleaning agents, (as determined by analysis of database 1 in 
Chapter 5). The data was complex to analyse but it gave the following information on the case 
study chemicals. P1 was found on the score plot located next to chemicals, which had 
previously been identified as being associated with the cleaning agents Acetone or DM. P2, 
P3, P4 P8, P10 and P11 were not located on the score plot. P5 was associated with products, 
which are cleaned from vessels post manufacture by Acetone or DMF. These are very 
different from the cleaning agents, which are listed in table 6-3. The next section examines the 
information provided in the Loading plot in section 6.5.3. 
6.6.3 Loading plot analysis of the original data and the case study data 
The PCA gave three plots, which provided information to help identify patterns and links 
within the data. This is the third plot, which will be used to identify the variables that provide 
the most variation in the data set. The Loading plot is shown below (figure 6-5). 
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Figure 6-5 Loading plot from PCA analysis including data obtained from industrial case 
studies for both Company C and Company B. 
Figure 6-5 indicates the variables of interest. Using the information in table 6-5 it is possible 
to see the variables, which provide the most variation in the data set. A lot of the variables are 
located around the zero axes. Those which add the most to the variability of the data set are 
those which are physically distinct from this area on the plot. The variables which are thought 
to add the most variation to the data set are Phosphonate, Hydrozone, Other, Phosphate, 
Steroid, Erythromycin derivative, Tetracycline, Macrolide, Na+, Secondary amine, Tertiary 
amine, Primary alcohol, Tertiary amine, Primary alcohol, Secondary alcohol, Tertiary alcohol, 
Carboxylic acid groups, Ketone, Ether, Fluorine and Pyridine. In addition the variables have 
clustered on the plot (figure 6-5). Some of the clusters include Tertiary alcohols, Oxime and 
features Tetracycline, Erythromycin derivative and Macrolide. It should be noted that 
although these variables show the most variability in the database, none of the chemicals in 
the case study contain these features. Variables which are considered to add the most to the 
variability in the data set are not found in the chemicals provided for the case study, with the 
exception of Ketone (P1), Primary alcohol P3 and Phenyl ring P10. In addition, variables 
provided by companies were not found within the scree plot to add considerably to the 
variability. This information indicates that it may be difficult to identify a cleaning agent for 
the chemicals in the case studies due to insufficient data. In order to understand the data better 
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it was appropriate to rerun the analysis using only the data, which was located around the zero 
axes. This will be carried out in section 6.5.4. 
6.6.4 Analysis of the main data set located around the zero axes. 
Analysis of the main data set located around the main axes (figure 6-3) was carried out to 
obtain a better understanding of the data. PCA was rerun on data used in section 6.5.2. 
Several products which lay outside of the data required were removed from the dataset. The 
products removed were Betamethasone disodium phosphate, Gopten, Halbetasol, 
Betamethasone acetate, Oxis, Meperidine, Fluticasone furoate, Epival, Clobetisol propionate 
and Plendil. The removal of these products was based on the physical location on the score 
plot in relation to the data of interest. PCA analysis was carried out and produced the 
following score plot (figure 6-5). Only the score plot is shown from this analysis because this 
is the plot which will show the relationship between the chemicals in the case study and the 
products used in the model development. It was considered that because of the products 
locations on figure 6-3, all of these products should have a relationship and that they may be 
considered to be linked with the cleaning agents DMF or Acetone. 
 
Figure 6-6 Score plot showing the relationship between the case study chemicals and the 
products used in the model. The coloured shapes refer to specific case study chemicals and 
products used in the original model. Those chemicals and products of note are identified by 
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the annotations. It seems as if the chemicals from the case studies are linked to the cleaning 
agents DMF or Acetone. 
There were 14 groups and points of interest identified on figure 6-6. Each of these will be 
discussed below. 
Groups or points of interest identified on figure 6-6 are described below - 
1. This point refers to the chemical Selelamer, which was not located on the previous score 
plot used as the model (database 1score plot). The cleaning agent for this product remains 
unknown but it does not appear to be physically located near the rest of the data on this score 
plot. 
2. The second group of interest contains the pharmaceutical products Hytrin, Nimbex and 
Nizatidine. All of these products were associated with different groups in the previous 
analysis of the data set prior to the addition of the case study data. Hytrin is associated with 
the cleaning agent DMF, Nizatidine was associated with group 5 and Nimbex was associated 
with group 12. It is not known why these products were clustered in this way in this analysis. 
3. The third group contained the products Betamethasone dipropionate, Betamethasone 
dipropionate monohydrate and Cycloserine. All of these products have previously been 
associated with the cleaning agents DMF or Acetone. 
4. The fourth group contained the chemicals Gabopentine, Doxycycline monohydrate and 
Furosemide. Both Gabopentine and Furosemide have been associated with the cleaning agent 
DMF. 
5. The fifth point of interest was the product Metronazole. This product was not associated 
with any cleaning agent in the model and it was not identified in the analysis (Chapter 5, table 
5-2). 
6. Both products identified in this group (Citanest and Androgel) were associated with the 
cleaning agent DMF in the previous analysis.  
7. The two products identified in this group were Deflox, associated with the cleaning agent 
DMF, and Advicor which was associated with group 10 in previous analysis (Chapter 5, table 
5-2). 
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8. Conolip was the only product found at this point. This was not identified as being 
associated with any cleaning agent in the research. This was due to limited availability of 
data. 
9. This group of products was found to include Aluvia, (previously associated with group 12 
in the research (Chapter 5, table 5-2)), and Isradipine, (which was previously associated with 
group 9). The rest of the group contained the case study chemicals P1, P9, P10 and P8.  
10. This group of products included Warfarin, Iodixamol, Atenonol and Brofen. All of these 
products were associated with the cleaning agent DMF in the research (Chapter 5, table 5-2). 
The following case study chemicals were found in this group. This included P2, P4, P5, P6, 
P7 and P11, although these chemicals had different cleaning agents reported by Company C 
and Company B. The combination of functional groups and structural features, which are 
associated with this group are diverse (table 6-1). It is considered that when there is limited 
information on a product or a chemical it is difficult to predict a cleaning agent.  
11. Point eleven was identified as Sumatriptan Base, which was not previously identified in 
the analysis. 
12. This group contained the case study chemical P3 which was the only known chemical or 
product in the analysis to be cleaned from vessels using Toluene. This was clustered with 
products which were associated with the cleaning agent DMF. These were Severane, 
Metaprobamate, Quinapril and one product (Mometasone furoate anhydrous), which was 
previously associated with the cleaning agents Acetone of DMF.  
13. This group contained a number of products which were previously identified in the 
research to be associated with the cleaning agents Acetone or DMF. These were Marcaine, 
Mometasone furoate monohydrate, and two products whose link to cleaning agents is 
unknown, (previously associated with group 7 in the analysis (table 5-2 Chapter 5)). These 
were Gadopentetate dimeglumine and Gadopentetate monomeglumine.  
14. The final group of interest contained the products Salmeterol xinafoate (associated with 
the cleaning agent DMF in this research) and Folic acid. Folic acid had not been associated 
with any cleaning agent in this research. 
6.6.5 Conclusion 
The products and chemicals identified on the score plot (figure 6-4) indicate that there are 
relationships in the data and other factors which have not yet been identified, and that affect 
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the results. It is considered that more information needs to be gathered on cleaning agents 
which can be used to populate the model. The information about the chemicals, which was 
provided by Company C and Company B for the case study, seem to be linked with the 
cleaning agent DMF. Considering the information provided by both companies shown in 
tables 6-2 and 6-3 did not mention the cleaning agent DMF, there must be other factors which 
are influencing the data. Factors which could be affecting the results could include that not 
much data was available on the case study chemicals. In fact, the data which was included in 
the PCA analysis was not a true reflection of the composition of the undefined chemicals, as 
the true composition of many of the chemicals was unknown (table 6- 3, (P8, P9 and P11)). 
This was not sufficient and the lack of information may have had an effect on the analysis. 
Another factor influencing the results may be the type of chemical functional groups, which 
are found in the case study chemicals. In all cases the functional groups and structural features 
were not strongly identified in the data. It is believed that the combination of the functional 
groups, not just the presence of the functional groups, indicate the cleaning agent which 
should be used to clean products from vessels post manufacturing. In addition, it should be 
noted that the model was based on information provided by one company. It may therefore be 
considered that different cleaning agents are cleaned from vessels using different cleaning 
agents with different degrees of success. This information is not currently available but it is 
thought that additional input from companies would greatly increase understanding of the 
model, and of the fundamental connection between the science behind cleaning and the 
selection of a cleaning agent. Finally, the model was constructed using data provided for 
products and not intermediates or side products, which are undetermined. The product 
information is better defined than the chemicals provided in the case study. Therefore it may 
be possible to conclude that data of this type requires its own model, which is not based on 
product data. This will be investigated in section 6.5.5.  
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6.6.6 PCA analysis of the Case study data 
The information provided by Company C and Company B was normalised and analysed by 
PCA on its own to determine if any links in the data could be determined. It was considered 
that there was insufficient data to carry out this analysis but for completeness the analysis was 
performed. Figures 6-6, 6-7 and 6-8 show the PCA results. Figure 6-6 shows the results of the 
analysis via the scree plot.  
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Figure 6-7 Scree plot from PCA analysis performed only on the case study chemicals.  
 
The scree plot shows that a high proportion of the variables are represented as showing 
variability in the data. This is because the amount of data used in the analysis is limited. There 
are 10 variables which appear to contain 100% variation in the data set. There appear to be 
two ‘elbow points’ in the data set. The first point appears to be at component 5, which 
accounts for 82.3% of the variation in the data. The second ‘elbow point’ appears to be at 
component 8. Component 8 accounts for 98.2% variation in the data set. The first component 
in the data accounts for 21.9% of variation in the data. The last 9 principal components 
account for none in the variation in the data. The variable which appears to account for the 
most variability in the data is Alkyl >5 carbons. This variable appears to add to the variation 
in the first 4 principal components. Primary Amine functional groups and Fluorine also add 
the greatest variation in the group.  
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In order to examine the data further it is necessary to look at the information provided on the 
Score plot. This was carried out with figure 6-8.  
 
Figure 6-8 Score plot from PCA analysis performed only on the case study chemicals. The 
numbers refer to the reference number of the chemical in the study. Annotations indicate 
groupings of chemicals, and also where chemicals are associated with particular cleaning 
agents, according to Company B and Company C. 
Figure 6-8 indicates the location of the chemicals on the score plot. The score plot indicates 
that the chemicals were widely distributed on the plot. There were a few notable groupings, 
which are shown annotated on the plot (on figure 6-8). There are two groupings; the first 
contains chemicals P2 and P3. The chemical P2 is unsuccessfully cleaned from vessels using 
methanol but P3 is successfully cleaned from vessels using Toluene. It may be considered that 
Toluene might be a good choice of cleaning agent to use to try and clean P2 from vessels post 
manufacture. This choice is recommended without an understanding of the vessels and the 
materials they are made from. This information should be identified using FUSE to ensure 
appropriate cleaning agents are chosen.  
The second grouping shown on figure 6-8 is P8 and P9. Although both chemicals are cleaned 
from vessels with potentially different cleaning agents by Company B, both of these 
chemicals have unknown or undefined numbers of functional groups (table 6-3). It is not 
possible to easily determine the cleaning agent used for these chemicals. Both cleaning agents 
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PIB and caustic could be considered choices as both are used to some degree to remove these 
chemicals. The cleaning agent for P9 is not yet known and PIB may be a good choice of 
cleaning agent. 
Points on figure 6-8 were annotated to indicate the cleaning agent used. This showed that 
chemicals cleaned from vessels using the same cleaning agents had not clustered. It is 
considered that there is not enough information on the chemicals or chemical variables in the 
database to allow this. In order to complete the analysis the loadings plot is investigated, 
figure 6-9.  
 
 
Figure 6-9 Loading plot from PCA analysis performed only on the case study chemicals. 
It is considered that there is not enough information presented in figure 6-9 to be able to 
derive significant conclusions. The plot indicates that the variables represented add to the 
variation of the data set.  
Conclusions have been drawn from the analysis of the chemicals presented in the case studies 
by Company B and Company C. These will be discussed in section 6.6 
6.7 Chapter Summary 
Analysis of the case study chemicals has not been able to definitively determine which 
cleaning agents should be used to remove them from vessels post manufacture. The 
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information was initially processed by comparing it with data (table 6-1). This indicated that 
although there was not a lot of data presented for each chemical, most of the information was 
thought to align with the group of chemicals which were cleaned from vessels with DMF. The 
lack of physicochemical information meant that the data selected for the model constructed 
from database 1 information (Chapter 5) was appropriate. It is considered that 
physicochemical data on products is difficult to obtain and therefore the provision of little 
data of this nature for the case studies was not surprising. PCA analysis was carried out. This 
showed that all of the case study chemicals seemed to locate on the score plot next to products 
which were linked to the cleaning agents DMF or acetone. Further PCA analysis of the 
products and the case study chemicals linked to the cleaning agents DMF and acetone, 
indicated that most of the chemicals had clustered together. The chemicals were all 
considered linked to the cleaning agent DMF when this analysis was examined. In order to 
establish if the data would yield any more information, clustering or linkages, it was 
normalised and PCA was again carried out. This time only the case study data was analysed. 
This showed that the data did not cluster according to known cleaning agents. The data 
showed two clusters of information amid distinct points. The two clusters mean may that a 
similar cleaning agent could be tried for each chemical. The main reason for the data failing to 
cluster was probably the limited amount of data used in the analysis. This does not result in an 
extraction of meaningful results with PCA.   
It should be noted that the provision of cleaning agents for the case studies and the data which 
was used in the original model may not be complete. It is known that many companies 
manufacture the same chemicals, which is why a lot of cleaning data is confidential and is 
difficult to obtain. A cleaning agent which works RFT is a competitive advantage. Companies 
who manufacture the same chemical may successfully clean the residues from vessels using 
different approaches which are both successful. It would be of benefit to obtain this data and 
use this to inform future case studies, and increase the size of the cleaning knowledge 
database/tool. 
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Chapter 7. Conclusions 
7.1 Introduction 
This chapter concludes the thesis by discussing the answer to the initial research question: 
RQ1: What would be the best way to increase the fundamental understanding of the science 
behind cleaning linked to solvent and cleaning agent use? 
This chapter also discusses the thesis contributions, conclusions are summarised, and future 
work is considered. 
7.2 Discussion 
The main aim of this thesis was to suggest the best way to increase the fundamental 
understanding of the science behind cleaning linked to solvent and cleaning agent use. This 
was to be achieved by creating, modifying or suggesting existing Britest tools. Chapter 3 
identified through site visits and questionnaires that there was a need for a better fundamental 
scientific understanding of industrial plant cleaning. It was believed that pharmaceutical plant 
cleaning was often neglected and not considered part of processing. The main contaminants 
forming residues in vessels were not fully understood and the cleaning agents selected to 
remove them was based on solubility rather than functional group or structural properties of 
the pharmaceuticals. Cleaning processes and protocols were not optimised and cleaning was 
therefore not often carried out RFT. This had a detrimental effect on processing schedules and 
resources.  
In addition, site visits conducted with Britest members identified that any tool developed 
needed to show cleaning challenges associated with the engineering aspects of cleaning 
pharmaceutical plant. These challenges range from difficult materials to clean, hard to reach 
places because of plant geometry and the age of plant vessels. It was considered that all of 
these aspects would be too complex to incorporate into one tool therefore a suite of tools was 
required. The Britest tools were examined and discussed with an aim to finding 
complementary tools and methodologies which could be used with the new tool developed 
during this research. The objective was to help achieve WPU and ideally, any tools developed 
should potentially eliminate the need for the manufacture of a pharmaceutical product in order 
to test its solubility. 
The cost associated with inadequate cleaning was considered and Benson’s ZEAL tool 
(developed for the food and drink industries for aqueous cleaning) was used to understand 
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cleaning costs. However, using Zeal was not effective for pharmaceutical cleaning as 
industrialists were not able to provide monetary values for their operations. In addition, ZEAL 
was not designed to consider the costs of waste disposal. Aqueous cleaning waste in the food 
and drink industries is generally cheaper and easier to dispose of. In the pharmaceutical sector 
chemical waste can be a major contributing factor to the cost of cleaning. 
Chapter 2 discussed the literature available on cleaning. The literature discussed indicated that 
a lot of information on pharmaceutical plant cleaning was not available in the public domain. 
There are a few reasons for this. Industry has not traditionally given any thought to cleaning 
and therefore has not considered gathering data, let alone publishing it. It is thought that a 
successful cleaning regime gives any manufacturer a significant advantage over competitors 
and therefore the information is not shared if it is known. There are tools which can be 
utilised to increase the understanding of cleaning, such as the Britest tools, but prior to this 
research they have not been used for this purpose. The literature indicated that there was no 
published research on tools or methodologies which could be utilised to increase 
understanding of the science behind plant cleaning. 
Chapter 4 discussed selecting and collating the data needed to understand the fundamental 
science behind cleaning. It was decided that the most fundamental data on pharmaceutical 
products was the structural and functional composition. This data was analysed by several 
methodologies until PCA was selected as the methodology to achieve the main aim of the 
research. 
Chapter 5 discussed the use of PCA analysis to create a tool used to begin to understand the 
science behind cleaning. This was carried out using two databases of information on a number 
of pharmaceutical products using information in the public domain. One database contained 
information of functional groups and structural features of API’s and the second contained 
information on the physicochemical properties of the same API’s. Analysis indicated a 
number of functional groups, structural features and physicochemical properties clustered,  
or were shown to be linked in the data. This was shown on a score plot for each database. 
Known industrial cleaning agents for specific API was then linked to the information on the 
score plots. This showed that the cleaning agents were clustered around API’s containing 
specific types of features and properties.  
This information was collated into a table which was used to determine cleaning agent 
selection for case studies with Company B and Company C in Chapter 6. The case study 
information provided was different from the API data collated. The information obtained 
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concerned undefined chemicals. These were not defined as intermediate products or side 
products. The structural or physicochemical characterisation was not complete. It was difficult 
to analyse this information, as there was not much information available to analyse. 
Nevertheless, cleaning agent selection was carried out for each undefined chemical and in 
addition PCA analysis was carried out which confirmed the choice of cleaning agent selection 
with the limited data (with the cleaning agent selected using the collated table of information). 
Further PCA analysis was carried out using only the information provided by the two case 
studies. The analysis showed that the case study chemicals failed to cluster according to the 
case study companies selected cleaning agent. It was thought that the information provided 
for these case studies was neither precise nor sufficient enough to analyse in these 
circumstances. A Transformation Map of the process prior to carrying out PCA would have 
helped to determine more information about the chemical functional groups and structures.  
7.3 Thesis Contributions 
In summary the main contributions of this thesis are as follows - 
 An extensive literature review identified and described methods used for cleaning in 
industry with a view to finding common cleaning methods in industry. 
 A further literature review described current analytical methods used in industry to 
determine the cleanliness of equipment. 
 Collated information on the regulatory documentation and regulations which are 
applicable to pharmaceutical plant cleaning. 
 Structured questionnaires and site visits identified the industrial challenges associated 
with pharmaceutical plant cleaning. 
 Established the level of understanding around plant cleaning in the pharmaceutical 
industry. 
 Developed a tool which increases understanding of the fundamental science behind 
pharmaceutical plant cleaning. 
 Modified existing Britest tools and identified others to create a suite of tools (FUSE) 
for use in pharmaceutical plant cleaning and the chemical industries.  
7.4 Conclusions 
In summary the main conclusions of this thesis are as follows - 
 Pharmaceutical and chemical companies require a better scientific understanding of 
plant cleaning. 
226 
 
 A better scientific understanding of pharmaceutical plant cleaning can be achieved by 
obtaining information on specific functional groups and structural features of API’s 
and carrying out PCA. 
 PCA analysis can be used to determine clusters and patterns relating to the 
composition of chemicals. This information can then be correlated to known cleaning 
agents for specific chemicals. Known functional groups and structural features of 
these API can be used to identify other chemicals which could be cleaned from vessels 
using the same cleaning agent. 
 A newly proposed methodology for the selection of cleaning agents and solvents for 
API’s based on their functional groups and structural features. 
 A method utilising physicochemical characteristics of API’s was not successful 
because this information was not easily available for API’s and therefore it was very 
difficult to obtain for side products, intermediate products and undetermined products. 
 Cleaning agent selection was not achieved during analysis of case study chemicals 
which were described as undefined chemicals by the case study companies. It is 
thought that more precise information would have improved the analysis. Tools such 
as the Britest Transformation Maps, used correctly, would provide much of the 
relevant information on chemical structure to facilitate cleaning agent selection. 
 It is considered that the model produced during this analysis for API’s is not 
appropriate for side products, intermediates or undetermined chemicals. This is 
because the model is based on API data and the API chosen for the model were well 
characterised. Therefore, it is recommended that either a new model is constructed for 
side products, intermediates or undetermined chemicals or better characterisation of 
the chemicals is needed. Better characterisation will give better analysis of the 
chemicals using the original model. 
 The new tool can be used in two ways for the selection of cleaning agents for API’s. 
The first way is to determine functional and structural groups in the table which have 
been linked to cleaning agents and compare these with the features of the chosen API. 
The second method is to use the loadings that were identified from the original data to 
calculate new scores and determine where the chosen API is located in relation to 
API’s with known cleaning agents. 
 This database will be more useful to industry if it is further populated with more data. 
Specifically, it should be populated with API’s with known cleaning agents. This will 
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help to determine if different companies use different cleaning agents to successfully 
remove the same product from vessels post manufacture. 
 
7.5 Future Work 
This section addresses particular areas where further research is required. 
7.5.1 Future Case Studies 
Britest Ltd intends to add this tool as part of the FUSE suite to their collection of tools and 
methodologies. The result of this will be the development of further case studies with the 
industrial members. These case studies will then be used in order to validate the findings of 
Chapter 5. 
API’s should be used for the case studies which would increase the data set used in the model. 
In addition, the opportunity to use FUSE as a suite of tools to help identify and resolve 
cleaning challenges in a case study on a site visit to a pharmaceutical company would validate 
the suite of tools.  
7.5.2 Future Research Recommendations 
It is recommended that the API model is further populated with more information to increase 
its robustness and effectiveness.  
It is recommended that further data analysis (cluster analysis) is carried out on the databases 
to both complement the PCA and provide further information. Other software packages such 
as R, which includes algorithms such as AGNES (Agglomerative NESting) would allow 
further examination of the data. It is recommended that AGNES, which uses a bottom up 
clustering approach, or DIANA (Divisive ANAlysis) a top down approach to clustering, are 
used to determine if any further linkages or patterns are found in the data. The data used in 
this research relates to API’s, their physicochemical properties and structural features. The 
analysis and initial conversations with industrialists has indicated that it may be possible for 
more than one cleaning agent to successfully remove an API from pharmaceutical equipment. 
The use of an algorithm which allows fuzzy clustering such as FANNY and not hard 
clustering which was used in this research may indicate dual cleaning agents to use for certain 
API.  
It is considered that the PCA principal components could be further analysed in this research. 
This may indicate further links and patterns in the data which were not indicated in the first 
few principal components. 
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It is recommended that Britest Ltd members share cleaning information specific to commonly 
manufactured API’s. This will help determine whether API’s can successful be cleaned from 
vessels by more than one cleaning agent. This information would greatly increase the 
effectiveness of the existing model but it was not available during this research. 
It is recommended that Britest Ltd obtain cleaning information for side products and 
intermediate products which have been better defined by the use of FUSE (using PrISM or 
TE3PO). This date could then be used to construct a model. 
During analysis of the data, consideration was given to the creation of another database of 
API physicochemical and structural information from non Britest member companies or data 
randomly generated by the software. This was not carried out during this research. It was 
considered that using this approach it would be difficult to obtain cleaning data for any non 
Britest companies indicating either successful cleaning or unsuccessful cleaning. A random 
generated set of data would not be linked to any cleaning agents. Knowledge of cleaning 
agents is critical to begin to understand the key variables which indicate the use of cleaning 
agents for specific API. It is recommended that proceeding with either of these approaches 
should happen only after the addition of Britest member data to increase cleaning knowledge.  
This research thesis focused on the challenges associated with cleaning pharmaceutical plant 
post manufacture. It is considered that the methodology used in this research may be useful in 
selecting final product formulations based on their functional and structural features and 
physicochemical characteristics. It is possible that these could be linked to known successful 
formulations which are well documented in the pharmaceutical literature. This may indicate 
formulations for new drug products and help to select new formulations for existing products. 
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Appendix I:  
Plant Cleaning Survey 
Introduction 
The purpose of this survey is to understand the current approaches to plant cleaning taken by 
Britest member companies in order to provide common background for further work on the 
plant cleaning project, building on the survey of Britest Members conducted in 2009. You 
may wish to print out the survey and complete by hand, or you may edit this document to 
include your responses. Any information provided will be treated as confidential between the 
Member, Britest, and the Newcastle University Plant Cleaning EngD (Wendy Carr); All 
results will be made anonymous before any analysis circulated within the Britest membership. 
 
Questions from the original survey are in black text. Additional questions to help provide 
further information are in blue text. 
Please provide the following details – we may wish to follow up specific points with you. 
Organisation: 
Contact details: 
Nature of process plants (mark all that apply): 
Multipurpose batch Y / N Single product batch Y / N  Continuous Y / N 
 Can you indicate which product type you are involved in manufacturing? 
 Chemical 
 Pharmaceutical 
 Biopharmaceutical 
 Other (please specify): 
Plant cleaning protocols 
 
1. With an emphasis on one process please provide a brief description of how your 
current plant cleaning protocols are/were developed, including an indication of where 
in the process lifecycle they were considered and an outline of any tools/methods used 
in their development. 
 
2. On what priority is the cleaning protocol based? 
The type of contaminants Y / N 
The type of product Y / N 
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The type of plant equipment Y / N 
The level of soiling Y / N 
Pharmaceutical or industry standards or requirements Y / N 
A combination of the above factors with no definite priority Y / N 
Other (please specify): 
 
3. Are your cleaning protocols based on utilising: 
 Volume of cleaning agent (e.g. solvent, detergent, water) used? Y / N 
 Contact time for the cleaning agent?     Y / N 
 Removal of contaminant(s) to specified levels?   Y / N 
Other (please specify): 
 
 
4. How many contaminants are you typically trying to remove? 
1-4   5-9  10 or more 
 
5. Are your cleaning protocols developed from an understanding of the contaminant 
types?  Y / N 
If yes please specify and give examples: 
 
 
6. Which is the priority, level of contamination or type of contamination? 
Level 
Type 
Both equally important 
 
7. What are the main contaminant types in your typical processes? 
Chemical based 
Biological based 
Residual cleaning agents 
Other (please specify): 
  
8. Do you typically clean at: 
 Ambient temperature? Y / N 
 Elevated temperature? Y / N 
 
9. How do you determine the cleaning temperature? 
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 Suppliers’ recommendations    Y / N 
Lab assessment during development   Y / N 
 In-plant assessment during commissioning  Y / N 
Other (please specify): 
 
10. Do you clean between batches of the same product? Y / N 
 
11. Do the protocols for cleaning between batches differ from cleanouts between 
products? Y / N 
If so, please briefly outline the key differences: 
 
Process-specific cleaning issues 
Consider a process that you operate which exhibits some cleaning difficulties: 
12. Does an increase in the product batch size affect the amount of soiling? Y / N 
 
13. Is there is an increase in the level of soiling between different batches Y / N 
 
 
14. Is it believed that the soiling is generally variable between batches? Y /N 
If yes, do you think the soiling variability is due to:  
Raw material batch variations 
The types of raw materials used 
Other (please specify): 
 
 
15. Do you know whether the main plant soiling occurs at one particular stage in the 
process?  Y / N 
 
16. Is the soiling specific to one area of the plant? Y /N 
If yes, please indicate where: 
 
 
17. Is this area targeted for specific cleaning? Y / N 
If yes, please specify all of which apply: 
Is it taken apart for cleaning? 
Flushed more than the other areas of the plant 
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Targeted with a specific cleaning agent  
Isolated from the other areas of the plant for cleaning 
Other (please specify): 
 
18. Have you identified any chemical or biological structures, or physical properties in the 
contaminants, that have been targeted by the inclusion of a specific cleaning agent in 
the design of the cleaning protocol? Y / N 
If Yes, please specify the nature of the structure/property and the cleaning agent 
selected: 
 
19. Has the cleaning protocol been developed to specifically remove any of these 
contaminants by the inclusion of specific cleaning agents such as acid or alkali?  
Y / N 
If Yes please specify: 
 
20. Can you specify the cleaning agent? 
Is the same cleaning method carried out on other similar processes at your site that 
manufacture different products Y / N 
If Yes please specify what the process is and if the cleaning is effective: 
 
 
 
21. In your opinion can you indicate how effective the current cleaning method is? 
It is very effective 
It is sometimes effective 
It is not very effective  
It is never effective 
 
22. If money, time and other resources were not limited how would you improve or 
change the cleaning method for this product? 
Briefly explain below:  
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Plant cleaning methods 
 
23. What methods do you use to clean your process plant? 
 Specific Clean-in-Place technology    Y / N 
 Washouts without disassembly of equipment/pipework Y / N 
 Manual cleaning with equipment/pipework disassembled Y / N 
Other (please specify): 
 
24. Do you use any specific cleaning equipment for this process? Y / N 
If yes please specify: 
 
25. Has any equipment been specifically designed for cleaning post manufacturing 
processes  Y / N 
If yes please specify: 
 
 
Cleaning agents 
26. What cleaning agents do you use? 
Organic Solvents Y / N 
 Aqueous detergent Y / N 
Mineral acid/alkali Y / N 
 Water   Y / N 
 
27. How are your cleaning agents selected? 
 Suppliers’ recommendation    Y / N 
 Lab assessment during development   Y / N 
 In-plant assessment during commissioning  Y / N 
Other (please specify) 
 
 
28. Do you use combinations of cleaning agents for individual processes (e.g. solvent 
cleaning followed by water washes)? Y / N 
Please provide a brief outline: 
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29. Do you recover cleaning agents used in cleaning operations: 
 For process use?    Y / N 
 For use in future cleaning operations? Y / N 
 
30. Are cleaning agents are recovered post cleaning processes? Y / N 
If yes please indicate what is recovered: 
 
 
31. Is there an identifiable reason that solvent recovery is not carried out. Is this due to any 
factors indicted below? Please indicate all that apply. 
Lack of solvent storage 
Level of soil in the solvent 
Type of soil in the solvent 
Never considered it 
Other (please specify): 
 
 
 
32. Do you recover the contaminants removed for further processing? Y / N 
 
Analysis and validation 
 
33. Please briefly outline how you validate your cleaning protocols: 
 
 
34. How do you validate plant cleanliness post-cleaning? 
 Analysis of surface swabs  Y / N 
 Analysis of cleaning agent effluent Y / N 
 Analysis of rinse effluent  Y / N 
 Visual inspection   Y / N 
 Other (please specify): 
  
 
35. Please briefly outline the analytical techniques you use to validate cleanliness: 
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36. What is the reasoning for using your current validation technique? Please indicate all 
that apply. 
 
Based on a standard industry technique for this process? 
Is it driven by a pharmaceutical standard? 
Is it based upon an FDA requirement? 
It is all that is available at this site 
Other (please specify):  
 
37. Do you think that this technique is an effective method for validating cleanliness?  
Y / N 
 
38. Are there specific reasons that you do not use an alternative validation technique? 
Please indicate all that apply: 
We are not aware there is another method for this process 
Introducing a new method is not cost effective 
Current method is the best for our requirements   
No time to validate a new method 
Regulatory restrictions 
Company protocol 
Other please specify: 
 
 
39. Please briefly outline how you determine your acceptance criteria: 
 
 
 
 
40. What course of action do you typically take if analysis indicates the plant is not 
cleaned to the acceptance criteria? 
Full plant cleaning to the standard protocol   Y / N 
Targeted cleaning using a subset of the standard protocol Y / N 
Targeted cleaning following a further protocol  Y / N 
Other (please specify): 
 
 
252 
 
41. Can you give an indication of the effectiveness of the current cleaning protocol? Does 
this method work:  
On the first attempt Every time / more than 50% of the time / less than 50% 
of the time 
On the second attempt Every time / more than 50% of the time / less than 50% 
of the time 
 
More than 2 attempts Every time / more than 50% of the time / less than 50% 
of the time 
 
  
Time and cost 
42. For a typical product cycle/campaign please indicate: 
 Batch cycle time, days; 
 Between batch cleaning time, days; 
Total production time, days; 
Post campaign cleaning time, days; 
 
43. What is the typical ratio of volume of cleaning agent to total volume of plant? 
 
44. Does this depend on the type of plant equipment? Y / N 
If Yes please explain: 
 
 
 
Does this depend on the size of the plant? Y / N 
If Yes please explain: 
 
 
 
45. For a typical product what is the approximate cost of the cleaning activity as a 
percentage of product cost? 
<5%  6-15%  17-25% >25% 
 
46. Please identify which of these the largest contributor to the cost of the cleaning 
activity: 
Plant downtime Labour  Energy  Cleaning agent  
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47. Can you indicate the potential cost of downtime incurred by ineffective cleaning 
methods as a percentage of the product costs 
<5%  6-15%  17-25% >25% 
    
 
48. As a percentage of total plant downtime what percent is attributable to cleaning 
activity 
<5%  6-15%  17-25% >25%   
 
>50%  >70% 
 
 
49. What would be your preferred approach to reduce process downtime associated with 
cleaning? Please give an illustrative example: 
 
 
 
 
General Questions 
50. Can you give your definition of clean with reference to your plant? 
 
 
 
51. In your opinion when would you state that you know something is clean? Please 
indicate all that apply. 
It looks visibly clean 
Is validated as clean but there is some soiling visible 
Is validated as clean but there are stains visible 
The vessel is only clean when the validation techniques indicate cleanliness 
Other 
 
52. If a vessel or piece of equipment is marked or stained is stain mapping carried out?  
Y / N 
If Yes, please indicate what instrumentation is used to carried this out 
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53. If the stains are permanent have you tried to remove them? Y / N 
If yes how was this carried out? Please specify: 
 
 
 
Was this effective? Y / N 
Please explain the above answer: 
 
 
 
      54. Is the stain a result of a known contaminant or a result of the cleaning process? 
Please indicate below 
 
 
 
55. Would the use of disposable equipment be effective on the plant to remove the need 
for cleaning? Y / N 
 
56. If the answer to question 55 is No, is this due to factors indicated below? Please 
indicate all that apply. 
Disposal technology is not suitable for this process  
Please indicate why this is the case: 
This is not cost effective 
The scale of the process makes the use of disposable technology unfeasible 
Other please specify: 
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Appendix II:  
Active Pharmaceutical Ingredients and Pharmaceutical Products used in this research. 
Information was obtained from the Pharmaceutical companies’ websites in the public domain. 
The website addresses are also given below. 
Shasun 
Products manufactured – Brofen (Ibuprofen), Cycloserine, HPMPC (Cidofovir), Isradipine, 
Ketoprofen, Gabapentin, Quinapril, Ranitidine, Sevelamar. 
www.shasun.com/ 
Abbott 
Products manufactured-Blopress (candesartan cilexetil), Calcijiex (Calcitrol), Clarithromycin, 
Hytrin, Klacid (Clarithromycin),Epival (Sodium valproate), Lupron (Leuproreline), Nimbex 
(Cisatracurium besilate), Paricalcitol (Zemplar), Progesterone, Severane, Eprosartan 
(Teveten). 
www.abbott.co.uk/ 
AstraZeneca 
Products manufactured – Citanest (Prilocaine), Imdur (Isosorbide mononitrate), Isoflurane, 
Marcaine (Bupivacaine), Oxis (Formoterol), Plendil (Felodipine). 
www.astrazeneca.co.uk/ 
AMRI (Albany Molecular Reseach Inc.) 
Products manufactured – Furosemide, Merperidine, Warfarin. 
www.amriglobal.com/ 
Hovione 
Products manufactured – Ciclesonide, Clobetasol propionate, Dexamethosone dipropionate, 
Halobetasol, Ixodixanol, Iohexol, Iopamidol, Ivermectin, Doxycycline hyclate, Doxycycline 
monohydrate, Fluticasone furaroate, Fluticasone propionate, Mometasone furoate anhydrous, 
Mometasone furoate monohydrate, Roxithromycin, Salmeterol xinafoate, Sumatriptan base, 
Tamsulosin. 
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www.hovione.com/ 
Pfizer 
Products manufactured – Venlafaxine 
www.pfizer.co.uk/ 
Eli Lilly 
Products manufactured – Nizatidine, Olanzapine 
www.lilly.co.uk 
UCB 
Products manufactured – Metolazone 
www.ucbpharma.co.uk/ 
Jhp pharmaceuticals 
Products manufactured – Methohexital 
www.pharmaceutical-technology.com/ 
Wyeth 
Products manufactured – Meprobamate 
www.wyeth.com 
Novartris 
Products manufactured – Ciclosporin 
www.novartris.co.uk 
GE 
Products manufactured – Gadopentetate dimeglumine, Gadopentetate monomeglumine 
www3.gehealthcare.co.uk/ 
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Watson Laboratories 
Products manufactured – Folic Acid 
Now known as Allergan  
www.allergan.com/ 
 
Note – Active Pharmaceutical Ingredients (API’s) have more than one name listed in some 
cases. This is due to the fact that some API’s have a brand name at some companies and also 
a generic drug name. Both are listed where appropriate. 
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Appendix III: 
Variables used in Database 2 Physicochemical Analysis 
Exact mass, molecular weight, atoms C (Carbon), O (Oxygen), F (Fluorine), H (Hydrogen). 
Sulphur (S), N (Nitrogen), Cl (Chlorine), Boiling Point both in Kelvin (K) and in °c, Melting 
point K, Critical Temperature K, Critical Pressure (Bar), Critical Volume (cm3/mol), Gibbs 
energy (kJ/mol), LogP, MR (cm3/mol) Henry’s Law, Heat of Form, tPSA, CLogP, CMR, 
ACD/LogP, ACD/LogD (ph5.5), ACD/BCF (ph5.5), ACD/KOC (ph5.5), H bond acceptors, 
Freely rotating bonds, Index of refraction, Molar Volume (cm), Surface Tension dyne/cm, 
Flash Point, ACD/Log D (ph7.4), ACD/BCF (ph7.4), ACD/KOC (ph7.4), H bond donors, 
Polar surface area, Molar Refractivity (cm), Polarizability, Density, Enthalpy of vaporisation 
(kJ/mol), Vapour pressure.    
Classes of API including Dermatological, Nasal and inhalation, Injectable, API (because of a 
lack of other classification given).  
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Appendix IV: 
This appendix shows variables used in database 1 and database 3 which were analysed by 
PCA. 
Functional Groups 
Amine functional groups; Primary, Secondary, Tertiary, Aromatic/enamine.        
Alcohol OH functional groups; Primary, Secondary, Tertiary, Vinyl alcohol, Phenol .        
Acidic functional groups; Carboxylic, Sulfonated, Other  
Carbonyl functional groups; Ketone, Aldehyde, Enone, Ester, primary, secondary, tertiary, 
Anhydride, Epoxide, Thioester           
Other Nitrogen groups; Oxime, Oxazolidinone, Urea, Guanidine                   
Other functional groups; Ether, Sulfonamide, Sulfone, N-Oxide, Nitrile, Thiol, Thioether, 
Fluorine, Pyridine, Alkyl halide, Aryl halide, Alkene, Nitrate, Nitro, Carbamate, Phosphate, 
Other, Hydrozone, Phosphonate, Alkylgreater than 5 C                    
            
Structural features and Organic framework               
Steroid, Hormone, O-heterocyclic, N-heterocyclic, S-heterocyclic, Long alkyl, Phenyl ring, 
Erythromycin derivative, Tetracycline, Macrocyclic, Macrolide, Benzodiazepine, Barbiturate, 
Water, Ethanol, HCl, Na+, Gd3+ 
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Appendix V:  
Information and results from analysis (Chapter 5) 
    
Principal Component Analysis: Database One: Chemical Functional Group 
Information. 
 
The Principal Components determined for the variables from database 1 are listed below.  
 
Eigenanalysis of the Covariance Matrix 
69 cases used, 2 cases contain missing values 
 
Eigenvalue   4.9682   4.1165   3.6005   3.3085   3.2663   3.0538   2.7193   2.6784 
Proportion    0.086    0.071    0.062    0.057    0.057    0.053    0.047    0.046 
Cumulative    0.086    0.157    0.220    0.277    0.333    0.386    0.433    0.480 
 
Eigenvalue   2.2458   2.0947   1.8695   1.8321   1.7762   1.5803   1.5134   1.3747 
Proportion    0.039    0.036    0.032    0.032    0.031    0.027    0.026    0.024 
Cumulative    0.519    0.555    0.587    0.619    0.650    0.677    0.703    0.727 
 
Eigenvalue   1.2593   1.1599   1.0904   1.0540   1.0011   0.9683   0.9409   0.8940 
Proportion    0.022    0.020    0.019    0.018    0.017    0.017    0.016    0.015 
Cumulative    0.749    0.769    0.788    0.806    0.823    0.840    0.856    0.872 
 
Eigenvalue   0.8392   0.8157   0.7700   0.6100   0.6064   0.5758   0.4579   0.3913 
Proportion    0.015    0.014    0.013    0.011    0.010    0.010    0.008    0.007 
Cumulative    0.886    0.901    0.914    0.924    0.935    0.945    0.953    0.960 
 
Eigenvalue   0.3387   0.3151   0.2813   0.2317   0.2049   0.1983   0.1556   0.1234 
Proportion    0.006    0.005    0.005    0.004    0.004    0.003    0.003    0.002 
Cumulative    0.966    0.971    0.976    0.980    0.983    0.987    0.990    0.992 
 
Eigenvalue   0.1052   0.0998   0.0866   0.0498   0.0431   0.0294   0.0272   0.0182 
Proportion    0.002    0.002    0.001    0.001    0.001    0.001    0.000    0.000 
Cumulative    0.993    0.995    0.997    0.998    0.998    0.999    0.999    1.000 
 
Eigenvalue   0.0112   0.0071   0.0036   0.0000   0.0000   0.0000   0.0000   -0.0000 
Proportion    0.000    0.000    0.000    0.000    0.000    0.000    0.000    -0.000 
Cumulative    1.000    1.000    1.000    1.000    1.000    1.000    1.000      1.000 
 
Eigenvalue   -0.0000   -0.0000   -0.0000   -0.0000   -0.0000   -0.0000   -0.0000 
Proportion    -0.000    -0.000    -0.000    -0.000    -0.000    -0.000    -0.000 
Cumulative      1.000      1.000      1.000      1.000      1.000      1.000      1.000 
 
Eigenvalue   -0.0000 
Proportion    -0.000 
Cumulative      1.000 
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Variable     PC1    PC2      PC3       PC4      PC5       PC6           PC7 
Primary   0.156   0.186    -0.05    -0.166    -0.122    -0.129  -0.214 
Secondary                     0.112    0.047    0.169    0.118    0.123     -0.247       -0.022 
Tertiary                         0.071   -0.069     0.378    0.190    0.108      0.005        0.121 
Aromatic/enamine        0.150    0.231     0.041   -0.118   -0.105      0.327       0.011 
Primary_1                     0.089    0.079    0.080    0.053     0.035     -0.127        0.177 
Secondary_1                 0.062   -0.021    0.062    0.115     0.108      0.019      -0.097 
Tertiary_1                    -0.163   -0.231    0.255   -0.244   -0.071      0.003     -0.013 
Vinyl alcohol               -0.022   -0.182    0.165    0.137   -0.421      0.013       -0.098 
Phenol                           0.104    0.137   -0.013   -0.116   -0.063     -0.154      -0.087 
Carboxylic                    0.095    0.075     0.255    0.206    0.175     -0.202        0.103 
Sulfonated                     0.000    0.000    0.000     0.000    0.000      0.000        0.000 
Other                             0.000    0.000    0.000     0.000    0.000      0.000        0.000 
Ketone                         -0.262   -0.123   -0.202    0.119    -0.030     0.058       -0.020 
Aldehyde                     -0.000    0.000   -0.000    0.000    -0.000    -0.000       -0.000 
Enone                          -0.025   -0.009   -0.088    0.044     0.024     -0.033       -0.052 
Ester                            -0.117   -0.190   -0.221   -0.066     0.081      0.092        0.048 
1o amide                       0.003   -0.099    0.014     0.052   -0.213     -0.001        0.095 
2o amide                       0.144    0.181   -0.054    -0.152   -0.147     -0.018        0.212 
3o amide                       0.065    0.055   -0.067    -0.073   -0.108     -0.035        0.370 
Anhydride                     0.000   -0.000    0.000    -0.000    0.000      0.000        0.000 
Epoxide                         0.000   -0.000    0.000   -0.000     0.000      0.000        0.000 
Thioester                      -0.059    0.009   -0.015    0.139     0.110      0.107        0.082 
Oxime                          -0.034   -0.200    0.179   -0.313     0.116      0.040        0.022 
Oxazolidinone             -0.003    -0.010  -0.026     0.019     0.006    -0.006        0.002 
Urea                              0.003     0.052   -0.007   -0.015    -0.007     0.018        0.048 
Guanidine                     0.116     0.143   -0.047   -0.179    -0.164     0.056        0.013 
Ether                            -0.010   -0.202    0.075   -0.321      0.116     0.040       -0.047 
Sulfonamide                 0.038    0.020     0.027    0.017      0.036    -0.065       -0.060 
Sulfone                         0.000   -0.049   -0.031   -0.085      0.044     0.030         0.007 
N-Oxide                       0.033    -0.009    0.016    0.048      0.092     0.035        -0.311 
Nitrile                         -0.000     0.000   -0.000    0.000     -0.000    -0.000       -0.000 
Thiol                           -0.000    0.000   -0.000    0.000      -0.000    -0.000       -0.000 
Thioether                     0.051     0.134    0.156    0.097       0.070     0.433        0.002 
Fluorine                      -0.191   -0.021   -0.157    0.106       0.078     0.058        0.037 
Pyridine                      -0.186    0.126    0.043   -0.049       -0.018   -0.002        0.022 
Alkyl halide                -0.110   -0.107   -0.233    0.105       0.034     0.060        0.002 
Aryl halide                  -0.031    0.141   -0.007   -0.098      -0.044   -0.142       -0.190 
Alkene                          0.007   -0.013    0.000   -0.069      -0.019   -0.038       -0.011 
Alkylgreater than5 C    0.041    0.007   -0.084   -0.057      -0.141   -0.006        0.300 
Phosphonate                -0.272    0.210    0.111   -0.057      -0.045   -0.022        0.013 
Hydrozone                   -0.273    0.210    0.162    0.011       0.008    0.037         0.025 
Other_1                       -0.361    0.228    0.138   -0.059      -0.048   -0.048       -0.011 
Phosphate                    -0.361    0.228    0.138   -0.059     -0.048   -0.048        -0.011 
Carbamate                    0.020    0.009   -0.008    0.007       0.008   -0.038        -0.023 
Nitro                             0.077    0.114    0.125    0.065       0.043    0.452        -0.030 
Nitrate                          0.033   -0.009    0.015    0.048       0.092    0.035        -0.309 
Steroid                         -0.266   -0.059   -0.268    0.135      0.074    0.051        -0.005 
Hormone                       0.010    0.057   -0.073   -0.033     -0.016   -0.125       -0.163 
O-heterocyclic              0.082    0.063    0.040    0.046       0.051    0.085        -0.306 
N-heterocyclic              0.107    0.183   -0.012   -0.127     -0.061    0.131         0.059 
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S-heterocyclic               0.057    0.094    0.097    0.040      0.024    0.379          0.016 
Long alkyl                    0.028    0.007    0.026   -0.037    0.007   -0.107   -0.015 
Phenyl ring                   0.156    0.186   -0.057   -0.166   -0.122   -0.129   -0.214 
Erythromycin deriv     -0.035   -0.203    0.182   -0.317    0.118    0.041    0.023 
Tetracycline                -0.028   -0.189    0.174    0.142   -0.421    0.017   -0.073 
Macrocyclic                 0.042    0.036   -0.063   -0.057   -0.095   -0.032    0.358 
Macrolide                   -0.045   -0.239    0.158   -0.320    0.131    0.044    0.018 
Benzodiazepine           0.013    0.001    0.044    0.071    0.053    0.033    0.062 
Barbiturate                  0.014    0.024   -0.017   -0.007   -0.000    0.011    0.039 
Water                         -0.011   -0.085   -0.031    0.029   -0.234    0.059   -0.042 
Ethanol                      -0.002   -0.099    0.104    0.092   -0.199    0.001   -0.030 
HCl                            -0.021   -0.156    0.152    0.126   -0.356    0.013   -0.066 
Na+                            -0.336    0.216    0.132   -0.049   -0.040   -0.054   -0.007 
Gd3+                            0.076    0.014    0.253    0.222    0.175   -0.195    0.138 
 
Variable                         PC8       PC9       PC10      PC11      PC12      PC13      PC14 
Primary                        0.126   -0.122      0.085      -0.115     -0.004    0.111       0.026 
Secondary                    0.047   -0.048     -0.029       0.066     -0.139   -0.015       0.111 
Tertiary                       0.120    -0.100      0.115      -0.061      0.055    0.090      -0.052 
Aromatic/enamine       0.089   -0.089      0.104       0.146      -0.008   -0.043     -0.141 
Primary_1                   -0.050   -0.030      0.079      0.256        0.081   -0.133     -0.112 
Secondary_1               -0.273   -0.109      0.134     -0.000      -0.043    0.031      -0.213 
Tertiary_1                    0.011   -0.017    -0.096       0.050       0.036   -0.116      -0.056 
Vinyl alcohol               0.021   -0.008     0.028      -0.008       0.054    0.012       0.013 
Phenol                          0.121   -0.094    -0.129       0.058       0.050   -0.204      -0.261 
Carboxylic                   0.113   -0.111     0.112       0.038      -0.061    0.110      -0.110 
Sulfonated                    0.000    0.000     0.000       0.000       0.000    0.000        0.000 
Other                            0.000    0.000     0.000       0.000       0.000    0.000        0.000 
Ketone                          0.092   -0.126    0.075       0.176      -0.003    0.027      -0.021 
Aldehyde                      0.000    0.000    0.000      -0.000      -0.000   -0.000      -0.000 
Enone                           0.057   -0.017   -0.212       0.090       0.219    0.244       -0.069 
Ester                             0.035   -0.102    0.137      -0.141      -0.306    0.078       -0.152 
1o amide                     -0.136   -0.044   -0.070     -0.252       -0.315    0.152       -0.349 
2o amide                     -0.084   -0.135    0.145       0.155        0.167   -0.104       -0.093 
3o amide                     -0.273   -0.107   -0.094       0.062        0.197    0.087        0.195 
Anhydride                   -0.000   -0.000   -0.000       0.000       0.000    0.000         0.000 
Epoxide                      -0.000   -0.000   -0.000       0.000        0.000    0.000         0.000 
Thioester                     0.094   -0.030    0.095       -0.454        0.369   -0.171       -0.072 
Oxime                         0.014   -0.066    0.001        0.047        0.156    0.094        -0.168 
Oxazolidinone           -0.001    0.049   -0.052        0.034       -0.002   -0.036        0.144 
Urea                            0.004    0.588    0.079        0.111         0.082    0.171       -0.178 
Guanidine                   0.067   -0.120    0.323        0.109         0.069   -0.084       -0.077 
Ether                           0.004   -0.024    0.132       -0.034        -0.073    0.022        0.192 
Sulfonamide                0.002    0.034   -0.050      -0.034        -0.063    0.028        0.251 
Sulfone                        0.014    0.047    0.107       -0.128        -0.207    0.013        0.223 
N-Oxide                     -0.447   -0.018    0.111        0.025         0.113   -0.048      -0.118 
Nitrile                         0.000    0.000    0.000        -0.000        -0.000   -0.000      -0.000 
Thiol                           0.000    0.000    0.000       -0.000        -0.000   -0.000       -0.000 
Thioether                    0.053   -0.061   -0.163       -0.040        0.004    0.034        -0.001 
Fluorine                      0.078   -0.094    0.069       -0.132        0.211   -0.122        -0.106 
Pyridine                     -0.056    0.018    0.094       -0.105       -0.183    0.024        -0.042 
Alkyl halide                0.091   -0.121    0.111        0.261       -0.067    0.027        -0.057 
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Aryl halide                  0.119   -0.089   -0.201      -0.127       0.038     0.219         -0.101 
Alkene                           0.020    0.080   -0.260   -0.041   -0.123   -0.351   -0.132 
Alkylgreater than5 C    -0.252   -0.096   -0.121   -0.215   -0.229    0.144   -0.277 
Phosphonate                 -0.048    0.115    0.045    0.075   -0.017    0.019   -0.016 
Hydrozone                   -0.015   -0.036    0.019   -0.135    0.060   -0.021    0.008 
Other_1                        -0.062   -0.036    0.016    0.027   -0.038    0.008    0.022 
Phosphate                    -0.062   -0.036    0.016    0.027   -0.038    0.008    0.022 
Carbamate                    0.000    0.034   -0.041   -0.012   -0.022   -0.012    0.120 
Nitro                            0.035   -0.063   -0.204    0.106   -0.082    0.068    0.006 
Nitrate                        -0.444   -0.018    0.111    0.024    0.112   -0.048   -0.117 
Steroid                         0.112   -0.149    0.022    0.151    0.130    0.061   -0.126 
Hormone                     0.141   -0.087   -0.286   -0.025    0.219    0.352   -0.150 
O-heterocyclic            -0.241   -0.059   -0.026   -0.003   -0.001    0.061    0.108 
N-heterocyclic             0.117    0.138    0.287   -0.176   -0.053   -0.001   -0.025 
S-heterocyclic             0.080   -0.033   -0.180    0.091   -0.080    0.052    0.007 
Long alkyl                   0.044    0.058   -0.283    0.083   -0.064   -0.500   -0.198 
Phenyl ring                  0.126   -0.122    0.085   -0.115   -0.004    0.111    0.026 
Erythromycin deriv     0.014   -0.067    0.001    0.048    0.158    0.096   -0.170 
Tetracycline                 0.022    0.001    0.025    0.003    0.061   -0.001   -0.005 
Macrocyclic               -0.272   -0.102   -0.163    0.011    0.180    0.125    0.198 
Macrolide                     0.021   -0.039    0.022    0.020    0.033    0.050    0.039 
Benzodiazepine            0.050    0.035    0.098   -0.376    0.264   -0.118   -0.005 
Barbiturate                  0.007    0.559    0.065    0.085    0.085    0.182   -0.177 
Water                           0.073   -0.091    0.229    0.169    0.000    0.001    0.005 
Ethanol                        0.011    0.043   -0.017   -0.023    0.063   -0.013    0.111 
HCl                              0.011    0.009    0.011   -0.013    0.070   -0.003    0.010 
Na+                            -0.061   -0.022    0.004    0.029   -0.041    0.004    0.044 
Gd3+                            0.076   -0.119    0.146    0.128   -0.093    0.127   -0.122 
 
Variable                        PC15      PC16      PC17      PC18      PC19      PC20      PC21 
Primary                        -0.208     0.067     0.025     -0.067     -0.003     -0.056      0.025 
Secondary                    -0.226     0.017     0.075       0.221     -0.159      0.132     -0.124 
Tertiary                         0.057      0.130   -0.088      -0.010      0.053      0.021      0.097 
Aromatic/enamine        0.031     -0.015    -0.009      0.042     -0.026     -0.134      0.045 
Primary_1                     0.121     -0.281     0.277     -0.141      0.035      0.011      0.333 
Secondary_1                 0.012     -0.173     0.011     -0.092     -0.042      0.150      0.013 
Tertiary_1                    -0.051      0.056    -0.074      0.008     -0.069     -0.148      0.081 
Vinyl alcohol               -0.011     0.052      0.067     -0.039     -0.034     -0.005     -0.029 
Phenol                           0.074     0.142      0.305      0.141      0.163       0.350     -0.187 
Carboxylic                     0.067     0.194     -0.030    -0.052      0.028     -0.137     -0.144 
Sulfonated                     0.000     0.000      0.000      0.000      0.000      0.000       0.000 
Other                             0.000     0.000      0.000      0.000       0.000      0.000      0.000 
Ketone                          -0.082    0.105       0.024    -0.044      0.160      -0.000     0.039 
Aldehyde                      -0.000    0.000       0.000   -0.000      -0.000     -0.000      0.000 
Enone                            0.328   -0.296      -0.214    0.217       -0.289    -0.059     -0.175 
Ester                              0.063    0.117        0.112   -0.211      -0.043     0.028       0.007 
1o amide                      -0.085   -0.138        0.045    0.304       0.081    -0.026       0.055 
2o amide                       0.032   -0.140        0.195   -0.073      -0.015    -0.057       0.091 
3o amide                       0.011    0.234       -0.029   -0.073      -0.031     0.049      -0.039 
Anhydride                    0.000   -0.000       -0.000    0.000        0.000     0.000      -0.000 
Epoxide                        0.000   -0.000       -0.000    0.000        0.000     0.000      -0.000 
Thioester                     -0.060    0.057        0.086    0.108       -0.005    -0.059      -0.050 
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Oxime                         -0.203   -0.083       -0.033   -0.119      -0.029     0.113       -0.186 
Oxazolidinone            -0.032   -0.192   -0.123   -0.035    0.764   -0.208   -0.344 
Urea                           -0.079    0.144    0.081    0.049    0.011   -0.008    0.038 
Guanidine                    0.058    0.004   -0.188    0.269   -0.032   -0.136   -0.086 
Ether                            0.274    0.148    0.160    0.244    0.045   -0.035    0.068 
Sulfonamide               -0.182   -0.012   -0.000    0.165   -0.194    0.095   -0.026 
Sulfone                        0.419    0.138    0.298    0.077   -0.048    0.001   -0.096 
N-Oxide                      0.127    0.124   -0.032   -0.001    0.052   -0.045   -0.051 
Nitrile                         -0.000    0.000    0.000   -0.000    0.000    0.000    0.000 
Thiol                           -0.000    0.000    0.000   -0.000   -0.000    0.000   -0.000 
Thioether                    -0.022    0.072    0.060    0.039    0.022    0.020   -0.085 
Fluorine                      -0.169    0.075    0.322    0.022   -0.132   -0.332   -0.145 
Pyridine                       0.107   -0.095   -0.108   -0.367   -0.154    0.257   -0.286 
Alkyl halide                -0.097    0.209   -0.100   -0.052    0.097    0.288    0.129 
Aryl halide                   0.077    0.244    0.058   -0.217    0.164   -0.024    0.218 
Alkene                         0.043    0.182   -0.347   -0.225   -0.153   -0.371    0.177 
Alkylgreater than5 C  -0.070    0.001   -0.029    0.176    0.049   -0.053    0.007 
Phosphonate                 0.012   -0.043    0.020    0.040    0.010   -0.008    0.135 
Hydrozone                    0.009    0.056    0.000    0.093    0.037   -0.015   -0.133 
Other_1                       -0.002    0.003    0.002    0.056    0.013    0.019    0.043 
Phosphate                   -0.002    0.003    0.002    0.056    0.013    0.019    0.043 
Carbamate                   -0.099   -0.128   -0.033    0.038   -0.039    0.038   -0.008 
Nitro                           -0.037    0.033    0.074   -0.006   -0.001    0.052    0.062 
Nitrate                         0.126    0.123   -0.032   -0.001    0.052   -0.045   -0.051 
Steroid                       -0.007    0.033    0.028    0.054   -0.141   -0.030   -0.058 
Hormone                     0.308    0.010   -0.029    0.009    0.044    0.012    0.034 
O-heterocyclic            -0.237    0.103    0.066    0.016   -0.103   -0.030    0.068 
N-heterocyclic             0.158    0.025   -0.150   -0.212   -0.099    0.048   -0.210 
S-heterocyclic             0.032    0.039    0.044   -0.028    0.035    0.057    0.008 
Long alkyl                   0.089    0.202   -0.008    0.097   -0.030    0.183   -0.189 
Phenyl ring                -0.208    0.067    0.025   -0.067   -0.003   -0.056    0.025 
Erythromycin deriv   -0.206   -0.084   -0.034   -0.121   -0.030    0.115   -0.189 
Tetracycline                0.032    0.041    0.057   -0.020   -0.028    0.008   -0.044 
Macrocyclic               -0.034    0.318   -0.025   -0.070   -0.024    0.057   -0.105 
Macrolide                    0.035    0.030    0.066    0.106    0.082   -0.068    0.182 
Benzodiazepine           0.049   -0.028   -0.245    0.054    0.141    0.390    0.372 
Barbiturate                 -0.098    0.193    0.078    0.054    0.011    0.006   -0.031 
Water                          0.022    0.200   -0.335    0.247    0.019    0.124   -0.014 
Ethanol                       0.092   -0.088    0.132   -0.176   -0.002    0.018   -0.026 
HCl                              0.054   -0.011    0.156   -0.135   -0.045    0.008   -0.074 
Na+                              0.000   -0.018   -0.013    0.060    0.021    0.010    0.043 
Gd3+                            0.062    0.161   -0.046   -0.030    0.002   -0.182   -0.034 
 
Variable                        PC22      PC23      PC24     PC25    PC26    PC27      PC28 
Primary                         0.076   -0.082    -0.000     -0.159     0.179   -0.006    0.076 
Secondary                    -0.102    0.062   -0.081      -0.073   -0.100    0.033   -0.224 
Tertiary                        -0.174   -0.022   -0.025      -0.035    0.083    0.052    0.013 
Aromatic/enamine       -0.194    0.050    0.004      -0.027   -0.017    0.098   -0.128 
Primary_1                     0.192    0.226    0.062        0.148   -0.101   -0.040    0.229 
Secondary_1                 0.365   -0.185   -0.077      -0.063   -0.057    0.413   -0.352 
Tertiary_1                     0.005    0.036   -0.162      -0.021    0.061   -0.012   -0.138 
Vinyl alcohol                0.102    0.207   -0.101      -0.064    0.082   -0.053    0.054 
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Phenol                         -0.078   -0.057   -0.105      -0.004    0.040    0.005   -0.024 
Carboxylic                    0.023   -0.009    0.040       0.062    0.079   -0.117    0.057 
Sulfonated                    0.000    0.000    0.000        0.000    0.000    0.000    0.000 
Other                            0.000    0.000    0.000        0.000    0.000    0.000    0.000 
Ketone                        -0.101    0.035   -0.100        0.003    0.188   -0.076   -0.066 
Aldehyde                     -0.000   -0.000   -0.000       0.000    0.000   -0.000    0.000 
Enone                          -0.058    0.066   -0.025       -0.060    0.274    0.058    0.028 
Ester                            -0.009    0.063   -0.048        0.022    0.036    0.107   -0.000 
1o amide                     -0.045    0.026    0.080         0.022   -0.027   -0.076    0.094 
2o amide                     -0.111    0.132   -0.006         0.088    0.164   -0.092   -0.253 
3o amide                      0.093   -0.012   -0.033        -0.030   -0.055    0.083    0.053 
Anhydride                    0.000    0.000    0.000        -0.000   -0.000    0.000   -0.000 
Epoxide                        0.000    0.000    0.000        -0.000   -0.000    0.000   -0.000 
Thioester                      0.113    0.024    0.019         0.097   -0.056   -0.005    0.027 
Oxime                         -0.010    0.122    0.279       -0.069   -0.069   -0.009    0.034 
Oxazolidinone            -0.058    0.191   -0.033       -0.017    0.013    0.193   -0.074 
Urea                            0.003    0.009   -0.003        -0.022    0.007    0.066    0.040 
Guanidine                  -0.045   -0.108    0.019         0.047   -0.154    0.193   -0.108 
Ether                           0.007   -0.094   -0.100         0.056   -0.008    0.038    0.008 
Sulfonamide              -0.286    0.305    0.010         0.406   -0.258   -0.001   -0.239 
Sulfone                       0.090    0.283    0.403        -0.276    0.054    0.119   -0.121 
N-Oxide                     -0.129    0.005    0.003       -0.032   -0.071   -0.217   -0.006 
Nitrile                        -0.000    0.000    0.000         0.000   -0.000    0.000   -0.000 
Thiol                         -0.000   -0.000   -0.000         0.000   -0.000    0.000    0.000 
Thioether                   0.243   -0.051    0.085          0.225    0.132   -0.049   -0.036 
Fluorine                    -0.084    0.021   -0.128        -0.137   -0.276    0.117    0.100 
Pyridine                    -0.031    0.037   -0.366         0.105   -0.093    0.128    0.115 
Alkyl halide             -0.053   -0.015    0.219         0.105    0.123   -0.156   -0.148 
Aryl halide                0.022    0.081    0.043         0.158   -0.342    0.056   -0.129 
Alkene                       0.021    0.064    0.156       -0.008    0.012    0.086   -0.186 
Alkylgreater than5 C -0.146   -0.012    0.046       0.034    0.039   -0.043   -0.003 
Phosphonate              -0.093    0.072    0.071      -0.106   -0.064   -0.000    0.291 
Hydrozone                  0.278   -0.089    0.173       0.327    0.187   -0.191   -0.122 
Other_1                     -0.037   -0.006    0.020      -0.085    0.015    0.057   -0.066 
Phosphate                  -0.037   -0.006    0.020      -0.085    0.015    0.057   -0.066 
Carbamate                  0.168   -0.202    0.042      -0.338   -0.161   -0.350   -0.145 
Nitro                          -0.012    0.023   -0.056      -0.116   -0.017    0.173    0.031 
Nitrate                       -0.128     0.005    0.003      -0.032   -0.070   -0.216   -0.006 
Steroid                      -0.101     0.020    0.021       -0.069    0.068    0.043   -0.072 
Hormone                    0.016     0.051   -0.035        0.082   -0.128    0.008   -0.022 
O-heterocyclic          -0.087    0.241     0.048        0.122    0.311    0.284    0.259 
N-heterocyclic         -0.135     0.107    -0.055        0.079    0.055   -0.251    0.028 
S-heterocyclic          -0.113   -0.015    -0.113       -0.255   -0.243   -0.228    0.018 
Long alkyl                -0.008   -0.007    -0.000      -0.026    0.109    0.085    0.181 
Phenyl ring                0.076   -0.082   -0.000       -0.159    0.179   -0.006    0.076 
Erythromycin deriv -0.010    0.123     0.283        -0.070   -0.070   -0.009    0.035 
Tetracycline              0.094    0.187    -0.102       -0.047   -0.006   -0.081   -0.033 
Macrocyclic             -0.012   -0.029   -0.055        -0.096    0.041    0.047   -0.011 
Macrolide                 -0.023   -0.168   -0.368        0.153    0.129   -0.042    0.030 
Benzodiazepine        -0.198    0.139   -0.016       -0.235    0.096    0.128   -0.081 
Barbiturate                 0.050   -0.044   -0.043        0.007    0.060    0.103   -0.194 
Water                         0.258    0.028    0.082         0.083   -0.314    0.134    0.267 
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Ethanol                     -0.392   -0.570    0.355        0.161   -0.051    0.195    0.139 
HCl                           -0.083   -0.053    0.023   -0.002    0.045    0.032   -0.269 
Na+                           -0.029   -0.024    0.040   -0.095    0.002    0.025   -0.034 
Gd3+                         -0.088    0.013   -0.019   -0.135    0.013    0.057    0.027 
 
Variable                        PC29      PC30      PC31      PC32      PC33      PC34      PC35 
Primary                       -0.185    -0.056     -0.166     -0.072      0.082       0.052      0.132 
Secondary                   -0.047      0.007     -0.337      0.317    -0.201       0.144    -0.287 
Tertiary                        0.067     -0.061     -0.035      0.039     0.227       0.100     0.147 
Aromatic/enamine       0.217      0.193      0.017       0.078     0.049      -0.107   -0.074 
Primary_1                   -0.061   -0.220      -0.198      -0.174    0.006        0.172    0.021 
Secondary_1                -0.165   0.258       0.045       -0.011    0.162        0.026    0.210 
Tertiary_1                   -0.020   -0.044      -0.109       0.238    -0.132        0.088    0.008 
Vinyl alcohol               0.025   -0.006        0.061       0.107     0.165       -0.058    0.120 
Phenol                          0.065    0.058         0.041      0.112     0.133       -0.066   -0.128 
Carboxylic                   0.012    0.068         0.177      -0.137   -0.047       -0.168   -0.029 
Sulfonated                    0.000    0.000        0.000       0.000    0.000         0.000    0.000 
Other                           0.000     0.000         0.000      0.000    0.000         0.000    0.000 
Ketone                         0.007    0.038         0.263       0.068   -0.094         0.554    0.108 
Aldehyde                   -0.000   -0.000         0.000      -0.000   -0.000         0.000   -0.000 
Enone                         -0.048   -0.034       -0.168      -0.089    0.232        -0.070   -0.122 
Ester                            0.086    0.006        -0.066      -0.065    0.346         0.155   -0.360 
1o amide                     -0.044   -0.052       -0.057      -0.068   -0.042       -0.064    0.073 
2o amide                      0.086   -0.153       -0.042       0.179     0.105       -0.073   -0.022 
3o amide                     -0.051    0.026       -0.024      -0.108    0.013         0.063   -0.002 
Anhydride                    0.000    0.000       -0.000      -0.000   -0.000         0.000   -0.000 
Epoxide                        0.000    0.000       -0.000      0.000     0.000        -0.000    0.000 
Thioester                      0.022   -0.009       -0.187      0.005    -0.019        -0.039   -0.007 
Oxime                         -0.012   -0.003        0.062     -0.029    -0.014         0.022   -0.002 
Oxazolidinone              0.019   -0.027       -0.222    -0.051    0.110         -0.029    0.016 
Urea                              0.038    0.138       -0.137     0.020     0.032          0.055    0.030 
Guanidine                     0.094   -0.065        0.078    -0.128    -0.172          0.203    0.092 
Ether                            -0.026   -0.004      -0.101    -0.127    -0.046         -0.075    0.128 
Sulfonamide                -0.078    0.054        0.042    -0.223     0.324           0.072    0.286 
Sulfone                         0.022   -0.073       -0.044     0.120    -0.058          0.058    0.125 
N-Oxide                      -0.041   -0.041        -0.062    0.028     0.021          0.022   -0.021 
Nitrile                           0.000   -0.000         0.000    0.000     0.000         -0.000    0.000 
Thiol                            -0.000   -0.000       -0.000    0.000      0.000          0.000    0.000 
Thioether                      0.061    0.016        -0.084    0.049     -0.032         0.066    0.008 
Fluorine                        0.007   -0.044       -0.028   -0.024     -0.051        -0.121   0.166 
Pyridine                        0.196   -0.236       -0.243    0.070     -0.177        -0.032    0.181 
Alkyl halide                  0.018    0.003       -0.343   -0.045     -0.153        -0.381    0.291 
Aryl halide                    0.116    0.030        0.036   -0.018      0.102        -0.076   -0.201 
Alkene                         -0.023   -0.050      -0.180    0.029      0.050          0.008    0.044 
Alkylgreater than5 C    0.054   -0.049      -0.039    0.010     -0.073          0.074    0.076 
Phosphonate                  0.056    0.612      -0.257    0.054      0.038          0.086    0.064 
Hydrozone                   -0.021   -0.020      -0.111    0.044      0.079          0.189   -0.054 
Other_1                        -0.041   -0.121      0.030   -0.058       0.075          0.020    0.025 
Phosphate                     -0.041   -0.121      0.030   -0.058      0.075           0.020    0.025 
Carbamate                     0.663   -0.081     -0.078   -0.182      0.209           0.109    0.089 
Nitro                              0.065   -0.047      0.031   -0.026     -0.065          -0.095    0.082 
Nitrate                          -0.041   -0.041     -0.062    0.028      0.021           0.022   -0.021 
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Steroid                         -0.028   -0.023     -0.138   -0.054      0.146          -0.030   -0.053 
Hormone                       0.109   -0.007    0.006    0.084   -0.269    0.181    0.254 
O-heterocyclic              0.309   -0.127    0.012   -0.101   -0.088    0.053   -0.092 
N-heterocyclic             -0.091    0.133    0.072   -0.052   -0.003    0.030    0.001 
S-heterocyclic             -0.394   -0.186   -0.130   -0.102    0.090    0.164   -0.040 
Long alkyl                    0.016    0.015    0.053   -0.270    0.084    0.112    0.179 
Phenyl ring                 -0.185   -0.056   -0.166   -0.072    0.082    0.052    0.132 
Erythromycin deriv    -0.012   -0.003    0.062   -0.030   -0.014    0.022   -0.002 
Tetracycline                 0.015    0.031    0.054    0.143    0.137   -0.135    0.121 
Macrocyclic                 0.007    0.096   -0.052    0.024    0.069   -0.009    0.002 
Macrolide                    0.065    0.024   -0.128   -0.114    0.113   -0.087   -0.005 
Benzodiazepine           0.011   -0.059    0.010   -0.043   -0.043    0.053   -0.057 
Barbiturate                -0.018    -0.340    0.043   -0.046    0.046    0.011    0.001 
Water                           0.001   -0.147   -0.107    0.056    0.101    0.025   -0.225 
Ethanol                        0.002   -0.130   -0.076    0.180    0.140    0.068    0.050 
HCl                            -0.008    0.154   -0.184   -0.576   -0.342    0.072   -0.279 
Na+                            -0.066   -0.152    0.256   -0.104   -0.064   -0.329   -0.125 
Gd3+                            0.078   -0.044   -0.048   -0.070    0.015    0.039    0.056 
 
Variable                      PC36      PC37    PC38     PC39    PC40    PC41    PC42 
Primary                       -0.041   -0.010    0.098    0.075   -0.032    0.098   -0.058 
Secondary                   -0.105   -0.200   -0.147    0.027    0.260   -0.004   -0.077 
Tertiary                       -0.010   -0.115    0.162    0.218    0.109   -0.030   -0.023 
Aromatic/enamine      -0.008   -0.036   -0.038    0.016    0.110    0.181    0.037 
Primary_1                   -0.043   -0.172    0.110   -0.042    0.028   -0.084   -0.207 
Secondary_1               -0.120    0.132   -0.161   -0.103    0.032   -0.059   -0.112 
Tertiary_1                   -0.164   -0.053   -0.096   -0.057   -0.456   -0.028   -0.306 
Vinyl alcohol               0.188   -0.038   -0.109    0.009    0.089   -0.122    0.009 
Phenol                         0.087    0.159    0.329   -0.113   -0.079    -0.391   -0.063 
Carboxylic                 -0.074    0.176   -0.158   -0.169   -0.246     0.014   -0.112 
Sulfonated                   0.000    0.000    0.000    0.000    0.000      0.000    0.000 
Other                           0.000    0.000    0.000    0.000    0.000      0.000    0.000 
Ketone                        -0.074    0.121    0.142   -0.197    0.277     0.169   -0.188 
Aldehyde                     0.000   -0.000    0.000    0.000    0.000    -0.000    0.000 
Enone                          0.031   -0.011    0.073   -0.238    0.208     0.057   -0.175 
Ester                            0.070   -0.107   -0.130    0.355    0.033    -0.153    0.004 
1o amide                      -0.077   -0.190   -0.102   -0.034    0.004    0.114    0.023 
2o amide                      -0.144    0.270   -0.186    0.104   -0.028    0.220    0.193 
3o amide                      -0.015   -0.211   -0.064   -0.037    0.020   -0.200   -0.102 
Anhydride                     0.000   -0.000    0.000   -0.000   -0.000    0.000    0.000 
Epoxide                       -0.000    0.000   -0.000   -0.000   -0.000    0.000   -0.000 
Thioester                       0.055    0.174   -0.073    0.012    0.215    0.023   -0.025 
Oxime                           0.037    0.005    0.031   -0.010    0.075    0.013    0.049 
Oxazolidinone             -0.068   -0.032   -0.061    0.025   -0.030   -0.050   -0.062 
Urea                              0.060    0.069    0.000    0.052   -0.030    0.045   -0.105 
Guanidine                     0.434   -0.208   -0.093    0.018   -0.039   -0.110   -0.139 
Ether                             0.037   -0.047    0.054   -0.127    0.041   -0.040    0.156 
Sulfonamide                -0.037    0.119    0.126    0.090   -0.114    0.015   -0.083 
Sulfone                        -0.030    0.112    0.023   -0.047   -0.038    0.121   -0.149 
N-Oxide                      -0.017   -0.074    0.092    0.068    0.004    0.061   -0.020 
Nitrile                          -0.000   -0.000    0.000   -0.000    0.000    0.000   -0.000 
Thiol                            -0.000   -0.000    0.000    0.000    0.000    0.000   -0.000 
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Thioether                     -0.006   -0.115    0.155    0.081   -0.082    0.067   -0.104 
Fluorine                       -0.172   -0.032    0.019   -0.085    0.068   -0.069   -0.062 
Pyridine                        0.176    0.101    0.129   -0.048   -0.049    0.211   -0.014 
Alkyl halide                  0.051   -0.044   -0.136   -0.065    0.156   -0.123   -0.079 
Aryl halide                    0.081   -0.181   -0.083   -0.354    0.056    0.286   -0.130 
Alkene                           0.031    0.141    0.180   -0.021    0.156   -0.224    0.023 
Alkylgreater than5 C   -0.025    0.203    0.147   -0.110   -0.021   -0.078   -0.115 
Phosphonate                  0.070    0.108   -0.012    0.038   -0.044   -0.003   -0.022 
Hydrozone                     0.134   -0.027   -0.060   -0.006   -0.055    0.005    0.059 
Other_1                        -0.120   -0.081   -0.020   -0.117    0.062   -0.118    0.290 
Phosphate                    -0.120   -0.081   -0.020   -0.117    0.062   -0.118    0.290 
Carbamate                   -0.098    0.033   -0.048   -0.046   -0.026   -0.068   -0.119 
Nitro                            -0.227   -0.169    0.234    0.020    0.001   -0.008    0.022 
Nitrate                         -0.016   -0.074    0.092    0.067    0.004    0.061   -0.020 
Steroid                         -0.024   -0.162   -0.004    0.037   -0.483    0.035    0.011 
Hormone                     -0.177    0.090   -0.204    0.405    0.015   -0.215    0.126 
O-heterocyclic             0.029    0.164   -0.286   -0.159   -0.025   -0.229   -0.036 
N-heterocyclic            -0.429   -0.185   -0.139   -0.160    0.089   -0.277   -0.149 
S-heterocyclic             0.246    0.317   -0.337   -0.104   -0.027   -0.082   -0.024 
Long alkyl                  -0.114   -0.137   -0.311    0.106    0.067    0.334    0.007 
Phenyl ring                -0.041   -0.010    0.098    0.075   -0.032    0.098   -0.058 
Erythromycin deriv    0.038    0.005    0.032   -0.010    0.076    0.013    0.050 
Tetracycline                0.092   -0.119   -0.034   -0.029    0.053   -0.013    0.006 
Macrocyclic                0.014    0.005    0.031    0.049    0.018    0.145    0.001 
Macrolide                  -0.096    0.118   -0.083   -0.009    0.178    0.047   -0.092 
Benzodiazepine          0.008   -0.035   -0.013   -0.067   -0.175    0.043   -0.026 
Barbiturate                -0.043   -0.041   -0.001   -0.028    0.029   -0.007    0.044 
Water                         -0.359    0.295    0.094    0.009   -0.017    0.083    0.037 
Ethanol                      -0.083    0.008   -0.110   -0.064   -0.009   -0.017   -0.118 
HCl                            -0.087    0.120    0.145    0.065   -0.014    0.038    0.085 
Na+                              0.021    0.118    0.001    0.405    0.174    0.011   -0.527 
Gd3+                            0.108    0.059    0.070   -0.009    0.009    0.030    0.149 
 
 
Variable                      PC43    PC44     PC45    PC46    PC47    PC48     PC49 
Primary                      -0.044    0.008    0.054   -0.010   -0.025   -0.027   -0.001 
Secondary                  -0.168   -0.077   -0.035    0.057    0.038   -0.106    0.116 
Tertiary                       0.432    0.049   -0.309    0.126   -0.047    0.076    0.134 
Aromatic/enamine     -0.146   -0.057    0.237    0.227   -0.087    0.309    0.083 
Primary_1                  -0.112    0.018    0.111    0.216    0.106    0.050   -0.037 
Secondary_1              -0.020    0.002   -0.072    0.022    0.070    0.055   -0.007 
Tertiary_1                   0.162    0.260    0.216   -0.143   -0.015    0.178   -0.152 
Vinyl alcohol             -0.144   -0.003    0.152   -0.061    0.119    0.274    0.518 
Phenol                         0.031   -0.029   -0.039    0.008   -0.105    0.117   -0.113 
Carboxylic                 -0.229   -0.125    0.267    0.154   -0.244   -0.203    0.098 
Sulfonated                   0.000    0.000    0.000    0.000    0.000    0.000     0.000 
Other                           0.000    0.000    0.000    0.000    0.000    0.000     0.000 
Ketone                        -0.170   -0.013   -0.035   -0.030   -0.123    0.043   -0.059 
Aldehyde                      0.000    0.000    0.000   -0.000   -0.000    0.000    0.000 
Enone                           0.078   -0.003    0.146   -0.143    0.001   -0.008   -0.068 
Ester                            -0.036    0.018    0.286   -0.115   -0.006   -0.110   -0.108 
1o amide                     -0.060   -0.157   -0.159    0.010   -0.334    0.304   -0.251 
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2o amide                      0.023   -0.033   -0.188   -0.298   -0.022   -0.125   -0.016 
3o amide                     -0.061   -0.059   -0.090   -0.337   -0.450   -0.013    0.178 
Anhydride                    0.000   -0.000   -0.000   -0.000   -0.000    0.000    0.000 
Epoxide                      -0.000   -0.000    0.000   -0.000   -0.000    0.000   -0.000 
Thioester                    -0.169    0.541    0.019    0.061   -0.197    0.016   -0.054 
Oxime                         -0.063   -0.038   -0.026    0.007    0.004   -0.023    0.014 
Oxazolidinone            -0.043   -0.005   -0.006    0.002    0.023   -0.007    0.008 
Urea                           -0.041   -0.033   -0.035   -0.057   -0.012   -0.031    0.002 
Guanidine                   0.102    0.028    0.016    0.064   -0.014   -0.187   -0.058 
Ether                          -0.416    0.004   -0.155   -0.163    0.236    0.116   -0.006 
Sulfonamide               -0.056    0.010    0.123   -0.048   -0.062    0.030   -0.051 
Sulfone                        0.172   -0.028    0.003    0.118   -0.151   -0.033    0.052 
N-Oxide                     -0.015   -0.002    0.063   -0.008   -0.040   -0.032    0.028 
Nitrile                        -0.000   -0.000    0.000   -0.000    0.000   -0.000   -0.000 
Thiol                          -0.000    0.000   -0.000   -0.000   -0.000    0.000   -0.000 
Thioether                   -0.063   -0.158   -0.003   -0.152    0.087   -0.075   -0.012 
Fluorine                      0.213   -0.419    0.109   -0.122    0.160    0.003   -0.007 
Pyridine                     -0.060   -0.064   -0.037    0.024   -0.127    0.035    0.035 
Alkyl halide                0.143    0.037    0.145   -0.059    0.021    0.013   -0.042 
Aryl halide                  0.111    0.089   -0.142   -0.081    0.097   -0.022    0.065 
Alkene                       -0.194   -0.181   -0.144    0.083   -0.103   -0.008   -0.017 
Alkylgreater than5 C  0.016    0.161     0.060    0.027    0.364   -0.301    0.326 
Phosphonate               0.002    0.003   -0.049   -0.099   -0.031   -0.110   -0.005 
Hydrozone                  0.062   -0.284    0.014   -0.025    0.126    0.083   -0.007 
Other_1                       0.035    0.103    0.129    0.079   -0.057   -0.058    0.006 
Phosphate                    0.035    0.103    0.129    0.079   -0.057   -0.058    0.006 
Carbamate                  -0.071    0.003   -0.023   -0.016    0.000    0.027   -0.026 
Nitro                           -0.113    0.167    0.074   -0.102   -0.062   -0.215   -0.003 
Nitrate                        -0.015   -0.002    0.062   -0.008   -0.040   -0.031    0.027 
Steroid                        -0.247    0.058   -0.421    0.252    0.021   -0.013    0.198 
Hormone                    -0.082   -0.059    0.056    0.065    0.008    0.010   -0.019 
O-heterocyclic             0.054   -0.008   -0.180    0.053    0.050    0.054   -0.113 
N-heterocyclic            -0.009    0.059   -0.195    0.025    0.180    0.071   -0.060 
S-heterocyclic              0.041   -0.029   -0.074    0.031    0.009    0.031   -0.043 
Long alkyl                   0.029    0.061    0.004   -0.057    0.109   -0.071    0.074 
Phenyl ring                 -0.044    0.008    0.054   -0.010   -0.025   -0.027   -0.001 
Erythromycin deriv    -0.064   -0.038   -0.027    0.007    0.004   -0.023    0.015 
Tetracycline               -0.129   -0.047   -0.112    0.102    0.028   -0.496   -0.404 
Macrocyclic               -0.026   -0.017    0.113    0.409    0.266    0.198   -0.318 
Macrolide                    0.091   -0.188   -0.023    0.236   -0.157   -0.195    0.106 
Benzodiazepine          -0.150   -0.326    0.145   -0.090    0.083   -0.056   -0.012 
Barbiturate                  -0.029    0.012    0.061    0.045   -0.021    0.014    0.009 
Water                           0.041   -0.053   -0.011   -0.025    0.028    0.022    0.012 
Ethanol                       -0.156   -0.019    0.068   -0.018   -0.002   -0.025   -0.029 
HCl                              0.113    0.002   -0.022   -0.002   -0.001    0.023    0.023 
Na+                            -0.156   -0.000   -0.156   -0.069    0.097    0.069   -0.033 
Gd3+                          -0.110    0.105   -0.012   -0.359    0.201    0.153   -0.249 
 
Variable                     PC50    PC51     PC52     PC53    PC54    PC55    PC56 
Primary                      0.047    0.011   -0.022    0.096    0.674    0.172   -0.034 
Secondary                 -0.042    0.028    0.000   -0.000    0.000    0.000   -0.000 
Tertiary                      0.073    0.349   -0.000    0.000    0.000    0.000    0.000 
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Aromatic/enamine     0.477   -0.018   -0.000    0.000   -0.000   -0.000   -0.000 
Primary_1                  0.034    0.013   -0.000    0.000    0.000   -0.000   -0.000 
Secondary_1               0.005    0.010   -0.000    0.000    0.000   -0.000    0.000 
Tertiary_1                   0.058    0.072   -0.000    0.000    0.000    0.000    0.000 
Vinyl alcohol             -0.301   -0.096    0.000   -0.000   -0.000   -0.000    0.000 
Phenol                        -0.033   -0.041   -0.000   -0.000   -0.000   -0.000    0.000 
Carboxylic                  -0.127    0.274   -0.000   -0.000    0.000    0.000    0.000 
Sulfonated                   0.000    0.000   -0.000    0.000   -0.000    0.000    0.000 
Other                           0.000    0.000    0.000    0.000    0.000    0.000   -0.000 
Ketone                        -0.028    0.072   -0.000    0.000    0.000    0.000    0.000 
Aldehyde                     0.000    0.000   -0.001    0.002   -0.003    0.010   -0.035 
Enone                         -0.033    0.114   -0.000   -0.000    0.000    0.000    0.000 
Ester                          -0.042    0.118   -0.000   -0.000    0.000    0.000   -0.000 
1o amide                    -0.179    0.006   -0.000   -0.000   -0.000   -0.000    0.000 
2o amide                    -0.236    0.134   -0.000   -0.000    0.000    0.000    0.000 
3o amide                     0.270   -0.057    0.000    0.000   -0.000   -0.000   -0.000 
Anhydride                   0.000    0.000   -0.022   -0.021   -0.022    0.098    0.343 
Epoxide                     -0.000   -0.000   -0.007    0.018   -0.012    0.107   -0.043 
Thioester                   -0.016   -0.029    0.000   -0.000    0.000    0.000   -0.000 
Oxime                       -0.010   -0.005    0.026    0.022   -0.063    0.011    0.048 
Oxazolidinone           -0.001    0.025   -0.000    0.000    0.000    0.000   -0.000 
Urea                          -0.031    0.050   -0.010    0.201   -0.042   -0.028    0.065 
Guanidine                 -0.281   -0.014    0.000   -0.000    0.000    0.000   -0.000 
Ether                          0.069    0.399   -0.000    0.000     0.000    0.000    0.000 
Sulfonamide             -0.005   -0.057    0.000   -0.000   -0.000   -0.000   -0.000 
Sulfone                      -0.009   -0.183    0.000   -0.000   -0.000   -0.000   -0.000 
N-Oxide                    -0.021   -0.018    0.703   -0.003    0.017    0.021   -0.028 
Nitrile                        0.000    0.000    0.035     0.027   -0.036    0.333     0.843 
Thiol                          -0.000    0.000   -0.008    0.051   -0.004   -0.194   -0.131 
Thioether                   -0.103   -0.051    0.010    0.577   -0.056   -0.053   -0.008 
Fluorine                      0.010    0.080   -0.000    0.000    0.000    0.000      0.000 
Pyridine                      0.024    0.046   -0.000    0.000   -0.000   -0.000     0.000 
Alkyl halide                0.008    0.027   -0.000   -0.000    0.000    0.000    -0.000 
Aryl halide                 -0.067    0.002    0.000    0.000    0.000   -0.000    0.000 
Alkene                       -0.111    0.030   -0.000   -0.000    0.000   -0.000    0.000 
Alkylgreater than5 C   0.211   -0.016    0.000    0.000   -0.000   -0.000   -0.000 
Phosphonate               -0.123    0.055    0.006   -0.127    0.027    0.018    -0.041 
Hydrozone                   0.140   -0.047   -0.008   -0.478    0.046    0.044    0.007 
Other_1                      -0.026   -0.004    0.027    0.165    0.159   -0.639    0.271 
Phosphate                   -0.026   -0.004   -0.025    0.266   -0.211    0.595   -0.246 
Carbamate                   -0.015    0.051   -0.000    0.000    0.000   -0.000    0.000 
Nitro                            -0.284   -0.017   -0.008   -0.478    0.046    0.044    0.007 
Nitrate                         -0.021   -0.018   -0.707    0.003   -0.017   -0.021    0.028 
Steroid                          0.016   -0.146    0.000    0.000   -0.000   -0.000    0.000 
Hormone                      0.043   -0.022    0.000   -0.000   -0.000    0.000   -0.000 
O-heterocyclic             0.056    0.037   -0.000    0.000    0.000   -0.000    0.000 
N-heterocyclic            -0.083   -0.123    0.000   -0.000   -0.000   -0.000    0.000 
S-heterocyclic             0.046    0.044   -0.000    0.000    0.000   -0.000    0.000 
Long alkyl                   0.061   -0.005    0.000    0.000    0.000    0.000   -0.000 
Phenyl ring                  0.047    0.011    0.022   -0.096   -0.674   -0.172    0.034 
Erythromycin deriv    -0.010   -0.005   -0.025   -0.021    0.062   -0.010   -0.047 
Tetracycline                 0.310    0.005    0.000    0.000   -0.000    0.000   -0.000 
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Macrocyclic                -0.278    0.052   -0.000   -0.000    0.000    0.000    0.000 
Macrolide                   -0.102   -0.454    0.000   -0.000   -0.000   -0.000   -0.000 
Benzodiazepine          -0.009   -0.058    0.000    0.000   -0.000   -0.000   -0.000 
Barbiturate                  0.039    0.015    0.009   -0.179    0.038    0.025   -0.058 
Water                           0.003    0.001    0.000    0.000    0.000    0.000    0.000 
Ethanol                      -0.027   -0.062    0.000   -0.000   -0.000   -0.000   -0.000 
HCl                              0.009    0.027   -0.000    0.000    0.000    0.000    0.000 
Na+                              0.026    0.000   -0.000    0.000   -0.000   -0.000    0.000 
Gd3+                            0.060   -0.503    0.000    0.000   -0.000   -0.000   -0.000 
 
Variable                        PC57     PC58      PC59     PC60    PC61   PC62    PC63 
Primary                         0.009    0.016     -0.000   -0.026   -0.000    0.000   -0.065 
Secondary                     0.000   -0.000      0.000   -0.000   -0.000    0.000   -0.000 
Tertiary                       -0.000   -0.000       0.000    0.000    0.000   -0.000   -0.000 
Aromatic/enamine        0.000   -0.000     -0.000    0.000    0.000   -0.000    0.000 
Primary_1                     0.000   -0.000      0.000   -0.000    0.000    0.000   -0.000 
Secondary_1                -0.000   -0.000      0.000    0.000    0.000   -0.000   -0.000 
Tertiary_1                    -0.000   -0.000      0.000    0.000    0.000   -0.000   -0.000 
Vinyl alcohol                0.000    0.000     -0.000    0.000    0.000   -0.000    0.000 
Phenol                         -0.000    0.000     -0.000    0.000    0.000   -0.000    0.000 
Carboxylic                    0.000    0.000     -0.000   -0.000   -0.000    0.000   -0.000 
Sulfonated                   -0.000   -0.000      0.000   -0.000   -0.985   -0.170    0.000 
Other                            0.000    0.000      0.000    -0.000    0.170   -0.985   -0.000 
Ketone                        -0.000   -0.000      0.000     0.000    0.000   -0.000   -0.000 
Aldehyde                     0.053    0.148      0.975     0.154    0.000    0.000    0.000 
Enone                         -0.000    0.000      0.000    -0.000    0.000    0.000   -0.000 
Ester                             0.000    0.000    0.000   -0.000   -0.000    0.000   -0.000 
1o amide                     -0.000    0.000   -0.000    0.000    0.000   -0.000   -0.000 
2o amide                     -0.000    0.000    0.000   -0.000    0.000    0.000   -0.000 
3o amide                     -0.000   -0.000   -0.000    0.000    0.000   -0.000    0.000 
Anhydride                   -0.371   -0.166    0.185   -0.817    0.000    0.000    0.061 
Epoxide                        0.402   -0.900    0.109    0.022    0.000   -0.000    0.038 
Thioester                      0.000    0.000   -0.000   -0.000   -0.000    0.000    0.000 
Oxime                         -0.003   -0.028    0.010   -0.022    0.000    0.000   -0.659 
Oxazolidinone            -0.000   -0.000    0.000   -0.000    0.000   -0.000   -0.000 
Urea                           -0.020   -0.020    0.001    0.029    0.000   -0.000   -0.210 
Guanidine                   0.000    0.000    0.000   -0.000   -0.000    0.000    0.000 
Ether                         -0.000   -0.000    0.000    0.000    0.000   -0.000   -0.000 
Sulfonamide              -0.000    0.000   -0.000    0.000    0.000   -0.000    0.000 
Sulfone                        0.000    0.000   -0.000   -0.000   -0.000   -0.000    0.000 
N-Oxide                     -0.005   -0.004    0.004   -0.023   -0.000    0.000    0.016 
Nitrile                          0.312    0.142   -0.046    0.217    0.000   -0.000    0.078 
Thiol                           0.771    0.313   -0.014   -0.497   -0.000    0.000   -0.026 
Thioether                   -0.037   -0.006    0.002   -0.001    0.000    0.000    0.103 
Fluorine                     -0.000   -0.000    0.000   -0.000    0.000    0.000   -0.000 
Pyridine                     -0.000   -0.000   -0.000    0.000    0.000   -0.000   -0.000 
Alkyl halide                0.000    0.000    0.000   -0.000   -0.000    0.000   -0.000 
Aryl halide                -0.000   -0.000    0.000    0.000    0.000   -0.000   -0.000 
Alkene                        -0.000    0.000    0.000   -0.000    0.000    0.000   -0.000 
Alkylgreater than5 C   0.000   -0.000    0.000   -0.000   -0.000    0.000    0.000 
Phosphonate                 0.013    0.013   -0.001   -0.018   -0.000    0.000    0.133 
Hydrozone                    0.031    0.005   -0.002    0.000   -0.000   -0.000   -0.085 
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Other_1                      -0.039   -0.101    0.023    0.071    0.000   -0.000   -0.012 
Phosphate                     0.008    0.089   -0.021   -0.059   -0.000    0.000   -0.022 
Carbamate                   -0.000   -0.000    0.000    0.000    0.000   -0.000   -0.000 
Nitro                              0.031    0.005   -0.002    0.000   -0.000   -0.000   -0.085 
Nitrate                          0.006    0.004   -0.004    0.023    0.000   -0.000   -0.016 
Steroid                          0.000   -0.000    0.000    0.000    0.000   -0.000    0.000 
Hormone                      0.000    0.000   -0.000   -0.000   -0.000    0.000    0.000 
O-heterocyclic             0.000   -0.000    0.000    0.000    0.000   -0.000   -0.000 
N-heterocyclic            -0.000   -0.000    0.000   -0.000    0.000    0.000    0.000 
S-heterocyclic             0.000   -0.000    0.000    0.000    0.000   -0.000   -0.000 
Long alkyl                   0.000   -0.000    0.000   -0.000   -0.000   -0.000    0.000 
Phenyl ring                -0.009   -0.016    0.000    0.026    0.000   -0.000    0.065 
Erythromycin deriv     0.003    0.028   -0.009    0.022   -0.000   -0.000    0.650 
Tetracycline                0.000   -0.000    0.000   -0.000   -0.000    0.000   -0.000 
Macrocyclic                -0.000    0.000    0.000   -0.000    0.000    0.000   -0.000 
Macrolide                     0.000    0.000   -0.000   -0.000   -0.000    0.000    0.000 
Benzodiazepine          -0.000    0.000    0.000   -0.000   -0.000    0.000    0.000 
Barbiturate                  0.018    0.018   -0.001   -0.026   -0.000    0.000    0.188 
Water                         -0.000    0.000   -0.000    0.000    0.000   -0.000    0.000 
Ethanol                      -0.000    0.000    0.000   -0.000   -0.000    0.000    0.000 
HCl                              0.000   -0.000   -0.000    0.000   -0.000   -0.000   -0.000 
Na+                            -0.000   -0.000    0.000    0.000    0.000   -0.000   -0.000 
Gd3+                           -0.000    0.000   -0.000    0.000    0.000    0.000    0.000 
 
 
 
Variable                        PC64 
Primary                        0.006 
Secondary                    0.000 
Tertiary                        0.000 
Aromatic/enamine       0.000 
Primary_1                   -0.000 
Secondary_1                 0.000 
Tertiary_1                     0.000 
Vinyl alcohol               0.000 
Phenol                         -0.000 
Carboxylic                   0.000 
Sulfonated                   0.000 
Other                          -0.000 
Ketone                         0.000 
Aldehyde                     0.001 
Enone                           0.000 
Ester                            0.000 
1o amide                      0.000 
2o amide                      0.000 
3o amide                      0.000 
Anhydride                    0.014 
Epoxide                      -0.002 
Thioester                    -0.000 
Oxime                        -0.252 
Oxazolidinone             0.000 
Urea                            0.586 
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Guanidine                  -0.000 
Ether                           0.000 
Sulfonamide              -0.000 
Sulfone                      -0.000 
N-Oxide                      0.025 
Nitrile                        -0.056 
Thiol                           0.040 
Thioether                   -0.207 
Fluorine                      0.000 
Pyridine                      0.000 
Alkyl halide                0.000 
Aryl halide                  0.000 
Alkene                       -0.000 
Alkylgreater than5 C -0.000 
Phosphonate              -0.370 
Hydrozone                  0.171 
Other_1                       0.039 
Phosphate                    0.103 
Carbamate                   0.000 
Nitro                            0.171 
Nitrate                        -0.025 
Steroid                        -0.000 
Hormone                    -0.000 
O-heterocyclic             0.000 
N-heterocyclic            -0.000 
S-heterocyclic              0.000 
Long alkyl                    0.000 
Phenyl ring                 -0.006 
Erythromycin deriv     0.249 
Tetracycline               -0.000 
Macrocyclic                -0.000 
Macrolide                   -0.000 
Benzodiazepine           0.000 
Barbiturate                 -0.524 
Water                           0.000 
Ethanol                      -0.000 
HCl                             0.000 
Na+                             0.000 
Gd3+                          -0.000 
 
 
Figure I Principle components for Chemical functional groups and structural properties in 
table form. 
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Table I 
Variable of interest Principal components identified as 
showing variability 
Primary amine group C1, C2, C4 (C7) 
Secondary amine group C1, C3, C6  
Aromatic/enamine group C1, C2, C6 
Tertiary alcohol (OH 
structure) 
C1, C2, C3, C4 
Vinyl alcohol group C2, C3, C5 
Carboxylic acid group C3, C4, C5, C6 
Secondary amide (carbonyl 
group) 
C1, C2, C4 (C7) 
Oxime (N group) C2, C3, C4, (C12, C14) 
Phosphonate group  C1, C2 
Hydrozone group C1, C2, C3 
Phosphate C1 C2 
Phenyl ring C1, C2, C3, C4 (C7) 
Macrolide  C2, C3, C4 
Na+ Associated group C1, C2 
Gd3+ Associated group C3, C4, C5, C6 
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Table I The data shown in brackets indicates variability within the data for the identified 
variable post principal component 6. Principal components account for 38% of the variability 
seen in the dataset. 
 
Table II 
Structural feature 
or Functional 
Group Identified 
Pharmaceutical Product Identified 
Primary amine Aluvial, Levothyroxine, Gabapentin, Cycloserine, 
Sevelamer, Folic acid 
Secondary amine Tamsulosin, Sumatriptan base, Sevelamer, Salmeterol 
xinafoate, Oxis, Metronazole, Marcaine, Gopten, 
Gadopentetate monomeglumine, Gadopentetate 
dimeglumine, Furosemide, Bambec 
Aromatic /enamine Folic acid, HPMPC, Hytrin, Deflox, Lupron, 
Nizatidine, Plendil, Ranitidine 
Tertiary alcohol (OH 
structure) 
Betamethasone acetate, Betamethasone disodium 
phosphate, Calcijex, Clarithromycin, Doxycycline 
hyclate, Doxycycline monohydrate, Invermectin, 
Klacid, Paricalcitol, Roxithromycin, Sevelamar 
Vinyl alcohol Doxycycline hyclate, Doxycycline monohydrate, 
Warfarin 
Carboxylic acid Blopress, Brofen, Epival, Folic acid, Furosemide, 
Gadopentetate dimeglumie, Gadopentetate 
monomeglumie, Gopten, Ketoprofen, Levothyroxine, 
Quinapril, Salmeterol xinafoate, Teveten 
Secondary amide 
(Carbonyl) 
Ciclosporin, Citanest, Folic acid, Iodixanol, Iohexol, 
Iopamidol, Lupron, Marcaine, Oxis, Quinapril 
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Structural feature 
or Functional 
Group Identified 
Pharmaceutical Product Identified 
Oxime (N group) Roxithromycin 
Phosphonate Betamethasone disodium phosphate, HPMPC 
Hydrozone Betamethasone disodium phosphate, Teveten 
Phosphate Betamethasone disodium phosphate 
Phenyl ring Atenolol, Bambec, Blopress, Brofen, Citanest, 
Deflox, Furosemide, Gopten, Hytrin, Levothyroxine, 
Lupron, Marcaine, Meperidine, Metronazole, Oxis, 
Plendil, Warfarin 
Macrolide Clarithromycin, Invermectin, Roxithromycin, Klacid 
Na+ Association Betamethasone disodium phosphate, Epival 
Gd3+ Association Gadopentetate monomeglumine, Gadopentetate 
dimeglumine 
Table II Identified chemical functional groups and structural properties in relation to the 
pharmaceutical products used for PCA. 
 
Table III  
Pharmaceutical Products not represented by the features identified as 
giving high variation amongst the dataset and their functional and 
structural features 
Pharmaceutical product Structural and functional group information 
Advicor Ketone, Ether, Alkyl >5 carbons, N- heterocyclic 
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Pharmaceutical Products not represented by the features identified as 
giving high variation amongst the dataset and their functional and 
structural features 
Pharmaceutical product Structural and functional group information 
Androgel Secondary alcohol, Enone, Steroid 
Beclomethasone 
dipropionate 
Secondary alcohol, Ketone, Ester, Steroid, Alkyl 
halide  
Beclomethasone 
dipropionate 
monohydrate 
Secondary alcohol, Water, Steroid, Alkyl halide, 
Ester, Ketone 
Ciclesonide Secondary alcohol, Ketone, Ester, Ether, Steroid 
Clobetasol proprionate Secondary alcohol, Ketone, Ester, Fluorine, 
Steroid, Alkyl halide 
Conholip Ketone, Ester, Alkyl >5 carbons 
Dexamethasone 
dipropionate 
Secondary alcohol, Ketone, Fluorine, Ester, 
Ether, Steroid 
Fluticasone furoate Secondary alcohol, Ketone, Fluorine, Ester, 
Thioester, Ether, Steroid 
Fluticasone propionate Secondary alcohol, ketone, Ester, Thioester, 
Steroid 
Halobetasol Steroid, Alkyl halide, Fluorine, Ester, Ketone, 
Secondary alcohol 
Imdur Secondary alcohol, Ether, Nitrate, O-heterocyclic 
Isoflurane Ether 
278 
 
Pharmaceutical Products not represented by the features identified as 
giving high variation amongst the dataset and their functional and 
structural features 
Pharmaceutical product Structural and functional group information 
Isradipine Ester, Pyridine, Alkyl >5 carbons, N-heterocyclic 
Meprobamate Carbamate 
Methohexital Urea, N-heterocyclic, Barbiturate 
Mometasone furoate 
anhydrous 
Secondary alcohol, Ketone, Ester, Ether, Alkyl 
halide, Steroid 
Mometasone furoate 
monohydrate 
Secondary alcohol, Ketone, Ester, Ether, Alkyl 
halide, Steroid, Water 
Nimbex Ester, Ether, Sulfone, N-heterocyclic 
Olanzapine Tertiary amine, Thioester 
Progesterone Ketone, Enone, Steroid, Hormone 
Severane Ether 
Venlafaxin Tertiary amine, Ether, Ethanol 
 
Table III Pharmaceutical products not containing features identified as contributing to 
the data variation in the first six principle components.  
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Table IV 
Identified 
group or 
prominent 
feature 
Identified 
pharmaceutical 
products  
Identified chemical or structural 
feature 
1 Betamethasone disodium 
phosphate (9) 
Na+ Association, Hydrozone, Phosphate, 
Phosphonate, Tertiary alcohol association, 
Secondary alcohol, Ketone, Aryl halide, 
Steroid 
2 Clarithromycin (15) 
 
 
Invermectin (42) 
 
 
Doxcycline monohydrate 
(22) 
 
 
 
Klacid (44) 
Macrolide, Tertiary alcohol structure, 
tertiary amine, secondary alcohol, ketone, 
ester, ether 
 
Macrolide, Tertiary alcohol structure, 
Secondary alcohol, Ester, Ether 
 
Tertiary alcohol structure, Vinyl alcohol, 
Tertiary amine, Secondary alcohol, 
Ketone, Primary amide, Tetracycline 
 
Tertiary alcohol structure, Macrolide, 
Secondary alcohol, Tertiary amine, 
Ketone, Ester, Ether 
3 Lupron (46) Aromatic enamine, Secondary amide, 
Phenyl ring, Primary alcohol, Phenol, 
Secondary amide, Guanidine, Alkyl >5 
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carbons, N-heterocyclic,  
4 Doxcycline hyclate (21) 
 
 
Roxithromycin(63) 
Tertiary alcohol structure, Vinyl alcohol, 
Tertiary amine, Tertiary alcohol, Ketone, 
Primary amide, Tetracycline 
 
Tertiary alcohol structure, Oxime group, 
Macrolide, Tertiary amine, Secondary 
alcohol, Ester, Oxime, Ether, 
Erythromycin derivative 
5 Nizatidine (55) Aromatic enamine, Tertiary amine, 
Thioester, Nitro, N-heterocyclic, S-
heterocyclic 
6 Levothyroxine (45) Primary amine, Carboxyl acid, Phenyl 
ring, Phenol, Ether, Aryl halide, Hormone 
7 Gadopentetate 
dimeglumine (29) 
 
 
Gadopentetate 
monomeglumine (30) 
 
 
Imdur (36) 
 
Secondary amine, Carboxylic acid, Gd3+ 
association, Secondary amide, Primary 
alcohol, Secondary alcohol 
 
Secondary amine, Carboxylic acid, Gd3+ 
association, Secondary amide, Water, 
Tertiary amine, Primary alcohol, 
Secondary alcohol 
 
No significant group identified by scree 
plot analysis. Contains Secondary alcohol, 
Ether, Nitrate, O-heterocyclic features. 
8 HPMPC (34) 
 
 
Teveten (69) 
Phosphonate, Aromatic enamine, Primary 
alcohol, Urea 
 
Carboxylic acid, Hydrozone, Tertiary 
amine, thioester, thioether, N-heterocyclic 
9 Epival (23) 
 
Isradipine (41) 
Carboxylic acid, Na+ associated  
 
No significant group identified by scree 
plot analysis. Contains Ester, Pyridine, 
Alkyl >5 carbons, N-heterocyclic 
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10 Advicor (1) 
 
 
Androgel (3) 
  
 
 
Ciclesonide (13) 
 
Conholip (17) 
 
 
 
Progesterone (60) 
No significant group identified by scree 
plot analysis. Contains Ether, Ketone, 
Alkyl >5 carbons, N-heterocyclic 
 
No significant group identified by scree 
plot analysis. Contains Secondary alcohol, 
Enome, Steroid 
 
No significant group identified by scree 
plot analysis. Contains Secondary alcohol, 
Ketone, Ester, Ether, Steroid 
 
No significant group identified by scree 
plot analysis. Contains Ketone, Ester, 
Alkyl >5 carbons 
 
No significant group identified by scree 
plot analysis. Contains Ketone, Enone, 
Steroid, Hormone 
11 
 
 
 
 
 
 
 
 
 
 
Beclomethasone 
dipropionate (6) 
 
Beclomethasone 
dipropionate  
monohydrate (7) 
 
Betamethasone acetate (8) 
 
 
 
Clobetasol propionate 
(16) 
 
 
Dexamethasone 
No significant group identified by scree 
plot analysis. Contains Secondary alcohol, 
Ketone, Ester, Steroid, Alkyl halide 
 
No significant group identified by scree 
plot analysis. Contains Secondary alcohol, 
Ketone, Ester, Steroid, Alkyl halide, water 
 
Tertiary alcohol, Secondary alcohol, 
Tertiary alcohol, Ketone, Ester, Fluorine, 
Steroid 
 
No significant group identified by scree 
plot analysis. Contains Secondary alcohol, 
Ketone, Ester, Fluorine, Steroid, Alkyl 
halide 
 
No significant group identified by scree 
plot analysis. Contains Secondary alcohol, 
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11 
dipropionate (20) 
 
Fluticasone furoate (24) 
 
 
 
Fluticasone propionate 
(25) 
 
 
Halobetasol (33) 
 
 
Mometasone furoate 
anhydrous (52) 
 
 
Mometasone furoate 
monohydrate  (53) 
Ketone, Ester, Fluorine, Steroid features 
 
No significant group identified by scree 
plot analysis. Contains Secondary alcohol, 
Ketone, Fluorine, Ester, Thioester, Ether, 
Steroid 
 
No significant group identified by scree 
plot analysis. Contains Secondary alcohol, 
Ketone, Ester, Thioester, Steroid 
 
No significant group identified by scree 
plot analysis. Contains Steroid, Alkyl 
halide, Fluorine, Ester, Ketone, Secondary 
alcohol 
 
No significant group identified by scree 
plot analysis. Contains Secondary alcohol, 
Ketone, Ester, Ether, Alkyl halide, Steroid 
 
No significant group identified by scree 
plot analysis. Contains Secondary alcohol, 
Ketone, Ester, Ether, Alkyl halide, 
Steroid, Water 
12 Aluvia (2) 
 
 
Nimbex (54) 
 
 
Venlafaxine (70) 
 
Primary amine and also Ester, Primary 
amide, Alkyl >5 carbon (nine present) 
 
No significant group identified by scree 
plot analysis. Contains Ester, Ether, 
Sulfone, N-heterocyclic 
 
No significant group identified by scree 
plot analysis. Contains Tertiary amine, 
Ether, Ethanol 
Main data set 
 
Atenolol (4) 
 
 
Phenyl Ring, Secondary amine, 
Secondary alcohol, Primary amide, Ether, 
Phenyl ring 
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Bambec (5) 
 
 
Blopress (10) 
 
Brofen (11) 
 
Calcijex (12)        
                                                                         
 
Citanest (14) 
 
 
Cycloserine (18) 
 
Deflox (19) 
 
 
Folic acid (26) 
 
 
Furosemide (27) 
 
Gabapentin (28) 
 
 
Ciclosporin (31) 
 
 
 
Phenyl Ring, Secondary amine, 
Secondary alcohol, Carbamate 
 
Carboxylic acid, Phenyl ring, Ether, N-
heterocyclic 
 
Carboxylic acid, Phenyl ring,  
 
Tertiary alcohol, Secondary alcohol, , 
Alkenes, Alkyl >5 carbons  
 
Phenyl ring, Secondary amine, Secondary 
amide 
 
Primary amine, Ketone, Oxazolidonone, 
 
Phenyl ring, Aromatic enamine, Tertiary 
amide, Guanidine, Ether, N-heterocyclic, 
Phenyl ring, Water 
 
Carboxylic acid, Primary amine 
,Secondary amide, , Secondary amide, N-
heterocyclic 
 
Secondary amine, Carboxylic acid, O-
heterocyclic, Aryl halide, Sulfonamide,  
 
Primary amine, Secondary amide, Ester 
 
Secondary amide, Secondary alcohol, 
Secondary amide, Tertiary amide, Alkyl 
>5C, Macrocyclic 
 
Phenyl ring, Aromatic enamine, Tertiary 
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Main dataset 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hytrin (35) 
 
 
Iodixanol (37) 
 
Iopanidol (39) 
 
 
Isoflurane (40) 
 
 
Marcaine (47) 
 
Meperidine (48) 
 
 
Meprobamate (49) 
 
 
Methohexital (50) 
 
 
 
Olanzapine (56) 
 
 
Oxis (57) 
 
 
amide, Guanidine, Ether, N-heterocyclic 
 
Secondary amide, Primary alcohol, 
Secondary alcohol, Tertiary amide 
 
Secondary amide, Primary alcohol, 
Secondary alcohol 
 
No significant group identified by scree 
plot analysis. Contains Ether 
 
Secondary amine, phenyl ring, secondary 
amide, O-heterocyclic 
 
Phenyl ring, Tertiary amine, Ester, N-
heterocyclic,  
 
No significant group identified by scree 
plot analysis. Contains Carbamate 
 
 
No significant group identified by scree 
plot analysis. Contains Urea, N-
heterocyclic, Barbituate 
 
No significant group identified by scree 
plot analysis. Contains Tertiary amine, 
Thioester 
 
Secondary amine, Secondary amide, 
Phenyl ring, Secondary alcohol, Phenol, 
Ether 
 
Tertiary alcohol, Secondary alcohol, 
Alkenes, Long alkyl 
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Main Dataset 
Paricalcitol (58) 
 
 
Plendil (59) 
 
 
Quinapril (61) 
 
 
Ranitidine (62) 
 
 
Salmeterol xinafoate (64) 
 
 
 
Severane (66) 
 
 
Tamsulosin (68) 
 
Warfarin (71) 
 
 
Phenyl ring, Aromatic enamine, Ester, 
Aryl halide, alkenes, N-heterocyclic 
 
Carboxylic acid, Secondary amide, Ester, 
Tertiary amide, Secondary amide, Ether, 
N-heterocyclic 
 
 
Aromatic enamine, Tertiary amine, 
Thioether, Nitro, O-heterocyclic 
 
Secondary amine, Carboxylic acid, 
Phenol, Primary alcohol, Secondary 
alcohol, Ether, Long alkyl 
 
 
No significant group identified by scree 
plot analysis. Contains Ether 
 
Secondary amine, Ether, Sulfonamide 
 
Vinyl alcohol, Phenyl ring, Ketone, Ester, 
O-heterocyclic 
Products not 
identified in 
score plot 
analysis 
Sumatriptan Base (67) 
 
 
 Sevelamer (65) 
 
Gopten (32) 
Secondary amine, Tertiary amine, 
Sulfonamide, N-heterocyclic 
 
Primary amine, Secondary amine, Tertiary 
alcohol,  
 
Secondary amine, Carboxylic acid, Phenyl 
ring, Ester, Tertiary amide, N-heterocyclic 
286 
 
Table IV Identified pharmaceutical products and associated chemical or structural features 
identified by examination of the score plot and the significant features of the pharmaceutical 
products. (Where blue writing indicates the information is not an identified feature by scree 
plot analysis). 
Figure II  
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Scree Plot of the main data set determined during analysis of database 1
 
Figure II Scree plot of the main data set determined during initial PCA analysis of  
database 1. 
 
 
 
Iohexol (38) 
 
 
Metronazole (51) 
 
Secondary amide, Primary Alcohol, 
Secondary alcohol, Tertiary amide. 
 
Secondary amine, Phenyl ring, N-
heterocyclic, Aryl halide, Sulfonamide, 
Tertiary amide 
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Figure III Score plot of the main data set determined during initial PCA analysis of  
database 1. 
 
Figure IV Loading Plot of of the main data set determined during initial PCA analysis of 
database 1. 
 
Table V 
Cluster 
identified 
Variables contained in 
cluster 
API associated with the 
variables in the data set 
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Cluster 
identified 
Variables contained in 
cluster 
API associated with the 
variables in the data set 
1 Tertiary alcohol group, 
Oxime group, macrolide, 
ether group 
Betamethasone disodium 
phosphate, Betamethasone 
acetate, Clarithromycin, 
Paricalcitol, Calcijex, Doxycline 
hyclate, Doxycline 
monohydrate, klacid, 
Roxithromycin, Sevelmer, 
Roxithromycin, Clarithromycin, 
Klacid, Ivermectin, 
Roxithromycin, Mometasone 
furoate anhydrous, Mometasone 
furoate monohydrate, Nimbex, 
Oxis, Quinapril, Roxithromycin, 
Salmeterol xinafoate, Severane, 
Tamsulosin, Venlafaxine. 
2 Primary amine group, alkyl 
halide group, guanidine 
group, phenol group  
Aluvia, cycloserine, Folic acid, 
Gabapentine, Levothyroxine, 
sevelamer, Beclomethasone 
dipropionate, Beclomethasone 
dipropionate monohydrate, 
Clobetasol propionate, 
Halobetasol, Mometasone 
furoate anhydrous, Mometasone 
furoate monohydrate, deflox, 
hytrin, lupron , Levothyroxine, 
lupron, oxis  
3 Phosphate group, 
Phosphonate group, Na+ 
group 
Betamethasone disodium 
phosphate, Betamethasone 
disodium phosphate, HPMPC, 
Betamethasone disodium 
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Cluster 
identified 
Variables contained in 
cluster 
API associated with the 
variables in the data set 
phosphate, epival.  
4 Tertiary amide group, 
aromatic /enamine group, 
N-heterocyclic group, 
alkenes group, pyridine 
group 
Cyclosporin, Deflox, Gopten, 
Iodixanol, Iohexol, Metolazone, 
Quinapril, Deflox, Folic acid, 
HPMPC, Hytrin, Lupron, 
Nizatidine, Plendil, Ranitidine, 
Advicor, Blopress, Deflox, 
Eprosartan, Folic acid, Gopten, 
HPMPC, Hytrin, Isradipine, 
lupron, Meperidine, 
Methohexital, Metolazone, 
Nimbex, Nizatidine, Olanzapine, 
Plendil, Quinapril, Sumatriptan 
base, Calcijex, Paricalcitol, 
Plendil, Betamethasone 
disodium phosphate, Isradipine 
5 Secondary amide group Ciclosporin, Lupron, Citanest, 
Folic acid, Iodixanol, Iohexol, 
Marcaine, Iopamidol, Oxis, 
Quinapril 
9 Carboxylic acid groups, 
Gd3+ structure, Thioether 
groups 
Blopress, Epival, Eprosartan, 
Folic acid, Furosemide, 
Gadopentetate dimeglumine, 
Gadopentetate monomeglmine, 
Gopten, Ketoprofen, 
Levothyroxine, Quinapril, 
Salmeterol xinafoate, 
Gadopentetate dimeglumine, 
Gaopentetate monomeglmine, 
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Cluster 
identified 
Variables contained in 
cluster 
API associated with the 
variables in the data set 
Eprosartan, Nizatidine, 
Ranitidine 
10 Erythromycin derivative 
structure, Ketone groups, 
Vinyl alcohol groups 
Roxithromycin, Advicor, 
Beclomethasone dipropionate, 
Beclomethasone dipropionate 
monohydrate monohydrate, 
Betamethasone acetate, 
Betamethasone disodium 
phosphate, Ciclesonide, 
Clarithromycin, Clobetasol 
propionate, Conholip, 
Cycloserine, Dexamethosone 
dipropionate, Doxycycline 
monohydrate, Fluticasone 
furaroate, Fluticasone 
propionate, Halobetasol, 
ketoprofen, Klacid, Mometasone 
furoate anhydrous, Mometasone 
furoate monohydrate, 
Progesterone, Warfarin, 
Doxycycline hyclate, 
Doxycycline monohydrate, 
Warfarin 
11 Steroid Androgel, Beclomethasone 
dipropionate, Beclomethasone 
dipropionate monohydrate, 
Betamethasone acetate, 
Betamethasone disodium 
phosphate, Ciclesonide, 
Clobetasol propionate, 
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Cluster 
identified 
Variables contained in 
cluster 
API associated with the 
variables in the data set 
Dexamethosone dipropionate, 
Fluticasone furaroate, 
Fluticasone propionate, 
Halobetasol, Mometasone 
furoate anhydrous, Mometasone 
furoate monohydrate, 
Progesterone 
12 Tertiary amine group Clarithromycin, Doxycycline 
hyclate, Doxycycline 
monohydrate, Eprosartan, 
Gadopentetate dimeglumine, 
Gadopenetate monomeglumine, 
Klacid, Meperidine, Nizatidine, 
Olanzapine, Rantidine, 
Roxithromycin, Sumatriptan 
base, Venlafaxine 
13 Thioester group Eprosartan, Fluticasone 
furaroate, Fluticasone 
propionate, Olanzapine 
14 Ester group Aluvia, Beclomethasone 
dipropinate, Betamethasone 
dipropionate monohydrate, 
Betamethasone acetate, 
Ciclesonide, Clarithromycin, 
Clobetasol propionate, 
Conholip, Dexamethosone 
dipropionate, Fluticasone 
propionate, Fluticasone 
furaroate, Gabapentin, Gopten, 
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Cluster 
identified 
Variables contained in 
cluster 
API associated with the 
variables in the data set 
Halobetasol, Isradipine, 
Ivermectin, Klacid, Meperidine, 
Mometasone furoate anhydrous, 
Mometasone furoate 
monohydrate, Nimbex, Plendil, 
Quinapril, Roxithromycin, 
Warfarin. 
15 Fluorine group Betamethasone acetate, 
Betamethasone disodium 
phosphate, Clobetasol 
propionate, Dexamethosone 
dipropionate, Fluticasone 
furaroate, Fluticasone 
propionate, Halobetasol, 
16 Enone group Androgel, Progesterone,  
17 Primary amide group Aluvia, Atenolol, Doxyxycline 
hyclate, Doxycycline 
monohydrate,  
18 Phenyl ring  Atenolol, Bambec, Blopress, 
Brofen, Citanest, Deflox, 
Furosemide , Gopten, hytrin, 
Marcaine, meparidine, 
metazone, oxis, plendil, 
warfarin, Levothyroxine, 
Marcaine 
19 Hydrozone Betamethasone disodium 
phosphate, Eprosartan 
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Table V Analysis of figure 5-7 score plot pc3 versus pc4 for Database 1 information. The 
API and the chemical functional groups and structural features it contains are shown in the 
same colour text. 
 
Table VI  
Cluster 
identified 
Variables contained in 
cluster 
API associated with the variables in the data 
set 
1 Vinyl alcohol group Doxycline hyclate, Doxycline monohydrate, 
Warfarin 
2 Secondary amine group Atenolol, Bambec, Citanest, Furosemide, 
Gabapentine monomeglumine, Gopten, 
Marcaine, Metolazone, Oxis, Salmeterol 
xinafoate, Sevelamer, Sumatriptan base, 
Tamsulosin,  
3 Gd3+, Carboxylic acid 
group, Primary amide 
group 
Gadopentetate dimeglumine, Gadopentetate 
monomeglumine, Blopress, Brofen, Epival, 
Eposartan, Folic acid, Flurosemide, 
Gadopentetate monomeglumine, Gopten, 
ketoprofen, Levthyroxine, Quinapril, 
Salmeterol xinafoate, Aluvia, Atenolol, 
Doxycycline hyclate, Doxcycline 
monohydrate. 
 
4 Primary amine group, 
Hormone structural 
features, Phenol acid 
group, Sulfonamide group. 
Aluvial, Atenolol, Doxycycline hyclate, 
Doxycycline monohydrate, Levothyroxine, 
Progesterone, Levothyroxine, Lupron, Oxis, 
Salmeterol xinafoate, Sumatriptan base, 
Tamsulosin, Metolazone, Doxycycline 
hyclate, Doxycycline monohydrate. 
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Cluster 
identified 
Variables contained in 
cluster 
API associated with the variables in the data 
set 
5 Alkyl halide group Beclomethasone dipropionate, 
Beclomethasone dipropionate monohydrate, 
Clobetasol propionate, Halobetasol, 
Mometasone furoate anhydrous, Mometasone 
furoate monohydrate. 
6 Secondary amide, Ether 
group, Oxime group 
Ciclosporin, Citanest, Folic acid, Fluticasone 
furaroate, Fluticasone propionate, Gabapentin, 
Gopten, Halobetasol, Isradipine, Klacid, 
Meperidine, Mometasone furoate anhydrous, 
Mometasone furoate monohydrate, Nimbex, 
Plendil, Quinapril, Roxithromycin, Warfarin. 
Advicor, Atenolol, Blopress, Ciclesonide, 
Clarithromycin, Deflox, Fluticasone furaroate, 
Hytrin, Imdur, Isoflurane, Ivermectin, Klacid, 
Levothyroxine, Mometasone furoate 
anhydrous, Mometasone furoate monohydrate, 
Nimbex, Oxis, Quinapril, Roxithromycin, 
Salmeterol xinafoate, Severane, Tamulosin, 
Venlafaxine. Roxithromycin  
 
7 Ester group, Thioester Aluvia, Beclomethasone dipropinate, 
Betamethasone dipropionate monohydrate, 
Betamethasone acetate, Ciclesonide, 
Clarithromycin, Clobetasol propionate, 
Conholip, Dexamethosone dipropionate, 
Fluticasone propionate, Fluticasone furaroate, 
Gabapentin, Gopten, Halobetasol, Isradipine, 
Ivermectin, Klacid, Meperidine, Mometasone 
furoate anhydrous, Mometasone furoate 
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Cluster 
identified 
Variables contained in 
cluster 
API associated with the variables in the data 
set 
monohydrate, Nimbex, Plendil, Quinapril, 
Roxithromycin, Warfarin., Fluticasone 
propionate, Fluticasone furaroate, Olazapine 
8 N-heterocyclic structural 
features 
Advicor, Blopress, Deflox, Eprosartan, Folic 
acid, Gopten, HPMPC, Hytrin, Isradipine, 
Lipron, Meperidine, Metolazone, Nimbex, 
Nizatidine, Olanzapine, Plendil, Quinapril, 
Sumatriptan base  
9 Aromatic/enamine, 
Thioether, S-heterocyclic 
structural features, Nitro 
Deflox, Folic acid, HPMPC, Hytrin, Lupron, 
Nizatidine, Plendil, Ranitidine,  
Eprosartan, Nizatidine, Ranitidine Nizatidine, 
Nizatidine 
 
10 Guanidine  Deflox, Hytrin, Lupron,  
11 Erythromycin derivative Roxithromycin 
12 Water group Mometasone furoate monohydrate 
13 HCL group, Tetracycline Doxycycline hyclate, Doxycycline hyclate 
14 Secondary amide group, 
Alkene group, Phenyl ring, 
Ethanol group 
Ciclosporin, Citanest, Folic acid, Iodixanol, 
Iohexol, Iopamidol, Lupron, Marcaine, Oxis, 
Quinapril. Calcijex, Paricalcitol, Plendil. 
Warfarin, Plendil, Oxis, Methohexital, 
Mepridine, Marcaine, Levothyroxine, Lupron, 
Hytrin, Gopten, Furosemide, Deflox, Citanest, 
Brofen, Blopress, Bambec, Atenolol, 
Doxycycline hyclate, Venlafaxine   
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Cluster 
identified 
Variables contained in 
cluster 
API associated with the variables in the data 
set 
15 Tertiary amine group, 
Primary alcohol OH 
group, Secondary alcohol 
OH group, Tertiary 
alcohol OH group, Ketone 
group, Enone group, 
Tertiary amide group. 
Oxazolidinone, Urea, 
Sulfone, N-oxide, 
Fluorine, Pyridine, 
Alkenes, Alkyl greater 
than 5 carbons, 
Phosphonate group, 
Hydrozone structure, 
Other functional groups, 
Phosphate, Carbamate, 
Steroid structural 
properties, O-heterocyclic 
structural properties, Long 
alkyl structures, Macro 
cyclic structures, 
Benzodiazepine structural 
features, Barbiturate 
structures, Na+ groups. 
All remaining APIs analysed in the data were 
considered to be present in this group. 
Table VI Variables associated with clusters identified in the analysis of figure 5-8.The 
API and the chemical functional groups and structural features it contains are shown in 
the same colour text. 
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Table VII 
Cluster 
number 
Features identified in the clusters on the Loading plot figure 5-11. 
1 Phosphate, Na+, Hydrozone, Phosphonate Other 
2 Aromatic enamine, Phenyl ring, Secondary amide, N-
heterocyclic, Phenol, Guanidine 
3 Secondary amine, Gd3+, Tertiary alcohol, Tertiary amine, 
Carboxylic acid also associated in this cluster but not distinctly 
4 Macrolide, Ether, Erythromycin derivative, plus other secondary 
characteristics 
5 Tertiary alcohol 
6 Ketone and Steroid 
                    
Table VII Features identified in the clusters on the Loading plot (figure 5-10). 
 
 
 
Table VIII 
Variable number Variable of interest Principle components showing 
variability 
1 Exact Mass C1 C3 
2 Molecular weight C1 C3 
3 C C3 C4 
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Variable number Variable of interest Principle components showing 
variability 
5 F C2 C3 
6 H C3 
8 N C2 C4 
9 Cl C3 
10 Boiling Point C1 
11 Melting Point C1 
12 Critical Temperature C1 
13 Critical Pressure C1 
14 Critical Volume C1 
15 Gibbs Energy C3 
16 Log P C2 C4 
17 MR C1 
18 Henry’s Law C2 
19 Heat of Form C3 
20 tPSA C1 C2 C3 C4 
21 CLogP C2 
22 CMR C1 
23 ACD/LogP C2 
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Variable number Variable of interest Principle components showing 
variability 
24 ACD/LogD (pH5.5) C2 
25 ACD/BCF (pH5.5) C2 C3 C4 
26 ACD/KOC (pH5.5) C2 C3 C4 
27 H bond acceptors C2 C3 C4 
28 Freely rotating bonds C4 
29 Index of Refraction C1 
30 Molar volume C1 
31 Surface Tension  C1 C2 
32 Flash Point C1 
33 Boiling Point C1 
34 ACD/LogD (pH7.4) C2 
35 ACD/BCF (pH7.4) C2 C3 C4 
36 ACD/KOC (pH7.4) C2 
37 H bond donors C2 
38 Polar surface area C1 C2 C3 C4 
39 Molar refractivity C1 
40 Polarizability C1 
41 Density C4 
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Variable number Variable of interest Principle components showing 
variability 
42 Enthalpy of 
vaporisation 
C1 
43 Vapour pressure C3 C4 
 
Table VIII Analysis of the first 4 Principal Components indicating which variabiles 
contribute to the variability. The Table can be interpreted as follows; the variable number 
refers to the number given to a specific variable this is named alongside it. The variables were 
identified by data analysis to add significantly to the variance. The third column identifies the 
principle component, which scored highly for the given variable.   
 
 
 
 
Table IX 
Identified Group 
or prominent 
feature 
Identified Pharmaceutical products  
1 Atenolol (3), Meprobamate (35), Gabapentin (20) 
2 Meperidine (34), Brofen (7) 
3 Isoflurane (28), Severane (49) 
4 Progesterone (45)  
5 Plendil (44) 
6 Calcijex (8) Paricalcitol (43) 
7 Ciclesonide (9) 
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Identified Group 
or prominent 
feature 
Identified Pharmaceutical products  
8 Fluticasone propionate (17) 
9 Gopten (22), Quinapril (46), Halobetasol (23), 
Mometasone furoate monohydrate (38), Clobetasol 
propionate (12), Dexamethasone dipropionate (15) 
10 Hytrin (25) 
11 Warfarin (54), Marcaine (33), Androgel (2) 
Products not 
identified in 
analysis of the 
score plot for 
principal 
components one 
and two 
Aluvia (1), Beclomethasone dipropionate 
monohydrate (4), Betamethasone acetate (5), 
Blopress (6), Citanest (10), Clarithromycin (11), 
Cycloserine (13), Deflox (14), Fluticasone 
propionate (17), Folic acid (18), Furosemide (19), 
Ciclosporin (21), HPMPC (24), Imdur (26), 
Iodixanol (27), Ketoprofen (29), Klacid (30), 
Levothyroxine (31), Lupron (32), Methohexital 
(36), Metronazole (37), Nimbex (39), Nizatidine 
(40), Olanzapine (41), Oxis (42), Ranitidine (47), 
Salmeterol xinafoate (48), Sumatriptan base (50), 
Tamulosin (51), Teveten (52), Venafaxine (53) 
          
Table IX Identified clusters and prominent features within score plot (figure 5-12) produced 
during PC analysis of Database 2.  
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Figure III Exact mass and Molecular weight of products used in a PCA of Database 2. The 
figure shows products from a score plot of principal component 1 and principal component 2.  
 
Physicochemical profile of API’s identified in table IX 
Atenonol 
Atenonol is an API which has physicochemical properties including an exact mass of 266.16 
and a molecular weight of 266.34. There are no Chlorine, Sulphur or Fluorine elements 
present but there are 63.13 Carbon, 18.02 Oxygen, 8.33 Hydrogen and 10.52 Nitrogen. It has 
a boiling point (K) at 841.7, a melting point (K) 524.88, a critical temperature (K) 887.27 and 
a critical pressure of 24.46. Atenonol has a critical volume of 806.5. It has a Gibbs energy 
value of -50 and a Log P value of 0.22. Atenonol has a MR 74.62cm3/mol. It has a Henry’s 
law value of 16.25 and it has a Heat of form value of -427.56. Atenonol also has a tSPA value 
of 84.58, a C Log P value of -0.1086 and a CMR value of 7.4783. This API has an ACD/Log 
P of 0.335, an ACD/Log D (pH5.5) value -2.75, an ACD/BCF (pH5.5) value of 1, and an 
ACD/KOC (pH5.5) value of 1 and 5 H bond acceptors. There are 9 freely rotating bonds and 
it has an Index of Refraction of 1.54 and a Molar Volume of 236.659. The surface tension 
associated with Atenonol is 45.019; it has a flash point of 261.059 °c, and a boiling point of 
508.049°c. Atenonol has an ACD/Log D (pH7.4) of -1.76, an ACD/BCF (pH7.4) of 1, an 
ACD/KOC (pH7.4) of 4 and it has the ability to donate 4 H bonds. The polar surface area of 
Atenonol is 84.58 the molar refractivity of Atenonol is 74.257, a polarizability of 29.438, a 
density of 1.125, an enthalpy of vaporisation of 81.95 and a vapour pressure of 7.69E-10. 
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Meprobamate 
Meprobamate is an API which has physicochemical properties including an exact mass of 
218.13 and a molecular weight of 218.2. There are no Chlorine, Sulphur or Fluorine elements 
present but there are 49.53 Carbon, 29.32 Oxygen, 8.31 Hydrogen and 12.84 Nitrogen. It has 
a boiling point (K) at 663.79, a melting point (K) 444.29, a critical temperature (K) 755.19 
and a critical pressure of 26.6. Meprobamate has a critical volume of 638.5. It has a Gibbs 
energy value of -460.1 and a Log P value of 1.06. Meprobamate has a MR 53.73cm3/mol. It 
has a Henry’s law value of 11.32 and it has a Heat of form value of -804.82. Meprobamate 
also has a tSPA value of 104.64, a C Log P value of 0.915 and a CMR value of 5.4666. This 
API has an ACD/Log P of 0.7, an ACD/Log D (pH5.5) value 0.7, an ACD/BCF (pH5.5) value 
of 2, and an ACD/KOC (pH5.5) value of 57.25 and 6 H bond acceptors. There are 8 freely 
rotating bonds and it has an Index of Refraction of 1.479 and a Molar Volume of 191.464. 
The surface tension associated with Meprobamate is 43.902; it has a flash point of 229.739 °c, 
and a boiling point of 434.212°c. Meprobamate has an ACD/Log D (pH7.4) of 0.7, an 
ACD/BCF (pH7.4) of 2, an ACD/KOC (pH7.4) of 57.25 and it has the ability to donate 4 H 
bonds. The polar surface area of Meprobamate is 104.64, the molar refractivity of 
Meprobamate is 54.331 and it has a polarizability value of 21.538, a density of 1.14 and a 
value for enthalpy of vaporisation of 69.029 and a vapour pressure of 4.66E+01. 
Gabapentin 
Gabapentin is an API which has physicochemical properties including an exact mass of 
171.13 and a molecular weight of 171.24. There are no Chlorine, Sulphur or Fluorine 
elements present but there are 63.13 Carbon, 18.69 Oxygen, 10.01 Hydrogen and 8.18 
Nitrogen. It has a boiling point (K) at 643.35, a melting point (K) 465.83, a critical 
temperature (K) 784.09 and a critical pressure of 35.18. Gabapentin has a critical volume of 
523.5. It has a Gibbs energy value of -233.6 and a Log P value of 0.88. Gabapentin has a MR 
45.22cm3/mol. It has a Henry’s law value of 8.13 and it has a Heat of form value of -476.01. 
Gabapentin also has a tSPA value of 63.32, a C Log P value of -0.66 and a CMR value of 
4.7317. This API has an ACD/Log P of 1.083, an ACD/Log D (pH5.5) value -1.47, an 
ACD/BCF (pH5.5) value of 1, and an ACD/KOC (pH5.5) value of 1 and 3 H bond acceptors. 
There are 4 freely rotating bonds and it has an Index of Refraction of 1.489 and a Molar 
Volume of 161.825. The surface tension associated with Gabapentin is 47.09, it has a flash 
point of 143.967 °c, and a boiling point of 314.438°c. Gabapentin has an ACD/Log D (pH7.4) 
of -1.42, an ACD/BCF (pH7.4) of 1, an ACD/KOC (pH7.4) of 1 and it has the ability to 
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donate 3 H bonds. The polar surface area of Gabapentin is 63.32, the molar refractivity of 
Gabapentin is 46.696; it has a polarizability value of 18.512, a density of 1.058 and a value 
for enthalpy of vaporisation of 61.095 and a vapour pressure of 2.94E-10. 
Meperidine 
Meperidine is an API which has physicochemical properties including an exact mass of 
247.16 and a molecular weight of 247.33. There are no Fluorine, Sulphur or Chlorine 
elements present but there are 72.84 Carbon, 12.94 Oxygen, 8.56 Hydrogen and 5.66 
Nitrogen. It has a boiling point (K) at 655.66, a melting point (K) 394.33, a critical 
temperature (K) 809.83 and a critical pressure of 22.7. Meperidine has a critical volume of 
750.5. It has a Gibbs energy value of 19.3 and a Log P value of 2.64. Meperidine has a MR 
71.89cm3/mol. It has a Henry’s law value of 6.4 and it has a Heat of form value of -290.43. 
Meperidine also has a tSPA value of 29.54, a C Log P value of 2.227 and a CMR value of 
7.2429. This API has an ACD/Log P of 2.185, an ACD/Log D (pH5.5) value -0.08, an 
ACD/BCF (pH5.5) value of 1, and an ACD/KOC (pH5.5) value of 1.98 and 3 H bond 
acceptors. There are 4 freely rotating bonds and it has an Index of Refraction of 1.52 and a 
Molar Volume of 234.243. The surface tension associated with Meperidine is 38.337; it has a 
flash point of 111.636 °c, and a boiling point of 328.866°c. Meperidine has an ACD/Log D 
(pH7.4) of 1.62, an ACD/BCF (pH7.4) of 7.25, an ACD/KOC (pH7.4) of 98.88 and it has the 
ability to donate 0 H bonds. The polar surface area of Meperidine is 29.54, the molar 
refractivity of Meperidine is 71.266, and it has a polarizability value of 28.252, a density of 
1.04.85 and a value for enthalpy of vaporisation of 57.13 and a vapour pressure of 8.43E-07. 
 
Brofen 
Brofen is an API which has physicochemical properties including an exact mass of 206.13 
and a molecular weight of 206.28. There are no Fluorine, Sulphur, Nitrogen or Chlorine 
elements present but there are 75.69 Carbon, 51.51 Oxygen and 8.8 Hydrogen. It has a boiling 
point (K) at 673.33, a melting point (K) 405.31, a critical temperature (K) 789.46 and a 
critical pressure of 23.91. Brofen has a critical volume of 667.5. It has a Gibbs energy value 
of -187.43 and a Log P value of 3.75. Brofen has a MR 61.2cm3/mol. It has a Henry’s law 
value of 5.21 and it has a Heat of form value of -447.42. Brofen also has a tSPA value of 
37.3, a C Log P value of 3.679 and a CMR value of 6.124. This API has an ACD/Log P of 
3.502, an ACD/Log D (pH5.5) value 2.38, an ACD/BCF (pH5.5) value of 20.4, and an 
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ACD/KOC (pH5.5) value of 144.58 and 2 H bond acceptors. There are 4 freely rotating bonds 
and it has an Index of Refraction of 1.519 and a Molar Volume of 200.339. The surface 
tension associated with Brofen is 38.678; it has a flash point of 216.702 °c, and a boiling point 
of 319.643°c. Brofen has an ACD/Log D (pH7.4) of 0.58, an ACD/BCF (pH7.4) of 1, an 
ACD/KOC (pH7.4) of 2.3 and it has the ability to donate 1 H bonds. The polar surface area of 
Brofen is 37.3, the molar refractivity of Brofen is 60.776, and it has a polarizability value of 
24.093, a density of 1.03 and a value for enthalpy of vaporisation of 59.252 and a vapour 
pressure of 1.86E-04. 
Isoflurane 
Isoflurane is an API which has physicochemical properties including an exact mass of 183.97 
and a molecular weight of 184.49. There are no Sulphur or Nitrogen elements present but 
there are 19.22 Carbon, 8.67 Oxygen, 51.49 Fluorine, 19.22 Chlorine and 1.09 Hydrogen. It 
has a boiling point (K) at 320.33, a melting point (K) 150.59, a critical temperature (K) 443.8 
and a critical pressure of 32.65. Isoflurane has a critical volume of 337.5. It has a Gibbs 
energy value of -1118.64 and a Log P value of 2.47. Isoflurane has a MR 23.96cm3/mol. It 
has a Henry’s law value of 0.0126 and it has a Heat of form value of -1253.07. Isoflurane also 
has a tSPA value of 9.23, a C Log P value of 1.764 and a CMR value of 2.2908. This API has 
an ACD/Log P of 2.118, an ACD/Log D (pH5.5) value 2.12, an ACD/BCF (pH5.5) value of 
23.96, and an ACD/KOC (pH5.5) value of 338.11 and 1 H bond acceptors. There are 2 freely 
rotating bonds and it has an Index of Refraction of 1.301 and a Molar Volume of 123.843. 
The surface tension associated with Isoflurane is 15.828; it has a flash point of 10.643 °c, and 
a boiling point of 48.49°c. Isoflurane has an ACD/Log D (pH7.4) of 2.12, an ACD/BCF 
(pH7.4) of 23.96, an ACD/KOC (pH7.4) of 338.11 and it has the ability to donate 0 H bonds. 
The polar surface area of Isoflurane is 9.23. The molar refractivity of Isoflurane is 23.244; it 
also has a polarizability value of 9.215, a density of 1.49 and a value for enthalpy of 
vaporisation of 28.001 and a vapour pressure of 3.23E+02. 
Severane 
Severane is an API which has physicochemical properties including an exact mass of 200.01 
and a molecular weight of 200.05. There are no Sulphur, Nitrogen or Chlorine elements 
present but there are 24.01 Carbon, 8 Oxygen, 66.48 Fluorine and 1.51 Hydrogen. It has a 
boiling point (K) at 301.53, a melting point (K) 150.54, a critical temperature (K) 383.12 and 
a critical pressure of 28.05. Severane has a critical volume of 375.5. It has a Gibbs energy 
value of -1482.63 and a Log P value of 2.24. Severane has a MR 23.78cm3/mol. It has a 
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Henry’s law value of -0.88 and it has a Heat of form value of -1653.66. Severane also has a 
tSPA value of 9.23, a C Log P value of 1.451 and a CMR value of 2.2942. This API has an 
ACD/Log P of 2.498, an ACD/Log D (pH5.5) value 2.5, an ACD/BCF (pH5.5) value of 
46.59, and an ACD/KOC (pH5.5) value of 544.23 and 1 H bond acceptors. There are 2 freely 
rotating bonds and it has an Index of Refraction of 1.266 and a Molar Volume of 139.532. 
The surface tension associated with Severane is 13.027; it has a flash point of 11.446 °c, and a 
boiling point of 49.472°c. Severane has an ACD/Log D (pH7.4) of 2.5, an ACD/BCF (pH7.4) 
of 46.59, an ACD/KOC (pH7.4) of 544.23 and it has the ability to donate 0 H bonds. The 
polar surface area of Severane is 9.23. The molar refractivity of Severane is 23.362; it also has 
a polarizability value of 9.261, a density of 1.434 and a value for enthalpy of vaporisation of 
28.084 and a vapour pressure of 3.11E+02. 
Progesterone 
Progesterone is an API which has physicochemical properties including an exact mass of 
314.22 and a molecular weight of 314.46. There are no Fluorine, Sulphur, Nitrogen or 
Chlorine elements present but there are 80.21 Carbon, 10.18 Oxygen, and 9.62 Hydrogen. It 
has a boiling point (K) at 845.36, a melting point (K) 550.84, a critical temperature (K) 868.2 
and a critical pressure of 16.71. Progesterone has a critical volume of 992.5. It has a Gibbs 
energy value of 50.86 and a Log P value of 3.78. Progesterone has a MR 92.44cm3/mol. It has 
a Henry’s law value of 5.58 and it has a Heat of form value of -430.54 also Progesterone has a 
tSPA value of 34.14, a C Log P value of 0.485839 and a CMR value of 9.3296. This API has 
an ACD/Log P of 3.827, an ACD/Log D (pH5.5) value 3.83, an ACD/BCF (pH5.5) value of 
476.94, and an ACD/KOC (pH5.5) value of 2876.39 and 2 H bond acceptors. There are 1 
freely rotating bonds and it has an Index of Refraction of 1.542 and a Molar Volume of 
288.952. The surface tension associated with Progesterone is 41.171; it has a flash point of 
166.683 °c, and a boiling point of 447.151°c. Progesterone has an ACD/Log D (pH7.4) of 
3.83, an ACD/BCF (pH7.4) of 476.94, an ACD/KOC (pH7.4) of 2876.39 and it has the ability 
to donate 0 H bonds. The polar surface area of Progesterone is 34.14. The molar refractivity 
of Progesterone is 90.955; it also has a polarizability value of 36.057, a density of 1.088 and a 
value for enthalpy of vaporisation of 70.544 and a vapour pressure of 2.69E-06. 
Plendil 
Plendil is an API which has physicochemical properties including an exact mass of 383.25 
and a molecular weight of 384.25. There are no Fluorine or Sulphur elements present but 
there are 56.26 Carbon, 16.66 Oxygen, 4.98 Hydrogen, 3.65 Nitrogen and 18.45 Chlorine. It 
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has a boiling point (K) at 925.72, a melting point (K) 652.09, a critical temperature (K) 
907.19 and a critical pressure of 16.43. Plendil has a critical volume of 1027.5. It has a Gibbs 
energy value of -317.21 and a Log P value of 2.24. Plendil has a MR 98.5cm3/mol. It has a 
Henry’s law value of 1.35E-11 and it has a Heat of form value of -705.49 also Plendil has a 
tSPA value of 64.63, a C Log P value of 5.2968 and a CMR value of 9.9071. This API has an 
ACD/Log P of 4.761, an ACD/Log D (pH5.5) value 4.76, an ACD/BCF (pH5.5) value of 
2440.56, and an ACD/KOC (pH5.5) value of 9250.27 and 5 H bond acceptors. There are 6 
freely rotating bonds and it has an Index of Refraction of 1.55 and a Molar Volume of 
300.844. The surface tension associated with Plendil is 42.194; it has a flash point of 238.964 
°c, and a boiling point of 471.516°c. Plendil has an ACD/Log D (pH7.4) of 4.76, an 
ACD/BCF (pH7.4) of 2444.58, an ACD/KOC (pH7.4) of 9265.53 and it has the ability to 
donate 1 H bonds. The polar surface area of Plendil is 64.63. The molar refractivity of is 
90.95595.782; it Plendil also has a polarizability value of 37.971, a density of 1.277 and a 
value for enthalpy of vaporisation of 73.428 and a vapour pressure of 0. 
Calcijex 
Calcijex is an API which has physicochemical properties including an exact mass of 416.33 
and a molecular weight of 416.64. There are no Fluorine, Sulphur, Nitrogen or Chlorine 
elements present but there are 77.83 Carbon, 11.52 Oxygen, and 10.64 Hydrogen. It has a 
boiling point (K) at 1139.41, a melting point (K) 645.95, a critical temperature (K) 966.71 and 
a critical pressure of 11.8. Calcijex has a critical volume of 1356.5. It has a Gibbs energy 
value of -0.86 and a Log P value of 4.49. Calcijex has a 126.14MR cm3/mol. It has a Henry’s 
law value of 4.9 and it has a Heat of form value of -679.03 also Calcijex has a tSPA value of 
60.69, a C Log P value of 4.475 and a CMR value of 12.8549. This API has an ACD/Log P of 
5.632, an ACD/Log D (pH5.5) value 5.63, an ACD/BCF (pH5.5) value of 11219.63, and an 
ACD/KOC (pH5.5) value of 27578.06 and 3 H bond acceptors. There are 9 freely rotating 
bonds and it has an Index of Refraction value of 1.547 and a Molar Volume of 391.894. The 
surface tension associated with is 44.083; Calcijex has a flash point of 238.428 °c, and a 
boiling point of 565.009°c. Calcijex has an ACD/Log D (pH7.4) of 5.63, an ACD/BCF 
(pH7.4) of 11219.63, an ACD/KOC (pH7.4) of 27578.06 and it has the ability to donate 3 H 
bonds. The polar surface area of Calcijex is 60.69. The molar refractivity of Calcijex is 
124.354; it also has a polarizability value of 49.298, a density of 1.063 and a value for 
enthalpy of vaporisation of 97.508 and a vapour pressure of 1.19E-12. 
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Paricalcitrol 
Paricalcitrol is an API which has physicochemical properties including an exact mass of 
416.33 and a molecular weight of 416.64. There are no Fluorine, Sulphur, Nitrogen or 
Chlorine elements present but there are 77.83 Carbon, 11.52 Oxygen, and 10.64 Hydrogen. It 
has a boiling point (K) at 1143.97, a melting point (K) 612.19, a critical temperature (K) 
963.36 and a critical pressure of 12.14. Paricalcitrol has a critical volume of 1346.5. It has a 
Gibbs energy value of 23.84 and a Log P value of 4.52. Paricalcitrol has a 127.99MR 
cm3/mol. It has a Henry’s law value of 4.81 and it has a Heat of form value of -651.33 also 
Paricalcitrol has a tSPA value of 60.69, a C Log P value of 5.688 and a CMR value of 
12.7029. This API has an ACD/Log P of 5.899, an ACD/Log D (pH5.5) value 5.9, an 
ACD/BCF (pH5.5) value of 17930.17, and an ACD/KOC (pH5.5) value of 38574.72 and 3 H 
bond acceptors. There are 8 freely rotating bonds and it has an Index of Refraction of 1.609 
and a Molar Volume of 371.436. The surface tension associated with is 54.659; Paricalcitrol 
has a flash point of 238.344 °c, and a boiling point of 564.843°c. Paricalcitrol has an 
ACD/Log D (pH7.4) of 5.9, an ACD/BCF (pH7.4) of 17930.17, an ACD/KOC (pH7.4) of 
38574.72 and it has the ability to donate 3 H bonds. The polar surface area of Paricalcitrol is 
60.69. The molar refractivity of Paricalcitrol is 128.646; it also has a polarizability value of 
50.999, a density of 1.122 and a value for enthalpy of vaporisation of 97.485 and a vapour 
pressure of 8.61E-14. 
Ciclesonide 
Ciclesonide is an API which has physicochemical properties including an exact mass of 
554.32 and a molecular weight of 554.71. There are no Fluorine, Sulphur, Nitrogen or 
Chlorine elements present but there are 71.45 Carbon, 20.19 Oxygen, and 5.59 Hydrogen. It 
has a boiling point (K) at 1340.13, a melting point (K) 868.87, a critical temperature (K) 
1098.37 and a critical pressure of 10.01. Ciclesonide has a critical volume of 1617.5. It has a 
Gibbs energy value of -375.72 and a Log P value of 3.97. Ciclesonide has a 152.9MR 
cm3/mol. It has a Henry’s law value of 16.55 and it has a Heat of form value of -1257.55 also 
Ciclesonide has a tSPA value of 99.13, a C Log P value of 5.87195 and a CMR value of 
15.2391. This API has an ACD/Log P of 6.13, an ACD/Log D (pH5.5) value 6.13, an 
ACD/BCF (pH5.5) value of 26845.77, and an ACD/KOC (pH5.5) value of 51496.1 and 7 H 
bond acceptors. There are 7 freely rotating bonds and it has an Index of Refraction of 1.576 
and a Molar Volume of 436.998. The surface tension associated with it is 51.861; Ciclesonide 
has a flash point of 209.975 °c, and a boiling point of 664.979°c. Ciclesonide has an 
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ACD/Log D (pH7.4) of 6.13, an ACD/BCF (pH7.4) of 26845.77, an ACD/KOC (pH7.4) of 
51496.1 and it has the ability to donate 1 H bonds. The polar surface area of Ciclesonide is 
99.13. The molar refractivity of Ciclesonide is 144.517; it also has a polarizability value of 
57.291, a density of 1.237 and a value for enthalpy of vaporisation of 111.927 and a vapour 
pressure of 0. 
Fluticasone propionate 
Fluticasone propionate is an API which has physicochemical properties including an exact 
mass of 500.18 and a molecular weight of 500.57. There are no Nitrogen or Chlorine elements 
present but there are 59.99 Carbon, 15.9 Oxygen, 11.39 Fluorine, 6.24 Hydrogen and 6.41 
Sulphur. It has a boiling point (K) at 1139.5, a melting point (K) 771.08, a critical temperature 
(K) 976.44 and a critical pressure of 12.54. Fluticasone propionate has a critical volume of 
1348.5. It has a Gibbs energy value of -918.11 and a Log P value of 3.12. Fluticasone 
propionate has a 122.92MR cm3/mol. It has a Henry’s law value of 4.34 and it has a Heat of 
form value of -1501.83 also Fluticasone propionate has a tSPA value of 80.67, a C Log P 
value of 3.0326 and a CMR value of 12.5188. This API has an ACD/Log P of 3.73, an 
ACD/Log D (pH5.5) value 3.73, an ACD/BCF (pH5.5) value of 402.74, and an ACD/KOC 
(pH5.5) value of 258.47 and 5 H bond acceptors. There are 7 freely rotating bonds and it has 
an Index of Refraction of 1.556 and a Molar Volume of 377.027. The surface tension 
associated with it is 48.063; Fluticasone propionate has a flash point of 297.491 °c, and a 
boiling point of 568.289°c. Fluticasone propionate has an ACD/Log D (pH7.4) of 3.73, an 
ACD/BCF (pH7.4) of 402.73, an ACD/KOC (pH7.4) of 2548.45 and it has the ability to 
donate 1 H bonds. The polar surface area of Fluticasone propionate is 105.97. The molar 
refractivity of Fluticasone propionate is 121.148; it also has a no given polarizability value, a 
density of 1.328 and a value for enthalpy of vaporisation of 97.97 and a vapour pressure of 0. 
Gopten 
Gopten is an API which has physicochemical properties including an exact mass of 430.25 
and a molecular weight of 430.54. There are no Fluorine, Sulphur or Chlorine elements 
present but there are 66.95 Carbon, 18.58 Oxygen, 7.96 Hydrogen and 6.51 Nitrogen. It has a 
boiling point (K) at 1112.08, a melting point (K) 718.75, a critical temperature (K) 1018.37 
and a critical pressure of 13.42. Gopten has a critical volume of 1265.5. It has a Gibbs energy 
value of -234.71 and a Log P value of 2.9. Gopten has a 117.2 MR cm3/mol. It has a Henry’s 
law value of 17.62 and it has a Heat of form value of -858.91, Gopten also has a tSPA value 
of 95.94, a C Log P value of 1.05352 and a CMR value of 11.8329. This API has an 
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ACD/Log P of 4.9, an ACD/Log D (pH5.5) value 2.64, an ACD/BCF (pH5.5) value of 17, 
and an ACD/KOC (pH5.5) value of 60.14 and 7 H bond acceptors. There are 10 freely 
rotating bonds and it has an Index of Refraction of 1.549 and a Molar Volume of 364.551. 
The surface tension associated with it is 48.73; Gopten has a flash point of 332.42 °c, and a 
boiling point of 626.044°c. Gopten has an ACD/Log D (pH7.4) of 1.33, an ACD/BCF 
(pH7.4) of 1, an ACD/KOC (pH7.4) of 2.99 and it has the ability to donate 2 H bonds. The 
polar surface area of Gopten is 95.94. The molar refractivity of Gopten is 116.03; it also has a 
polarizability value of 45.998, a density of 1.181 and a value for enthalpy of vaporisation of 
97.42 and a vapour pressure of 5.57E-14. 
Quinapril 
Quinapril is an API which has physicochemical properties including an exact mass of 438.22 
and a molecular weight of 438.52. There are no Fluorine, Sulphur or Chlorine elements 
present but there are 68.47 Carbon, 18.24 Oxygen, 6.9 Hydrogen and 6.39 Nitrogen. It has a 
boiling point (K) at 1156.01, a melting point (K) 762.3, a critical temperature (K) 1049.32 and 
a critical pressure of 14.17. Quinapril has a critical volume of 1273.5. It has a Gibbs energy 
value of -152.35 and a Log P value of 3.17. Quinapril has a 121.81cm3/mol MR value. It has a 
Henry’s law value of 19.06 and it has a Heat of form value of -694.63, Quinapril also has a 
tSPA value of 95.94, a C Log P value of 1.9111 and a CMR value of 12.2025. This API has 
an ACD/Log P of 4.788, an ACD/Log D (pH5.5) value 2.6, an ACD/BCF (pH5.5) value of 
16.7, and an ACD/KOC (pH5.5) value of 62.44 and 7 H bond acceptors. There are 10 freely 
rotating bonds and it has an Index of Refraction of 1.578 and a Molar Volume of 360.125. 
The surface tension associated with it is 52.295; Quinapril has a flash point of 35.149 °c, and 
a boiling point of 661.974°c. Quinapril has an ACD/Log D (pH7.4) of 1.24, an ACD/BCF 
(pH7.4) of 1, an ACD/KOC (pH7.4) of 2.68 and it has the ability to donate 2 H bonds. The 
polar surface area of Quinapril is 95.94. The molar refractivity of Quinapril is 119.511; it also 
has a polarizability value of 47.378, a density of 1.218 and a value for enthalpy of 
vaporisation of 102.322 and a vapour pressure of 3.24E+02. 
Halobetasol 
Halobetasol is an API which has physicochemical properties including an exact mass of 
470.93 and a molecular weight of 470.93. There are no Nitrogen or Sulphur elements present 
but there are 61.21 Carbon, 16.99 Oxygen, 8.07 Fluorine, 6.21 Hydrogen and Chlorine 7.53. 
It has a boiling point (K) at 1081.73, a melting point (K) 758.26, a critical temperature (K) 
957.88 and a critical pressure of 13.11. Halobetasol has a critical volume of 1277.5. It has a 
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Gibbs energy value of -764.67 and a Log P value of 2.08. Halobetasol has a 116.59cm3/mol 
MR value. It has a Henry’s law value of 12.7 and it has a Heat of form value of -1336.53, 
Halobetasol also has a tSPA value of 80.67, a C Log P value of 1.9538 and a CMR value of 
11.6359. This API has an ACD/Log P of 2.947, an ACD/Log D (pH5.5) value 2.95, an 
ACD/BCF (pH5.5) value of 102.28, and an ACD/KOC (pH5.5) value of 955.48 and 5 H bond 
acceptors. There are 6 freely rotating bonds and it has an Index of Refraction of 1.551 and a 
Molar Volume of 369.639. The surface tension associated with it is 47.439; Halobetasol has a 
flash point of 298.944 °c, and a boiling point of 570.691°c. Halobetasol has an ACD/Log D 
(pH7.4) of 2.95, an ACD/BCF (pH7.4) of 102.28, an ACD/KOC (pH7.4) of 955.48 and it has 
the ability to donate 1 H bond. The polar surface area of Halobetasol is 80.67. The molar 
refractivity of Halobetasol is 117.848; it also has a polarizability value of 46.718, a density of 
1.312 and a value for enthalpy of vaporisation of 98.309 and a vapour pressure of 0. 
Momentasome fuorate monohydrate 
Momentasome fuorate monohydrate is an API which has physicochemical properties 
including an exact mass of 520.14 and a molecular weight of 521.43. There are no Fluorine, 
Nitrogen or Sulphur elements present but there are 62.19 Carbon, 18.4 Oxygen, 5.8 Hydrogen 
and Chlorine 13.6. It has a boiling point (K) at 1248.4, a melting point (K) 877.28, a critical 
temperature (K) 1957.14 and a critical pressure of 13.94. Momentasome fuorate monohydrate 
has a critical volume of 1386.5. It has a Gibbs energy value of -357.68 and a Log P value of 
3.21. Momentasome fuorate monohydrate has a 133.63cm3/mol MR value. It has a Henry’s 
law value of 14.45 and it has a Heat of form value of -954.88, Momentasome fuorate 
monohydrate also has a tSPA value of 89.9, a C Log P value of 2.37052 and a CMR value of 
13.3576. This API has an ACD/Log P of 2.675, an ACD/Log D (pH5.5) value 2.68, an 
ACD/BCF (pH5.5) value of 63.48, and an ACD/KOC (pH5.5) value of 679.14 and 4 H bond 
acceptors. There are 4 freely rotating bonds and it has an Index of Refraction of 1.6 and a 
Molar Volume of 316.548. The surface tension associated with it is 55.51599; Momentasome 
fuorate monohydrate has a flash point of 308.544 °c, and a boiling point of 586.566°c. 
Momentasome fuorate monohydrate has an ACD/Log D (pH7.4) of 2.68, an ACD/BCF 
(pH7.4) of 63.48, an ACD/KOC (pH7.4) of 679.12 and it has the ability to donate 2 H bonds. 
The polar surface area of Momentasome fuorate monohydrate is 74.6. The molar refractivity 
of Momentasome fuorate monohydrate is 108.251; it also has a polarizability value of 42.914, 
a density of 1.35 and a value for enthalpy of vaporisation of 100.559 and a vapour pressure of 
0. 
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Clobetasol propionate 
Clobetasol propionate is an API which has physicochemical properties including an exact 
mass of 466.19 and a molecular weight of 466.97. There are no Nitrogen or Sulphur elements 
present but there are 64.3 Carbon, 17.13 Oxygen, 6.91 Hydrogen, Fluorine 4.07 and Chlorine 
7.59. It has a boiling point (K) at 1114.28, a melting point (K), 769.66, a critical temperature 
(K) 976.38 and a critical pressure of 13.18. Clobetasol propionate has a critical volume of 
1308.5. It has a Gibbs energy value of -565.83 and a Log P value of 2.63. Clobetasol 
propionate has a 121.17cm3/mol MR value. It has a Henry’s law value of 12.87 and it has a 
Heat of form value of -11146.9, Clobetasol propionate also has a tSPA value of 80.67, a C 
Log P value of 3.15848 and a CMR value of 12.0842. This API has an ACD/Log P of 3.142, 
an ACD/Log D (pH5.5) value 3.14, an ACD/BCF (pH5.5) value of 143.87, and an ACD/KOC 
(pH5.5) value of 1219.77 and 5 H bond acceptors. There are 6 freely rotating bonds and it has 
an Index of Refraction of 1.56 and a Molar Volume of 364.135. The surface tension 
associated with it is 48.914; Clobetasol propionate has a flash point of 297.905 °c, and a 
boiling point of 568.973°c. Clobetasol propionate has an ACD/Log D (pH7.4) of 3.14, an 
ACD/BCF (pH7.4) of 143.87, an ACD/KOC (pH7.4) of 1219.77 and it has the ability to 
donate 1 H bond. The polar surface area of Clobetasol propionate is 80.67. The molar 
refractivity of Clobetasol propionate is 117.751; it also has a polarizability value of 46.68,  
a density of 1.282 and a value for enthalpy of vaporisation of 98.067 and a vapour pressure  
of 0. 
Dexamethasome dipropionate 
Dexamethasome dipropionate is an API which has physicochemical properties including an 
exact mass of 504.25 and a molecular weight of 504.59. There are no Chlorine, Nitrogen or 
Sulphur elements present but there are 66.65 Carbon, 22.2 Oxygen, 7.39 Hydrogen and 3.77 
Fluorine. It has a boiling point (K) at 1203.71, a melting point (K), 815.88, a critical 
temperature (K) 1013.35 and a critical pressure of 11.1. Dexamethasome dipropionate has a 
critical volume of 1453.5. It has a Gibbs energy value of -839.01 and a Log P value of 2.49. 
Dexamethasome dipropionate has a 132.14cm3/mol MR value. It has a Henry’s law value of 
14.92 and it has a Heat of form value of -1510.34, Dexamethasome dipropionate also has a 
tSPA value of 106.97, a C Log P value of 2.26712 and a CMR value of 13.173. This API has 
an ACD/Log P of 3.666, an ACD/Log D (pH5.5) value 3.67, an ACD/BCF (pH5.5) value of 
360.11, and an ACD/KOC (pH5.5) value of 2352.34 and 7 H bond acceptors. There are 9 
freely rotating bonds and it has an Index of Refraction of 1.55 and a Molar Volume of 403.95. 
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The surface tension associated with it is 49.18999; Dexamethasome dipropionate has a flash 
point of 318.585 °c, and a boiling point of 603.169°c. Dexamethasome dipropionate has an 
ACD/Log D (pH7.4) of 3.67, an ACD/BCF (pH7.4) of 360.11, an ACD/KOC (pH7.4) of 
2352.33 and it has the ability to donate 1 H bond. The polar surface area of Dexamethasome 
dipropionate is 106.97. The molar refractivity of Dexamethasome dipropionate is 128.667; it 
also has a polarizability value of 51.008, a density of 1.249 and a value for enthalpy of 
vaporisation of 102.93 and a vapour pressure of 0. 
Hytrin 
Hytrin is an API which has physicochemical properties including an exact mass of 387.19 and 
a molecular weight of 387.43. There are no Fluorine, Chlorine or Sulphur elements present 
but there are 58.9Carbon, 16.52 Oxygen, 6.5 Hydrogen and 18.08 Nitrogen. It has a boiling 
point (K) at 1075.94, a melting point (K), 854.39, a critical temperature (K) 1034.08 and a 
critical pressure of 23.05. Hytrin has a critical volume of 1030.5. It has a Gibbs energy value 
of 399.62 and a Log P value of 1.13. Hytrin has a 107.91cm3/mol MR value. It has a Henry’s 
law value of 22.02 and it has a Heat of form value of -180.9, Hytrin also has a tSPA value of 
101.98, a C Log P value of 2.18152 and a CMR value of 10.3025. This API has an ACD/Log 
P of 0.797, an ACD/Log D (pH5.5) value -0.25, an ACD/BCF (pH5.5) value of 1, and an 
ACD/KOC (pH5.5) value of 5.77 and 9 H bond acceptors. There are 4 freely rotating bonds 
and it has an Index of Refraction of 1.636 and a Molar Volume of 290.672. The surface 
tension associated with it is 64.138; Hytrin has a flash point of 355.66 °c, and a boiling point 
of 664.477°c. Hytrin has an ACD/Log D (pH7.4) of 0.74, an ACD/BCF (pH7.4) of 2.1, an 
ACD/KOC (pH7.4) of 57.08 and it has the ability to donate 2 H bond. The polar surface area 
of Hytrin is 103.04. The molar refractivity of Hytrin is 104.264; it also has a polarizability 
value of 1.334, a density of 1.333 and a value for enthalpy of vaporisation of 97.721 and a 
vapour pressure of 1.67E-12. 
Androgel 
Androgel is an API which has physicochemical properties including an exact mass of 288.21 
and a molecular weight of 288.42. There are no Fluorine, Chlorine, Nitrogen or Sulphur 
elements present but there are 79.12 Carbon, 11.09 Oxygen and 9.78 Hydrogen. It has a 
boiling point (K) at 837.91, a melting point (K), 539.19, a critical temperature (K) 850.34 and 
a critical pressure of 20.2. Androgel has a critical volume of 89.5. It has a Gibbs energy value 
of 26.12 and a Log P value of 3.31. Androgel has an 84.29cm3/mol MR value. It has a 
Henry’s law value of 6.84 and it has a Heat of form value of -428.91, Androgel also has a 
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tSPA value of 37.3, a C Log P value of -0.11016 and a CMR value of 8.5194. This API has an 
ACD/Log P of 3.179, an ACD/Log D (pH5.5) value 1.38, an ACD/BCF (pH5.5) value of 
153.38, and an ACD/KOC (pH5.5) value of 1276.96 and 2 H bond acceptors. There is 1 
freely rotating bond and it has an Index of Refraction of 1.56 and a Molar Volume of 256.96. 
The surface tension associated with it is 44.49; Androgel has a flash point of 184.655 °c, and 
a boiling point of 432.925°c. Androgel has an ACD/Log D (pH7.4) of 3.18, an ACD/BCF 
(pH7.4) of 153.38, an ACD/KOC (pH7.4) of 1276.96 and it has the ability to donate 1 H 
bond. The polar surface area of Androgel is 37.3. The molar refractivity of Androgel is 
83.113; it also has a polarizability value of 32.949, a density of 1.122 and a value for enthalpy 
of vaporisation of 79.521 and a vapour pressure of 1.71E-08. 
Marcaine 
Marcaine is an API which has physicochemical properties including an exact mass of 288.22 
and a molecular weight of 288.43. There are no Fluorine, Chlorine or Sulphur elements 
present but there are 74.96 Carbon, 5.55 Oxygen, 9.78 Hydrogen and 9.71 Nitrogen. It has a 
boiling point (K) at 800.71, a melting point (K), 553.16, a critical temperature (K) 934.64 and 
a critical pressure of 18. Marcaine has a critical volume of 922.5. It has a Gibbs energy value 
of 282.08 and a Log P value of 3.86. Marcaine has an MR value of 89.94cm3/mol. It has a 
Henry’s law value of 9.43 and it has a Heat of form value of -185.46, Marcaine also has a 
tSPA value of 32.34, a C Log P value of 3.6912 and a CMR value of 8.8499. This API has an 
ACD/Log P of 3.312, an ACD/Log D (pH5.5) value 1.27, an ACD/BCF (pH5.5) value of 
1.77, and an ACD/KOC (pH5.5) value of 13.82 and 3 H bond acceptors. There are 5 freely 
rotating bond and it has an Index of Refraction of 1.547 and a Molar Volume of 279.243. The 
surface tension associated with it is 41.579; Marcaine has a flash point of 209.878 °c, and a 
boiling point of 423.422°c. Marcaine has an ACD/Log D (pH7.4) of 2.92, an ACD/BCF 
(pH7.4) of 77.82, an ACD/KOC (pH7.4) of 606.39 and it has the ability to donate 1 H bond. 
The polar surface area of Marcaine is 32.34. The molar refractivity of Marcaine is 88.62; it 
also has a polarizability value of 35.132, a density of 1.033 and a value for enthalpy of 
vaporisation of 67.775 and a vapour pressure of 0. 
Warfarin 
Warfarin is an API which has physicochemical properties including an exact mass of 308.1 
and a molecular weight of 308.33. There are no Fluorine, Nitrogen, Chlorine or Sulphur 
elements present but there are 74.01 Carbon, 20.76 Oxygen, and 5.23 Hydrogen. It has a 
boiling point (K) at 912.75, a melting point (K), 558.33, a critical temperature (K), 958.8 and 
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a critical pressure of 23.05. Warfarin has a critical volume of 880.5. It has a Gibbs energy 
value of -163 and a Log P value of 2.97. Warfarin has an MR value of 85.93cm3/mol. It has a 
Henry’s law value of 11.03 and it has a Heat of form value of -427.13, Warfarin also has a 
tSPA value of 63.6, a C Log P value of 2.9013 and a CMR value of 8.7182. This API has an 
ACD/Log P of 3.129, an ACD/Log D (pH5.5) value 2.09, an ACD/BCF (pH5.5) value of 
12.83, and an ACD/KOC (pH5.5) value of 109.47 and 4 H bond acceptors. There are 5 freely 
rotating bond and it has an Index of Refraction of 1.635 and a Molar Volume of 235.758. The 
surface tension associated with it is 58.658; Warfarin has a flash point of 188.828 °c, and a 
boiling point of 515.155°c. Warfarin has an ACD/Log D (pH7.4) of 0.33, an ACD/BCF 
(pH7.4) of 1, an ACD/KOC (pH7.4) of 1.89 and it has the ability to donate 1 H bond. The 
polar surface area of Warfarin is 63.6. The molar refractivity of Warfarin is 84.447; it also has 
a polarizability value of 33.477, a density of 1.308 and a value for enthalpy of vaporisation of 
82.854 and a vapour pressure of 1.16E-07. 
 
Physicochemical properties and values compared for the groups of API’s in table IX 
Group 1 
In group 1 the chemicals Atenonol, Meprobamate and Gabapentin were identified. The 
similar physicochemical properties in the group are the fact that the chemicals all have the 
same elements present which are Carbon, Oxygen, Hydrogen and Nitrogen. All three 
chemicals have a low C Log P value ranging between -0.66 and 0.915, which is the lowest of 
all identified groups. This group also has low ACD/LogD (pH5.5), ACD/LogP (pH5.5), 
ACD/BCF (pH5.5), ACD/Log D (pH7.4) values. Additionally surface tension values are 
similar and H bond donor ability has a tendency to be higher in this group than the other 
identified groups.  
Group 2 
Group 2 chemicals were identified as Meperidine and Brofen. Both of these API contain no 
Fluorine, Sulphur or Chlorine. Meperidine has Nitrogen present but Brofen does not. The 
chemicals both have a similar Henry’s Law value, a similar C Log P value and a similar CMR 
value. They have the same number of freely rotating bonds (4). They have a similar value for 
Index of Refraction and Surface Tension and a similar Boiling point.  
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Group 3 
This group of API consist of 2 chemicals which are Isoflurane and Severane. These chemicals 
both contain no Sulphur and no Nitrogen but Isoflurane contains Chlorine. The API in this 
group contain the lowest Gibbs Energy and Henry’s Law values identified among the data set 
which has been defined by PCA groupings on the score plot. Similar characteristics in this 
group between the two chemicals are also a low Heat of Form value and the same value for 
tPSA. They also have similar C Log P values, CMR values, Vapour pressure values, Enthalpy 
of vaporisation, Density, Polarisation value, no H bond acceptors, and similar ACD/Log D 
(pH7.4 values. Both API have a similar Boiling point, and Surface Tension and Molar 
Volume. The Index of Refraction is also similar and the number of Freely rotating bonds is 
the same (2). The number of H bond acceptors is the same and the ACD/ Log D value (pH5.5) 
and ACD/Log P values are similar.  
Groups 4, 5, 7, 8 and 10  
Groups 4, 5, 7, 8 and 10 only contain one chemical each. It is therefore not possible to 
compare the common physicochemical features in these groups.  
Group 6 
Group 6 contains two API’s these are Calcijex and Paricalcitrol. These chemicals have very 
similar physicochemical characteristics. These include the same exact mass, the same 
molecular weight, the same number of Carbons, Oxygen and the same number of Hydrogen’s. 
Both chemicals have no Fluorine, Sulphur, Nitrogen or Chlorine. The chemicals have similar 
boiling points, melting points, critical temperature values, and critical pressure values. The 
API have similar Log P numbers, MR values, Henry’s Law values, similar Heat of Form 
values and the same tPSA values. Calcijex and Paricalcitrol have similar CMR values, 
ACD/Log P (pH5.5) and ACD/Log D values. The ACD/BCF (pH5.5) values are very similar 
and also higher than those of the other groups, with the exception of group 7. The ACD/KOC 
(pH5.5) values are a lot higher in this group than in all other groups. Both chemicals have 3 H 
bond acceptors and a higher number of freely rotating bonds than most other groups 
identified. The API’s have similar molar volumes and boiling points and the same flash point 
values. High ACD/BCF (pH7.4) and ACD/KOC (pH7.4) values are indicative of this group. 
The group of chemicals also has the same number of H bond donors, the same polar surface 
volume, similar molar refractivity values, similar polarizability values and Enthalpy of 
vaporisation values. 
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Group 9 
Group 9 is the largest group of chemicals identified. It contains chemicals Gopten, Quinapril, 
Halobetasol, Mometasone furoate monohydrate, Clobetasol propionate and Dexamethasone 
dipropionate. The chemicals in this group are identified by the fact that they have a very 
similar number of Carbons and a similar number of Oxygen and Hydrogen atoms. None of the 
chemicals in this group have Sulphur present but the amount of Fluorine, Nitrogen and 
Chlorine varies between the chemicals. The API’s have a similar boiling point which is higher 
in this group than in the other groups except for group 10. The chemicals in this group also 
have similar critical pressure values, critical pressure values, and critical volume values, 
Gibbs Energy values and Log P values. Heat of form values in this group are similar and all 
of these values are negative. The chemicals have similar tPSA values and CMR values  
Group 11 
In group 11 there are three chemicals. These are Warfarin, Marcaine and Androgel. Similar 
physicochemical characteristics between the three chemicals are the amount Carbon present. 
All of these chemicals have no Fluorine, Sulphur, and Chlorine. One chemical, Marcaine has 
Nitrogen present. The chemicals have similar melting points, MR values, CMR values, 
ACD/Log P values and molar volumes. The API’s are all able to donate one H bond and they 
have a similar molar refractivity value.  
 
Analysis of grouping in table IX based on physicochemical property values against 
average values for the data set. 
Information relating to each identified group is given below and this indicated whether the 
values given for each physicochemical characteristic was below or above the average value 
for the data set. Using this information it was possible to define the following identifying 
features in each group. 
Group 1 
Group one features API’s that had the following characteristics which were below the average 
value for the data set. Elements C, F, H, S and Cl were lower than the average for the data set 
as were molecular weight and the exact mass. Both the boiling point and melting point were 
lower than the average value. Critical temperature, critical volume, Log P, MR, CLogP and 
CMR were lower than the averages for the physicochemical characteristics within the data set. 
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Characteristics ACD/Log P (pH5.5), ACD/LogD (pH5.5), ACD/BCF (pH5.5) and ACD/KOC 
(pH5.5) were found to be lower than the average values for the data set. The values for H 
bond acceptors; molar volume, surface tension, flash point [K] and boiling point [K] were 
lower than the average values for the data set. Characteristics ACD/BCF (pH7.4), ACD/KOC 
(pH7.4), Molar Refractivity, Polarizability, Density and Enthalpy of vaporisation were lower 
than average values in group one. 
Higher than the average data set values in group one included atoms of the elements O and N. 
Values for Critical pressure, Heat of form and H bond donor were found to be higher in this 
group than the average values.  
Variability is found in data for Gibbs energy, Henry’s Law, tPSA, freely rotating bonds, Index 
of refraction, ACD/LogD (7.4), Polar surface area and vapour pressure within group one. 
These physicochemical characteristics were both below and above the average values for this 
particular set of data. This could indicate that these physicochemical characteristics were not 
of importance in this group. 
Group 2 
Group two was characterised by the following physicochemical features that were lower than 
average for the data set; exact mass, Molecular weight and elements F, S, N and Cl. The 
boiling point and melting point, ACD/KOC (pH7.4), H bond donors, critical temperature and 
critical volume were below the averages for the dataset. Log P values, polar surface area, 
molar refractivity and polarizability were also below average values within this data set. The 
values for MR, Henry’s Law, tPSA, CMR and Enthalpy of vaporisation were below average 
values. Characteristics ACD/BCF (pH5.5), ACD/KOC (pH5.5), ACD/BCF (pH7.4), 
availability of H bond acceptors and number of freely rotating bonds were also below the 
average value for the data set. 
Physicochemical characteristics with values higher than average were elements C and H and 
features critical pressure, Gibbs energy, Heat of Form, C LogP and ACD/LogD (pH7.4). 
Variability in group two was found in the data associated with physicochemical 
characteristics ACD/Log P (pH5.5), density, vapour pressure and the element O. 
Group 3 
Lower than average values for the data set were found in group 3 for the elements C, O, H, S 
and N. Both the exact mass of the API and the molecular weight were lower than average in 
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group three. The following physicochemical characteristics were also found to be lower than 
average within the data set; critical volume and Gibbs energy, the boiling point and the 
melting point, critical temperature, the Log P value, MR, Henry’s Law and heat of form. The 
values for tPSA, C LogP, CMR, ACD/BCF (pH5.5), ACD/KOC (pH5.5), number of H bond 
acceptors, number of freely rotating bonds and Index of Refraction were lower than the 
average of the data set. Features including Molar volume, surface tension, flash point and 
boiling point[k], ACD/KOC (pH7.4), the number of H bond donors, polar surface area and 
molar refractivity, enthalpy of vaporisation, density and polarizability were all below the 
average values for the data set. 
Group three had the following common physicochemical features which were above average 
in the data set; the element F, critical pressure, the values for both ACD/Log D (pH5.5) and 
ACD/Log D (pH7.4) and vapour pressure. 
Physicochemical features which vary and occur both above and below the value for the 
average in the data set include the element Chlorine and the value for ACD/Log P (pH5.5). 
Group 4 
Group four contains only one API. This group was differentiated from the other groups 
identified by the following features identified as below the average values in the data set; 
exact mass, molecular weight, the elements O, F, S, N, and Cl, both the boiling point and the 
melting point, critical pressure, critical temperature and critical volume, Log P, MR and 
Henry’s Law. Other physicochemical characteristics below the average of the data set include 
tPSA, C Log P, CMR, ACD/BCF (pH5.5), ACD/KOC (pH5.5), and number of H bond 
acceptors along with the number of freely rotating bonds.  
Higher than average physicochemical values were found for elements C and H and the 
characteristics Gibbs energy, Heat of Form, ACD/LogP (pH5.5), ACD/LogD (pH5.5), Index 
of refraction and ACD/LogD (pH7.4). 
Group 5  
There was only one API in this group, it was differentiated from the other groups by the 
following features; physicochemical characteristics below average values in the data set 
include exact mass, molecular weight and elements C, O, F, H, S and N, boiling point, critical 
temperature and critical pressure. Gibbs energy, Log P, Henry’s Law, tPSA, number of H 
bond acceptors and number of freely rotating bonds were also below average values in this 
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group. Values for molar volume, surface tension, flash point [K] and boiling point [K], 
number of H bond donors, polar surface area, molar refractivity, polarizability, density, 
enthalpy of vaporization and vapour pressure were also below average values in group five. 
Physicochemical characteristics above average values in the data set were as follows; the 
element Cl, melting point, critical volume, MR, Heat of Form, C Log P, CMR, ACD/Log P 
(pH 5.5), ACD/Log D (pH5.5) and ACD/BCF (pH5.5). Other features with values higher than 
the average value were ACD/KOC (pH5.5), Index of refraction, ACD/Log D (pH7.4), 
ACD/BCF (pH7.4) and ACD/KOC (pH7.4). 
Group 6 
Group six had the following physicochemical features in common which were lower than the 
average value for the data set; exact mass, molecular weight, the elements O, F, S, N, and Cl, 
critical pressure, Log P, Henry’s Law, tPSA, number of H bond acceptors. The values for 
flash point, boiling point, polar surface area, density and vapour pressure were also lower than 
the average value for the data set. 
Physicochemical characteristics which had values higher than the average in the data set 
include the elements C and H, boiling point, melting point, critical temperature, critical 
volume, Gibbs energy, MR, heat of form and C Log P. Other features which were of a higher 
than average value were CMR, ACD/Log P (pH5.5), ACD/Log D (pH5.5), ACD/BCF 
(pH5.5), ACD/KOC (pH5.5), number of freely rotating bonds, index of refraction and molar 
volume. Characteristics including ACD/BCF (pH7.4), ACD/Log D (7.4), ACD/KOC (7.4), 
number of H bond donors, molar refraction, polarizability and enthalpy of vaporisation also 
had greater than the average values. 
Within group six there was only one characteristic which was variable; it does not appear to 
be either lower or higher than the average, this was surface tension.  
Group 7  
There was only one API in group seven the characteristics of this included physicochemical 
features which were below the average value for the data set. These were elements F, H, S, N 
and Cl, critical pressure, Gibbs energy, Log P, Heat of form, flash point, the number of H 
bond donors, density and vapour pressure. All other physicochemical characteristics were 
above the average values for the data set.  
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Group 8  
There was only one API in group eight and the characteristics of this included the following 
physicochemical features which were below average in the data set; the elements C, O, H, N 
and Cl, critical pressure, Gibbs energy, Log P, Henry’s Law, Heat of Form, ACD/BCF 
(pH5.5), ACD/KOC (pH5.5), the number of H bond acceptors and surface tension. This group 
also included flash point [k] and boiling point [k], ACD/BCF (pH7.4) and the number of H 
bond donors. The values for polar density and vapour pressure were unknown. All other 
physicochemical properties in this group were higher than the given average value. 
Group 9 
Group nine was the largest of the groups identified and it had the following below average 
physicochemical characteristics within the data set; the elements S and N, critical pressure, 
Log P, ACD/BCF (pH5.5), ACD/KOC (pH5.5), ACD/BCF (pH7.4), ACD/KOC (pH7.4), 
number of H bond donors and density. 
Common physicochemical characteristics which were above the average for the data set were; 
boiling point, melting point, critical temperature, critical volume, MR, Henry’s Law, tPSA 
and CMR. Other characteristics above average include ACD/Log P (pH5.5), ACD/Log D 
(pH5.5), molar refractivity, enthalpy of vaporisation and polarizability. 
There were a number of physicochemical characteristics which were variable either below or 
above the average in the group. These included the following characteristics exact mass, 
molecular weight, elements C, O, F, H and Cl, Gibbs energy, heat of form, C Log P, number 
of H bond acceptors and number of freely rotating bonds. Also included in this category were 
surface tension, flash point [K], boiling point [K], polar surface area and vapour pressure. 
Group 10  
There was only one API in group ten. This API was identified by the following characteristics 
which were lower than the average value in the data set; exact mass, molecular weight and the 
elements O, F, H, S and Cl. This group also featured Log P, ACD/Log D (pH5.5), ACD/BCF 
(pH5.5), ACD/KOC (pH5.5), it had a lower than average number of freely rotating bonds and 
molar volume. Other lower than average value physicochemical characteristics were 
ACD/BCF (pH7.4), ACD/KOC (pH7.4), number of H bond donors, molar refractivity, 
polarizability, density and enthalpy of vaporisation. All other physicochemical features had 
values greater than the averages determined for the data set. 
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Group 11 
Group eleven was composed of several API’s, these had the following physicochemical 
features which were below the average value within the data set; exact mass, molecular 
weight, the elements F, S and Cl, both boiling point and melting point, critical volume and 
Log P. Other characteristics included MR, tPSA, CMR, ACD/BCF (pH5.5), ACD/KOC 
(pH5.5), number of H bond acceptors, number of freely rotational bonds, molar volume, flash 
point [K] and boiling point [K]. Physicochemical features below the average value for the 
data set also included ACD/BCF (pH7.4), ACD/KOC (pH7.4), number of H bond donors, 
polar surface area, molar refractivity, polarizability, density, enthalpy of vaporisation and 
vapour pressure. 
In group eleven there were several physicochemical characteristics which had common values 
greater than the average. These were the element C, Gibbs energy, Heat of Form, ACD/Log P 
(pH5.5), ACD/Log D (pH5.5), Index of refraction and ACD/Log D (pH7.4). 
There were a number of physicochemical characteristics which were variable within group 
eleven. These had values both above and below the average within the group. These included 
the elements O, H and N, critical temperature, critical pressure, Henry’s Law, C Log P and 
surface tension. 
A flow chart was constructed to help determine possible distinguishing characteristics for 
each group (figure XI). 
Figure XI indicates the simplest way to distinguish identified groups from each other. Using 
this flow chart it is possible to determine which potential group an API may belong to within 
this data set. The flow chart is primarily based on elements identified in the API in each group 
for this particular data set. The flow chart also indicates key physicochemical characteristics 
that can be used to define each group. These can be listed as molecular weight, elements 
present, the boiling point, number of H bonds which can be donated, ACD/Log D (pH7.4) and 
ACD/BCF (pH5.5). 
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Does the API contain 
Fluorine? 
Group 3, 
8 or 9 
YES NO 
Group 1, 
2, 4, 5, 6, 
7, 10, 11 
Does the API have 
a molecular weight 
greater than 300? 
YES NO 
Group 
3 
Group 
8 or 9 
Does the API 
contain Sulphur? 
NO YES 
Group 
9 
Group 8 
Does the API contain 
Chlorine? 
YES 
Group 5 
NO 
Group 1, 2, 4, 6, 
7, 10, 11 
Does the API have a Boiling Point 
greater than 1000[K]? 
YES NO 
Groups 6, 7, 10 Groups 1, 2, 4, 11 
Does the API have more 
than one 1 H bond which 
can be donated? 
YES NO 
Group 1 Group 2, 4, 
11 
Does the API have an 
ACD/Log D (pH7.4) value 
of greater than 2? 
NO YES 
Group 2 Groups 4, 11 
Is the ACD/BCF (pH5.5) 
value greater than 200? NO 
YES 
Group 11 Group 4 
Does the API have more than 2 H bonds which 
can be donated? 
YES 
Group 6 
NO 
Groups 7, 10 
Does the API have an 
ACD/Log D (pH7.4) 
value of greater than 
10? 
 
YES 
NO 
Group 7  
Group 
10 
Figure XI Distinguishing 
groupings simplified 
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Variable name 
Functional and 
structural 
features 
Principal 
component 
associated with 
the variable 
Variable name 
Physicochemical features 
Principal component 
associated with the 
variable 
Primary c7 c8 c9 Dermatological 
classification 
c10 c13 
Secondary c7 c11 c12 Nasal and inhalation 
classification 
c4 c5 
Tertiary c11 c13 Injectable classification c4 c5 
Aromatic/enamine c2 c9 c12 Antibiotic classification c4 c5 
Primary 1 c6 c8 API classification c4 c5 
Secondary 1 c8 c14 Exact mass c2 c6 
Tertiary 1 c5 c6 Molecular weight c6 
Vinyl alcohol c10 Contains C c8 c12 
Phenol c7 Contains O c8 c12 c13 
Carboxylic acid c8 c11 c13 Contains F c13 
Ketone c3 c10 c12 Contains S c9 c11 
Ester c12 Contains N c2 c3 
1 amide c10 Contains P c4 c11 c13 
2 amide c2 c6 c13 Contains Na c4 
Tertiary amide c2 c12 c13 Contains I c6 c8 
Thioester c11 Contains Cl c8 c12 
Table XII 
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Variable name 
Functional and 
structural 
features 
Principal 
component 
associated with 
the variable 
Variable name 
Physicochemical features 
Principal component 
associated with the 
variable 
Oxime c10 Boiling Point [K] c1 
Urea c11 c13 Melting Point [K] c1 c3 
Guanidine c12  Critical Temperature [K] c1 c3 
Ether c6 c8 c10 Critical Pressure [Bar] c3 
Thioether c6 c9 Critical Volume (cm3/mol) c1 
Fluorine c5 c7 c11 Gibbs Energy (KJ/mol) c5 
Pyridine c4 Log P c11 c13 
Alkyl halide c10 c12 MR (cm3/mol) c1 
Aryl halide c4 Henrys Law c1 c3 
Alkenes c5 c7 tPSA c3 
Phosphonate c4 c13 C Log P c1 
Hydrozone c4 c11 CMR c1 c3 
Other features c4 ACD/Log P c1 
Phosphate c4 ACD/Log D (ph5.5) c1 c3 c13 
Nitro c6 ACD/BCF (pH5.5) c1 c5 c7 c9 
Nitrate c14 ACD/KOC (pH5.5) c1 c5 c7 c9 
Steroid c3 c5 c12 H bond acceptors c2 c3 
Table XII 
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Variable name 
Functional and 
structural 
features 
Principal 
component 
associated with 
the variable 
Variable name 
Physicochemical features 
Principal component 
associated with the 
variable 
O-heterocyclic c14 Freely rotating bonds c2 
N-heterocyclic c12 c14 Index of Refraction c1 c6 
S-heterocyclic c6 c9 Molar Volume (cm) c2 c7 
Long alkyl c7 Surface Tension dyne/cm c6 
Phenyl ring c8 c9 Flash Point c2 
Erythromycin 
derivative 
c10 Boiling Point (°c) c2 
Tetracycline c10 c12 ACD/BCF (pH7.4) c1 c5 c7 c9 
Macrocyclic c13 ACD/KOC (pH7.4) c1 c5 c7 c9 
Macrolide c7 c10 H bond donors c2 
Barbiturate c11 c14 Polar surface area A c2 
Water c10 Molar Refractivity (cm) c2 c7 
Ethanol c10 Enthalpy of vaporisation 
kJ/mo 
c2 
HCL c10 c12   
Gd3+ c8 c11 c13   
Table VII Eigenvalues from the first 14 principal components identified by PCA of database 
three. Where c stands for principal component and the number following the c is the principal 
component of interest. 
Table XII 
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Table XIII  
Variables  
Functional groups and structural 
features 
Variables 
Physicochemical properties 
Enone groups 
Oxazolidinone groups 
Sulfonamide groups 
Sulfone groups 
N-Oxide groups 
Alkyl groups greater than 5 
Carbons 
Carbamate groups 
Hormone structural features 
Na+ associations 
Hydrogen associations 
Benzodiazepine structures 
Heat of Form 
ACD/Log D (pH7.4) 
Polazirability 
Density 
Vapour pressure 
 
Table XIII indicates the variables which are not found within the first 14 principal 
components of the scree plot.  
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Table XIV 
Product Name Cleaning Agent Solubility 
Beclomethasone dipropionate  Acetone or DMF Very soluble in DMF and soluble 
in acetone 
Beclomethasone dipropionate 
monohydrate 
Acetone or DMF Very soluble in DMF and soluble 
in acetone 
Fluticasone propionate  Acetone Freely soluble in acetone 
Mometasone furoate anhydrous  Acetone Freely soluble in DMF and 
soluble in acetone 
Mometasone furoate monohydrate Acetone Freely soluble in DMF and 
soluble in acetone 
Sumatriptan Base  DMF Not Applicable 
Clobetasol propionate  Acetone or DMF Freely soluble in acetone and 
DMF 
Dexamethasone dipropionate  Acetone or DMF Very soluble in DMF and freely 
soluble in acetone 
Halobetasol  Acetone or DMF Freely soluble in acetone 
Betamethasone acetate  Acetone or DMF Very soluble in DMF and freely 
soluble in acetone 
Betamethasone disodium phosphate  Water Freely soluble 
Doxycycline hyclate  Methanol Freely soluble 
Doxycycline monohydrate  Methanol 1% HCL Soluble 
Roxithromycin  Methanol Soluble 
Tamsulosin  DMF Not Applicable 
Iohexol  Water Very soluble 
Table XIV Pharmaceutical products and known cleaning agents used to remove them from 
production equipment post manufacturing. Information provided by company D.  
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Appendix VI 
Principal Component Analysis: the model data set and the chemicals provided for the 
case study 
 
Eigenanalysis of the Correlation Matrix 
 
Eigenvalue  4.4057  4.1336  3.3076  3.2543  3.0987  2.7237  2.3525  2.1065 
Proportion   0.085   0.079   0.064   0.063   0.060   0.052   0.045   0.041 
Cumulative   0.085   0.164   0.228   0.290   0.350   0.402   0.448   0.488 
 
Eigenvalue  1.9042  1.8484  1.7535  1.5966  1.5067  1.4557  1.2033  1.1304 
Proportion   0.037   0.036   0.034   0.031   0.029   0.028   0.023   0.022 
Cumulative   0.525   0.560   0.594   0.625   0.654   0.682   0.705   0.727 
 
Eigenvalue  1.1118  1.0703  0.9971  0.9673  0.9219  0.9050  0.8593  0.8324 
Proportion   0.021   0.021   0.019   0.019   0.018   0.017   0.017   0.016 
Cumulative   0.748   0.769   0.788   0.806   0.824   0.841   0.858   0.874 
 
Eigenvalue  0.7553  0.7276  0.6369  0.5999  0.4982  0.4660  0.4321  0.3880 
Proportion   0.015   0.014   0.012   0.012   0.010   0.009   0.008   0.007 
Cumulative   0.888   0.902   0.915   0.926   0.936   0.945   0.953   0.961 
 
Eigenvalue  0.3344  0.2937  0.2399  0.2308  0.1871  0.1634  0.1369  0.1075 
Proportion   0.006   0.006   0.005   0.004   0.004   0.003   0.003   0.002 
Cumulative   0.967   0.973   0.977   0.982   0.985   0.988   0.991   0.993 
 
Eigenvalue  0.0878  0.0769  0.0657  0.0541  0.0319  0.0244  0.0151  0.0000 
Proportion   0.002   0.001   0.001   0.001   0.001   0.000   0.000   0.000 
Cumulative   0.995   0.996   0.998   0.999   0.999   1.000   1.000   1.000 
 
Eigenvalue  -0.0000  -0.0000  -0.0000  -0.0000 
Proportion   -0.000   -0.000   -0.000   -0.000 
Cumulative    1.000    1.000    1.000    1.000 
 
 
Variable                 PC1     PC2     PC3     PC4     PC5     PC6     PC7 
Primary                0.052  -0.043  -0.031   0.030   0.071  -0.143   0.042 
Secondary              0.020  -0.152   0.248  -0.056   0.111  -0.162  -0.036 
Tertiary              -0.149  -0.134   0.354  -0.110  -0.177   0.086   0.031 
Aromatic/enamine       0.114  -0.091   0.004   0.252  -0.303   0.056   0.091 
Primary_1             -0.009  -0.085   0.210  -0.064   0.054  -0.011   0.020 
Secondary_1           -0.241  -0.064   0.303  -0.157   0.086   0.084  -0.017 
Tertiary_1            -0.377   0.088  -0.059  -0.008  -0.104  -0.097  -0.013 
Vinyl alcohol         -0.092   0.005  -0.122  -0.341  -0.334  -0.144  -0.036 
Phenol                 0.059  -0.067   0.016   0.070   0.037  -0.188   0.056 
Carboxylic            -0.024  -0.133   0.436  -0.098   0.024  -0.026   0.023 
Ketone                -0.035   0.255  -0.122  -0.185   0.058   0.236   0.051 
Thioester              0.022   0.070   0.068  -0.010  -0.028   0.225   0.105 
Oxime                 -0.393  -0.046  -0.060   0.192   0.018   0.001   0.037 
Oxazolidinone          0.017   0.002  -0.036  -0.010   0.032   0.001   0.009 
Urea                   0.040   0.013  -0.022   0.064  -0.019  -0.058   0.065 
Guanidine              0.062  -0.065  -0.080   0.122  -0.122  -0.120   0.137 
Ether                 -0.264  -0.055  -0.111   0.130   0.045  -0.003  -0.039 
Sulfonamide            0.044  -0.057   0.019   0.030   0.046  -0.116  -0.060 
Sulfone               -0.018  -0.019  -0.049   0.045   0.015  -0.010   0.003 
N-Oxide                0.008  -0.026  -0.045   0.020   0.028   0.053  -0.579 
Thioether              0.067  -0.034   0.114   0.206  -0.341   0.268  -0.027 
Fluorine               0.015   0.188  -0.007  -0.063   0.080   0.221   0.099 
Pyridine               0.006   0.216   0.076   0.084  -0.047  -0.118  -0.013 
Alkyl halide           0.007   0.111  -0.101  -0.125   0.114   0.261   0.088 
Aryl halide            0.055   0.057   0.024   0.092   0.039  -0.251   0.003 
Alkene                -0.013  -0.015  -0.026   0.009   0.023  -0.059   0.002 
Alkylgreater than5 C   0.050  -0.025  -0.051   0.032   0.037  -0.063   0.038 
Phosphonate           -0.008   0.321   0.130   0.106  -0.073  -0.143  -0.033 
Hydrozone             -0.012   0.318   0.196   0.105  -0.122  -0.046  -0.034 
Other_1               -0.012   0.279   0.107   0.066  -0.035  -0.113  -0.049 
Phosphate             -0.035   0.409   0.165   0.091  -0.068  -0.151  -0.068 
Carbamate              0.026  -0.022  -0.023  -0.005   0.042  -0.020  -0.011 
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Nitro                  0.068  -0.068   0.061   0.211  -0.342   0.265  -0.047 
Nitrate                0.008  -0.026  -0.045   0.020   0.028   0.053  -0.579 
Steroid                0.001   0.277  -0.067  -0.124   0.134   0.297   0.106 
Hormone                0.042   0.009  -0.030   0.025   0.070  -0.121   0.041 
O-heterocyclic         0.057  -0.054  -0.032   0.059  -0.049   0.054  -0.414 
N-heterocyclic         0.123  -0.070  -0.006   0.209  -0.144  -0.118   0.157 
S-heterocyclic         0.054  -0.053   0.053   0.178  -0.288   0.218   0.014 
Long alkyl             0.014  -0.032  -0.007  -0.015   0.066  -0.036  -0.053 
Phenyl ring            0.125  -0.101  -0.044   0.119   0.021  -0.279   0.047 
Erythromycin deriv    -0.393  -0.046  -0.060   0.192   0.018   0.001   0.037 
Tetracycline          -0.393  -0.046  -0.060   0.192   0.018   0.001   0.037 
Macrocyclic           -0.099   0.008  -0.115  -0.346  -0.339  -0.142  -0.020 
Macrolide             -0.351  -0.040  -0.053   0.119   0.033   0.024   0.006 
Benzodiazepine         0.009  -0.014   0.047  -0.004  -0.033   0.077   0.066 
Barbiturate            0.032  -0.007  -0.033   0.042  -0.004  -0.040   0.062 
Water                 -0.023  -0.005  -0.124  -0.139  -0.201  -0.079   0.073 
Ethanol               -0.043  -0.009  -0.056  -0.185  -0.175  -0.071  -0.019 
HCl                   -0.081   0.006  -0.096  -0.298  -0.292  -0.127  -0.024 
Na+                   -0.029   0.383   0.158   0.085  -0.059  -0.146  -0.068 
Gd3+                  -0.070  -0.129   0.442  -0.154   0.036   0.017   0.008 
 
Variable                 PC8     PC9    PC10    PC11    PC12    PC13    PC14 
Primary                0.125   0.289   0.015  -0.067  -0.119   0.185  -0.493 
Secondary              0.093   0.046   0.048   0.089   0.298   0.150   0.090 
Tertiary              -0.008  -0.006   0.163   0.014  -0.030  -0.017  -0.095 
Aromatic/enamine       0.050  -0.215  -0.148  -0.004  -0.140   0.108  -0.010 
Primary_1             -0.084  -0.081  -0.238  -0.085  -0.199  -0.004   0.148 
Secondary_1           -0.010  -0.133  -0.188   0.003  -0.093  -0.065  -0.012 
Tertiary_1             0.038   0.085  -0.068  -0.056  -0.041  -0.083   0.007 
Vinyl alcohol          0.022   0.023   0.031   0.062  -0.006   0.018   0.023 
Phenol                 0.191  -0.101  -0.090   0.146  -0.278  -0.153   0.159 
Carboxylic             0.020  -0.084   0.024   0.091  -0.042   0.017  -0.103 
Ketone                 0.092  -0.111  -0.119   0.135   0.044   0.035  -0.062 
Thioester             -0.020   0.030   0.536  -0.047  -0.234  -0.089   0.117 
Oxime                  0.031   0.044   0.058   0.113  -0.054   0.221   0.075 
Oxazolidinone          0.016   0.135  -0.021  -0.058  -0.001   0.116  -0.291 
Urea                  -0.561   0.093  -0.078   0.344  -0.072  -0.032  -0.020 
Guanidine              0.004  -0.486  -0.038  -0.104  -0.155   0.165  -0.002 
Ether                 -0.031  -0.239   0.015  -0.122   0.171  -0.408  -0.182 
Sulfonamide            0.066   0.037   0.147   0.119   0.410   0.061   0.191 
Sulfone               -0.074  -0.121   0.044  -0.153   0.201  -0.404  -0.197 
N-Oxide               -0.065  -0.149   0.083   0.042  -0.173   0.053  -0.110 
Thioether              0.099   0.142  -0.001   0.060   0.029  -0.080   0.002 
Fluorine               0.059  -0.029   0.210   0.029  -0.135   0.074   0.074 
Pyridine              -0.054  -0.028   0.009  -0.108   0.044   0.058  -0.048 
Alkyl halide           0.070  -0.166  -0.155   0.184   0.081   0.097  -0.058 
Aryl halide            0.285   0.044   0.063   0.359  -0.126  -0.227  -0.091 
Alkene                 0.034   0.164  -0.138  -0.152  -0.235  -0.152   0.182 
Alkylgreater than5 C   0.020   0.193  -0.080  -0.268  -0.225   0.224  -0.272 
Phosphonate           -0.125  -0.026  -0.086   0.021  -0.008   0.027   0.013 
Hydrozone              0.013   0.022   0.134  -0.039  -0.026  -0.045   0.018 
Other_1                0.009   0.015  -0.006  -0.077   0.047   0.032   0.013 
Phosphate              0.020  -0.024  -0.048  -0.031   0.030   0.015   0.001 
Carbamate             -0.022   0.092   0.003  -0.069   0.163   0.057   0.132 
Nitro                  0.122   0.134  -0.170   0.091   0.083  -0.041  -0.015 
Nitrate               -0.065  -0.149   0.083   0.042  -0.173   0.053  -0.110 
Steroid                0.108  -0.146  -0.033   0.203  -0.023   0.048  -0.023 
Hormone                0.263   0.040   0.032   0.384  -0.205  -0.258  -0.201 
O-heterocyclic         0.071   0.011   0.010   0.112   0.080   0.069   0.160 
N-heterocyclic        -0.180  -0.219   0.175  -0.042   0.023   0.030  -0.072 
S-heterocyclic         0.093   0.111  -0.153   0.067   0.072  -0.055  -0.059 
Long alkyl             0.033   0.132  -0.227  -0.144  -0.253  -0.174   0.403 
Phenyl ring            0.187  -0.166   0.136   0.157   0.081   0.094   0.109 
Erythromycin deriv     0.031   0.044   0.058   0.113  -0.054   0.221   0.075 
Tetracycline           0.031   0.044   0.058   0.113  -0.054   0.221   0.075 
Macrocyclic            0.014   0.025   0.027   0.051  -0.019   0.007   0.005 
Macrolide             -0.007  -0.055  -0.024  -0.051   0.077  -0.226  -0.100 
Benzodiazepine        -0.072   0.029   0.436  -0.096  -0.172  -0.093   0.069 
Barbiturate           -0.526   0.109  -0.050   0.352  -0.059  -0.046  -0.031 
Water                  0.008  -0.326  -0.030  -0.014  -0.041   0.125  -0.032 
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Ethanol               -0.017   0.080   0.053  -0.004   0.027  -0.055  -0.008 
HCl                    0.010   0.060   0.038   0.051  -0.010  -0.017   0.007 
Na+                    0.013  -0.013  -0.049  -0.041   0.038   0.016   0.003 
Gd3+                  -0.017  -0.118  -0.056   0.072  -0.006   0.061  -0.135 
 
Variable                PC15    PC16    PC17    PC18    PC19    PC20    PC21 
Primary                0.109  -0.069  -0.154   0.036  -0.051   0.065  -0.096 
Secondary              0.149  -0.060  -0.197   0.015  -0.077   0.054  -0.060 
Tertiary               0.056   0.028   0.046   0.012   0.076   0.129   0.197 
Aromatic/enamine       0.027   0.075  -0.074  -0.056   0.103  -0.039   0.086 
Primary_1             -0.314  -0.070  -0.079  -0.090   0.355  -0.142  -0.407 
Secondary_1            0.040   0.135  -0.021  -0.002   0.114  -0.041  -0.146 
Tertiary_1             0.248   0.132  -0.038   0.088   0.012   0.010  -0.053 
Vinyl alcohol          0.017  -0.035  -0.036   0.004  -0.066  -0.007  -0.179 
Phenol                -0.135  -0.281  -0.226  -0.000  -0.093   0.130   0.071 
Carboxylic             0.052  -0.096   0.081   0.001  -0.249  -0.048   0.102 
Ketone                 0.119  -0.174   0.036   0.086  -0.001   0.075   0.060 
Thioester              0.040  -0.016  -0.166   0.040  -0.076  -0.062  -0.118 
Oxime                 -0.091  -0.095   0.073  -0.057  -0.075  -0.070   0.000 
Oxazolidinone         -0.060  -0.249  -0.138   0.526   0.179  -0.524   0.159 
Urea                   0.068   0.020  -0.109   0.013  -0.006   0.030   0.008 
Guanidine              0.057   0.065  -0.136   0.107  -0.012   0.022   0.129 
Ether                  0.047  -0.021  -0.176  -0.007  -0.003   0.080   0.039 
Sulfonamide            0.273  -0.096  -0.042  -0.062   0.257  -0.032  -0.186 
Sulfone               -0.089  -0.217  -0.007  -0.234  -0.317  -0.222  -0.087 
N-Oxide               -0.018   0.047   0.052  -0.020  -0.017  -0.044  -0.024 
Thioether              0.018  -0.056  -0.052   0.063  -0.171  -0.011  -0.068 
Fluorine               0.064   0.215  -0.371  -0.308  -0.050  -0.263  -0.008 
Pyridine              -0.014  -0.148   0.378  -0.139   0.011  -0.003  -0.175 
Alkyl halide           0.081  -0.157   0.250   0.033  -0.025   0.160   0.082 
Aryl halide            0.045   0.116   0.128   0.009   0.082  -0.054  -0.060 
Alkene                 0.467   0.324   0.320   0.041  -0.060  -0.308   0.115 
Alkylgreater than5 C   0.137  -0.015  -0.068  -0.318  -0.081   0.366  -0.061 
Phosphonate           -0.045  -0.011  -0.039   0.011   0.140  -0.008  -0.041 
Hydrozone              0.020  -0.098  -0.051   0.113  -0.245  -0.027  -0.043 
Other_1               -0.073   0.117  -0.121  -0.067   0.069   0.069   0.214 
Phosphate              0.005  -0.008  -0.039   0.035   0.017   0.042   0.028 
Carbamate             -0.457   0.417   0.098   0.308  -0.370   0.142  -0.023 
Nitro                  0.005   0.024  -0.041  -0.011   0.049   0.043  -0.019 
Nitrate               -0.018   0.047   0.052  -0.020  -0.017  -0.044  -0.024 
Steroid                0.046   0.007   0.021  -0.083  -0.032  -0.024  -0.024 
Hormone               -0.162   0.074   0.117   0.026   0.022   0.065  -0.092 
O-heterocyclic         0.151  -0.155  -0.111   0.030  -0.009   0.107   0.071 
N-heterocyclic         0.097  -0.158   0.331  -0.093  -0.028  -0.129  -0.081 
S-heterocyclic        -0.027   0.060   0.039  -0.041   0.069  -0.013  -0.085 
Long alkyl             0.110  -0.381  -0.035   0.088  -0.193   0.071   0.114 
Phenyl ring            0.064   0.139  -0.071  -0.058  -0.008  -0.057   0.117 
Erythromycin deriv    -0.091  -0.095   0.073  -0.057  -0.075  -0.070   0.000 
Tetracycline          -0.091  -0.095   0.073  -0.057  -0.075  -0.070   0.000 
Macrocyclic            0.008  -0.027  -0.026   0.001  -0.065  -0.014  -0.194 
Macrolide              0.087   0.114  -0.155   0.104   0.178   0.198   0.025 
Benzodiazepine        -0.001  -0.112   0.194   0.257   0.325   0.343   0.011 
Barbiturate            0.110   0.026  -0.113   0.024  -0.096   0.060   0.051 
Water                  0.126   0.052  -0.047   0.278  -0.145   0.079  -0.143 
Ethanol               -0.223  -0.040   0.062  -0.258   0.184  -0.057   0.592 
HCl                   -0.082  -0.058  -0.003  -0.153   0.023  -0.067   0.057 
Na+                   -0.018  -0.008  -0.026   0.044   0.008   0.041   0.043 
Gd3+                   0.068   0.023   0.057  -0.013  -0.125  -0.014   0.122 
 
Variable                PC22    PC23    PC24    PC25    PC26    PC27    PC28 
Primary                0.081   0.116   0.169  -0.070  -0.006  -0.267   0.021 
Secondary              0.228   0.270   0.140  -0.002   0.009  -0.278  -0.088 
Tertiary              -0.092   0.067  -0.079   0.058  -0.051   0.103  -0.005 
Aromatic/enamine      -0.013   0.094   0.034  -0.153  -0.254   0.113   0.073 
Primary_1             -0.135  -0.110   0.129  -0.115   0.083  -0.049  -0.166 
Secondary_1            0.082  -0.007   0.018  -0.092  -0.012   0.008  -0.237 
Tertiary_1             0.165   0.067   0.024  -0.071  -0.024  -0.096   0.017 
Vinyl alcohol         -0.033   0.040  -0.147  -0.102   0.030   0.070   0.027 
Phenol                 0.343   0.238   0.023  -0.022   0.033   0.167  -0.184 
Carboxylic            -0.011  -0.124  -0.037   0.001  -0.004   0.091   0.220 
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Ketone                 0.028  -0.032  -0.118  -0.132  -0.108   0.094   0.094 
Thioester              0.069  -0.085   0.099  -0.021  -0.038  -0.005  -0.076 
Oxime                 -0.100   0.045   0.022   0.021   0.003   0.000  -0.008 
Oxazolidinone          0.032   0.025  -0.132   0.023  -0.095   0.219  -0.158 
Urea                  -0.016   0.039   0.027  -0.041  -0.071  -0.008   0.030 
Guanidine             -0.040  -0.049   0.132   0.091  -0.143   0.026  -0.110 
Ether                  0.049  -0.030   0.017   0.024  -0.042   0.039  -0.026 
Sulfonamide           -0.058  -0.026   0.320   0.278  -0.215   0.416  -0.014 
Sulfone               -0.349   0.327   0.047  -0.101  -0.104  -0.034  -0.176 
N-Oxide                0.119   0.106   0.096   0.061   0.067   0.067   0.038 
Thioether              0.022  -0.233   0.132  -0.062   0.137   0.008  -0.114 
Fluorine               0.094   0.114  -0.183   0.119  -0.197  -0.005   0.003 
Pyridine               0.353  -0.121  -0.356   0.245  -0.226  -0.136  -0.369 
Alkyl halide           0.021   0.127   0.227  -0.209   0.184   0.129  -0.216 
Aryl halide           -0.123  -0.042   0.048   0.002  -0.110   0.124  -0.125 
Alkene                -0.068   0.122   0.129  -0.088  -0.003   0.009  -0.154 
Alkylgreater than5 C  -0.123  -0.083   0.038  -0.029  -0.136   0.338  -0.158 
Phosphonate           -0.068   0.138   0.130  -0.214  -0.222  -0.092   0.385 
Hydrozone              0.039  -0.320   0.278  -0.120   0.195   0.083  -0.072 
Other_1               -0.229   0.145  -0.248   0.233   0.429   0.247  -0.069 
Phosphate             -0.022   0.093   0.045  -0.024  -0.059  -0.036  -0.072 
Carbamate              0.111   0.102   0.068  -0.074  -0.333   0.202  -0.101 
Nitro                 -0.028   0.103  -0.085   0.027  -0.070  -0.098  -0.118 
Nitrate                0.119   0.106   0.096   0.061   0.067   0.067   0.038 
Steroid                0.057   0.086   0.080   0.035  -0.087  -0.059  -0.014 
Hormone               -0.127  -0.129  -0.036   0.204  -0.110  -0.079   0.143 
O-heterocyclic        -0.272  -0.206  -0.261  -0.246  -0.292  -0.183  -0.178 
N-heterocyclic         0.224  -0.016  -0.055  -0.100   0.032   0.073   0.210 
S-heterocyclic         0.155   0.297   0.002   0.230   0.134   0.015   0.089 
Long alkyl             0.012   0.041  -0.051   0.226  -0.100   0.010   0.203 
Phenyl ring            0.026   0.005  -0.232  -0.330   0.255  -0.065  -0.118 
Erythromycin deriv    -0.100   0.045   0.022   0.021   0.003   0.000  -0.008 
Tetracycline          -0.100   0.045   0.022   0.021   0.003   0.000  -0.008 
Macrocyclic            0.004   0.072  -0.080  -0.033   0.033   0.105   0.048 
Macrolide              0.245  -0.202  -0.101  -0.068  -0.020   0.077   0.071 
Benzodiazepine        -0.138   0.355  -0.026  -0.095  -0.044  -0.074  -0.108 
Barbiturate            0.018  -0.007  -0.039   0.093   0.048   0.038  -0.273 
Water                 -0.225  -0.039   0.112   0.413   0.049  -0.275  -0.097 
Ethanol                0.093  -0.158   0.343   0.111  -0.109  -0.244  -0.143 
HCl                    0.117   0.033   0.061  -0.140  -0.060   0.153  -0.027 
Na+                   -0.046   0.077   0.045  -0.003  -0.036  -0.057  -0.015 
Gd3+                  -0.068   0.055  -0.100   0.042  -0.142   0.042   0.022 
 
Variable                PC29    PC30    PC31    PC32    PC33    PC34    PC35 
Primary               -0.203  -0.005  -0.384  -0.076   0.123   0.042  -0.060 
Secondary             -0.089  -0.107   0.095   0.198   0.068  -0.002   0.100 
Tertiary              -0.064   0.119   0.050  -0.074   0.092   0.257  -0.159 
Aromatic/enamine      -0.249  -0.047  -0.005  -0.151  -0.017   0.089   0.005 
Primary_1              0.017  -0.013  -0.212  -0.003   0.154   0.085  -0.065 
Secondary_1            0.092  -0.034   0.003   0.135   0.119  -0.102  -0.119 
Tertiary_1            -0.094  -0.136   0.001  -0.030   0.184   0.087  -0.023 
Vinyl alcohol          0.009   0.053   0.067  -0.110   0.088   0.217   0.134 
Phenol                -0.107   0.138   0.295  -0.201   0.082  -0.246  -0.031 
Carboxylic             0.021   0.013  -0.102  -0.132  -0.139  -0.113   0.026 
Ketone                 0.179  -0.101  -0.056  -0.051   0.474  -0.263   0.058 
Thioester              0.007   0.070  -0.058   0.143   0.009  -0.046   0.184 
Oxime                  0.019  -0.002   0.006   0.002  -0.003  -0.026   0.015 
Oxazolidinone          0.090   0.051   0.108   0.130  -0.038   0.070  -0.061 
Urea                  -0.034   0.132   0.048   0.137   0.007  -0.005   0.049 
Guanidine             -0.036  -0.318  -0.080   0.119   0.008   0.142   0.337 
Ether                  0.016   0.071  -0.075   0.086  -0.091   0.013   0.047 
Sulfonamide           -0.030  -0.026  -0.005  -0.029   0.078   0.064  -0.121 
Sulfone                0.013  -0.030   0.039   0.012   0.097   0.046  -0.026 
N-Oxide                0.022   0.008   0.005   0.003   0.017   0.040  -0.058 
Thioether             -0.112   0.026   0.086   0.081   0.011  -0.011  -0.106 
Fluorine               0.005   0.158  -0.162  -0.068  -0.043   0.130  -0.109 
Pyridine              -0.151   0.122   0.038   0.104  -0.075   0.079   0.134 
Alkyl halide          -0.171   0.259  -0.194   0.089  -0.220   0.331   0.071 
Aryl halide            0.065   0.269  -0.337  -0.157  -0.033  -0.175   0.184 
Alkene                -0.065  -0.001   0.121   0.042   0.039  -0.073   0.020 
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Alkylgreater than5 C   0.284   0.075   0.198   0.183   0.023  -0.016  -0.072 
Phosphonate           -0.062   0.388   0.178   0.321  -0.014  -0.040   0.058 
Hydrozone              0.034  -0.051   0.052   0.064   0.105   0.095   0.070 
Other_1               -0.395  -0.007  -0.160   0.202   0.241  -0.123   0.019 
Phosphate              0.166  -0.115  -0.058  -0.089   0.005   0.078  -0.135 
Carbamate             -0.003   0.048  -0.174   0.054   0.171   0.034  -0.103 
Nitro                 -0.051   0.002   0.012  -0.029  -0.088  -0.053  -0.295 
Nitrate                0.022   0.008   0.005   0.003   0.017   0.040  -0.058 
Steroid               -0.033  -0.177   0.098   0.100   0.018   0.013  -0.227 
Hormone               -0.093  -0.293   0.213   0.282   0.066   0.248  -0.098 
O-heterocyclic        -0.066  -0.015  -0.121   0.057   0.118  -0.091   0.122 
N-heterocyclic         0.001  -0.042  -0.197   0.006   0.298  -0.084  -0.310 
S-heterocyclic         0.461   0.002  -0.141   0.164   0.100  -0.002   0.397 
Long alkyl             0.085   0.026  -0.331   0.190  -0.009   0.279  -0.159 
Phenyl ring            0.366   0.098  -0.015   0.227   0.009   0.227  -0.240 
Erythromycin deriv     0.019  -0.002   0.006   0.002  -0.003  -0.026   0.015 
Tetracycline           0.019  -0.002   0.006   0.002  -0.003  -0.026   0.015 
Macrocyclic           -0.041   0.048   0.066  -0.122   0.044   0.202   0.070 
Macrolide              0.004   0.108  -0.097   0.021  -0.064   0.040  -0.084 
Benzodiazepine         0.067  -0.109  -0.006   0.007  -0.027  -0.042  -0.043 
Barbiturate            0.089  -0.183  -0.101  -0.118   0.021   0.062  -0.053 
Water                  0.100   0.331  -0.004   0.053  -0.022  -0.256  -0.264 
Ethanol                0.110   0.129  -0.009  -0.028   0.249   0.054  -0.022 
HCl                   -0.055  -0.278  -0.250   0.380  -0.402  -0.377  -0.127 
Na+                    0.235  -0.201  -0.019  -0.338  -0.319   0.037  -0.074 
Gd3+                   0.045  -0.007  -0.010   0.086  -0.005  -0.018   0.100 
 
Variable                PC36    PC37    PC38    PC39    PC40    PC41    PC42 
Primary                0.095   0.125  -0.283   0.152  -0.094  -0.073  -0.126 
Secondary             -0.202  -0.157   0.421  -0.147  -0.122   0.032  -0.006 
Tertiary              -0.290   0.226  -0.228  -0.115  -0.272  -0.133   0.193 
Aromatic/enamine      -0.074  -0.082   0.161  -0.363  -0.012  -0.174  -0.389 
Primary_1             -0.085   0.160   0.070  -0.003   0.158   0.087  -0.149 
Secondary_1            0.231  -0.190  -0.019   0.076  -0.266  -0.203   0.253 
Tertiary_1             0.011  -0.014   0.038  -0.092   0.603  -0.070   0.228 
Vinyl alcohol          0.168  -0.051  -0.021   0.072  -0.085   0.045  -0.127 
Phenol                 0.121   0.237  -0.127   0.047  -0.001   0.042   0.040 
Carboxylic             0.224   0.070   0.075  -0.031   0.425   0.099  -0.051 
Ketone                -0.403   0.077   0.087   0.228   0.024  -0.104  -0.165 
Thioester              0.190  -0.032   0.190   0.180  -0.055  -0.197  -0.280 
Oxime                 -0.012  -0.003   0.001   0.028  -0.051   0.019  -0.035 
Oxazolidinone          0.061  -0.044   0.113  -0.078   0.035   0.021   0.048 
Urea                  -0.005   0.006  -0.036   0.064   0.057  -0.129   0.028 
Guanidine             -0.036  -0.074  -0.148   0.252   0.019   0.019   0.272 
Ether                  0.057  -0.019   0.010   0.177  -0.096   0.336  -0.167 
Sulfonamide            0.087   0.118  -0.159   0.128   0.103  -0.068  -0.089 
Sulfone               -0.068   0.020  -0.027  -0.094   0.099  -0.222   0.029 
N-Oxide               -0.080  -0.041   0.011   0.025   0.038  -0.033  -0.038 
Thioether             -0.116  -0.100  -0.046   0.145   0.090  -0.062   0.099 
Fluorine              -0.131   0.189   0.108  -0.001   0.071   0.191   0.245 
Pyridine              -0.103   0.017  -0.113   0.023   0.095  -0.097  -0.120 
Alkyl halide           0.068   0.182   0.230   0.051   0.051   0.047   0.083 
Aryl halide           -0.149  -0.388   0.032  -0.117  -0.034  -0.022   0.163 
Alkene                 0.024   0.220   0.022   0.088  -0.131   0.097  -0.174 
Alkylgreater than5 C   0.036  -0.088   0.207  -0.066   0.070   0.036   0.047 
Phosphonate            0.022   0.000  -0.091   0.128   0.016   0.010   0.075 
Hydrozone             -0.142   0.055  -0.131  -0.250  -0.052   0.099   0.027 
Other_1                0.143  -0.051   0.099   0.027   0.039  -0.086  -0.061 
Phosphate             -0.009  -0.011  -0.010  -0.078  -0.128   0.480  -0.134 
Carbamate              0.061   0.059   0.012   0.022   0.031  -0.010  -0.020 
Nitro                 -0.006  -0.185   0.067   0.370   0.071   0.166  -0.001 
Nitrate               -0.080  -0.041   0.011   0.025   0.038  -0.033  -0.038 
Steroid                0.333  -0.284  -0.322  -0.282  -0.001  -0.035  -0.111 
Hormone                0.026   0.249   0.241   0.051  -0.026   0.022  -0.010 
O-heterocyclic         0.311   0.246   0.018  -0.163  -0.069   0.053   0.137 
N-heterocyclic         0.212   0.021   0.240   0.004  -0.173   0.099   0.220 
S-heterocyclic         0.171   0.234  -0.079  -0.191  -0.009  -0.020   0.019 
Long alkyl            -0.053  -0.194  -0.011  -0.003  -0.054  -0.104  -0.022 
Phenyl ring           -0.042  -0.004  -0.183   0.101   0.165  -0.142  -0.190 
Erythromycin deriv    -0.012  -0.003   0.001   0.028  -0.051   0.019  -0.035 
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Tetracycline          -0.012  -0.003   0.001   0.028  -0.051   0.019  -0.035 
Macrocyclic            0.086  -0.169   0.086   0.062  -0.088   0.080   0.004 
Macrolide              0.028   0.081   0.090  -0.167  -0.066  -0.158  -0.153 
Benzodiazepine        -0.021  -0.072  -0.038  -0.050   0.187   0.123   0.018 
Barbiturate           -0.025   0.001   0.018  -0.058  -0.011   0.089  -0.089 
Water                 -0.023   0.149   0.080  -0.141   0.039  -0.044  -0.066 
Ethanol                0.130  -0.064   0.104   0.030   0.082  -0.016  -0.049 
HCl                   -0.166   0.163  -0.073  -0.074  -0.020  -0.014   0.009 
Na+                    0.137   0.144   0.244   0.220  -0.087  -0.437   0.043 
Gd3+                   0.004  -0.067  -0.083   0.167   0.046   0.100  -0.275 
 
Variable                PC43    PC44    PC45    PC46    PC47    PC48    PC49 
Primary               -0.105  -0.053   0.000  -0.003   0.042  -0.000   0.000 
Secondary              0.080  -0.172   0.083   0.101  -0.096   0.000   0.000 
Tertiary               0.250   0.055  -0.074   0.329  -0.091   0.000   0.000 
Aromatic/enamine      -0.228   0.017  -0.243  -0.028   0.034  -0.000   0.000 
Primary_1              0.252  -0.160   0.061   0.096  -0.021   0.000   0.000 
Secondary_1           -0.486   0.105  -0.156  -0.046   0.017  -0.000  -0.000 
Tertiary_1             0.199   0.242  -0.250  -0.023  -0.004  -0.000  -0.000 
Vinyl alcohol         -0.049  -0.091   0.034  -0.182  -0.663   0.000  -0.000 
Phenol                 0.071   0.034   0.019  -0.053   0.026  -0.000  -0.000 
Carboxylic            -0.269  -0.147   0.171   0.369  -0.094   0.000   0.000 
Ketone                -0.091  -0.073   0.010   0.108   0.000  -0.000   0.000 
Thioester              0.143   0.356  -0.037   0.194  -0.011  -0.000  -0.000 
Oxime                 -0.022  -0.034   0.014   0.004   0.001   0.003   0.064 
Oxazolidinone          0.050  -0.031  -0.011   0.021  -0.021   0.000  -0.000 
Urea                   0.001  -0.121  -0.013   0.023  -0.002  -0.016   0.010 
Guanidine              0.038  -0.024   0.266   0.077  -0.050   0.000   0.000 
Ether                  0.057  -0.310  -0.443   0.183  -0.026  -0.000   0.000 
Sulfonamide           -0.113   0.022  -0.001  -0.048   0.025  -0.000  -0.000 
Sulfone               -0.062   0.110   0.221  -0.037   0.007   0.000   0.000 
N-Oxide                0.001  -0.007   0.036   0.007  -0.022   0.707   0.000 
Thioether             -0.005  -0.239   0.021  -0.129   0.003   0.008  -0.012 
Fluorine              -0.149  -0.200   0.022  -0.197   0.013  -0.000   0.000 
Pyridine              -0.083  -0.062  -0.007   0.080   0.002  -0.000   0.000 
Alkyl halide          -0.013   0.117  -0.020  -0.054   0.005  -0.000  -0.000 
Aryl halide            0.143  -0.019   0.011   0.011  -0.063   0.000   0.000 
Alkene                 0.030  -0.192   0.144   0.081  -0.007   0.000   0.000 
Alkylgreater than5 C   0.094  -0.056   0.001   0.051  -0.041   0.000  -0.000 
Phosphonate           -0.019   0.003   0.058   0.052  -0.012   0.010  -0.006 
Hydrozone             -0.113  -0.135  -0.050  -0.181   0.056  -0.006   0.010 
Other_1               -0.005  -0.071   0.021   0.016  -0.009   0.000   0.000 
Phosphate             -0.094   0.398   0.122   0.093  -0.020  -0.002  -0.003 
Carbamate              0.027  -0.079  -0.015   0.043  -0.010  -0.000   0.000 
Nitro                  0.039   0.127   0.162   0.091  -0.067  -0.006   0.010 
Nitrate                0.001  -0.007   0.036   0.007  -0.022  -0.707  -0.000 
Steroid                0.296  -0.238   0.082   0.144  -0.045   0.000   0.000 
Hormone               -0.102   0.022  -0.027  -0.041   0.013  -0.000  -0.000 
O-heterocyclic         0.085  -0.029  -0.027   0.005   0.087  -0.000   0.000 
N-heterocyclic         0.178  -0.022  -0.014  -0.106  -0.020   0.000  -0.000 
S-heterocyclic        -0.002  -0.020  -0.017   0.020   0.043  -0.000   0.000 
Long alkyl            -0.041  -0.018  -0.030  -0.020  -0.014   0.000  -0.000 
Phenyl ring           -0.054  -0.011  -0.054   0.073   0.067  -0.000   0.000 
Erythromycin deriv    -0.022  -0.034   0.014   0.004   0.001  -0.002  -0.737 
Tetracycline          -0.022  -0.034   0.014   0.004   0.001  -0.002   0.673 
Macrocyclic           -0.011  -0.126   0.115   0.169   0.676  -0.000   0.000 
Macrolide              0.026  -0.024   0.610  -0.157   0.020   0.000   0.000 
Benzodiazepine        -0.206  -0.266   0.040  -0.166   0.033  -0.000   0.000 
Barbiturate           -0.033   0.062   0.006   0.036  -0.004   0.014  -0.009 
Water                 -0.010   0.022  -0.030  -0.042   0.003  -0.000  -0.000 
Ethanol               -0.055  -0.055   0.037  -0.041   0.010   0.000  -0.000 
HCl                    0.027   0.044  -0.030   0.004  -0.019   0.000  -0.000 
Na+                    0.166  -0.238  -0.101  -0.041   0.008   0.000   0.000 
Gd3+                   0.307   0.074  -0.058  -0.590   0.184  -0.000   0.000 
 
Variable                PC50    PC51    PC52 
Primary                0.000   0.000  -0.000 
Secondary              0.000   0.000   0.000 
Tertiary               0.000  -0.000   0.000 
Aromatic/enamine       0.000  -0.000  -0.000 
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Primary_1             -0.000  -0.000   0.000 
Secondary_1            0.000   0.000  -0.000 
Tertiary_1            -0.000  -0.000   0.000 
Vinyl alcohol          0.000  -0.000   0.000 
Phenol                -0.000  -0.000  -0.000 
Carboxylic             0.000   0.000   0.000 
Ketone                 0.000   0.000   0.000 
Thioester              0.000  -0.000   0.000 
Oxime                 -0.066   0.811   0.009 
Oxazolidinone         -0.000  -0.000   0.000 
Urea                   0.370   0.035  -0.530 
Guanidine              0.000   0.000   0.000 
Ether                 -0.000  -0.000  -0.000 
Sulfonamide           -0.000  -0.000  -0.000 
Sulfone                0.000   0.000   0.000 
N-Oxide                0.004  -0.002  -0.018 
Thioether              0.462   0.034   0.401 
Fluorine              -0.000   0.000  -0.000 
Pyridine               0.000   0.000   0.000 
Alkyl halide          -0.000  -0.000   0.000 
Aryl halide            0.000  -0.000   0.000 
Alkene                 0.000   0.000   0.000 
Alkylgreater than5 C   0.000  -0.000   0.000 
Phosphonate           -0.234  -0.022   0.335 
Hydrozone             -0.379  -0.028  -0.330 
Other_1               -0.000   0.000   0.000 
Phosphate              0.436   0.036  -0.004 
Carbamate             -0.000  -0.000   0.000 
Nitro                 -0.379  -0.028  -0.330 
Nitrate               -0.004   0.002   0.018 
Steroid               -0.000   0.000   0.000 
Hormone               -0.000  -0.000  -0.000 
O-heterocyclic        -0.000   0.000  -0.000 
N-heterocyclic        -0.000  -0.000  -0.000 
S-heterocyclic        -0.000   0.000  -0.000 
Long alkyl             0.000  -0.000  -0.000 
Phenyl ring           -0.000  -0.000   0.000 
Erythromycin deriv     0.024  -0.350  -0.020 
Tetracycline           0.042  -0.461   0.012 
Macrocyclic           -0.000   0.000  -0.000 
Macrolide              0.000   0.000  -0.000 
Benzodiazepine        -0.000   0.000  -0.000 
Barbiturate           -0.333  -0.031   0.477 
Water                 -0.000  -0.000  -0.000 
Ethanol               -0.000   0.000  -0.000 
HCl                   -0.000  -0.000   0.000 
Na+                   -0.000  -0.000  -0.000 
Gd3+                  -0.000  -0.000  -0.000 
 
Figure I PCA data for analysis of chemical data given in the case studies. 
 
